<SEC-DOCUMENT>0001437749-25-035999.txt : 20251121
<SEC-HEADER>0001437749-25-035999.hdr.sgml : 20251121
<ACCEPTANCE-DATETIME>20251121161642
ACCESSION NUMBER:		0001437749-25-035999
CONFORMED SUBMISSION TYPE:	S-3
PUBLIC DOCUMENT COUNT:		32
FILED AS OF DATE:		20251121
DATE AS OF CHANGE:		20251121

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Comstock Inc.
		CENTRAL INDEX KEY:			0001120970
		STANDARD INDUSTRIAL CLASSIFICATION:	INDUSTRIAL ORGANIC CHEMICALS [2860]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				650955118
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-291705
		FILM NUMBER:		251508190

	BUSINESS ADDRESS:	
		STREET 1:		117 AMERICAN FLAT ROAD
		STREET 2:		PO BOX 1118
		CITY:			VIRGINIA CITY,
		STATE:			NV
		ZIP:			89440
		BUSINESS PHONE:		775-847-5272

	MAIL ADDRESS:	
		STREET 1:		117 AMERICAN FLAT ROAD
		STREET 2:		PO BOX 1118
		CITY:			VIRGINIA CITY,
		STATE:			NV
		ZIP:			89440

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Comstock Mining Inc.
		DATE OF NAME CHANGE:	20100720

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GOLDSPRING INC
		DATE OF NAME CHANGE:	20040730

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GOLDSPRING
		DATE OF NAME CHANGE:	20030821
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-3
<SEQUENCE>1
<FILENAME>lode20251007_s3.htm
<DESCRIPTION>FORM S-3
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:naics="http://xbrl.sec.gov/naics/2025" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:utreg="http://www.xbrl.org/2009/utr" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:us-roles="http://fasb.org/us-roles/2017-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2025" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:thunderdome="http://www.RDGFilings.com" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:lode="http://comstock.inc/20250630" xmlns:rr="http://xbrl.sec.gov/rr/2023" xmlns:currency="http://xbrl.sec.gov/currency/2025" xmlns:sic="http://xbrl.sec.gov/sic/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:exch="http://xbrl.sec.gov/exch/2025" xmlns:ecd="http://xbrl.sec.gov/ecd/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21"><head>
	<title>lode20251007_s3.htm</title>
	<!-- Generated by ThunderDome Portal - 11/20/2025 9:20:48 PM -->
<meta http-equiv="Content-Type" content="text/html"/></head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;"><div style="display: none;"><ix:header><ix:hidden>
<ix:nonNumeric contextRef="d_2025-01-01_2025-06-30" name="dei:AmendmentFlag" id="ixv-3467">false</ix:nonNumeric>
<ix:nonNumeric contextRef="d_2025-01-01_2025-06-30" name="dei:EntityCentralIndexKey" id="ixv-3468">0001120970</ix:nonNumeric></ix:hidden>
<ix:references>
<link:schemaRef xlink:href="lode-20250630.xsd" xlink:type="simple"/></ix:references>
<ix:resources>
<xbrli:context id="d_2025-01-01_2025-06-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001120970</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:unit id="NonApplicable"><xbrli:measure>thunderdome:item</xbrli:measure></xbrli:unit></ix:resources>
</ix:header></div>
<div>&#160;</div>

<div>
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><a href="#toc" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt">Table of Contents</a></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>As filed with the Securities and Exchange Commission on November 21, 2025</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b>Registration No. 333-</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>UNITED STATES </b><br/>
<b>SECURITIES AND EXCHANGE COMMISSION </b><br/>
<b>Washington, D.C. 20549 </b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</p>

<hr style="text-align: center; height: 1px; color: #000000; background-color: #000000; width: 25%; border: none; margin: 3pt auto"/>
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>FORM <ix:nonNumeric contextRef="d_2025-01-01_2025-06-30" name="dei:DocumentType" id="c3">S-3</ix:nonNumeric> </b><br/>
<b>REGISTRATION STATEMENT </b><br/>
<b>UNDER </b><br/>
<b>THE SECURITIES ACT OF 1933</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</p>

<hr style="text-align: center; height: 1px; color: #000000; background-color: #000000; width: 25%; border: none; margin: 3pt auto"/>
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:18pt;font-variant:normal;text-align:center;margin:0pt;"><b><ix:nonNumeric contextRef="d_2025-01-01_2025-06-30" name="dei:EntityRegistrantName" id="c4">COMSTOCK INC.</ix:nonNumeric></b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i>(Exact name of registrant as specified in its charter)</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:23.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><ix:nonNumeric contextRef="d_2025-01-01_2025-06-30" name="dei:EntityIncorporationStateCountryCode" id="c5" format="ixt-sec:stateprovnameen">Nevada</ix:nonNumeric></b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i>(State or Other</i></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i>Jurisdiction of Incorporation or Organization)</i></p>
			</td>
			<td style="vertical-align:top;width:23.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><ix:nonNumeric contextRef="d_2025-01-01_2025-06-30" name="dei:EntityTaxIdentificationNumber" id="c6">65-0955118</ix:nonNumeric></b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i>(I.R.S. Employer</i></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i>Identification Number)</i></p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><ix:nonNumeric contextRef="d_2025-01-01_2025-06-30" name="dei:EntityAddressAddressLine1" id="c7">117 American Flat Road</ix:nonNumeric></b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><ix:nonNumeric contextRef="d_2025-01-01_2025-06-30" name="dei:EntityAddressCityOrTown" id="c8">Virginia City</ix:nonNumeric>, <ix:nonNumeric contextRef="d_2025-01-01_2025-06-30" name="dei:EntityAddressStateOrProvince" id="c9">NV</ix:nonNumeric> <ix:nonNumeric contextRef="d_2025-01-01_2025-06-30" name="dei:EntityAddressPostalZipCode" id="c10">89440</ix:nonNumeric></b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(<ix:nonNumeric contextRef="d_2025-01-01_2025-06-30" name="dei:CityAreaCode" id="c11">775</ix:nonNumeric>) <ix:nonNumeric contextRef="d_2025-01-01_2025-06-30" name="dei:LocalPhoneNumber" id="c12">847-5272</ix:nonNumeric></b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i>(Address, including zip code, and telephone number, including area code,</i></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i>of registrant</i>&#8217;<i>s principal executive offices)</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Corrado De Gasperis</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Executive Chairman &amp; Chief Executive Officer</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>117 American Flat Road</b><br/>
<b>Virginia City, NV 89440 </b><br/>
<b>(775) 847-4755</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i>(Name, address, including zip code, and telephone number,</i></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i>including area code, of agent for service)</i></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</p>

<hr style="text-align: center; height: 1px; color: #000000; background-color: #000000; width: 25%; border: none; margin: 3pt auto"/>
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><i>Copies to:</i></b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Clyde W. Tinnen, Jr., Esq.</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Foley &amp; Lardner LLP</b><br/>
<b>777 East Wisconsin Avenue</b><br/>
<b>Milwaukee, WI 53202</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(414) 271-2400</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Approximate date of commencement of proposed sale to the public:</b> From time to time after the effective date of this registration statement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box. &#9744;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box. &#9746;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">If this Form is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box. &#9744;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">If this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.D. filed to register additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box. &#9744;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:0.9%;">&#160;</td>
			<td style="vertical-align:top;width:18.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Large accelerated filer &#9744;</p>
			</td>
			<td style="vertical-align:top;width:26.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Accelerated Filer &#9744;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:0.9%;">&#160;</td>
			<td style="vertical-align:top;width:18.5%;">&#160;</td>
			<td style="vertical-align:top;width:26.9%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:0.9%;">&#160;</td>
			<td style="vertical-align:top;width:18.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><ix:nonNumeric contextRef="d_2025-01-01_2025-06-30" name="dei:EntityFilerCategory" id="c13" format="ixt-sec:entityfilercategoryen">Non-accelerated filer</ix:nonNumeric>&#160;&#9746;</p>
			</td>
			<td style="vertical-align:top;width:26.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Smaller reporting company <ix:nonNumeric contextRef="d_2025-01-01_2025-06-30" name="dei:EntitySmallBusiness" id="c14" format="ixt-sec:boolballotbox">&#9746;</ix:nonNumeric></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:0.9%;">&#160;</td>
			<td style="vertical-align:top;width:18.5%;">&#160;</td>
			<td style="vertical-align:top;width:26.9%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:0.9%;">&#160;</td>
			<td style="vertical-align:top;width:18.5%;">&#160;</td>
			<td style="vertical-align:top;width:26.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Emerging growth company&#160;<ix:nonNumeric contextRef="d_2025-01-01_2025-06-30" name="dei:EntityEmergingGrowthCompany" id="c15" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of Securities Act. &#9744;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b style="font-size: 10pt;">The registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective in accordance with Section 8(a) of the&#160;Securities Act of 1933, or until this Registration Statement shall become effective on such date as the Securities and Exchange Commission, acting pursuant to Section 8(a), may determine.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><b>EXPLANATORY NOTE</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-align: justify;">This registration statement contains two prospectuses:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-align: justify;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width: 40pt; text-align: justify;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">&#8226;</td>
			<td style="vertical-align:top;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">a base prospectus, which covers the offering, issuance and sale by the Company of shares of its common stock, preferred stock, debt securities, rights, units and/or warrants from time to time in one or more offerings, which together shall have an aggregate offering price not to exceed $200,000,000&#894;&#160;and</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width: 40pt; text-align: justify;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">&#8226;</td>
			<td style="vertical-align:top;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">an at the market offering agreement, or sales agreement, prospectus supplement (the &#8220;Sales Agreement Prospectus Supplement&#8221;) covering the offering, issuance and sale by the Company of up to a maximum aggregate offering price of $100,000,000 of its common stock that may be issued and sold from time to time under an at the market offering agreement, or sales agreement (the &#8220;Sales Agreement&#8221;), with Titan Partners Group LLC, a division of American Capital Partners, LLC, as sales agent.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-align: justify;">The base prospectus immediately follows this explanatory note. The specific terms of any securities to be offered pursuant to the base prospectus will be specified in one or more prospectus supplements to the base prospectus. The Sales Agreement Prospectus Supplement immediately follows the base prospectus. The $100,000,000 of shares of the Company&#8217;s common stock that may be offered, issued and sold pursuant to the Sales Agreement and under the Sales Agreement Prospectus Supplement is included in the $200,000,000 of securities that may be offered, issued and sold by the Company under the base prospectus. Upon termination of the Sales Agreement, any portion of the $200,000,000 included in the Sales Agreement Prospectus Supplement that is not sold pursuant to the Sales Agreement will be available for sale in other offerings pursuant to the base prospectus and corresponding prospectus supplements, and if no shares are sold under the Sales Agreement, the full $200,000,000 of securities may be sold in other offerings pursuant to the base prospectus and corresponding prospectus supplements.</p>

<p style="text-align: justify; font-size: 10pt; font-family: &quot;Times New Roman&quot;; margin: 0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="border-width: 3px; border-style: double; border-color: black black rgb(0, 0, 0); vertical-align: middle; width: auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><span style="color:#ff0000;">The information in this prospectus is not complete and may be changed. We may not sell these securities pursuant to this prospectus until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and it is not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.</span></p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><span style="color:#ff0000;"><b>SUBJECT TO COMPLETION, DATED NOVEMBER 21, 2025</b></span></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>PROSPECTUS</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div style="text-align: center;"><img alt="logomd.jpg" src="logomd.jpg"/></div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>$200,000,000</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Common Stock</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Preferred Stock</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Debt Securities</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Rights</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Units</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Warrants</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">From time to time, we may offer up to an aggregate of $200,000,000 of any combination of the securities described in this prospectus, either individually or in units. We may also offer shares of our $0.000666 par value, per share common stock (&#8220;Common Stock&#8221;), or preferred stock upon conversion of debt securities, Common Stock upon conversion of preferred stock, or Common Stock, preferred stock or debt securities upon the exercise of warrants. We will provide the specific terms of these offerings and securities in one or more supplements to this prospectus. We may also authorize the provision to you of one or more free writing prospectuses in connection with these offerings. The prospectus supplement and any related free writing prospectus may also add, update or change information we include in this prospectus. You should carefully read this prospectus, the applicable prospectus supplement and any related free writing prospectus, as well as any documents we incorporate by reference, before buying any of the securities being offered.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">You should read this prospectus and any applicable prospectus supplement, as well as the documents incorporated by reference or deemed incorporated by reference into this prospectus and any prospectus supplement, carefully before you invest in our shares.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We may offer and sell the securities described in this prospectus and any prospectus supplement to or through one or more underwriters, dealers and agents, or directly to purchasers, or through a combination of these methods. If any underwriters, dealers or agents are involved in the sale of any of the securities, their names and any applicable purchase price, fee, commission or discount arrangement between or among them will be set forth, or will be calculable from the information set forth, in the applicable prospectus supplement. See the sections of this prospectus entitled &#8220;About this Prospectus&#8221; and &#8220;Plan of Distribution&#8221; for more information. No securities may be sold without delivery of this prospectus and the applicable prospectus supplement describing the method and terms of the offering of such securities.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our Common Stock is listed on the NYSE AMERICAN LLC under the symbol &#8220;LODE.&#8221;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><b>Investing in our securities involves risks that are referenced in the </b>&#8220;<b>Risk Factors</b>&#8221;<b> section, at page <a class="tocPGNUM" href="#RISK_FACTORS">7</a></b><b>, of this prospectus and are set forth in our periodic reports filed with the Securities and Exchange Commission.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><b>Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0"/>
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;">The date of this prospectus is &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; , 2025</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td colspan="2" style="vertical-align:top;width:44%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><a id="toc" href="#"></a>TABLE OF CONTENTS</b></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:44%;">&#160;</td>
			<td style="vertical-align:top;width:2.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Page</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:44%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a href="#ABOUT" style="-sec-extract:exhibit;">About This Prospectus</a></p>
			</td>
			<td style="vertical-align:top;width:2.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a class="tocPGNUM" href="#ABOUT">1</a></p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:44%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a href="#WHERE" style="-sec-extract:exhibit;">Where You Can find More Information</a></p>
			</td>
			<td style="vertical-align:top;width:2.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a class="tocPGNUM" href="#WHERE">1</a></p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:44%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a href="#INCORPORATION" style="-sec-extract:exhibit;">Incorporation of Certain Documents by Reference</a></p>
			</td>
			<td style="vertical-align:top;width:2.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a class="tocPGNUM" href="#INCORPORATION">2</a></p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:44%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a href="#SUMMARY" style="-sec-extract:exhibit;">Summary</a></p>
			</td>
			<td style="vertical-align:top;width:2.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a class="tocPGNUM" href="#SUMMARY">3</a></p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:44%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a href="#FORWARD" style="-sec-extract:exhibit;">Forward Looking Statements</a></p>
			</td>
			<td style="vertical-align:top;width:2.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a class="tocPGNUM" href="#FORWARD">7</a></p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:44%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a href="#RISK_FACTORS" style="-sec-extract:exhibit;">Risk Factors</a></p>
			</td>
			<td style="vertical-align:top;width:2.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a class="tocPGNUM" href="#RISK_FACTORS">7</a></p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:44%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a href="#USE_OF" style="-sec-extract:exhibit;">Use of Proceeds</a></p>
			</td>
			<td style="vertical-align:top;width:2.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a class="tocPGNUM" href="#USE_OF">7</a></p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:44%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a href="#COMMON_STOCK" style="-sec-extract:exhibit;">Description of Common Stock</a></p>
			</td>
			<td style="vertical-align:top;width:2.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a class="tocPGNUM" href="#COMMON_STOCK">7</a></p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:44%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a href="#PREFERRED_STOCK" style="-sec-extract:exhibit;">Description of Preferred Stock</a></p>
			</td>
			<td style="vertical-align:top;width:2.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a class="tocPGNUM" href="#PREFERRED_STOCK">7</a></p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:44%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a href="#DEBT_SECURITIES" style="-sec-extract:exhibit;">Description of Debt Securities</a></p>
			</td>
			<td style="vertical-align:top;width:2.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a class="tocPGNUM" href="#DEBT_SECURITIES">8</a></p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:44%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a href="#RIGHTS" style="-sec-extract:exhibit;">Description of Rights</a></p>
			</td>
			<td style="vertical-align:top;width:2.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a class="tocPGNUM" href="#RIGHTS">11</a></p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:44%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a href="#WARRANTS" style="-sec-extract:exhibit;">Description of Warrants</a></p>
			</td>
			<td style="vertical-align:top;width:2.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a class="tocPGNUM" href="#WARRANTS">12</a></p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:44%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a href="#UNITS" style="-sec-extract:exhibit;">Description of Units</a></p>
			</td>
			<td style="vertical-align:top;width:2.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a class="tocPGNUM" href="#UNITS">13</a></p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:44%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a href="#LEGAL_OWNERSHIP" style="-sec-extract:exhibit;">Legal Ownership of Securities</a></p>
			</td>
			<td style="vertical-align:top;width:2.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a class="tocPGNUM" href="#LEGAL_OWNERSHIP">14</a></p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:44%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a href="#PLAN_OF_DIST" style="-sec-extract:exhibit;">Plan of Distribution</a></p>
			</td>
			<td style="vertical-align:top;width:2.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a class="tocPGNUM" href="#PLAN_OF_DIST">16</a></p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:44%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a href="#VALIDITY" style="-sec-extract:exhibit;">Validity of the Securities</a></p>
			</td>
			<td style="vertical-align:top;width:2.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a class="tocPGNUM" href="#VALIDITY">17</a></p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:44%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a href="#EXPERTS" style="-sec-extract:exhibit;">Experts</a></p>
			</td>
			<td style="vertical-align:top;width:2.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a class="tocPGNUM" href="#EXPERTS">17</a></p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<div>&#160;</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><a id="ABOUT" href="#"></a>ABOUT THIS PROSPECTUS</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">This prospectus is part of a registration statement that we filed with the Securities and Exchange Commission (the &#8220;Commission&#8221;)&#160;utilizing a &#8220;shelf&#8221; registration process. Under this shelf registration process, we may, from time to time, offer and sell securities pursuant to this prospectus. This prospectus provides you with a general description of the securities we may offer.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Each time we offer and sell our securities, we will provide a prospectus supplement that will contain specific information about the terms of the specific securities being offered and which may add, update or change information in this prospectus. If there is any inconsistency between the information in this prospectus and the applicable prospectus supplement, you must rely on the information in the prospectus supplement. You should read carefully both this prospectus and any prospectus supplement, together with additional information described below under &#8220;Where You Can Find More Information&#8221; before you invest in our securities.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">You should rely only on the information contained or incorporated by reference in this prospectus, any prospectus supplement or any free writing prospectus related to the applicable securities that is prepared by us or on our behalf or that is otherwise authorized by us. We have not authorized any other person to provide you with additional or different information. If anyone provides you with additional, different or inconsistent information, you should not rely on it. This prospectus is not an offer to sell these securities and it is not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted. You should not assume that the information contained in this prospectus and the accompanying prospectus supplement is accurate on any date subsequent to the date set forth on the front of the document or that any information that we have incorporated by reference is correct on any date subsequent to the date of the document incorporated by reference. Our business, financial condition, results of operation and prospects may have changed since those dates.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We will not use this prospectus to offer and sell securities unless it is accompanied by a prospectus supplement that more fully describes the securities being offered and the terms of the offering.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">This prospectus does not contain all the information provided in the registration statement we filed with the Commission. For further information about us or the securities offered hereby, you should refer to that registration statement, which you can obtain from the Commission as described below under &#8220;Where You Can Find More Information.&#8221;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">In this prospectus, unless otherwise specified or the context otherwise requires, &#8220;Comstock,&#8221; &#8220;we,&#8221; &#8220;us&#8221; and &#8220;our,&#8221; &#8220;our Company&#8221; or the &#8220;Company&#8221; refer to Comstock Inc. and its consolidated subsidiaries. In addition, unless the context requires otherwise, reference to the &#8220;Board&#8221; refers to the Board of Directors of Comstock Inc.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><a id="WHERE" href="#"></a>WHERE YOU CAN FIND MORE INFORMATION</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We are required to file periodic reports, proxy statements and other information relating to our business, financial and other matters with the Commission under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;). Our filings are available to the public over the Internet at the Commission&#8217;s website at http://www.sec.gov.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We have filed with the Commission a registration statement on Form S-3 under the Securities Act with respect to our securities described in this prospectus. References to the &#8220;registration statement&#8221; or the &#8220;registration statement of which this prospectus is a part&#8221; mean the original registration statement and all amendments, including all schedules and exhibits. This prospectus does, and any prospectus supplement will, not contain all of the information in the registration statement because we have omitted parts of the registration statement in accordance with the rules of the Commission. Please refer to the registration statement for any information in the registration statement that is not contained in this prospectus or a prospectus supplement. The registration statement is available to the public over the Internet at the Commission&#8217;s website described above and can be read and copied at the locations described above.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Each statement made in this prospectus or any prospectus supplement concerning a document filed as an exhibit to the registration statement is qualified in its entirety by reference to that exhibit for a complete description of its provisions.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We make available, free of charge, on or through our website, copies of our proxy statements, our annual reports on Form 10-K, our quarterly reports on Form 10-Q, our current reports on Form 8-K and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act as soon as reasonably practicable after we electronically file them with or furnish them to the Commission. We maintain a website at <span style="text-decoration: underline; ">http://www.comstock.inc</span>. The information contained on our website is not part of this prospectus, any prospectus supplement or the registration statement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: Times New Roman;">1</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><a id="INCORPORATION" href="#"></a>INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We have filed the following documents with the Commission pursuant to the Exchange Act and hereby incorporate them by reference in the registration statement:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We incorporate by reference the documents listed below and any future documents that we file with the Commission under Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act after the date of this prospectus:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(a) Our annual report on <a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1120970/000143774925006453/lode20241231_10k.htm" style="-sec-extract:exhibit;">Form 10-K</a> for the fiscal year ended December 31, 2024, filed with the Commission on March 6, 2025 (the &#8220;Form 10-K&#8221;);</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(b) Our quarterly report on <a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1120970/000143774925015474/lode20250331_10q.htm" style="-sec-extract:exhibit;">Form 10-Q</a> for the fiscal quarter ended March 31, 2025, filed with the Commission on May 8, 2025 (the &#8220;First Quarter Form 10-Q&#8221;);</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(c) Our quarterly report on <a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/0001120970/000143774925026942/lode20250630_10q.htm" style="-sec-extract:exhibit;">Form 10-Q</a> for the fiscal quarter ended June 30, 2025, filed with the Commission on August 14, 2025 (the &#8220;Second Quarter Form 10-Q&#8221;);</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(d) Our quarterly report on <a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1120970/000143774925032230/lode20250930_10q.htm" style="-sec-extract:exhibit;">Form 10-Q</a> for the fiscal quarter ended September 30, 2025, filed with the Commission on October 30, 2025 (the &#8220;Third Quarter Form 10-Q,&#8221; and together with the First Quarter 10-Q and the Second Quarter 10-Q, the &#8220;Form 10-Qs&#8221;);</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(e) current reports on Form 8-K filed with the Commission on <a href="http://www.sec.gov/Archives/edgar/data/1120970/000143774925000902/lode20250108_8k.htm" style="-sec-extract:exhibit;">January 13, 2025</a> (with respect to Item 1.01 and Item 2.03), <a href="http://www.sec.gov/Archives/edgar/data/1120970/000143774925001450/lode20250120_8k.htm" style="-sec-extract:exhibit;">January 21, 2025</a>, <a href="http://www.sec.gov/Archives/edgar/data/1120970/000143774925002314/lode20250130_8k.htm" style="-sec-extract:exhibit;">January 31, 2025</a>, <a href="http://www.sec.gov/Archives/edgar/data/1120970/000143774925003068/lode20250206_8k.htm" style="-sec-extract:exhibit;">February 7, 2025</a>, <a href="http://www.sec.gov/Archives/edgar/data/1120970/000143774925003661/lode20250211_8k.htm" style="-sec-extract:exhibit;">February 13, 2025</a>, <a href="http://www.sec.gov/Archives/edgar/data/1120970/000143774925004211/lode20250213_8k.htm" style="-sec-extract:exhibit;">February 18, 2025</a>, <a href="http://www.sec.gov/Archives/edgar/data/1120970/000143774925004570/lode20250220_8k.htm" style="-sec-extract:exhibit;">February 20, 2025</a>, <a href="http://www.sec.gov/Archives/edgar/data/1120970/000143774925005571/lode20250227_8k.htm" style="-sec-extract:exhibit;">February 28, 2025</a>, <a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1120970/000143774925007109/lode20250311_8k.htm" style="-sec-extract:exhibit;">March 12, 2025</a>, <a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1120970/000143774925009023/lode20250320_8k.htm" style="-sec-extract:exhibit;">March 25, 2025</a>, <a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1120970/000143774925017218/lode20250515_8k.htm" style="-sec-extract:exhibit;">May 15, 2025</a>, <a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1120970/000143774925018373/lode20250515c_8k.htm" style="-sec-extract:exhibit;">May 27, 2025</a>, <a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1120970/000143774925018680/lode20250523_8k.htm" style="-sec-extract:exhibit;">May 28, 2025</a>, <a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/0001120970/000143774925019869/lode20250430_8k.htm" style="-sec-extract:exhibit;">June 9, 2025</a>, <a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1120970/000143774925020198/lode20250610_8k.htm" style="-sec-extract:exhibit;">June 12, 2025</a>,&#160;&#160;<a href="http://www.sec.gov/Archives/edgar/data/1120970/000143774925026275/lode20250808c_8k.htm" style="-sec-extract:exhibit;">August 12, 2025</a> (with respect to Item 1.01, Item 2.03, Item 3.02 and Item 5.02), and <a href="http://www.sec.gov/Archives/edgar/data/1120970/000143774925026920/lode20250808d_8k.htm" style="-sec-extract:exhibit;">August 14, 2025</a>&#160;(with respect to Item 1.01 and&#160;Item 3.02);</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(f) the description of our Common Stock contained in our <a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1120970/000143774925007109/lode20250311_8k.htm" style="-sec-extract:exhibit;">Form 8-K</a>, filed with the Commission on March 12, 2025, in lieu of the description of our Common Stock contained in our Form <a href="http://www.sec.gov/Archives/edgar/data/1120970/000114420411034651/v224648_8a12b.htm" style="-sec-extract:exhibit;">8-A</a> (File No. 001-35200), filed with the Commission under Section 12 of the Exchange Act on June 8, 2011 (the &#8220;Form 8-A&#8221;); and</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(g) Our proxy statement on <a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1120970/000143774925011451/lode20250130_def14a.htm" style="-sec-extract:exhibit;">Schedule 14A</a>, filed with the Commission on April 9, 2025.&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">All documents subsequently filed by us with the Commission pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act, prior to the filing of a post-effective amendment which indicates that all securities offered have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference in the registration statement and to be a part hereof from the date of filing of such documents.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Notwithstanding the foregoing, documents or portions thereof containing information furnished under Items 2.02 and 7.01 of any Current Report on Form 8-K, including the related exhibits under Item 9.01, are not incorporated by reference in this prospectus.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We make available copies of the documents incorporated by reference in this prospectus to each person, including any beneficial owner, to whom a prospectus is delivered, without charge, upon written or oral request. Such requests should be directed to:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Comstock Inc.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">117 American Flat Road</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Virginia City, Nevada 89440</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Attention: Investor Relations</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Telephone: (775) 847-5272</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">2</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><a id="SUMMARY" href="#"></a>SUMMARY</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><i>This summary highlights information contained elsewhere or incorporated by reference in this prospectus and does not contain all of the information you should consider in making your investment decision. You should read this summary together with the more detailed information included elsewhere or incorporated by reference in this prospectus, including financial statements and the related notes. You should carefully consider, among other things, the matters discussed under </i>&#8220;<i>Risks Factors</i>&#8221;<i> in the Form 10-K, the Form 10-Qs and in other documents that we subsequently file with the Commission that are incorporated by reference herein.</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>The Company</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">OVERVIEW</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">Comstock innovates and commercializes technologies, systems and supply chains that extract, integrate and convert under-utilized natural and waste&#160;resources into clean energy products, including pioneering technologies that produce electrification metals and minerals from end-of-life solar panels, including aluminum, silver and other critical and rare earth metals.&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 45pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">Bioleum innovates and commercializes technologies, systems and supply chains that secure, extract, integrate and convert carbon-based materials from under-utilized waste and purpose grown energy crops that would ultimately produce a broad range of extremely low carbon renewable fuels, including cellulosic ethanol, renewable diesel and sustainable aviation fuels.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 45pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">Our goal is to&#160;<i>Accelerate the Commercialization of Breakthrough Technologies.</i>&#160;We plan on delivering extraordinary shareholder value by using systemic management practices, disciplined frontier scientific discovery, and applied engineering to innovate, develop, deploy&#160;and monetize&#160;clean energy technologies with integrated teams and partners in dedicated lines of business, especially in sustainable, renewable systems with the potential for superior, sustained throughput generation. Our plans to generate these throughputs involve both deploying and licensing our technologies, within a purpose-driven and designed ecosystem, including extended and interdependent partners that leverages their capital, human capacity, infrastructures, and other resources, often integrated directly with us and our solutions,&#160;to accelerate and maximize adoption.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 45pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">We also own and manage investments in related assets that support our businesses, including existing minority equity positions and partnerships in strategic technology developers, two Wisconsin renewable fuels demonstration facilities, an existing&#160;Nevada-based solar panel recycling demonstration facility and currently ordered equipment for a Nevada-based industry-scale solar panel recycling facility. We also own, control and/or manage direct investments in northern Nevada real estate comprised primarily of industrial and commercial land, water rights and about twelve&#160;square miles of gold and silver mining claims and surface parcels that we own, lease or have a royalty interest in,&#160;some of which&#160;contain significant amounts of measured and&#160;indicated, and inferred gold and silver resources.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><b><i>Lines of Business</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><i>Metals Segment</i></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our Metals Segment has established a goal of s<i>etting the global standard for solar panel recycling</i>. For the past 21 months, we have operated a permitted, demonstration-scale solar panel recycling facility that delivers environmentally superior, zero-landfilled recycling solutions to support U.S. mineral industries. During 2024, this facility&#160;generated $0.4 million in revenue and, in the first nine months of 2025,&#160; billable revenues (both recognized and deferred) increased&#160;nearly six-fold due, in part, to service fees for decommissioning services, recycling&#160;and processing end-of-life solar panels, and offtake sales of high-value recycled materials, including aluminum, copper, glass, and concentrated precious metals. We believe this technology deployment is globally leading and positioned to operate a world-class, quality, global solar panel recycling operation and the Metals Segment has&#160;the potential to establish the pace of metal recycling and ultimately, global solar panel recycling network deployment.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Comstock Metals has progressed all&#160;permitting requirements for its first industry-scale production facility, located on the same campus as the operating demonstration-scale facility, that can scale the operation, over 3 million panels per year representing up to&#160;100,000 tons of processed waste materials per year. This strategically located facility will enable the expeditious transition of proven processes from commercial demonstration to full-scale production. The industry-scale facility is expected to significantly enhance our ability to meet the rapid and&#160;continuously growing demand for domestically recovered metals.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our plan supports the creation of a more robust domestic supply chain for critical materials by innovating and scaling sustainable recycling technologies. The Company&#160;plans to build up to seven facilities in the United States over the next five years and support&#160;American energy and resource independence while simultaneously delivering significant economic and environmental value.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our Metals Segment's 2025 objectives included (1) finalizing the industry-scale engineering, (2) submitting and receiving all prerequisite permits, (3) closing on equity and/or debt financing for Comstock Metals to sufficiently fund the construction and commissioning of the Company&#8217;s first industry-scale facility, (4) ordering all of the industry-scale equipment for our first industry-scale facility,&#160;(5)&#160;securing larger and longer terms supply contracts and (6) accelerating site selection for our second facility.&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">3</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><i>Mining Segment</i></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our Mining Segment generated&#160;income from&#160;leases, licenses, and related fees during 2024, and is administered by our wholly owned subsidiaries, Comstock Mining LLC, Comstock Processing LLC and various other local subsidiaries that collectively own,&#160;control, or retain&#160;royalty interest in twelve&#160;square miles of properties of patented mining claims, unpatented mining claims and surface parcels in northern Nevada, including six and a half&#160;miles of continuous mineralized strike length (the &#8220;Comstock Mineral Estate&#8221;).</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">On December 18, 2024,&#160;the Company executed a membership interest purchase agreement with Mackay Precious Metals Inc. (&#8220;Mackay&#8221;) pursuant to which the Company sold all of its right, title, and interest in its wholly owned subsidiary&#160;Comstock Northern Exploration LLC, and the Company's 25% interest in Pelen Limited Liability Company (&#8220;Pelen&#8221;), for an aggregate purchase price of $2,750,000. The Northern Targets encompass both the Gold Hill and Occidental Lode claim groups in Storey County, Nevada. Pelen owns certain claims adjacent to and/or relevant to these northern claim groups. The Company was paid $1.0&#160;million in cash in 2024.&#160;On June 6, 2025, the parties&#160;executed an amendment (the &#8220;First Amendment&#8221;), to the membership interest purchase agreement.&#160;Pursuant to the First Amendment, the membership interest purchase agreement was amended to increase the purchase price to $2,950,000 bringing all final cash amounts due to a total of $1,950,000. As of September 30, 2025, the Company received all remaining cash payments of&#160;$1,950,000.&#160;For the nine-months ended&#160;September 30, 2025, pursuant to the First Amendment, the Company&#160;recognized an additional gain on the sale of mineral rights of $200,000&#160;in our condensed consolidated statement of operations.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">On June 30, 2023, the Company&#160;entered a Mineral Exploration and Mining Lease Agreement (&#8220;Mackay Mining Lease&#8221;) with Mackay. The Mackay Mining Lease terminated on December 18, 2024.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our Mining Segment's 2025 objectives include (1) monetizing over&#160;$2.0&#160;million from the sale of the northern mining claims, (2) advancing the preliminary economic assessment for the Dayton Consolidated Project and (3) the development of preliminary Dayton mine and reclamation plans,&#160;progressing toward full economic feasibility for Dayton.&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><i>Fuels Segment - Bioleum Corporation</i></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We hold an investment in Bioleum, through our Preferred Series 1 equity position. Bioleum&#160;delivers advanced lignocellulosic biomass refining solutions that are setting new industry standards for the production of cellulosic ethanol, gasoline, renewable diesel, sustainable aviation fuel (&#8220;SAF&#8221;), and other renewable Bioleum&#8482; fuels, with extremely low carbon intensity scores of 15 and market-leading yields of up to 125&#160;gallons per dry metric ton of feedstock (on a gasoline gallon equivalent basis, or &#8220;GGE&#8221;), depending on feedstock, site conditions, and other process parameters. Bioleum has also negotiated the exclusive rights to intellectual properties developed by Hexas, subject to certain preexisting agreements, for production of purpose grown energy crops in liquid fuels applications with proven yields exceeding 25 to 30 dry metric tons per acre per year. The combination of Bioleum's&#160;high yielding refining platform and Hexas&#8217; high yielding energy crops enables&#160;the production of enough feedstock to produce upwards of 100 barrels (at 42 gallons per barrel) of fuel per acre per year, with regenerative practices that can effectively transform&#160;marginal agricultural lands&#160;into perpetual &#8220;drop-in sedimentary oilfields&#8221; with the potential to dramatically boost regional energy security and rural economies. Bioleum plans to contribute to domestic energy dominance by directly building, owning, and operating a network of Bioleum refineries in the U.S. to produce up to 200 million barrels of renewable fuel per year by 2035, starting with its planned first 400,000 barrel per year commercial demonstration facility in Oklahoma. Bioleum will also license&#160;its advanced feedstock and refining solutions to third parties for additional production in&#160;global markets. Bioleum does not currently generate revenue.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Bioleum operates two complementary and interdependent pilot facilities, including a feedstock conversion and biointermediate production pilot in Wausau, Wisconsin (&#8220;Wausau Facility&#8221;), and a biointermediate conversion and renewable fuel production development pilot in Madison, Wisconsin (&#8220;Madison Facility&#8221;). Bioleum continues innovating its existing commercial process for the purpose of advancing its technological readiness, stabilizing and increasing its market-leading yields, further decreasing carbon intensities,&#160;and driving costs down in the longer-term pursuit of fossil parity. In addition to Hexas, Bioleum&#8217;s innovations group has also partnered with National Renewable Energy Laboratory (&#8220;NREL&#8221;), the Massachusetts Institute of Technology (&#8220;MIT&#8221;), RenFuel K2B AB (&#8220;RenFuel&#8221;), Emerging Fuels Technologies Inc. (&#8220;EFT&#8221;), and others with sponsored research, licensing, and other agreements.&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Effective February 28, 2025, we effectively entered into a series of definitive agreements with subsidiaries of Marathon Petroleum Corporation (&#8220;Marathon&#8221;),&#160;involving the purchase of $14,000,000 in Bioleum equity as part of the Series A Financing, subject to a $700,000,000 valuation cap (&#8220;Investment&#8221;). The purchase price includes $1,000,000 in cash and $13,000,000 in payment-in-kind assets comprised of equipment, related intellectual properties, and other materials located at Marathon&#8217;s former renewable fuel demonstration facility in Madison, Wisconsin (&#8220;Payment-In-Kind Assets&#8221;).</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">In May 2025, Bioleum also completed the initial $20 million closing of its Series A preferred equity offering (&#8220;Series A Financing&#8221;).&#160;Bioleum also plans to complete its Series A Financing during 2025&#160;and commence project equity and debt financings that includes an allocation of $152 million from the State of Oklahoma in project activity bonds for the construction of its planned first 400,000 barrel per year facility in Oklahoma.&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 16pt;text-indent:18pt;"><i>Strategic Investments Segment</i></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 16pt;text-indent:18pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 16pt;text-indent:18pt;">We own and manage several investments and projects that are strategic to our plans and ability to produce and maximize throughput in our Metals&#160;and Mining Segments, that are held for the purpose of complementing or enhancing our mission of accelerating the commercialization of hard technologies for the energy transition and creating value but that are not a component of such other segments or otherwise have distinct operating activities. Our Strategic Investments Segment includes minority equity and equity-linked&#160;investments in Green Li-ion Pte Limited (lithium-ion battery component recycler and remanufacturing), RenFuel (advanced biofuel development and production), Hexas (propagation and production of purpose grown energy crops),&#160;and Sierra Springs Opportunity Fund (northern Nevada real estate) and other&#160;equity investments. In November 2024, we completed a transaction for the disposition of our minority equity investment in GenMat while retaining the rights for using the technologies.&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-indent: 27pt; text-align: justify;"><b><i>Other</i></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-indent: 27pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-indent: 27pt; text-align: justify;"><i style="font-size: 10pt;">Investments in Properties&#160;</i>&#8211; The Company directly owns three types of properties in Silver Springs, NV, including 98 acres of industrial land, 160 acres of commercial land, both centrally located in Silver Springs, just south of the Silver Springs Regional Airport and a portfolio of water rights. The Company has begun marketing these assets for sale as both industrial and commercial development as interest in Silver Springs, NV has increased.&#160;</p>

<p style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; margin: 0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">4</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:-8pt;"><b>Outlook</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:-8pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 8pt; text-indent: 28pt;">Our goal is to&#160;<i>Accelerate the Commercialization of Breakthrough Technologies.</i></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 8pt; text-indent: 46pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 8pt; text-indent: 28pt;">Comstock innovates and commercializes technologies, systems and supply chains that extract, integrate and convert under-utilized natural and waste&#160;resources into clean energy products, including pioneering technologies that produce electrification metals and minerals from end-of-life solar panels, including aluminum, silver and other critical and rare earth metals.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 8pt; text-indent: 46pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 8pt; text-indent: 28pt;">Bioleum innovates and commercializes technologies, systems and supply chains that secure, extract, integrate and convert carbon-based materials from under-utilized waste and purpose grown energy crops that would ultimately produce a broad range of extremely low carbon renewable fuels, including cellulosic ethanol, renewable diesel and sustainable aviation fuels.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 8pt; text-indent: 46pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 8pt; text-indent: 28pt;">We are pushing the boundaries of what is possible in technology and sustainability by leveraging our teams&#8217; unique skills, our investments and the related diverse technology portfolios and our frontier research and development networks toward achieving breakthrough innovations that deliver meaningful positive impact across industries, economies and communities. The primary focus for 2025&#160;is the commercialization of Comstock Metals and the continuous innovation, development and engineering of technologies and solutions, by us and by our partners, that support the efficient conversion of these resources into clean, profitable energy products.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-indent: 37pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-indent: 28pt; text-align: justify;"><i>Corporate</i>&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-indent: 37pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-indent: 28pt; text-align: justify;">The growth opportunities for both Comstock Metals and&#160;Bioleum developed beyond our original plans, and we have now realigned both the organizations and their respective capital bases with some of the most sophisticated partners for investment, feedstocks, technologies, operations, and offtakes, including significant investments.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-indent: 37pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-indent: 28pt; text-align: justify;">We are&#160;expanding those partnerships across both our extended metals and fuels systems and supply chains, positioning them for industry leadership, exponential revenue growth and superior throughput profiles, especially for Metals and leading to cash profitability for Comstock Metals in 2026.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-indent: 37pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-indent: 28pt; text-align: justify;">Comstock now owns a $65 million face value convertible preferred stock in Bioleum Corporation, ultimately convertible into 32.5 million common shares, positioning an exceptional value potential for Comstock&#8217;s shareholders and preserving Comstock&#8217;s ability to accelerate the growth and delivery of that value directly to shareholders.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">The Company&#8217;s Corporate remaining objectives for the rest of 2025 include:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Advance our legacy real estate and non-strategic investments for ultimate monetization;</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Support the next phases of accelerating Metals growth; and</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Finalize,&#160;communicate&#160;and implement plans to unlock maximum value from the separation of Bioleum.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 36pt;">The Company's 2025 efforts to date have now resulted&#160;in two, fully dedicated, high-growth companies: our Nevada-based renewable metals operation with expanding production and our Oklahoma-headquartered Bioleum Corporation, with major research, development and pilot production&#160;operations based in Wausau and Madison,&#160;Wisconsin.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 45pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;"><i>Comstock Metals</i></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 45pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Comstock Metals has now been operating its first commercial demonstration facility for nearly 21&#160;months&#160;and in November of 2024, submitted permits for the first industry-scale photovoltaic recycling facility. The Company expects these permits to be issued imminently during the fourth quarter of 2025. The industry-scale facilities are designed for 100,000 tons of annual capacity with operations commencing post commissioning during the second quarter 2026.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 45pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Additional site selection activities are ongoing for the next two industry-scale facilities and multiple associated storage sites.&#160;The Company plans to ultimately build up to 7 industry-scale U.S. based recycling facilities.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-indent: 27pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-indent: 27pt; text-align: justify;">The Company's Metals remaining objectives for the rest of 2025 include:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Receive final permits for our first industry-scale&#160;facility in Silver Springs, NV;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Procure, deploy, and assemble plant and equipment for our first industry-scale&#160;facility in Silver Springs, NV;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Secure additional Master Service Agreements (MSA) with national and regional customers;&#160;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Complete site selection&#160;for two additional solar panel recycling locations;&#160;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Expand the system globally with international strategic and capital partners; and</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Advance&#160;R&amp;D efforts to recover more and higher-purity materials from recycled streams for offtake.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">5</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-indent: 27pt; text-align: justify;"><i>Comstock Mining</i></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-indent: 27pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-indent: 27pt; text-align: justify;">Comstock Mining&#160;has amassed the single largest known repository of historical and current geological data within the Comstock mineral district, including extensive geophysical surveys, geological mapping, and drilling data, including the Dayton resource.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">The Company's Mining remaining objectives for the rest of 2025 include:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Commercialize agreements that either monetize or enable resource expansion of the central claims;&#160;</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr>
			<td style="width: 27pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#8226;</td>
			<td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Publish the Dayton Consolidated Project technical work with preliminary economics and sensitivities; and&#160;</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Complete the preliminary mine plans that enable the economic development of the southern district claims.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 36pt;">The Company&#8217;s 2025&#160;efforts will apply economic analysis to Comstock&#8217;s existing gold and silver resources progressing toward preliminary economic feasibility for the southern part of the district and the ultimate development of full mine and reclamation plans and the development of post productive land and community development plans.&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 36pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 36pt;"><i>Bioleum</i></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 36pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 36pt;">Bioleum is actively engaged in the expansion of its pilot production facilities and the planning for its first commercial demonstration facilities and the associated supply chain participants (including feedstock, site selection, engineering, construction and procurement, and offtake).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Bioleum's remaining objectives for the rest of 2025 include:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Advance efforts on the remaining subsidiary-level &#8220;Series A&#8221;&#160;equity financing in the separate Fuels entity;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Plan and deploy a Hexas-based, scalable, commercial demonstration&#160;fuel farm;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Complete site selection for first commercial biorefinery project in Oklahoma;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Expand integrated pilot&#160;production capabilities to up to two barrels per week of intermediates and fuels; and</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Advance our innovation and development efforts toward even higher yields, lower costs and lower capital.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Comstock Fuels also&#160;offers integrations of its solutions into existing agriculture, forestry, pulp and paper, ethanol, and existing petroleum infrastructures to generate additional capacities, revenues, technical services, engineering and royalties. The plans also include integrating Bioleum&#8217;s high yield Bioleum refining platform with Hexas&#8217; high yield energy crops to provide enough feedstock to produce upwards of 100 barrels of fuel per acre per year, effectively transforming agricultural lands into perpetual &#8220;drop-in sedimentary oilfields&#8221; with the potential to dramatically boost domestic&#160;energy resources.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-indent: 27pt; text-align: justify;"><b><i>Strategic Investments</i></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-indent: 27pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-indent: 27pt; text-align: justify;"><i>Investment in Green Li-ion</i></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-indent: 27pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-indent: 27pt; text-align: justify;">Green Li-ion continues making meaningful progress in the development and deployment of its system that remanufactures critical precursor cathode active materials (&#8220;PCAM&#8221;), having now deployed its first commercial battery remanufacturing facility from fully recycled battery materials deployed.&#160;The Company intends to sell the remaining 35,662 Green Li-ion preferred shares&#160;in&#160;2026.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-indent: 27pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-indent: 27pt; text-align: justify;"><i>Investments in other&#160;non-mining real estate, water rights and securities</i></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-indent: 27pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-indent: 27pt; text-align: justify;">The Company has announced plans for selling its non-mining real estate and water rights anticipated in the latter part of&#160;2026.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>Corporate Information</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">The Company&#8217;s executive offices are located at 117 American Flat Road, Virginia City, Nevada 89440 and its telephone number is (775) 847-5272. The Company&#8217;s mailing address is P.O. Box 1118, Virginia City, Nevada 89440. The Company&#8217;s website address is <span style="text-decoration: underline; ">www.comstock.inc</span>. The Company&#8217;s website and the information contained on, or that can be accessed through, the website are not part of this prospectus.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: Times New Roman;">6</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><a id="FORWARD" href="#"></a>FORWARD LOOKING STATEMENTS</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The information appearing under &#8220;Cautionary Notice Regarding Forward Looking Statements&#8221; in the Form 10-K and the Form 10-Qs, is hereby incorporated by reference.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><a id="RISK_FACTORS" href="#"></a>RISK FACTORS</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Investment in any securities offered pursuant to this prospectus and the applicable prospectus supplement involves risks. You should carefully consider the risk factors incorporated by reference to the Form 10-K, the Form 10-Qs or periodic reports we file after the date of this prospectus, and all other information contained or incorporated by reference into this prospectus, as updated by our subsequent filings under the Exchange Act, and the risk factors and other information contained in the applicable prospectus supplement before acquiring any of such securities. The occurrence of any of these risks might cause you to lose all or part of your investment in the offered securities.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><a id="USE_OF" href="#"></a>USE OF PROCEEDS</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Except as may be described otherwise in any applicable prospectus supplement or free writing prospectus, we intend to use the net proceeds from the sale by us of the securities under this prospectus for general corporate purposes, including capital expenditures associated with commercializing&#160;subsequent industry scale processing and storage facilities for Comstock Metals, in addition to acquisitions, and technical, operational and human resource development expenses for supporting growth.&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">We&#160;have not determined the amounts we plan to spend on the areas listed above or the timing of these expenditures. As a result, our management will have broad discretion to allocate the net proceeds of the offerings. We have no current plans, commitments, or agreements with respect to any acquisitions as of the date of this prospectus.&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><a id="COMMON_STOCK" href="#"></a>DESCRIPTION OF COMMON STOCK</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company&#8217;s authorized Common Stock consists of 245,000,000 shares, par value $0.000666 per share. The description of our Common Stock contained in our <a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1120970/000143774925007109/lode20250311_8k.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">Form 8-K</span></a>, filed with the Commission on March 12, 2025, is hereby incorporated by reference. The Company currently has 51,264,247&#160;shares of Common Stock issued and outstanding as of November 20, 2025. All shares of Common Stock presently outstanding are fully&#160;paid and non-assessable.&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><a id="PREFERRED_STOCK" href="#"></a>DESCRIPTION OF PREFERRED STOCK</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:27pt;">Pursuant to our articles of incorporation, the Board has the authority, without further action by the stockholders (unless such stockholder action is required by applicable law or NYSE AMERICAN rules), to designate and issue up to 50,000,000 shares of preferred stock in one or more series, to establish from time to time the number of shares to be included in each such series, and to fix the voting powers, designations, preferences, privileges, qualifications, limitations, restrictions and relative, participating, optional and other rights of such series. The Company currently has not designated any series of preferred stock nor does it have any issued and outstanding shares of preferred stock.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:27pt;">The Board will fix the voting powers, designations, preferences, privileges, qualifications, limitations, restrictions and relative, participating, optional and other rights of each such series, as well as the qualifications, limitations or restrictions thereon, in the certificate of designation relating to that series. We will file as an exhibit to the registration statement of which this prospectus is a part, or will incorporate by reference from reports that we file with the Commission, the form of any certificate of designation that describes the terms of the series of preferred stock we are offering before the issuance of that series of preferred stock. This description will include, as applicable:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:1.7%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">the number of shares we are offering;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.7%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">the liquidation preference per share;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.7%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">the purchase price;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.7%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">the dividend rate, period and payment date and method of calculation for dividends;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.7%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">whether dividends will be cumulative or non-cumulative and, if cumulative, the date from which dividends will accumulate;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.7%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">the procedures for any auction and remarketing, if any;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.7%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">the provisions for a sinking fund, if any;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.7%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">the provisions for redemption or repurchase, if applicable, and any restrictions on our ability to exercise those redemption and repurchase rights;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.7%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">any listing of the preferred stock on any securities exchange or market;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.7%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">whether the preferred stock will be convertible into our Common Stock, and, if applicable, the conversion price, or how it will be calculated, and the conversion period;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.7%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">whether the preferred stock will be exchangeable into debt securities, and, if applicable, the exchange price, or how it will be calculated, and the exchange period;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.7%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">voting rights, if any, of the preferred stock;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.7%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">preemptive rights, if any;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.7%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">restrictions on transfer, sale or other assignment, if any;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.7%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">whether interests in the preferred stock will be represented by depositary shares;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.7%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">a discussion of any material United States federal income tax considerations applicable to the preferred stock;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.7%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">the relative ranking and preferences of the preferred stock as to dividend rights and rights if we liquidate, dissolve or wind up our affairs;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.7%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">any limitations on the issuance of any&#160;series of preferred stock ranking senior to or on a parity with the series of preferred stock as to dividend rights and rights if we liquidate, dissolve or wind up our affairs; and</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.7%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">any other specific terms, preferences, rights or limitations of, or restrictions on, the preferred stock.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Board may authorize the issuance of preferred stock with voting or conversion rights that could adversely affect the voting power or other rights of the holders of our Common Stock. Preferred stock could be issued quickly with terms designed to delay or prevent a change in control of our company or make removal of management more difficult. Additionally, the issuance of preferred stock may have the effect of decreasing the market price of our Common Stock.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: Times New Roman;">7</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;text-indent:36pt;"><b><a id="DEBT_SECURITIES" href="#"></a>DESCRIPTION OF DEBT SECURITIES</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 34pt;">We may issue debt securities, in one or more series, as either senior or subordinated debt or as senior or subordinated convertible debt. Pursuant to the terms of our outstanding indebtedness and a Stockholders Agreement with our largest shareholder, we are prohibited from issuing debt without the prior written consent. While the terms we have summarized below will apply generally to any debt securities that we may offer under this prospectus, we will describe the particular terms of any debt securities that we may offer in more detail in the applicable prospectus supplement. The terms of any debt securities offered under a prospectus supplement may differ from the terms&#160;described below. Unless the context requires otherwise, whenever we refer to the indentures, we also are referring to any supplemental indentures that specify the terms of a particular series of debt securities.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 34pt;">We will issue the senior debt securities under the senior indenture that we will enter into with the trustee named in the senior indenture. We will issue the subordinated debt securities under the subordinated indenture that we will enter into with the trustee named in the subordinated indenture. Generally, the indentures will be qualified under the Trust Indenture Act of 1939. We use the term &#8220;debenture trustee&#8221; to refer to either the trustee under the senior indenture or the trustee under the subordinated indenture, as applicable. We will file forms of indentures to the registration statement of which this prospectus is a part, and supplemental indentures and forms of debt securities containing the terms of the debt securities being offered will be filed as exhibits to the registration statement of which this prospectus is a part or will be incorporated by reference from reports that we file with the Commission.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 34pt;">The following summaries of material provisions of the senior debt securities, the subordinated debt securities and the indentures are subject to, and qualified in their entirety by reference to, all of the provisions of the indenture applicable to a particular series of debt securities. We urge you to read the applicable prospectus supplements and any related free writing prospectuses related to the debt securities that we may offer under this prospectus, as well as the complete indentures that will contain the terms of the debt securities. Except as we may otherwise indicate, the terms of the senior indenture and the subordinated indenture are identical.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>General</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We will describe in the applicable prospectus supplement the terms of the series of debt securities being offered, including:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:1.7%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">the title;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.7%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">whether or not such debt securities are guaranteed by our subsidiaries or other entities;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.7%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">the principal amount being offered, and if a series, the total amount authorized and the total amount outstanding;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.7%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">any limit on the amount that may be issued;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.7%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">whether or not we will issue the series of debt securities in global form, the terms and who the depositary will be;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.7%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">the maturity date;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.7%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">whether and under what circumstances, if any, we will pay additional amounts on any debt securities held by a person who is not a United States person for tax purposes, and whether we can redeem the debt securities if we have to pay such additional amounts;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.7%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">the annual interest rate, which may be fixed or variable, or the method for determining the rate and the date interest will begin to accrue, the dates interest will be payable and the regular record dates for interest payment dates or the method for determining such dates;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.7%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">whether or not the debt securities will be secured or unsecured, and the terms of any secured debt;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.7%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">the terms of the subordination of any series of subordinated debt;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.7%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">the place where payments will be payable;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.7%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">restrictions on transfer, sale or other assignment, if any;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.7%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">our right, if any, to defer payment of interest and the maximum length of any such deferral period;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.7%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">the date, if any, after which, and the price at which, we may, at our option, redeem the series of debt securities pursuant to any optional or provisional redemption provisions and the terms of those redemption provisions;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.7%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">the date, if any, on which, and the price at which we are obligated, pursuant to any mandatory sinking fund or analogous fund provisions or otherwise, to redeem, or at the holder&#8217;s option to purchase, the series of debt securities and the currency or currency unit in which the debt securities are payable;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.7%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">whether the indenture will restrict our ability and/or the ability of our subsidiaries to:</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.7%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">incur additional indebtedness;</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:1.7%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">issue additional securities;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.7%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">create liens;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.7%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">pay dividends and make distributions in respect of our capital stock and the capital stock of our subsidiaries;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.7%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">redeem capital stock;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.7%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">place restrictions on our subsidiaries&#8217;&#160;ability to pay dividends, make distributions or transfer assets;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.7%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">make investments or other restricted payments;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.7%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">sell or otherwise dispose of assets;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.7%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">enter into sale-leaseback transactions;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.7%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">engage in transactions with stockholders and affiliates;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.7%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">issue or sell stock of our subsidiaries; or</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.7%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">effect a consolidation or merger;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.7%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">whether the indenture will require us to maintain any interest coverage, fixed charge, cash flow-based, asset-based or other financial ratios;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.7%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">a discussion of any material United States federal income tax considerations applicable to the debt securities;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.7%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">information describing any book-entry features;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.7%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">provisions for a sinking fund purchase or other analogous fund, if any;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.7%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">the applicability of the provisions in the indenture on discharge;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.7%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">whether the debt securities are to be offered at a price such that they will be deemed to be offered at an &#8220;original issue discount&#8221;&#160;as defined in paragraph (a) of Section 1273 of the Internal Revenue Code;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.7%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">the denominations in which we will issue the series of debt securities, if other than denominations of $1,000 and any integral multiple thereof;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.7%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">the currency of payment of debt securities if other than U.S. dollars and the manner of determining the equivalent amount in U.S. dollars; and</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.7%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">any other specific terms, preferences, rights or limitations of, or restrictions on, the debt securities, including any additional events of default or covenants provided with respect to the debt securities, and any terms that may be required by us or advisable under applicable laws or regulations.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: Times New Roman;">8</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Conversion or Exchange Rights</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We will set forth in the prospectus supplement the terms on which a series of debt securities may be convertible into or exchangeable for our Common Stock or our other securities. We will include provisions as to whether conversion or exchange is mandatory, at the option of the holder or at our option. We may include provisions pursuant to which the number of shares of our Common Stock or our other securities that the holders of the series of debt securities receive would be subject to adjustment.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Consolidation, Merger or Sale</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Unless we provide otherwise in the prospectus supplement applicable to a particular series of debt securities, the indentures will not contain any covenant that restricts our ability to merge or consolidate, or sell, convey, transfer or otherwise dispose of all or substantially all of our assets. However, any successor to or acquirer of such assets must assume all of our obligations under the indentures or the debt securities, as appropriate. If the debt securities are convertible into or exchangeable for our other securities or securities of other entities, the person with whom we consolidate or merge or to whom we sell all of our property must make provisions for the conversion of the debt securities into securities that the holders of the debt securities would have received if they had converted the debt securities before the consolidation, merger or sale.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Events of Default Under the Indenture</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Unless we provide otherwise in the prospectus supplement applicable to a particular series of debt securities, the following are events of default under the indentures with respect to any series of debt securities that we may issue:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">if we fail to pay interest when due and payable and our failure continues for 90 days and the time for payment has not been extended or deferred;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">if we fail to pay the principal, premium or sinking fund payment, if any, when due and payable and the time for payment has not been extended or delayed;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">if we fail to observe or perform any other covenant contained in the debt securities or the indentures, other than a covenant specifically relating to another series of debt securities, and our failure continues for 90 days after we receive notice from the debenture trustee or holders of at least 25% in aggregate principal amount of the outstanding debt securities of the applicable series; and</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">if specified events of bankruptcy, insolvency or reorganization occur.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">If an event of default with respect to debt securities of any series occurs and is continuing, other than an event of default specified in the last bullet point above, the debenture trustee or the holders of at least 25% in aggregate principal amount of the outstanding debt securities of that series, by notice to us in writing, and to the debenture trustee if notice is given by such holders, may declare the unpaid principal of, premium, if any, and accrued interest, if any, due and payable immediately. If an event of default specified in the last bullet point above occurs with respect to us, the principal amount of and accrued interest, if any, of each issue of debt securities then outstanding shall be due and payable without any notice or other action on the part of the debenture trustee or any holder.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The holders of a majority in principal amount of the outstanding debt securities of an affected series may waive any default or event of default with respect to the series and its consequences, except defaults or events of default regarding payment of principal, premium, if any, or interest, unless we have cured the default or event of default in accordance with the indenture. Any waiver shall cure the default or event of default.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Subject to the terms of the indentures, if an event of default under an indenture shall occur and be continuing, the debenture trustee will be under no obligation to exercise any of its rights or powers under such indenture at the request or direction of any of the holders of the applicable series of debt securities, unless such holders have offered the debenture trustee reasonable indemnity. The holders of a majority in principal amount of the outstanding debt securities of any series will have the right to direct the time, method and place of conducting any proceeding for any remedy available to the debenture trustee, or exercising any trust or power conferred on the debenture trustee, with respect to the debt securities of that series, provided that:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">the direction so given by the holder is not in conflict with any law or the applicable indenture; and</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">subject to its duties under the Trust Indenture Act of 1939, the debenture trustee need not take any action that might involve it in personal liability or might be unduly prejudicial to the holders not involved in the proceeding.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">A holder of the debt securities of any series will have the right to institute a proceeding under the indentures or to appoint a receiver or trustee, or to seek other remedies only if:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">the holder has given written notice to the debenture trustee of a continuing event of default with respect to that series;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">the holders of at least 25% in aggregate principal amount of the outstanding debt securities of that series have made written request, and such holders have offered reasonable indemnity to the debenture trustee to institute the proceeding as trustee; and</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">the debenture trustee does not institute the proceeding, and does not receive from the holders of a majority in aggregate principal amount of the outstanding debt securities of that series other conflicting directions within 90 days after the notice, request and offer.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">These limitations do not apply to a suit instituted by a holder of debt securities if we default in the payment of the principal, premium, if any, or interest on, the debt securities.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We will periodically file statements with the debenture trustee regarding our compliance with specified covenants in the indentures.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: Times New Roman;">9</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Modification of Indenture; Waiver</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We and the debenture trustee may change an indenture without the consent of any holders with respect to specific matters to:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">fix any ambiguity, defect or inconsistency in the indenture;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">comply with provisions described above under &#8220;Description of Debt Securities - Consolidation, Merge or Sale;&#8221;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">comply with any requirements of the Commission in connection with the qualification of any indenture under the Trust Indenture Act of 1939;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">provide for the issuance of and establish the form and terms and conditions of the debt securities of any series as provided under &#8220;Description of Debt Securities - General&#8221;&#160;to establish the form of any certifications required;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">be furnished pursuant to the terms of the indenture or any series of debt securities, or to add to the rights of the holders of any series of debt securities;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">evidence and provide for the acceptance of appointment hereunder by a successor trustee;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">provide for uncertificated debt securities in addition to or in place of certificated debt securities and to make all appropriate changes for such purpose;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">add to our covenants such new covenants, restrictions, conditions or provisions for the protection of the holders, and to make the occurrence, or the occurrence and the continuance, of a default in any such additional covenants, restrictions, conditions or provisions an event of default; or</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">change anything that does not materially adversely affect the interests of any holder of debt securities of any series.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">In addition, under the indentures, the rights of holders of a series of debt securities may be changed by us and the debenture trustee with the written consent of the holders of at least a majority in aggregate principal amount of the outstanding debt securities of each series that is affected. However, unless we provide otherwise in the prospectus supplement applicable to a particular series of debt securities, we and the debenture trustee may make the following changes only with the consent of each holder of any outstanding debt securities affected:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">extending the fixed maturity of the series of debt securities;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">reducing the principal amount, reducing the rate of or extending the time of payment of interest, or reducing any premium payable upon the redemption of any debt securities; or</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">reducing the percentage of debt securities, the holders of which are required to consent to any amendment, supplement, modification or waiver.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Discharge</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Each indenture provides that we can elect to be discharged from our obligations with respect to one or more series of debt securities, except for specified obligations, including obligations to:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">register the transfer or exchange of debt securities of the series;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">replace stolen, lost or mutilated debt securities of the series;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">maintain paying agencies;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">hold monies for payment in trust;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">recover excess money held by the debenture trustee;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">compensate and indemnify the debenture trustee; and</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">appoint any successor trustee.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">In order to exercise our rights to be discharged, we must deposit with the debenture trustee money or government obligations sufficient to pay all the principal of, any premium, if any, and interest on, the debt securities of the series on the dates payments are due.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Form, Exchange and Transfer</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We will issue the debt securities of each series only in fully registered form without coupons and, unless we provide otherwise in the applicable prospectus supplement, in denominations of $1,000 and any integral multiple thereof. The indentures provide that we may issue debt securities of a series in temporary or permanent global form and as book-entry securities that will be deposited with, or on behalf of, The Depository Trust Company or another depositary named by us and identified in a prospectus supplement with respect to that series. See &#8220;Legal Ownership of Securities&#8221; for a further description of the terms relating to any book-entry securities.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">At the option of the holder, subject to the terms of the indentures and the limitations applicable to global securities described in the applicable prospectus supplement, the holder of the debt securities of any series can exchange the debt securities for other debt securities of the same series, in any authorized denomination and of like tenor and aggregate principal amount.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Subject to the terms of the indentures and the limitations applicable to global securities set forth in the applicable prospectus supplement, holders of the debt securities may present the debt securities for exchange or for registration of transfer, duly endorsed or with the form of transfer endorsed thereon duly executed if so required by us or the security registrar, at the office of the security registrar or at the office of any transfer agent designated by us for this purpose. Unless otherwise provided in the debt securities that the holder presents for transfer or exchange, we will impose no service charge for any registration of transfer or exchange, but we may require payment of any taxes or other governmental charges.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We will name in the applicable prospectus supplement the security registrar, and any transfer agent in addition to the security registrar, that we initially designate for any debt securities. We may at any time designate additional transfer agents or rescind the designation of any transfer agent or approve a change in the office through which any transfer agent acts, except that we will be required to maintain a transfer agent in each place of payment for the debt securities of each series.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">If we elect to redeem the debt securities of any series, we will not be required to:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">issue, register the transfer of, or exchange any debt securities of that series during a period beginning at the opening of business 15 days before the day of mailing of a notice of redemption of any debt securities that may be selected for redemption and ending at the close of business on the day of the mailing; or</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">register the transfer of or exchange any debt securities so selected for redemption, in whole or in part, except the unredeemed portion of any debt securities we are redeeming in part.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: Times New Roman;">10</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Information Concerning the Debenture Trustee</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The debenture trustee, other than during the occurrence and continuance of an event of default under an indenture, undertakes to perform only those duties as are specifically set forth in the applicable indenture. Upon an event of default under an indenture, the debenture trustee must use the same degree of care as a prudent person would exercise or use in the conduct of his or her own affairs. Subject to this provision, the debenture trustee is under no obligation to exercise any of the powers given it by the indentures at the request of any holder of debt securities unless it is offered reasonable security and indemnity against the costs, expenses and liabilities that it might incur.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Payment and Paying Agents</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Unless we otherwise indicate in the applicable prospectus supplement, we will make payment of the interest on any debt securities on any interest payment date to the person in whose name the debt securities, or one or more predecessor securities, are registered at the close of business on the regular record date for the interest.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We will pay principal of and any premium and interest on the debt securities of a particular series at the office of the paying agents designated by us, except that unless we otherwise indicate in the applicable prospectus supplement, we will make interest payments by check that we will mail to the holder or by wire transfer to certain holders. Unless we otherwise indicate in the applicable prospectus supplement, we will designate the corporate trust&#160;office of the debenture trustee in the City of New York as our sole paying agent for payments with respect to debt securities of each series. We will name in the applicable prospectus supplement any other paying agents that we initially designate for the debt securities of a particular series. We will maintain a paying agent in each place of payment for the debt securities of a particular series.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">All money we pay to a paying agent or the debenture trustee for the payment of the principal of or any premium or interest on any debt securities that remains unclaimed at the end of two years after such principal, premium or interest has become due and payable will be repaid to us, and the holder of the debt security thereafter may look only to us for payment thereof.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Governing Law</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The indentures and the debt securities will be governed by and construed in accordance with the laws of the State of New York, except to the extent that the Trust Indenture Act of 1939 is applicable.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Subordination of Subordinated Debt Securities</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The subordinated debt securities will be unsecured and will be subordinate and junior in priority of payment to certain of our other indebtedness to the extent described in a prospectus supplement. The subordinated indenture does not limit the amount of subordinated debt securities that we may issue, nor does it limit us from issuing any other secured or unsecured debt.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><a id="RIGHTS" href="#"></a>DESCRIPTION OF RIGHTS</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>General</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We may issue rights to our stockholders to purchase shares of our Common Stock, preferred stock or the other securities described in this prospectus. We may offer rights separately or together with one or more additional rights, debt securities, preferred stock, Common Stock, warrants or any combination of those securities in the form of units, as described in the applicable prospectus supplement. Each series of rights will be issued under a separate rights agreement to be entered into between us and a bank or trust company, as rights agent. The rights agent will act solely as our agent in connection with the certificates relating to the rights of the series of certificates and will not assume any obligation or relationship of agency or trust for or with any holders of rights certificates or beneficial owners of rights. The following description sets forth certain general terms and provisions of the rights to which any prospectus supplement may relate. The particular terms of the rights to which any prospectus supplement may relate and the extent, if any, to which the general provisions may apply to the rights so offered will be described in the applicable prospectus supplement. To the extent that any particular terms of the rights, rights agreement or rights certificates described in a prospectus supplement differ from any of the terms described below, then the terms described below will be deemed to have been superseded by that prospectus supplement. We encourage you to read the applicable rights agreement and rights certificate for additional information before you decide whether to purchase any of our rights. We will provide in a prospectus supplement the following terms of the rights being issued:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">the date of determining the stockholders entitled to the rights distribution;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">the aggregate number of shares of Common Stock, preferred stock or other securities purchasable upon exercise of the rights;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">the exercise price;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">the aggregate number of rights issued;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">whether the rights are transferrable and the date, if any, on and after which the rights may be separately transferred;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">the date on which the right to exercise the rights will commence, and the date on which the right to exercise the rights will expire;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">the method by which holders of rights will be entitled to exercise;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">the conditions to the completion of the offering, if any;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">the withdrawal, termination and cancellation rights, if any;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">whether there are any backstop or standby purchaser or purchasers and the terms of their commitment, if any;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">whether stockholders are entitled to oversubscription rights, if any;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">any applicable U.S. federal income tax considerations; and</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">any other terms of the rights, including terms, procedures and limitations relating to the distribution, exchange and exercise of the rights, as applicable.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: Times New Roman;">11</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Each right will entitle the holder of rights to purchase for cash the amount of shares of Common Stock, preferred stock or other securities at the exercise price provided in the applicable prospectus supplement. Rights may be exercised at any time up to the close of business on the expiration date for the rights provided in the applicable prospectus supplement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Holders may exercise rights as described in the applicable prospectus supplement. Upon receipt of payment and the rights certificate properly completed and duly executed at the corporate trust office of the rights agent or any other office indicated in the prospectus supplement, we will, as soon as practicable, forward the shares of common stock, preferred stock or other securities, as applicable, purchasable upon exercise of the rights. If less than all of the rights issued in any rights offering are exercised, we may offer any unsubscribed securities directly to persons other than stockholders, to or through agents, underwriters or dealers or through a combination of such methods, including pursuant to standby arrangements, as described in the applicable prospectus supplement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Rights Agent</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The rights agent for any rights we offer will be set forth in the applicable prospectus supplement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><a id="WARRANTS" href="#"></a>DESCRIPTION OF WARRANTS</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We may issue warrants for the purchase of Common Stock, preferred stock and/or debt securities in one or more series. We may issue warrants independently or together with Common Stock, preferred stock and/or debt securities, and the warrants may be attached to or separate from these securities. While the terms summarized below will apply generally to any warrants that we may offer, we will describe the particular terms of any series of warrants in more detail in the applicable prospectus supplement. The terms of any warrants offered under a prospectus supplement may differ from the terms described below.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We will file as exhibits to the registration statement of which this prospectus is a part, or will incorporate by reference from reports that we file with the Commission, the form of warrant agreement, including a form of warrant certificate, that describes the terms of the particular series of warrants we are offering before the issuance of the related series of warrants. The following summaries of material provisions of the warrants and the warrant agreements are subject to, and qualified in their entirety by reference to, all the provisions of the warrant agreement and warrant certificate applicable to the particular series of warrants that we may offer under this prospectus. We urge you to read the applicable prospectus supplements related to the particular series of warrants that we may offer under this prospectus, as well as any related free writing prospectuses, and the complete warrant agreements and warrant certificates that contain the terms of the warrants.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>General</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We will describe in the applicable prospectus supplement the terms of the series of warrants being offered, including:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">the offering price and aggregate number of warrants offered;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">the currency for which the warrants may be purchased;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">if applicable, the designation and terms of the securities with which the warrants are issued and the number of warrants issued with each such security or each principal amount of such security;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">if applicable, the date on and after which the warrants and the related securities will be separately transferable;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">in the case of warrants to purchase debt securities, the principal amount of debt securities purchasable upon exercise of one warrant and the price at, and currency in which, this principal amount of debt securities may be purchased upon such exercise;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">in the case of warrants to purchase Common Stock or preferred stock, the number of shares of Common Stock or preferred stock, as the case may be, purchasable upon the exercise of one warrant and the price at which these shares may be purchased upon such exercise;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">the effect of any merger, consolidation, sale or other disposition of our business on the warrant agreements and the warrants;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">the terms of any rights to redeem or call the warrants;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">any provisions for changes to or adjustments in the exercise price or number of securities issuable upon exercise of the warrants;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">the dates on which the right to exercise the warrants will commence and expire;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">the manner in which the warrant agreements and warrants may be modified;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">a discussion of any material or special United States federal income tax consequences of holding or exercising the warrants;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">the terms of the securities issuable upon exercise of the warrants; and</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">any other specific terms, preferences, rights or limitations of or restrictions on the warrants.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Before exercising their warrants, holders of warrants will not have any of the rights of holders of the securities purchasable upon such exercise, including:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">in the case of warrants to purchase debt securities, the right to receive payments of principal of, or premium, if any, or interest on, the debt securities purchasable upon exercise or to enforce covenants in the applicable indenture; or</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">in the case of warrants to purchase Common Stock or preferred stock, the right to receive dividends, if any, or payments upon our liquidation, dissolution or winding up or to exercise voting rights, if any.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: Times New Roman;">12</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Exercise of Warrants</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Each warrant will entitle the holder to purchase the securities that we specify in the applicable prospectus supplement at the exercise price that we describe in the applicable prospectus supplement. Holders of the warrants may exercise the warrants at any time up to the specified time on the expiration date that we set forth in the applicable prospectus supplement. After the close of business on the expiration date, unexercised warrants will become void.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Holders of the warrants may exercise the warrants by delivering the warrant certificate representing the warrants to be exercised together with specified information, and paying the required amount to the warrant agent in immediately available funds, as provided in the applicable prospectus supplement. We will set forth on the reverse side of the warrant certificate and in the applicable prospectus supplement the information that the holder of the warrant will be required to deliver to the warrant agent.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Upon receipt of the required payment and the warrant certificate properly completed and duly executed at the corporate trust office of the warrant agent or any other office indicated in the applicable prospectus supplement, we will issue and deliver the securities purchasable upon such exercise. If fewer than all of the warrants represented by the warrant certificate are exercised, then we will issue a new warrant certificate for the remaining amount of warrants. If we so indicate in the applicable prospectus supplement, holders of the warrants may surrender securities as all or part of the exercise price for warrants.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Governing Law</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Unless we provide otherwise in the applicable prospectus supplement, the warrants and warrant agreements will be governed by and construed in accordance with the laws of the State of New York.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Enforceability of Rights by Holders of Warrants</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Each warrant agent will act solely as our agent under the applicable warrant agreement and will not assume any obligation or relationship of agency or trust with any holder of any warrant. A single bank or trust company may act as warrant agent for more than one issue of warrants. A warrant agent will have no duty or responsibility in case of any default by us under the applicable warrant agreement or warrant, including any duty or responsibility to initiate any proceedings at law or otherwise, or to make any demand upon us. Any holder of a warrant may, without the consent of the related warrant agent or the holder of any other warrant, enforce by appropriate legal action its right to exercise, and receive the securities purchasable upon exercise of, its warrants.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><a id="UNITS" href="#"></a>DESCRIPTION OF UNITS</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We may issue, in one more series, units consisting of Common Stock, preferred stock, debt securities and/or warrants for the purchase of Common Stock, preferred stock and/or debt securities in any combination. While the terms we have summarized below will apply generally to any units that we may offer under this prospectus, we will describe the particular terms of any series of units in more detail in the applicable prospectus supplement. The terms of any units offered under a prospectus supplement may differ from the terms described below.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We will file as exhibits to the registration statement of which this prospectus is a part, or will incorporate by reference from reports that we file with the Commission, the form of unit agreement that describes the terms of the series of units we are offering, and any supplemental agreements, before the issuance of the related series of units. The following summaries of material terms and provisions of the units are subject to, and qualified in their entirety by reference to, all the provisions of the unit agreement and any supplemental agreements applicable to a particular series of units. We urge you to read the applicable prospectus supplements related to the particular series of units that we may offer under this prospectus, as well as any related free writing prospectuses and the complete unit agreement and any supplemental agreements that contain the terms of the units.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: Times New Roman;">13</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>General</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We will issue each unit so that the holder of the unit is also the holder of each security included in the unit. Thus, the holder of a unit will have the rights and obligations of a holder of each included security. The unit agreement under which we issue a unit may provide that the securities included in the unit may not be held or transferred separately, at any time or at any time before a specified date.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We will describe in the applicable prospectus supplement the terms of the series of units being offered, including:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">the designation and terms of the units and of the securities comprising the units, including whether and under what circumstances those securities may be held or transferred separately;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">any provisions of the governing unit agreement that differ from those described below; and</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">any provisions for the issuance, payment, settlement, transfer or exchange of the units or of the securities comprising the units.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The provisions described in this section, as well as those described under &#8220;Description of Common Stock,&#8221; &#8220;Description of Preferred Stock,&#8221; &#8220;Description of Debt Securities&#8221; and &#8220;Description of Warrants&#8221; will apply to each unit and to any Common stock, preferred stock, debt security or warrant included in each unit, respectively.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Issuance in Series</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We may issue units in such amounts and in such numerous distinct series as we determine.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Enforceability of Rights by Holders of Units</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Each unit agent will act solely as our agent under the applicable unit agreement and will not assume any obligation or relationship of agency or trust with any holder of any unit. A single bank or trust company may act as unit agent for more than one series of units. A unit agent will have no duty or responsibility in case of any default by us under the applicable unit agreement or unit, including any duty or responsibility to initiate any proceedings at law or otherwise, or to make any demand upon us. Any holder of a unit may, without the consent of the related unit agent or the holder of any other unit, enforce by appropriate legal action its rights as holder under any security included in the unit.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We, and any unit agent and any of their agents, may treat the registered holder of any unit certificate as an absolute owner of the units evidenced by that certificate for any purpose and as the person entitled to exercise the rights attaching to the units so requested, despite any notice to the contrary. See &#8220;Legal Ownership of Securities&#8221; below.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><a id="LEGAL_OWNERSHIP" href="#"></a>LEGAL OWNERSHIP OF SECURITIES</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We can issue securities in definitive form or in the form of one or more global securities. We describe global securities in greater detail below. We refer to those persons who have securities registered in their own names on the books that we or any applicable trustee, depositary or warrant agent maintain for this purpose as the &#8220;holders&#8221; of those securities. These persons are the legal holders of the securities. We refer to those persons who, indirectly through others, own beneficial interests in securities that are not registered in their own names, as &#8220;indirect holders&#8221; of those securities. As we discuss below, indirect holders are not legal holders, and investors in securities issued in book-entry form or in street name will be indirect holders.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Book-Entry Holders</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We may issue securities in book-entry form only, as we will specify in the applicable prospectus supplement. This means securities may be represented by one or more global securities registered in the name of a financial institution that holds them as depositary on behalf of other financial institutions that participate in the depositary&#8217;s book-entry system. These participating institutions, which are referred to as participants, in turn, hold beneficial interests in the securities on behalf of themselves or their customers.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Only the person in whose name a security is registered is recognized as the holder of that security. Securities issued in global form will be registered in the name of the depositary or its participants. Consequently, for securities issued in global form, we will recognize only the depositary as the holder of the securities, and we will make all payments on the securities to the depositary. The depositary passes along the payments it receives to its participants, which in turn pass the payments along to their customers who are the beneficial owners. The depositary and its participants do so under agreements they have made with one another or with their customers; they are not obligated to do so under the terms of the securities.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: Times New Roman;">14</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">As a result, investors in a book-entry security will not own securities directly. Instead, they will own beneficial interests in a global security, through a bank, broker or other financial institution that participates in the depositary&#8217;s book-entry system or holds an interest through a participant. As long as the securities are issued in global form, investors will be indirect holders, and not holders, of the securities.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Street Name Holders</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We may terminate a global security or issue securities in non-global form. In these cases, investors may choose to hold their securities in their own names or in &#8220;street name.&#8221; Securities held by an investor in street name would be registered in the name of a bank, broker or other financial institution that the investor chooses, and the investor would hold only a beneficial interest in those securities through an account he or she maintains at that institution.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">For securities held in street name, we will recognize only the intermediary banks, brokers and other financial institutions in whose names the securities are registered as the holders of those securities, and we will make all payments on those securities to them. These institutions pass along the payments they receive to their customers who are the beneficial owners, but only because they agree to do so in their customer agreements or because they are legally required to do so. Investors who hold securities in street name will be indirect holders, not holders, of those securities.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Legal Holders</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our obligations, as well as the obligations of any applicable trustee and of any third parties employed by us or a trustee, run only to the legal holders of the securities. We do not have obligations to investors who hold beneficial interests in global securities, in street name or by any other indirect means. This will be the case whether an investor chooses to be an indirect holder of a security or has no choice because we are issuing the securities only in global form.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">For example, once we make a payment or give a notice to the holder, we have no further responsibility for the payment or notice even if that holder is required, under agreements with depositary participants or customers or by law, to pass it along to the indirect holders but does not do so. Similarly, we may want to obtain the approval of the holders to amend an indenture, to relieve us of the consequences of a default or of our obligation to comply with a particular provision of the indenture or for other purposes. In such an event, we would seek approval only from the holders, and not the indirect holders, of the securities. Whether and how the holders contact the indirect holders is up to the holders.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Special Considerations For Indirect Holders</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">If you hold securities through a bank, broker or other financial institution, either in book-entry form or in street name, you should check with your own institution to find out:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">how it handles securities payments and notices;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">whether it imposes fees or charges;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">how it would handle a request for the holders&#8217;&#160;consent, if ever required;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">whether and how you can instruct it to send you securities registered in your own name so you can be a holder, if that is permitted in the future;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">how it would exercise rights under the securities if there were a default or other event triggering the need for holders to act to protect their interests; and</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">if the securities are in book-entry form, how the depositary&#8217;s rules and procedures will affect these matters.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Global Securities</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">A global security is a security that represents one or any other number of individual securities held by a depositary. Generally, all securities represented by the same global securities will have the same terms.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Each security issued in book-entry form will be represented by a global security that we deposit with and register in the name of a financial institution or its nominee that we select. The financial institution that we select for this purpose is called the depositary. Unless we specify otherwise in the applicable prospectus supplement, The Depository Trust Company, New York, New York, known as DTC, will be the depositary for all securities issued in book-entry form.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">A global security may not be transferred to or registered in the name of anyone other than the depositary, its nominee or a successor depositary, unless special termination situations arise. We describe those situations below under &#8220;Special Situations When a Global Security Will Be Terminated.&#8221; As a result of these arrangements, the depositary, or its nominee, will be the sole registered owner and holder of all securities represented by a global security, and investors will be permitted to own only beneficial interests in a global security. Beneficial interests must be held by means of an account with a broker, bank or other financial institution that in turn has an account with the depositary or with another institution that does. Thus, an investor whose security is represented by a global security will not be a holder of the security, but only an indirect holder of a beneficial interest in the global security.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">If the prospectus supplement for a particular security indicates that the security will be issued in global form only, then the security will be represented by a global security at all times unless and until the global security is terminated. If termination occurs, we may issue the securities through another book-entry clearing system or decide that the securities may no longer be held through any book-entry clearing system.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: Times New Roman;">15</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Special Considerations For Global Securities</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The rights of an indirect holder relating to a global security will be governed by the account rules of the investor&#8217;s financial institution and of the depositary, as well as general laws relating to securities transfers. We do not recognize an indirect holder as a holder of securities and instead deal only with the depositary that holds the global security.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">If securities are issued only in the form of a global security, an investor should be aware of the following:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">an investor cannot cause the securities to be registered in his or her name, and cannot obtain non-global certificates for his or her interest in the securities, except in the special situations we describe below;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">an investor will be an indirect holder and must look to his or her own bank or broker for payments on the securities and protection of his or her legal rights relating to the securities, as we describe above;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">an investor may not be able to sell interests in the securities to some insurance companies and to other institutions that are required by law to own their securities in non-book-entry form;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">an investor may not be able to pledge his or her interest in a global security in circumstances where certificates representing the securities must be delivered to the lender or other beneficiary of the pledge in order for the pledge to be effective;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">the depositary&#8217;s policies, which may change from time to time, will govern payments, transfers, exchanges and other matters relating to an investor&#8217;s interest in a global security;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">we and any applicable trustee have no responsibility for any aspect of the depositary&#8217;s actions or for its records of ownership interests in a global security, nor do we or any applicable trustee supervise the depositary in any way;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">the depositary may, and we understand that DTC will, require that those who purchase and sell interests in a global security within its book-entry system use immediately available funds, and your broker or bank may require you to do so as well; and</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">financial institutions that participate in the depositary&#8217;s book-entry system, and through which an investor holds its interest in a global security, may also have their own policies affecting payments, notices and other matters relating to the securities.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">There may be more than one financial intermediary in the chain of ownership for an investor. We do not monitor and are not responsible for the actions of any of those intermediaries.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Special Situations When a Global Security Will Be Terminated</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">In a few special situations described below, the global security will terminate and interests in it will be exchanged for physical certificates representing those interests. After that exchange, the choice of whether to hold securities directly or in street name will be up to the investor. Investors must consult their own banks or brokers to find out how to have their interests in securities transferred to their own name, so that they will be direct holders. We have described the rights of holders and street name investors above.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Unless we provide otherwise in the applicable prospectus supplement, the global security will terminate when the following special situations occur:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: top; width: 11px;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align: top; width: 2668px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">if the depositary notifies us that it is unwilling, unable or no longer qualified to continue as depositary for that global security and we do not appoint another institution to act as depositary within 90 days;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 11px;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align: top; width: 2668px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">if we notify any applicable trustee that we wish to terminate that global security; or</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 11px;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align: top; width: 2668px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">if an event of default has occurred with regard to securities represented by that global security and has not been cured or waived.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The prospectus supplement may also list additional situations for terminating a global security that would apply only to the particular series of securities covered by the applicable prospectus supplement. When a global security terminates, the depositary, and not we or any applicable trustee, is responsible for deciding the names of the institutions that will be the initial direct holders.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><a id="PLAN_OF_DIST" href="#"></a>PLAN OF DISTRIBUTION</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We may sell the securities covered by this prospectus from time to time. Registration of the securities covered by this prospectus does not mean, however, that those securities will necessarily be offered or sold. We may sell the securities separately or together: through one or more underwriters in a public offering and sale by them; directly to investors (in those jurisdictions where we are authorized to do so); in &#8220;at the market offerings,&#8221; within the meaning of Rule 415(a)(4) of the Securities Act, to or through a market maker or into an existing trading market on an exchange or otherwise; through agents; or through a combination of any of these methods of sale, or through any other method permitted by applicable law and described in the applicable prospectus supplement. We may sell the securities from time to time: in one or more transactions at a fixed price or prices that may be changed from time to time; at market prices prevailing at the time of sale; at prices related to prevailing market prices; or at negotiated prices. We will describe the method of distribution of the securities and the terms of the offering in the applicable prospectus supplement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">If underwriters are used for the sale of any securities, the securities will be acquired by the underwriters for their own account and may be resold from time to time in one or more transactions described above. The securities may be either offered to the public through underwriting syndicates represented by managing underwriters, or directly by underwriters. Generally, the underwriters&#8217; obligations to purchase the securities will be subject to conditions precedent and the underwriters will be obligated to purchase all of the securities if they purchase any of the securities. We may grant underwriters who participate in the distribution of securities an option to purchase additional securities in connection with the distribution. Any underwriter or agent involved in the offer and sale of the securities will be named in the related prospectus supplement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Underwriters may offer and sell the securities at a fixed price or prices that may be changed, at market prices prevailing at the time of sale, at prices related to prevailing market prices, or at negotiated prices. We also may, from time to time, authorize dealers, acting as our agents, to offer and sell the securities upon the terms and conditions described in the related prospectus supplement. Underwriters may receive compensation from us in the form of underwriting discounts or commissions and may also receive commissions from purchasers of the securities for whom they may act as agent. Underwriters may sell the securities to or through dealers, and the dealers may receive compensation in the form of discounts, concessions or commissions from the underwriters or commissions, which may be changed from time to time, from the purchasers for whom they may act as agents.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: Times New Roman;">16</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Any underwriting compensation paid by us to underwriters or agents in connection with the offering of the securities, and any discounts, concessions or commissions allowed by underwriters to participating dealers, will be stated in the related prospectus supplement. Dealers and agents participating in the distribution of the securities may be deemed to be underwriters, and any discounts and commissions received by them and any profit realized by them on resale of the securities may be deemed to be underwriting discounts and commissions under the applicable securities laws.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Shares of our Common Stock are quoted on the NYSE AMERICAN. In connection with any offering of securities, the underwriters may purchase and sell securities in the open market and engage in over-allotment transactions, short-covering transactions, penalty bids and stabilizing transactions in accordance with Regulation M under the Exchange Act. Over-allotment involves sales of securities in excess of the offering size of securities to be purchased by the underwriters in an offering, which creates a short position for the underwriters. Short-covering transactions involve purchases of the securities in the open market after the distribution has been completed in order to cover short positions. Penalty bids permit the underwriters to reclaim a selling concession from a dealer when the securities originally sold by the dealer are purchased in a covering transaction to cover short positions. Stabilizing transactions consist of certain bids or purchases of securities made for the purpose of preventing or retarding a decline in the market price of the securities while the offering is in progress. Any of these activities may have the effect of preventing or retarding a decline in the market price of the securities being offered. They may also cause the price of the securities being offered to be higher than the price that otherwise would exist in the open market in the absence of these transactions. The underwriters may conduct these transactions in the over-the-counter market or otherwise. If the underwriters commence any of these transactions, they may discontinue them at any time. We make no representation as to the direction or magnitude of any affect that such transactions may have on the price of the securities.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Underwriters, dealers and agents may be entitled, under agreements entered into with us to indemnification by us against certain civil liabilities, including liabilities under the Securities Act, or to contribution with respect to payments made by such underwriters, dealers or agents related to such civil liabilities.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Certain of the underwriters, dealers or agents and their associates may engage in transactions with, and perform other services for us in the ordinary course of business for which they may receive compensation.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><a id="VALIDITY" href="#"></a>VALIDITY OF THE SECURITIES</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The validity of the securities offered and to be offered hereby and certain other legal matters will be passed upon for us by McDonald Carano LLP,&#160;Reno, Nevada. Counsel for any underwriter or agent will be named in the applicable prospectus supplement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><a id="EXPERTS" href="#"></a>EXPERTS</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">The consolidated financial statements as of and&#160;for the years ended December&#160;31, 2024 and 2023 incorporated in this prospectus by reference to the Form&#160;10-K have been so incorporated in reliance on the report of Assure CPA, LLC., an independent registered public accounting firm, given on the authority of said firm as experts in auditing and accounting.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: Times New Roman;">17</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<div>&#160;</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 100%;">

		<tbody><tr>
			<td style="width: 100%; border: 3px double black; text-align: justify;"><span style="color:#ff0000;">The information in this prospectus supplement is not complete and may be changed. We may not sell these securities pursuant to this prospectus supplement until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus supplement is not an offer to sell these securities and it is not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.</span></td>
		</tr>

</tbody></table>

<div style="color: rgb(255, 0, 0); font-size: 10pt;">&#160;</div>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><span style="color:#ff0000;"><b>SUBJECT TO COMPLETION, DATED NOVEMBER 21, 2025</b></span></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>PROSPECTUS SUPPLEMENT</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="text-align:center;font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><img alt="logo02.jpg" src="logo02.jpg"/></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><b>Up to $100,000,000</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><b>Common Stock</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;">___________________________________</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">We have entered into an At the Market Offering Agreement (the&#160;&#8220;Sales Agreement&#8221;), with Titan Partners Group LLC, a division of American Capital Partners, LLC (&#8220;Titan Partners&#8221;), dated November 21, 2025, relating to shares of our common stock, par value $0.000666 per share (the&#160;&#8220;Common Stock&#8221;), offered by this prospectus supplement. In accordance with the terms of the Sales Agreement, we may offer and sell shares of our Common Stock having an aggregate offering price of up to $100,000,000 from time to time through&#160;Titan Partners, acting as our sales agent.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">Sales of our Common Stock, if any, under this prospectus supplement may be made by any method permitted that is deemed an &#8220;at the market offering&#8221; as defined in Rule 415 under the Securities Act of 1933, as amended (the&#160;&#8220;Securities Act&#8221;). Titan Partners is not required to sell any specific amount but will act as our sales agent and use commercially reasonable efforts to sell on our behalf the shares of our Common Stock requested to be sold by us, consistent with its normal trading and sales practices, on mutually agreed terms between Titan Partners and us. There is no arrangement for funds to be received in escrow, trust or similar arrangement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">Titan Partners will be entitled to compensation at a commission rate equal to 3.0% of the gross sales price per share of Common Stock sold through it as sales agent pursuant to the Sales Agreement. In connection with the sale of shares of our Common Stock on our behalf, Titan Partners will be deemed to be an &#8220;underwriter&#8221; within the meaning of the Securities Act and the compensation of Titan Partners will be deemed to be underwriting commissions or discounts. We have also agreed to provide indemnification and contribution to Titan Partners with respect to certain liabilities, including liabilities under the Securities Act. See &#8220;Plan of Distribution&#8221; beginning on page&#160;<a class="tocPGNUM" href="#plan">S-11</a> of this prospectus supplement regarding the compensation to be paid to Titan Partners.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">Our Common Stock is listed on the NYSE American under the symbol &#8220;LODE.&#8221;&#160;The last reported sale price of our Common Stock on the NYSE American on November 20, 2025 was $3.28&#160;per share.&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;"><b>Investing in our securities involves significant risk. Please read carefully the section entitled </b>&#8220;<b>Risk Factors</b>&#8221;<b> beginning on page <a class="tocPGNUM" href="#risk">S-9</a></b>&#160;<b>of this prospectus supplement.</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;"><b>Neither the Securities and Exchange Commission (the </b>&#8220;<b>Commission</b>&#8221;<b>) nor any state securities commission has approved or disapproved of the securities or determined if this prospectus supplement is truthful or complete. Any representation to the contrary is a criminal offense.</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><b>Titan Partners Group</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><i>a division of American Capital Partners</i></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;">The date of this prospectus supplement is &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; , 2025.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><b>TABLE OF CONTENTS </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><b>Prospectus Supplement</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:middle;width:auto;">&#160;</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Page</b></p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="#about" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">About This Prospectus Supplement</span></a></p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><a class="tocPGNUM" href="#about">S-1</a></p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="#where" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">Where You Can Find More Information</span></a></p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><a class="tocPGNUM" href="#where">S-2</a></p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="#incorp" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">Incorporation of Certain Documents by Reference</span></a></p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><a class="tocPGNUM" href="#incorp">S-2</a></p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="#prosup" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">Prospectus Supplement Summary</span></a></p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><a class="tocPGNUM" href="#prosup">S-3</a></p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="#forward" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">Cautionary Notice Regarding Forward-Looking Statements</span></a></p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><a class="tocPGNUM" href="#forward">S-7</a></p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="#offer" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">The Offering</span></a></p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><a class="tocPGNUM" href="#offer">S-8</a></p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="#risk" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">Risk Factors</span></a></p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><a class="tocPGNUM" href="#risk">S-9</a></p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="#use_of" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">Use of Proceeds</span></a></p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><a class="tocPGNUM" href="#use_of">S-10</a></p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="#desc" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">Description of Securities Being Offered</span></a></p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><a class="tocPGNUM" href="#desc">S-10</a></p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="#plan" style="-sec-extract:exhibit;">Plan<span style="text-decoration: underline; ">&#160;of Distribution</span></a></p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><a class="tocPGNUM" href="#plan">S-11</a></p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="#legal" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">Legal Matters</span></a></p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><a class="tocPGNUM" href="#legal">S-12</a></p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="#experts" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">Experts</span></a></p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><a class="tocPGNUM" href="#experts">S-12</a></p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div>&#160;</div>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><b><a id="about" href="#"></a>ABOUT THIS PROSPECTUS SUPPLEMENT</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-indent: 36pt; text-align: justify;">This prospectus supplement is part of a registration statement that we have filed with the U.S. Securities and Exchange Commission&#160;utilizing a &#8220;shelf&#8221; registration process. By using a shelf registration statement, we may offer shares of Common Stock under this prospectus supplement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-indent: 36pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-indent: 36pt; text-align: justify;">We provide information to you about this offering in two separate documents that are bound together: (1) this prospectus supplement, which describes the specific details regarding this offering; and (2) the accompanying prospectus, which provides general information, some of which may not apply to this offering. Generally, when we refer to this &#8220;prospectus,&#8221; we are referring to both documents combined. If information in this prospectus supplement is inconsistent with the accompanying prospectus, you should rely on this prospectus supplement. However, if any statement in one of these documents is inconsistent with a statement in another document having a later date, for example, a document incorporated by reference in this prospectus supplement, the statement in the document having the later date modifies or supersedes the earlier statement as our business, financial condition, results of operations and prospects may have changed since the earlier dates.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-indent: 36pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-indent: 36pt; text-align: justify;">You should rely only on the information contained in, or incorporated by reference into, this prospectus supplement, the accompanying prospectus and in any free writing prospectus that we may authorize for use in connection with this offering. We have not, and Titan Partners has not, authorized any other person to provide you with different information. If anyone provides you with different or inconsistent information, you should not rely on it. We are not, and the Investor is not, making an offer to sell or soliciting an offer to buy our securities in any jurisdiction where an offer or solicitation is not authorized or in which the person making that offer or solicitation is not qualified to do so or to anyone to whom it is unlawful to make an offer or solicitation. You should assume that the information appearing in this prospectus supplement, the accompanying prospectus, the documents incorporated by reference into this prospectus supplement, and in any free writing prospectus that we may authorize for use in connection with this offering, is accurate only as of the date of those respective documents. Our business, financial condition, results of operations and prospects may have changed since those dates. You should read this prospectus supplement, the accompanying prospectus, the documents incorporated by reference into this prospectus supplement, and any free writing prospectus that we may authorize for use in connection with this offering, in their entirety before making an investment decision. You should also read and consider the information in the documents to which we have referred you in the sections of this prospectus supplement entitled &#8220;Where You Can Find More Information&#8221; and &#8220;Incorporation by Reference.&#8221;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-indent: 36pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-indent: 36pt; text-align: justify;">We are offering to sell, and seeking offers to buy, securities only in jurisdictions where offers and sales are permitted. The distribution of this prospectus supplement, the accompanying prospectus and the offering of the securities in certain jurisdictions may be restricted by law. Persons outside the United States who come into possession of this prospectus supplement and the accompanying prospectus&#160;must inform themselves about, and observe any restrictions relating to, the offering of the securities and the distribution of this prospectus supplement and the accompanying prospectus outside the United States. Neither this prospectus supplement or the accompanying prospectus constitutes, and may not be used in connection with, an offer to sell, or a solicitation of an offer to buy, any securities offered by this prospectus supplement or the accompanying prospectus by any person in any jurisdiction in which it is unlawful for such person to make such an offer or solicitation.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-indent: 36pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-indent: 36pt; text-align: justify;">We may also authorize one or more &#8220;free writing prospectuses&#8221; (i.e., written communications concerning the offering that are not part of this prospectus supplement) that may contain certain material information relating to this offering. Before you invest in the securities offered under this prospectus supplement, you should carefully read both this prospectus supplement and the accompanying prospectus together with additional information under the heading &#8220;Where You Can Find More Information&#8221; and &#8220;Incorporation of Certain Documents by Reference.&#8221;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-indent: 36pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-indent: 36pt; text-align: justify;">References in this prospectus supplement and the accompanying prospectus to the terms &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our&#8221; &#8220;Comstock&#8221; or &#8220;the Company&#8221; or other similar terms mean Comstock Inc. and its consolidated subsidiaries, unless we state otherwise or the context indicates otherwise.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: Times New Roman;">S-1</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><b><a id="where" href="#"></a>WHERE YOU CAN FIND MORE INFORMATION</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">We are required to file periodic reports, proxy statements and other information relating to our business, financial and other matters with the Commission under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;). Our filings are available to the public over the Internet at the Commission&#8217;s website at http://www.sec.gov.&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">We have filed with the Commission a registration statement on Form S-3 under the Securities Act with respect to our securities described in this prospectus supplement. References to the &#8220;registration statement&#8221; or the &#8220;registration statement of which this prospectus supplement is a part&#8221; mean the original registration statement and all amendments, including all schedules and exhibits. This prospectus supplement does&#160;not contain all of the information in the registration statement because we have omitted parts of the registration statement in accordance with the rules of the Commission. Please refer to the registration statement for any information in the registration statement that is not contained in this prospectus supplement or the accompanying prospectus. The registration statement is available to the public over the Internet at the Commission&#8217;s website described above and can be read and copied at the locations described above.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">Each statement made in this prospectus supplement or the accompanying prospectus concerning a document filed as an exhibit to the registration statement is qualified in its entirety by reference to that exhibit for a complete description of its provisions.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">We make available, free of charge, on or through our website, copies of our proxy statements, our annual reports on Form 10-K, our quarterly reports on Form 10-Q, our current reports on Form 8-K and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act as soon as reasonably practicable after we electronically file them with or furnish them to the Commission. We maintain a website at <span style="text-decoration: underline; ">http://www.comstock.inc</span>. The information contained on our website is not part of this prospectus supplement, the accompanying prospectus or the registration statement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><b><a id="incorp" href="#"></a>INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 16pt;text-indent:27pt;">The Commission allows us to &#8220;incorporate by reference&#8221; information that we file with it. Incorporation by reference allows us to disclose important information to you by referring you to those other documents. The information incorporated by reference is an important part of this prospectus supplement, and information that we file later with the Commission will automatically update and supersede this information. This prospectus supplement omits certain information contained in the registration statement, as permitted by the Commission. You should refer to the registration statement, the accompanying prospectus&#160;and any prospectus supplement filed hereafter, including the exhibits, for further information about us and the securities offered by&#160;this prospectus supplement. Statements in this prospectus supplement or the accompanying prospectus regarding the provisions of certain documents filed with, or incorporated by reference in, the registration statement are not necessarily complete and each statement is qualified in all respects by that reference.&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 16pt;text-indent:27pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 16pt;text-indent:27pt;">We incorporate by reference the documents listed below and any future documents that we file with the Commission under Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act after the date of this prospectus supplement:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(a) Our annual report on <a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1120970/000143774925006453/lode20241231_10k.htm" style="-sec-extract:exhibit;">Form 10-K</a> for the fiscal year ended December 31, 2024, filed with the Commission on March 6, 2025 (the &#8220;Form 10-K&#8221;);</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(b) Our quarterly report on <a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1120970/000143774925015474/lode20250331_10q.htm" style="-sec-extract:exhibit;">Form 10-Q</a> for the fiscal quarter ended March 31, 2025, filed with the Commission on May 8, 2025 (the &#8220;First Quarter Form 10-Q&#8221;);</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(c) Our quarterly report on <a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/0001120970/000143774925026942/lode20250630_10q.htm" style="-sec-extract:exhibit;">Form 10-Q</a> for the fiscal quarter ended June 30, 2025, filed with the Commission on August 14, 2025 (the &#8220;Second Quarter Form 10-Q&#8221;);</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(d) Our quarterly report on <a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1120970/000143774925032230/lode20250930_10q.htm" style="-sec-extract:exhibit;">Form 10-Q</a> for the fiscal quarter ended September 30, 2025, filed with the Commission on October 30, 2025 (the &#8220;Third Quarter Form 10-Q,&#8221; and together with the First Quarter 10-Q and the Second Quarter 10-Q, the &#8220;Form 10-Qs&#8221;);</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(e) current reports on Form 8-K filed with the Commission on <a href="http://www.sec.gov/Archives/edgar/data/1120970/000143774925000902/lode20250108_8k.htm" style="-sec-extract:exhibit;">January 13, 2025</a> (with respect to Item 1.01 and Item 2.03), <a href="http://www.sec.gov/Archives/edgar/data/1120970/000143774925001450/lode20250120_8k.htm" style="-sec-extract:exhibit;">January 21, 2025</a>, <a href="http://www.sec.gov/Archives/edgar/data/1120970/000143774925002314/lode20250130_8k.htm" style="-sec-extract:exhibit;">January 31, 2025</a>, <a href="http://www.sec.gov/Archives/edgar/data/1120970/000143774925003068/lode20250206_8k.htm" style="-sec-extract:exhibit;">February 7, 2025</a>, <a href="http://www.sec.gov/Archives/edgar/data/1120970/000143774925003661/lode20250211_8k.htm" style="-sec-extract:exhibit;">February 13, 2025</a>, <a href="http://www.sec.gov/Archives/edgar/data/1120970/000143774925004211/lode20250213_8k.htm" style="-sec-extract:exhibit;">February 18, 2025</a>, <a href="http://www.sec.gov/Archives/edgar/data/1120970/000143774925004570/lode20250220_8k.htm" style="-sec-extract:exhibit;">February 20, 2025</a>, <a href="http://www.sec.gov/Archives/edgar/data/1120970/000143774925005571/lode20250227_8k.htm" style="-sec-extract:exhibit;">February 28, 2025</a>, <a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1120970/000143774925007109/lode20250311_8k.htm" style="-sec-extract:exhibit;">March 12, 2025</a>, <a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1120970/000143774925009023/lode20250320_8k.htm" style="-sec-extract:exhibit;">March 25, 2025</a>, <a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1120970/000143774925017218/lode20250515_8k.htm" style="-sec-extract:exhibit;">May 15, 2025</a>, <a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1120970/000143774925018373/lode20250515c_8k.htm" style="-sec-extract:exhibit;">May 27, 2025</a>, <a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1120970/000143774925018680/lode20250523_8k.htm" style="-sec-extract:exhibit;">May 28, 2025</a>, <a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/0001120970/000143774925019869/lode20250430_8k.htm" style="-sec-extract:exhibit;">June 9, 2025</a>, <a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1120970/000143774925020198/lode20250610_8k.htm" style="-sec-extract:exhibit;">June 12, 2025</a>,&#160;&#160;<a href="http://www.sec.gov/Archives/edgar/data/1120970/000143774925026275/lode20250808c_8k.htm" style="-sec-extract:exhibit;">August 12, 2025</a> (with respect to Item 1.01, Item 2.03, Item 3.02 and Item 5.02), and <a href="http://www.sec.gov/Archives/edgar/data/1120970/000143774925026920/lode20250808d_8k.htm" style="-sec-extract:exhibit;">August 14, 2025</a>&#160;(with respect to Item 1.01 and&#160;Item 3.02);</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(f) the description of our Common Stock contained in our <a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1120970/000143774925007109/lode20250311_8k.htm" style="-sec-extract:exhibit;">Form 8-K</a>, filed with the Commission on March 12, 2025, in lieu of the description of our Common Stock contained in our Form <a href="http://www.sec.gov/Archives/edgar/data/1120970/000114420411034651/v224648_8a12b.htm" style="-sec-extract:exhibit;">8-A</a> (File No. 001-35200), filed with the Commission under Section 12 of the Exchange Act on June 8, 2011 (the &#8220;Form 8-A&#8221;); and</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(g) Our proxy statement on <a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1120970/000143774925011451/lode20250130_def14a.htm" style="-sec-extract:exhibit;">Schedule 14A</a>, filed with the Commission on April 9, 2025.&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">All documents subsequently filed by us with the Commission pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act, prior to the filing of a post-effective amendment which indicates that all securities offered have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference in the registration statement and to be a part hereof from the date of filing of such documents.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Pursuant to Rule 412 under the Securities Act, any statement contained in the documents incorporated or deemed to be incorporated by reference in this prospectus supplement shall be deemed to be modified, superseded or replaced for purposes of this prospectus supplement to the extent that a statement contained herein or in any other subsequently filed document which also is incorporated or deemed to be incorporated by reference in this prospectus supplement modifies, supersedes or replaces such statement. Any such statement so modified, superseded or replaced shall not be deemed, except as so modified, superseded or replaced, to constitute a part of this prospectus supplement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Notwithstanding the foregoing, documents or portions thereof containing information furnished under Items 2.02 and 7.01 of any Current Report on Form 8-K, including the related exhibits under Item 9.01, are not incorporated by reference in this prospectus supplement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">We make available copies of the documents incorporated by reference in this prospectus&#160;supplement to each person, including any beneficial owner, to whom a prospectus is delivered, without charge, upon written or oral request. Such requests should be directed to:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;">Comstock Inc.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;">117 American Flat Road</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;">Virginia City, Nevada 89440</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;">Attention: Investor Relations</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;">Telephone: (775) 847-5272</p>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: Times New Roman;">S-2</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><b><a id="prosup" href="#"></a>PROSPECTUS SUPPLEMENT SUMMARY</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">This summary highlights information contained or incorporated by reference in this prospectus supplement and the accompanying prospectus. This summary may not contain all of the information that you should consider before investing in our securities. We urge you to read this entire prospectus supplement, the accompanying prospectus&#160;and the documents incorporated by reference carefully, including the section entitled &#8220;Risk Factors&#8221; and the financial statements and other information included or incorporated by reference in this prospectus supplement and&#160;the accompanying prospectus.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 0pt;"><b>The Company</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 0pt; text-align: justify;">OVERVIEW</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 0pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Comstock innovates and commercializes technologies, systems and supply chains that extract, integrate and convert under-utilized natural and waste&#160;resources into clean energy products, including pioneering technologies that produce electrification metals and minerals from end-of-life solar panels, including aluminum, silver and other critical and rare earth metals.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 45pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Bioleum innovates and commercializes technologies, systems and supply chains that secure, extract, integrate and convert carbon-based materials from under-utilized waste and purpose grown energy crops that would ultimately produce a broad range of extremely low carbon renewable fuels, including cellulosic ethanol, renewable diesel and sustainable aviation fuels.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 45pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Our goal is to&#160;<i>Accelerate the Commercialization of Breakthrough Technologies.</i>&#160;We plan on delivering extraordinary shareholder value by using systemic management practices, disciplined frontier scientific discovery, and applied engineering to innovate, develop, deploy&#160;and monetize&#160;clean energy technologies with integrated teams and partners in dedicated lines of business, especially in sustainable, renewable systems with the potential for superior, sustained throughput generation. Our plans to generate these throughputs involve both deploying and licensing our technologies, within a purpose-driven and designed ecosystem, including extended and interdependent partners that leverages their capital, human capacity, infrastructures, and other resources, often integrated directly with us and our solutions,&#160;to accelerate and maximize adoption.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 45pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">We also own and manage investments in related assets that support our businesses, including existing minority equity positions and partnerships in strategic technology developers, two Wisconsin renewable fuels demonstration facilities, an existing&#160;Nevada-based solar panel recycling demonstration facility and currently ordered equipment for a Nevada-based industry-scale solar panel recycling facility. We also own, control and/or manage direct investments in northern Nevada real estate comprised primarily of industrial and commercial land, water rights and about twelve&#160;square miles of gold and silver mining claims and surface parcels that we own, lease or have a royalty interest in,&#160;some of which&#160;contain significant amounts of measured and&#160;indicated, and inferred gold and silver resources.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;"><b><i>Lines of Business</i></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;"><i>Metals Segment&#160;</i></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Our Metals Segment has established a goal of s<i>etting the global standard for solar panel recycling</i>. For the past 21 months, we have operated a permitted, demonstration-scale solar panel recycling facility that delivers environmentally superior, zero-landfilled recycling solutions to support U.S. mineral industries. During 2024, this facility&#160;generated $0.4 million in revenue and, in the first nine months of 2025,&#160; billable revenues (both recognized and deferred) increased&#160;nearly six-fold due, in part, to service fees for decommissioning services, recycling&#160;and processing end-of-life solar panels, and offtake sales of high-value recycled materials, including aluminum, copper, glass, and concentrated precious metals. We believe this technology deployment is globally leading and positioned to operate a world-class, quality, global solar panel recycling operation and the Metals Segment has&#160;the potential to establish the pace of metal recycling and ultimately, global solar panel recycling network deployment.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Comstock Metals has progressed all&#160;permitting requirements for its first industry-scale production facility, located on the same campus as the operating demonstration-scale facility, that can scale the operation, over 3 million panels per year representing up to&#160;100,000 tons of processed waste materials per year. This strategically located facility will enable the expeditious transition of proven processes from commercial demonstration to full-scale production. The industry-scale facility is expected to significantly enhance our ability to meet the rapid and&#160;continuously growing demand for domestically recovered metals.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Our plan supports the creation of a more robust domestic supply chain for critical materials by innovating and scaling sustainable recycling technologies. The Company&#160;plans to build up to seven facilities in the United States over the next five years and support&#160;American energy and resource independence while simultaneously delivering significant economic and environmental value.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Our Metals Segment's 2025 objectives included (1) finalizing the industry-scale engineering, (2) submitting and receiving all prerequisite permits, (3) closing on equity and/or debt financing for Comstock Metals to sufficiently fund the construction and commissioning of the Company&#8217;s first industry-scale facility, (4) ordering all of the industry-scale equipment for our first industry-scale facility,&#160;(5)&#160;securing larger and longer terms supply contracts and (6) accelerating site selection for our second facility.&#160;</p>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: Times New Roman;">S-3</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;"><i>Mining Segment</i></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Our Mining Segment generated&#160;income from&#160;leases, licenses, and related fees during 2024, and is administered by our wholly owned subsidiaries, Comstock Mining LLC, Comstock Processing LLC and various other local subsidiaries that collectively own,&#160;control, or retain&#160;royalty interest in twelve&#160;square miles of properties of patented mining claims, unpatented mining claims and surface parcels in northern Nevada, including six and a half&#160;miles of continuous mineralized strike length (the &#8220;Comstock Mineral Estate&#8221;).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">On December 18, 2024,&#160;the Company executed a membership interest purchase agreement with Mackay Precious Metals Inc. (&#8220;Mackay&#8221;) pursuant to which the Company sold all of its right, title, and interest in its wholly owned subsidiary&#160;Comstock Northern Exploration LLC, and the Company's 25% interest in Pelen Limited Liability Company (&#8220;Pelen&#8221;), for an aggregate purchase price of $2,750,000. The Northern Targets encompass both the Gold Hill and Occidental Lode claim groups in Storey County, Nevada. Pelen owns certain claims adjacent to and/or relevant to these northern claim groups. The Company was paid $1.0&#160;million in cash in 2024.&#160;On June 6, 2025, the parties&#160;executed an amendment (the &#8220;First Amendment&#8221;), to the membership interest purchase agreement.&#160;Pursuant to the First Amendment, the membership interest purchase agreement was amended to increase the purchase price to $2,950,000 bringing all final cash amounts due to a total of $1,950,000. As of September 30, 2025, the Company received all remaining cash payments of&#160;$1,950,000.&#160;For the nine-months ended&#160;September 30, 2025, pursuant to the First Amendment, the Company&#160;recognized an additional gain on the sale of mineral rights of $200,000&#160;in our condensed consolidated statement of operations.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">On June 30, 2023, the Company&#160;entered a Mineral Exploration and Mining Lease Agreement (&#8220;Mackay Mining Lease&#8221;) with Mackay. The Mackay Mining Lease terminated on December 18, 2024.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Our Mining Segment's 2025 objectives include (1) monetizing over&#160;$2.0&#160;million from the sale of the northern mining claims, (2) advancing the preliminary economic assessment for the Dayton Consolidated Project and (3) the development of preliminary Dayton mine and reclamation plans,&#160;progressing toward full economic feasibility for Dayton.&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;"><i style="font-size: 10pt; text-align: justify;">Fuels Segment - Bioleum Corporation</i></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">We hold an investment in Bioleum, through our Preferred Series 1 equity position. Bioleum&#160;delivers advanced lignocellulosic biomass refining solutions that are setting new industry standards for the production of cellulosic ethanol, gasoline, renewable diesel, sustainable aviation fuel (&#8220;SAF&#8221;), and other renewable Bioleum&#8482; fuels, with extremely low carbon intensity scores of 15 and market-leading yields of up to 125&#160;gallons per dry metric ton of feedstock (on a gasoline gallon equivalent basis, or &#8220;GGE&#8221;), depending on feedstock, site conditions, and other process parameters. Bioleum has also negotiated the exclusive rights to intellectual properties developed by Hexas, subject to certain preexisting agreements, for production of purpose grown energy crops in liquid fuels applications with proven yields exceeding 25 to 30 dry metric tons per acre per year. The combination of Bioleum's&#160;high yielding refining platform and Hexas&#8217; high yielding energy crops enables&#160;the production of enough feedstock to produce upwards of 100 barrels (at 42 gallons per barrel) of fuel per acre per year, with regenerative practices that can effectively transform&#160;marginal agricultural lands&#160;into perpetual &#8220;drop-in sedimentary oilfields&#8221; with the potential to dramatically boost regional energy security and rural economies. Bioleum plans to contribute to domestic energy dominance by directly building, owning, and operating a network of Bioleum refineries in the U.S. to produce up to 200 million barrels of renewable fuel per year by 2035, starting with its planned first 400,000 barrel per year commercial demonstration facility in Oklahoma. Bioleum will also license&#160;its advanced feedstock and refining solutions to third parties for additional production in&#160;global markets. Bioleum does not currently generate revenue.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Bioleum operates two complementary and interdependent pilot facilities, including a feedstock conversion and biointermediate production pilot in Wausau, Wisconsin (&#8220;Wausau Facility&#8221;), and a biointermediate conversion and renewable fuel production development pilot in Madison, Wisconsin (&#8220;Madison Facility&#8221;). Bioleum continues innovating its existing commercial process for the purpose of advancing its technological readiness, stabilizing and increasing its market-leading yields, further decreasing carbon intensities,&#160;and driving costs down in the longer-term pursuit of fossil parity. In addition to Hexas, Bioleum&#8217;s innovations group has also partnered with National Renewable Energy Laboratory (&#8220;NREL&#8221;), the Massachusetts Institute of Technology (&#8220;MIT&#8221;), RenFuel K2B AB (&#8220;RenFuel&#8221;), Emerging Fuels Technologies Inc. (&#8220;EFT&#8221;), and others with sponsored research, licensing, and other agreements.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Effective February 28, 2025, we effectively entered into a series of definitive agreements with subsidiaries of Marathon Petroleum Corporation (&#8220;Marathon&#8221;),&#160;involving the purchase of $14,000,000 in Bioleum equity as part of the Series A Financing, subject to a $700,000,000 valuation cap (&#8220;Investment&#8221;). The purchase price includes $1,000,000 in cash and $13,000,000 in payment-in-kind assets comprised of equipment, related intellectual properties, and other materials located at Marathon&#8217;s former renewable fuel demonstration facility in Madison, Wisconsin (&#8220;Payment-In-Kind Assets&#8221;).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">In May 2025, Bioleum also completed the initial $20 million closing of its Series A preferred equity offering (&#8220;Series A Financing&#8221;).&#160;Bioleum also plans to complete its Series A Financing during 2025&#160;and commence project equity and debt financings that includes an allocation of $152 million from the State of Oklahoma in project activity bonds for the construction of its planned first 400,000 barrel per year facility in Oklahoma.&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;"><i>Strategic Investments Segment</i></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">We own and manage several investments and projects that are strategic to our plans and ability to produce and maximize throughput in our Metals&#160;and Mining Segments, that are held for the purpose of complementing or enhancing our mission of accelerating the commercialization of hard technologies for the energy transition and creating value but that are not a component of such other segments or otherwise have distinct operating activities. Our Strategic Investments Segment includes minority equity and equity-linked&#160;investments in Green Li-ion Pte Limited (lithium-ion battery component recycler and remanufacturing), RenFuel (advanced biofuel development and production), Hexas (propagation and production of purpose grown energy crops),&#160;and Sierra Springs Opportunity Fund (northern Nevada real estate) and other&#160;equity investments. In November 2024, we completed a transaction for the disposition of our minority equity investment in GenMat while retaining the rights for using the technologies.&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;"><b><i>Other</i></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;"><i style="font-size: 10pt;">Investments in Properties&#160;</i>&#8211; The Company directly owns three types of properties in Silver Springs, NV, including 98 acres of industrial land, 160 acres of commercial land, both centrally located in Silver Springs, just south of the Silver Springs Regional Airport and a portfolio of water rights. The Company has begun marketing these assets for sale as both industrial and commercial development as interest in Silver Springs, NV has increased.&#160;</p>

<p style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; margin: 0pt;">&#160;</p>

<p style="text-align: justify; font-size: 10pt; font-family: &quot;Times New Roman&quot;; margin: 0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: Times New Roman;">S-4</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 16pt; text-indent: -8pt;"><b>Outlook</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 16pt;text-indent:-8pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 16pt; text-indent: 28pt;">Our goal is to&#160;<i>Accelerate the Commercialization of Breakthrough Technologies.</i></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 16pt; text-indent: 37pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 16pt; text-indent: 28pt;">Comstock innovates and commercializes technologies, systems and supply chains that extract, integrate and convert under-utilized natural and waste&#160;resources into clean energy products, including pioneering technologies that produce electrification metals and minerals from end-of-life solar panels, including aluminum, silver and other critical and rare earth metals.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 16pt; text-indent: 37pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 16pt; text-indent: 28pt;">Bioleum innovates and commercializes technologies, systems and supply chains that secure, extract, integrate and convert carbon-based materials from under-utilized waste and purpose grown energy crops that would ultimately produce a broad range of extremely low carbon renewable fuels, including cellulosic ethanol, renewable diesel and sustainable aviation fuels.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 16pt; text-indent: 37pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 16pt; text-indent: 28pt;">We are pushing the boundaries of what is possible in technology and sustainability by leveraging our teams&#8217; unique skills, our investments and the related diverse technology portfolios and our frontier research and development networks toward achieving breakthrough innovations that deliver meaningful positive impact across industries, economies and communities. The primary focus for 2025&#160;is the commercialization of Comstock Metals and the continuous innovation, development and engineering of technologies and solutions, by us and by our partners, that support the efficient conversion of these resources into clean, profitable energy products.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 16pt; text-indent: 37pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 16pt; text-indent: 28pt;"><i>Corporate</i>&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 16pt; text-indent: 37pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 16pt; text-indent: 28pt;">The growth opportunities for both Comstock Metals and&#160;Bioleum developed beyond our original plans, and we have now realigned both the organizations and their respective capital bases with some of the most sophisticated partners for investment, feedstocks, technologies, operations, and offtakes, including significant investments.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 16pt; text-indent: 37pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 16pt; text-indent: 28pt;">We are&#160;expanding those partnerships across both our extended metals and fuels systems and supply chains, positioning them for industry leadership, exponential revenue growth and superior throughput profiles, especially for Metals and leading to cash profitability for Comstock Metals in 2026.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 16pt; text-indent: 37pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 16pt; text-indent: 28pt;">Comstock now owns a $65 million face value convertible preferred stock in Bioleum Corporation, ultimately convertible into 32.5 million common shares, positioning an exceptional value potential for Comstock&#8217;s shareholders and preserving Comstock&#8217;s ability to accelerate the growth and delivery of that value directly to shareholders.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 16pt;text-indent:28pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 16pt;text-indent:28pt;">The Company&#8217;s Corporate remaining objectives for the rest of 2025 include:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: top; width: 17px;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align: top; width: 2661px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Advance our legacy real estate and non-strategic investments for ultimate monetization;</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: top; width: 15px;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align: top; width: 2664px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Support the next phases of accelerating Metals growth; and</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 15px;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align: top; width: 2664px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Finalize,&#160;communicate&#160;and implement plans to unlock maximum value from the separation&#160;of Bioleum</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: Times New Roman;">S-5</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 45pt;">The Company's 2025 efforts to date have now resulted&#160;in two, fully dedicated, high-growth companies: our Nevada-based renewable metals operation with expanding production and our Oklahoma-headquartered Bioleum Corporation, with major research, development and pilot production&#160;operations based in Wausau and Madison,&#160;Wisconsin.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 45pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 45pt;"><i>Comstock Metals</i></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 45pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 45pt;">Comstock Metals has now been operating its first commercial demonstration facility for nearly 21&#160;months&#160;and in November of 2024, submitted permits for the first industry-scale photovoltaic recycling facility. The Company expects these permits to be issued imminently during the fourth quarter of 2025. The industry-scale facilities are designed for 100,000 tons of annual capacity, with operations commencing post commissioning during the second quarter 2026.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 45pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 45pt;">Additional site selection activities are ongoing for the next two industry-scale facilities and multiple associated storage sites.&#160;The Company plans to ultimately build up to 7 industry-scale U.S. based recycling facilities.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 45pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 45pt;">The Company's Metals remaining objectives for the rest of 2025 include:</p>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-indent: 45pt; text-align: justify;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: top; width: 23px;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align: top; width: 2656px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Receive final permits&#160;for our first industry-scale&#160;facility in Silver Springs, NV;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 23px;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align: top; width: 2656px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Procure, deploy, and assemble plant and equipment for our first industry-scale&#160;facility in Silver Springs, NV;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 23px;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align: top; width: 2656px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Secure additional Master Service Agreements (MSA) with national and regional customers;&#160;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 23px;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align: top; width: 2656px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Complete site selection for two additional solar panel recycling locations;&#160;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 23px;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align: top; width: 2656px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Expand the system globally with international strategic and capital partners; and</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 23px;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align: top; width: 2656px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Advance&#160;R&amp;D efforts to recover more and higher-purity materials from recycled streams for offtake.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 45pt; text-align: justify;"><i>Comstock Mining</i></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 45pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 45pt; text-align: justify;">Comstock Mining&#160;has amassed the single largest known repository of historical and current geological data within the Comstock mineral district, including extensive geophysical surveys, geological mapping, and drilling data, including the Dayton resource.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 45pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 45pt; text-align: justify;">The Company's Mining remaining objectives for the rest of 2025 include:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: top; width: 21px;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#8226;</p>
			</td>
			<td style="vertical-align: top; width: 2658px;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Commercialize agreements that either monetize or enable resource expansion of the central claims;&#160;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 21px;">&#8226;</td>
			<td style="vertical-align: top; width: 2658px;">Publish&#160;the Dayton Consolidated Project technical work with preliminary economics and sensitivities; and</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: top; width: 22px;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#8226;</p>
			</td>
			<td style="vertical-align: top; width: 2657px;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Complete the preliminary mine plans that enable the economic development of the southern district claims.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 45pt;">The Company&#8217;s 2025&#160;efforts will apply economic analysis to Comstock&#8217;s existing gold and silver resources progressing toward preliminary economic feasibility for the southern part of the district and the ultimate development of full mine and reclamation plans and the development of post productive land and community development plans.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 45pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 45pt;"><i>Bioleum</i></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 45pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 45pt;">Bioleum is actively engaged in the expansion of its pilot production facilities and the planning for its first commercial demonstration facilities and the associated supply chain participants (including feedstock, site selection, engineering, construction and procurement, and offtake).</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">Bioleum&#8217;s remaining objectives for the rest of 2025 include:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: top; width: 20px;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align: top; width: 2659px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Advance efforts on the remaining subsidiary-level &#8220;Series A&#8221; equity financing in the separate Fuels entity;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 20px;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align: top; width: 2659px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Plan and deploy a Hexas-based, scalable, commercial demonstration fuel farm;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 20px;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align: top; width: 2659px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Complete site selection for first commercial biorefinery project in Oklahoma;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 20px;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align: top; width: 2659px;">Expand integrated pilot&#160;production capabilities to up to two barrels per week of intermediates and fuels; and</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 20px;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align: top; width: 2659px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Advance our innovation and development efforts toward even higher yields, lower costs and lower capital.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 45pt;">Comstock Fuels also offers integrations of its solutions into existing agriculture, forestry, pulp and paper, ethanol, and existing petroleum infrastructures to generate additional capacities, revenues, technical services, engineering and royalties. The plans also include integrating Bioleum&#8217;s high yield Bioleum refining platform with Hexas&#8217; high yield energy crops to provide enough feedstock to produce upwards of 100 barrels of fuel per acre per year, effectively transforming agricultural lands into perpetual &#8220;drop-in sedimentary oilfields&#8221; with the potential to dramatically boost domestic&#160;energy resources.</p>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: Times New Roman;">S-6</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 16pt;text-indent:27pt;"><b><i>Strategic Investments</i></b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 16pt;text-indent:27pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 16pt;text-indent:27pt;"><i>Investment in Green Li-ion</i></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 16pt;text-indent:27pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 16pt;text-indent:27pt;">Green Li-ion continues making meaningful progress in the development and deployment of its system that remanufactures critical precursor cathode active materials (&#8220;PCAM&#8221;), having now deployed its first commercial battery remanufacturing facility from fully recycled battery materials deployed.&#160;The Company intends to sell the remaining 35,662 Green Li-ion preferred shares&#160;in&#160;2026.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 16pt;text-indent:27pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 16pt;text-indent:27pt;"><i>Investments in other&#160;non-mining real estate, water rights and securities</i></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 16pt;text-indent:27pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 16pt;text-indent:27pt;">The Company has announced plans for selling its non-mining real estate and water rights anticipated in the latter part of&#160;2026.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>Corporate Information</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 16pt;text-indent:27pt;">The Company&#8217;s executive offices are located at 117 American Flat Road, Virginia City, Nevada 89440 and its telephone number is (775) 847-5272. The Company&#8217;s mailing address is P.O. Box 1118, Virginia City, Nevada 89440. The Company&#8217;s website address is&#160;<span style="text-decoration: underline; ">www.comstock.inc</span>. The Company&#8217;s website and the information contained on, or that can be accessed through, the website are not part of this prospectus supplement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><b><a id="forward" href="#"></a>FORWARD LOOKING STATEMENTS</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">Certain statements contained in this prospectus supplement or the accompanying prospectus&#160;or incorporated by reference in this prospectus supplement are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical facts, are forward-looking statements. The words &#8220;believe,&#8221; &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;estimate,&#8221; &#8220;project,&#8221; &#8220;plan,&#8221; &#8220;should,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; &#8220;potential&#8221; and similar expressions identify forward-looking statements, but are not the exclusive means of doing so. Forward-looking statements include statements about matters such as: future market conditions; future explorations or acquisitions, divestitures, spin-offs or similar distribution transactions; future changes in our research, development and exploration activities; future financial, natural, and social gains; future prices and sales of, and demand for, our products and services; land entitlements and uses; permits; production capacity and operations; operating and overhead costs; future capital expenditures and their impact on us; operational and management changes (including changes in our&#160;Board); changes in business strategies, planning and tactics; future employment and contributions of personnel, including consultants; future land and asset sales; investments, acquisitions, joint ventures, strategic alliances, business combinations, operational, tax, financial and restructuring initiatives, including the nature, timing and accounting for restructuring charges, derivative assets and liabilities and the impact thereof; contingencies; litigation, administrative or arbitration proceedings; environmental compliance and changes in the regulatory environment; offerings, limitations on sales or offering of equity or debt securities, including asset sales and associated costs; and future capital needs, revenues, variable costs, throughput rates, operating expenses, debt levels, cash flows, margins, taxes and earnings.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">These statements are based on assumptions and assessments made by our management in light of their experience and their perception of historical and current trends, current conditions, possible future developments and other factors they believe to be appropriate. Forward-looking statements are not guarantees, representations or warranties and are subject to risks and uncertainties, many of which are unforeseeable and beyond our control and could cause actual results, developments and business decisions to differ materially from those contemplated by such forward-looking statements. Some of those risks and uncertainties include the risk factors set forth in this prospectus supplement or the accompanying prospectus or incorporated by reference in this prospectus supplement and our Annual Report on Form 10-K, and the following: adverse effects of climate changes or natural disasters; adverse effects of global or regional pandemic disease spread or other crises; global economic and capital market uncertainties; difficulties involved in developing renewable, decarbonizing and/or clean energy technologies, hazards and uncertainties associated with hazardous material and metal recycling, processing or mining and mineral extraction activities; the speculative nature of gold or mineral exploration, and aluminum, cadmium, copper, silica, silver, steel, and other metal and materials recycling, including risks of diminishing quantities or grades of qualified resources; operational or technical difficulties in connection with exploration, metal recycling, material processing or mining activities; costs, hazards and uncertainties associated with precious and other metal based activities, including environmentally friendly and economically enhancing, novel clean mining and processing technologies, precious metal exploration, resource development, economic feasibility assessment, environmental reclamations and historical restorations and cash generating mineral production; contests over our title to properties; potential dilution to our stockholders from our stock issuances, recapitalization and balance sheet restructuring activities; potential inability to comply with applicable government regulations or law; adoption of or changes in legislation or regulations adversely affecting our businesses; permitting constraints or delays; challenges to, or potential inability to, achieve the benefits of business opportunities, including research and development stage activities that may be presented to, or pursued by, us, including those involving quantum computing and material science based artificial intelligence supported advanced materials development and development services, development of cellulosic technology in bio-fuels and related material production; commercialization of cellulosic technology in bio-fuels; ability to successfully identify, finance, complete and integrate acquisitions, joint ventures, strategic alliances, collaborative research and development agreement, business combinations, asset and equity investment sales, and investments that we may be party to in the future; changes in the United States or other monetary or fiscal policies or regulations; interruptions in our production capabilities due to capital constraints; equipment failures; fluctuation of prices for gold or certain other commodities (such aluminum, cadmium, copper, silica, silver, steel, and other metal and materials, cyanide, water, diesel, gasoline and alternative fuels and electricity); changes in generally accepted accounting principles; adverse effects of war, mass shooting, terrorism and geopolitical events; potential inability to implement our business strategies; potential inability to grow revenues; potential inability to attract and retain key personnel; interruptions in delivery of critical supplies, equipment and raw materials due to credit or other limitations imposed by vendors; assertion of claims, lawsuits and proceedings against us; potential inability to satisfy debt and lease obligations; potential inability to maintain an effective system of internal controls over financial reporting; potential inability or failure to timely file periodic reports with the Securities and Exchange Commission; potential inability to list our securities on any securities exchange or market or maintain the listing of our securities; and work stoppages or other labor difficulties. Occurrence of such events or circumstances could have a material adverse effect on our business, financial condition, results of operations or cash flows, or the market price of our securities. All subsequent written and oral forward-looking statements by or attributable to us or persons acting on our behalf are expressly qualified in their entirety by these factors. Except as may be required by securities or other law, we undertake no obligation to publicly update or revise any forward-looking statements, whether from new information, future events, or otherwise.</p>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: Times New Roman;">S-7</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><b><a id="offer" href="#"></a>THE OFFERING</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: middle; width: 1337px;">&#160;</td>
			<td style="vertical-align: middle; width: 5px;">&#160;</td>
			<td style="vertical-align: middle; width: 1334px;">&#160;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 1337px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Common Stock&#160;offered by us</p>
			</td>
			<td style="vertical-align: top; width: 5px;">&#160;</td>
			<td style="vertical-align: bottom; width: 1334px;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Shares of our Common Stock, par value $0.000666 per share, having an aggregate offering price of up to $100,000,000. The actual number of shares issued by us in this offering will vary depending on the sales price under this offering.</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 1337px;">&#160;</td>
			<td style="vertical-align: top; width: 5px;">&#160;</td>
			<td style="vertical-align: bottom; width: 1334px;">&#160;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 1337px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Common Stock outstanding prior to this offering</p>
			</td>
			<td style="vertical-align: top; width: 5px;">&#160;</td>
			<td style="vertical-align: bottom; width: 1334px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">51,264,247 shares of Common Stock outstanding as of September 30, 2025. The actual number of shares issued by us in this offering will vary depending on the sales price under this offering.</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 1337px;">&#160;</td>
			<td style="vertical-align: top; width: 5px;">&#160;</td>
			<td style="vertical-align: bottom; width: 1334px;">&#160;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 1337px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Manner of offering</p>
			</td>
			<td style="vertical-align: top; width: 5px;">&#160;</td>
			<td style="vertical-align: bottom; width: 1334px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">We have entered into the Sales Agreement&#160;with Titan Partners relating to the sale of up to $100,000,000 of shares of our Common Stock. In accordance with the terms of the Sales Agreement, under this prospectus supplement we may offer and sell Common Stock having an aggregate offering price of up to $100,000,000 from time to time through Titan Partners, acting as our sales agent. Sales of Common Stock, if any, under this prospectus supplement may be made by any method permitted that is deemed an &#8220;at the market offering&#8221;&#160;as defined in Rule 415 under the Securities Act of 1933, as amended. See the section entitled &#8220;Plan of Distribution&#8221;&#160;on page&#160;<a class="tocPGNUM" href="#plan">S-11</a> of this prospectus supplement.</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 1337px;">&#160;</td>
			<td style="vertical-align: top; width: 5px;">&#160;</td>
			<td style="vertical-align: bottom; width: 1334px;">&#160;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 1337px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Use of Proceeds</p>
			</td>
			<td style="vertical-align: top; width: 5px;">&#160;</td>
			<td style="vertical-align: bottom; width: 1334px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">We intend to use the net proceeds from this offering for general corporate purposes, including capital expenditures associated with commercializing&#160;subsequent industry scale and storage facilities for Comstock Metals, in addition to acquisitions, and technical, operational and human resource development expenses for supporting growth. See &#8220;Use of Proceeds.&#8221;</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 1337px;">&#160;</td>
			<td style="vertical-align: top; width: 5px;">&#160;</td>
			<td style="vertical-align: bottom; width: 1334px;">&#160;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 1337px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Risk Factors</p>
			</td>
			<td style="vertical-align: top; width: 5px;">&#160;</td>
			<td style="vertical-align: bottom; width: 1334px;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">You should carefully read and consider the information set forth in &#8220;Risk Factors&#8221;&#160;beginning on the next page of this prospectus supplement before investing in our Common Stock.</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 1337px;">&#160;</td>
			<td style="vertical-align: top; width: 5px;">&#160;</td>
			<td style="vertical-align: bottom; width: 1334px;">&#160;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 1337px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">NYSE American symbol</p>
			</td>
			<td style="vertical-align: top; width: 5px;">&#160;</td>
			<td style="vertical-align: bottom; width: 1334px;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">LODE</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 45pt;">The number of shares of Common Stock to be outstanding after the offering is based on 51,264,247&#160;shares issued and outstanding at September 30, 2025, and excludes the following, in each case, as of such date:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: top; width: 20px;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align: top; width: 2659px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">up to 726,000 shares of Common Stock reserved for issuance under the Comstock Inc. 2022 Equity Incentive Plan and the Comstock Mining Inc. 2020 Equity Incentive Plan;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 20px;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align: top; width: 2659px;">220,000 shares of Common Stock issuable upon the exercise of outstanding warrants at an exercise price of $4.56 per warrant; and</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 20px;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align: top; width: 2659px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">1,073,334 shares of Common Stock issuable upon the exercise of outstanding warrants at an exercise price of $2.58 per warrant.&#160;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: Times New Roman;">S-8</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><b><a id="risk" href="#"></a>RISK FACTORS</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 45pt; text-align: justify;">Investing in our securities involves significant risk. Prior to making a decision about investing in our securities, you should carefully consider the specific risk factors included below, as well as the risk factors discussed under the heading &#8220;Risk Factors&#8221; in the Form 10-K and the Form 10-Q, each of which are incorporated by reference in this prospectus supplement and the accompanying prospectus and may be amended, supplemented or superseded from time to time by other reports we file with the Commission in the future. The risks and uncertainties we have described are not the only ones we may face. Additional risks and uncertainties not currently known to us or that we currently deem immaterial may also affect our operations. If any of these risks actually occurs, our business, results of operations and financial condition could suffer. In that case, the trading price of our Common Stock decline, and you could lose all or a part of your investment.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-indent: -9pt; text-align: justify;"><b>Risks Relating to the Company</b>&#8217;<b>s Common Stock and this Offering</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-indent: -9pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-indent: -9pt; text-align: justify;"><b><i>The actual number of shares of Common Stock we will issue under the Sales Agreement, at any one time or in total, and the gross proceeds resulting from those sales is uncertain.</i></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-indent: -9pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-indent: -9pt; text-align: justify;">Subject to certain limitations in the Sales Agreement and compliance with applicable law, we have the discretion to request Titan Partners to sell on our behalf shares of Common Stock at any time throughout the term of the Sales Agreement, and Titan Partners will use commercially reasonable efforts to sell the shares. The number of shares that are sold by Titan Partners after we request that sales be made will fluctuate based on the market price of our Common Stock during the sales period and limits we set with Titan Partners. Because the price per share of our Common Stock sold will fluctuate based on the market price of our Common Stock during the sales period, it is not possible to predict the number of shares of Common Stock that will ultimately be issued by us under the Sales Agreement or the amount of gross proceeds to be raised in connection with those sales. In addition, investors may experience a decline in the value of the shares they purchase in this offering as a result of sales made at prices lower than the prices they paid.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-indent: -9pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-indent: -9pt; text-align: justify;"><b><i>The shares of Common Stock offered hereby will be sold in </i></b>&#8220;<b><i>at the market offerings,</i></b>&#8221;<b><i> and investors who buy shares at different times will likely pay different prices.</i></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-indent: -9pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-indent: -9pt; text-align: justify;">Investors who purchase shares in this offering at different times will likely pay different prices and accordingly may experience different levels of dilution and different outcomes in their investment results. We will have discretion, subject to market demand and the terms of the Sales Agreement, to vary the timing, prices and number of shares sold in this offering. In addition, subject to the final determination by our Board or any restrictions we may place in any applicable placement notice, there is no minimum or maximum sales price for shares to be sold in this offering. Investors may experience a decline in the value of the shares they purchase in this offering as a result of sales made at prices lower than the prices they paid.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-indent: -9pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-indent: -9pt; text-align: justify;"><b><i>The Company may issue additional Common Stock or other equity securities in the future that could dilute the ownership interest of existing shareholders.</i></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-indent: -9pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-indent: -9pt; text-align: justify;">The Company is currently authorized to issue 245,000,000 shares of Common Stock, of which 51,264,247 were issued and outstanding as of November 20, 2025, and 50,000,000 shares of preferred stock, of which no Preferred Shares are issued or outstanding as of November 20, 2025. To maintain its capital at desired levels or to fund future growth, the Board may decide from time to time to issue additional shares of Common Stock, or securities convertible into, exchangeable for or representing rights to acquire shares of Common Stock. The sale of these securities may significantly dilute stockholders&#8217; ownership interest and the market price of the Common Stock. New investors in other equity securities issued by the Company in the future may also have rights, preferences and privileges senior to the Company&#8217;s current stockholders that may adversely impact its current stockholders.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-indent: -9pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-indent: -9pt; text-align: justify;"><b><i>You may experience immediate and substantial dilution in the net tangible book value per share of the Common Stock you purchase.</i></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-indent: -9pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-indent: -9pt; text-align: justify;">If the price per share of our Common Stock is offered at price that is substantially higher than the net tangible book value per share of our Common Stock, you will suffer substantial dilution in the net tangible book value of the Common Stock you purchase in this offering. The net tangible book value of our Common Stock on September 30, 2025, was approximately $1.88 per share. Purchasing our Common Stock at a purchase price in excess of the net tangible book value per share, will result in you suffering an immediate and substantial dilution.&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-indent: -9pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-indent: -9pt; text-align: justify;"><b><i>If we are unable to maintain the listing standards of the NYSE American, our Common Stock may be delisted, which may have a material adverse effect on the liquidity and value of our Common Stock.</i></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-indent: -9pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-indent: -9pt; text-align: justify;">Our Common Stock is traded on the NYSE American. To maintain our listing on the NYSE American, we must meet certain financial and liquidity criteria. The market price of our Common Stock has been and may continue to be subject to significant fluctuation as a result of periodic variations in our revenues and results of operations. If we fail to meet any of the NYSE American&#8217;s listing standards, we may be delisted. In the event of delisting, trading of our Common Stock would most likely be conducted in the over the counter market on an electronic bulletin board established for unlisted securities, which could have a material adverse effect on the market liquidity and value of our Common Stock.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-indent: -9pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-indent: -9pt; text-align: justify;"><b><i>We will have broad discretion in how we use the proceeds, and we may use the proceeds in ways in which you and other stockholders may disagree.</i></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-indent: -9pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-indent: -9pt; text-align: justify;">We intend to use the net proceeds from this offering for general corporate purposes, including capital expenditures associated with commercializing&#160;subsequent industry scale and storage facilities for Comstock Metals, in addition to acquisitions, and technical, operational and human resource development expenses for supporting growth. See the section entitled &#8220;Use of Proceeds.&#8221; Our management will have broad discretion in the application of the proceeds from this offering and could spend the proceeds in ways that do not necessarily improve our operating results or enhance the value of our Common Stock.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-indent: -9pt; text-align: justify;"><b><i>The price of our Common Stock has and may continue to fluctuate significantly, which could negatively affect the Company and holders of our Common Stock.</i></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-indent: -9pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-indent: -9pt; text-align: justify;">The market price of our Common Stock is subject to volatility, has fluctuated, and may continue to fluctuate significantly due to, among other things, changes in market sentiment regarding our operations, financial results or business prospects, the mining, metals, recycling or environmental remediation industries generally, coordinated trading activities, large derivative positions or the macroeconomic outlook. The price of our Common Stock has been, and may continue to be, highly volatile in response to our recent transactions. Certain events or changes in the market or our industries generally are beyond our control. In addition to the other risk factors contained or incorporated by reference herein, factors that could impact our trading price include:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: top; width: 20px;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align: top; width: 2659px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">our actual or anticipated operating and financial results, including how those results vary from the expectations of management, securities analysts and investors;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 20px;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align: top; width: 2659px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">changes in financial estimates or publication of research reports and recommendations by financial analysts or actions taken by rating agencies with respect to us or other industry participants;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 20px;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align: top; width: 2659px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">failure to declare dividends on our Common Stock from time to time;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 20px;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align: top; width: 2659px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">reports in the press or investment community relating to our reputation or the financial services industry;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 20px;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align: top; width: 2659px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">developments in our business or operations, or our industry sectors generally;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 20px;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align: top; width: 2659px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">any future offerings by us of our Common Stock;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 20px;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align: top; width: 2659px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">any coordinated trading activities or large derivative positions in our Common Stock, for example, a short squeeze, which occurs when a number of investors take a short position in a stock and have to buy the borrowed securities to close out the position at a time that other short sellers of the same security also want to close out their positions, resulting in surges of stock prices when demand is greater than supply;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 20px;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align: top; width: 2659px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">legislative or regulatory changes affecting our industry generally or our business and operations specifically;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: Times New Roman;">S-9</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: top; width: 17px;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align: top; width: 2661px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">the operating and stock price performance of companies that investors consider to be comparable to us;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 17px;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align: top; width: 2661px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">announcements of strategic developments, acquisitions, restructurings, dispositions, financings and other material events by us or our competitors;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 17px;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align: top; width: 2661px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">expectations of (or actual) equity dilution, including the actual or expected dilution to various financial measures, including earnings per share, that may be caused by this offering;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 17px;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align: top; width: 2661px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">actions by our current shareholders, including future sales of common shares by existing shareholders, including our directors and executive officers;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 17px;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align: top; width: 2661px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">proposed or final regulatory changes or developments;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 17px;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align: top; width: 2661px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">anticipated or pending regulatory investigations, proceedings, or litigation that may involve or affect us; and</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 17px;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align: top; width: 2661px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">other changes in U.S. or global financial markets, global economies and general market conditions, such as interest or foreign exchange rates, stock, commodity prices, credit or asset valuations or volatility.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><b><a id="use_of" href="#"></a>USE OF PROCEEDS</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 45pt;">We may offer and sell shares of our Common Stock having aggregate sales proceeds of up to $100,000,000 from time to time. The amount of proceeds we receive, if any, will depend on the actual number of shares of our Common Stock sold and the market price at which such shares are sold. There can be no assurance that we will be able to sell any shares or fully utilize the Sales Agreement with Titan Partners as a source of financing. Because there is no minimum offering amount required as a condition to close this offering, the net proceeds to us, if any, are not determinable at this time.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 45pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 45pt;">We will have broad discretion in the use of the net proceeds from the sale of the shares of Common Stock offered under this prospectus supplement. We presently intend to use the net proceeds from this offering for general corporate purposes, capital expenditures associated with commercializing&#160;subsequent industry scale and storage facilities for Comstock Metals, in addition to acquisitions, and technical, operational and human resource development expenses for supporting growth. However, our management will have broad discretion in the application of the proceeds from this offering and could spend the proceeds in ways that do not necessarily improve our operating results or enhance the value of our Common Stock.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 45pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 45pt;">Pending the use of the proceeds from this offering, we may invest the net proceeds in a variety of capital preservation instruments, which may include all or a combination of short-term and long-term interest-bearing instruments, investment-grade securities, and direct or guaranteed obligations of the U.S. government. We cannot predict whether the proceeds invested will yield a favorable return.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><b><a id="desc" href="#"></a>DESCRIPTION OF SECURITIES BEING OFFERED</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 8pt; text-indent: 0pt;"><b>Common Stock</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 45pt; text-align: justify;">We are offering shares of our Common Stock in this offering. See &#8220;Description of Capital Stock&#8221; in the accompanying prospectus for more information regarding our shares of Common Stock.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: Times New Roman;">S-10</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><b><a id="plan" href="#"></a>PLAN OF DISTRIBUTION</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 45pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 45pt; text-align: justify;">We have entered into the Sales Agreement with Titan Partners, under which we may offer and sell up to $100,000,000 of our shares of Common Stock from time to time through Titan Partners acting as our sales agent.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 45pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 45pt; text-align: justify;">Sales of our shares of Common Stock, if any, under this prospectus supplement and the accompanying prospectus will be made by any method that is deemed to be an &#8220;at the market offering&#8221; as defined in Rule 415(a)(4) under the Securities Act.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 45pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 45pt; text-align: justify;">Each time we wish to issue and sell our shares of Common Stock under the Sales Agreement, we will notify Titan Partners of the maximum number of shares to be sold on such day, the minimum price per share below which sales may not be made, and any other limitation specified by us and mutually agreed by Titan Partners. Once we have so instructed Titan Partners, unless Titan Partners declines to accept the terms of such notice in accordance with the Sales Agreement, Titan Partners has agreed to use its commercially reasonable efforts consistent with its normal trading and sales practices to sell such shares up to the amount specified on such terms. The obligations of Titan Partners under the Sales Agreement to sell our shares of Common Stock are subject to a number of conditions that we must meet. We or Titan Partners may suspend the offering of shares of Common Stock being made through Titan Partners under the Sales Agreement upon proper notice to the other party.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 45pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 45pt; text-align: justify;">The settlement of sales of shares between us and Titan Partners is generally anticipated to occur on the first trading day following the date on which the sale was made. Sales of our shares of Common Stock as contemplated in this prospectus supplement will be settled through the facilities of The Depository Trust Company or by such other means as we and Titan Partners may agree upon. There is no arrangement for funds to be received in an escrow, trust or similar arrangement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 45pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 45pt; text-align: justify;">We will pay Titan Partners a commission equal to 3.0% of the aggregate gross proceeds we receive from each sale of our shares of Common Stock. Because there is no minimum offering amount required as a condition to close this offering, the actual total public offering amount, commissions and proceeds to us, if any, are not determinable at this time. In addition, we have agreed to reimburse Titan Partners certain specified expenses. We estimate that the total expenses for the offering, excluding any commissions or expense reimbursement payable to Titan Partners under the terms of the Sales Agreement, will be approximately $150,000. The remaining sale proceeds, after deducting any other transaction fees, will equal our net proceeds from the sale of such shares. We will report at least quarterly the number of shares of Common Stock sold through Titan Partners&#160;under the Sales Agreement, the net proceeds to us and the compensation paid by us to Titan Partners in connection with the sales of our Common Stock.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 45pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 45pt; text-align: justify;">Titan Partners will provide written confirmation to us before the open on the NYSE American on the day following each day on which our shares of Common Stock are sold under the Sales Agreement. Each confirmation will include the number of shares sold on that day, the aggregate gross proceeds of such sales and the proceeds to us.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 45pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 45pt; text-align: justify;">In connection with the sale of our shares of Common Stock on our behalf, Titan Partners will be deemed to be an &#8220;underwriter&#8221; within the meaning of the Securities Act, and the compensation of Titan Partners will be deemed to be underwriting commissions or discounts. We have agreed to indemnify Titan Partners against certain civil liabilities, including liabilities under the Securities Act. We have also agreed to contribute to payments Titan Partners may be required to make in respect of such liabilities.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 45pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 45pt; text-align: justify;">The offering of our shares of Common Stock pursuant to the Sales Agreement will terminate upon the earlier of (i) the sale of all shares of Common Stock subject to the Sales Agreement and (ii) the termination of the Sales Agreement as permitted therein. We and Titan Partners may each terminate the Sales Agreement at any time upon ten days&#8217; prior notice.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 45pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 45pt; text-align: justify;">This summary of the material provisions of the Sales Agreement does not purport to be a complete statement of its terms and conditions.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 45pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 45pt; text-align: justify;">Titan Partners and certain of its affiliates are full service financial institutions engaged in various activities, which may include securities trading, commercial and investment banking, financial advisory, investment management, investment research, principal investment, hedging, financing and brokerage activities. Titan Partners and certain of its affiliates have, from time to time, performed, and may in the future perform various commercial and investment banking, and financial advisory services for us and our affiliates, for which they received or will receive customary fees and expenses.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 45pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 45pt; text-align: justify;">In the ordinary course of their various business activities, Titan Partners and certain of its affiliates may make or hold a broad array of investments and actively trade debt and equity securities (or related derivative securities) and financial instruments (including bank loans) for their own account or for the accounts of their customers, and such investment and securities activities may involve securities and/or instruments issued by us and our affiliates. If Titan Partners or its affiliates have a lending relationship with us, they routinely hedge their credit exposure to us consistent with their customary risk management policies. Titan Partners and its affiliates may hedge such exposure by entering into transactions that consist of either the purchase of credit default swaps or the creation of short positions in our securities or the securities of our affiliates, including potentially the common stock offered hereby. Any such short positions could adversely affect future trading prices of the common stock offered hereby. Titan Partners and certain of its affiliates may also communicate independent investment recommendations, market color or trading ideas and/or publish or express independent research views in respect of such securities or instruments and may at any time hold, or recommend to clients that they acquire, long and/or short positions in such securities and instruments.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 45pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 45pt; text-align: justify;">This prospectus supplement and the accompanying prospectus in electronic format may be made available on a website maintained by Titan Partners, and Titan&#160;Partners may distribute the prospectus supplement and the accompanying prospectus electronically.&#160;</p>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: Times New Roman;">S-11</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><b><a id="legal" href="#"></a>LEGAL MATTERS</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 16pt; text-indent: 18pt; text-align: justify;">The validity of the issuance of the securities offered in this offering and certain other legal matters has been passed upon for us by McDonald Carano LLP, Reno, Nevada. Foley &amp; Lardner LLP, Milwaukee, Wisconsin, is acting as our counsel regarding securities law matters. Titan Partners is being represented in connection with this offering by McGuireWoods LLP, New York, New York.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><b><a id="experts" href="#"></a>EXPERTS</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 16pt; text-indent: 18pt; text-align: justify;">The consolidated financial statements for the fiscal years ended December 31, 2024 and December 31, 2023, incorporated in this prospectus supplement by reference from the Form 10-K have been audited by Assure CPA, LLC, an independent registered public accounting firm, as stated in its report, which is incorporated herein by reference. Such consolidated financial statements have been so incorporated in reliance upon the reports of such firm given upon its authority as an expert in accounting and auditing.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 16pt; text-indent: 18pt; text-align: justify;">No expert or counsel named in this prospectus supplement or the accompanying prospectus as having prepared or certified any part thereof or having given an opinion upon the validity of the securities being registered or upon other legal matters in connection with the registration or offering of our Common Stock was employed on a contingency basis or had or is to receive, in connection with the offering, a substantial interest, directly or indirectly, in us. Additionally, no such expert or counsel was connected with us as a promoter, managing or principal underwriter, voting trustee, director, officer or employee.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 16pt;text-indent:18pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: Times New Roman;">S-12</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;&#160;</p>

<div>&#160;</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="text-align:center;font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><img alt="logo02.jpg" src="logo02.jpg"/></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><b>Comstock Inc.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><b>Up to $100,000,000 </b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><b>Common Stock</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><b>PROSPECTUS SUPPLEMENT</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><b>Titan Partners Group</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><i>a division of American Capital Partners</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><b>, 2025</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div>&#160;</div>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>PART II</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>INFORMATION NOT REQUIRED IN PROSPECTUS</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Item 14. Other Expenses of Issuance and Distribution.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:18pt;">The following table sets forth all fees and expenses payable by the registrant in connection with the issuance and distribution of the securities being registered hereby (other than underwriting discounts and commissions).&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr style="background-color: rgb(204, 238, 255);">
			<td style="border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0) black; vertical-align: bottom; width: 39.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Commission registration fee</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.5%; border-top: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.5%; border-top: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 5.6%; border-top: 1px solid rgb(0, 0, 0); text-align: right;">27,620</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.5%; border-top: 1px solid rgb(0, 0, 0); border-right: 1px solid black;">&#160;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: auto; border-right: 1px solid black; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">FINRA filing fee</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:5.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">30,500</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.5%; border-right: 1px solid black;">&#160;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: auto; border-right: 1px solid black; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">NYSE AMERICAN supplemental listing fee</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 5.6%; text-align: right;">(1)</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.5%; border-right: 1px solid black;">&#160;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: auto; border-right: 1px solid black; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Fees and expenses of the trustee</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:5.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">(1)</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.5%; border-right: 1px solid black;">&#160;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: auto; border-right: 1px solid black; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Accounting fees and expenses</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:5.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">(1)</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.5%; border-right: 1px solid black;">&#160;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: auto; border-right: 1px solid black; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Legal fees and expenses</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:5.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">(1)</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.5%; border-right: 1px solid black;">&#160;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: auto; border-right: 1px solid black; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Blue Sky, qualification fees and expenses</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:5.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">(1)</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.5%; border-right: 1px solid black;">&#160;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: auto; border-right: 1px solid black; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Transfer agent fees and expenses</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:5.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">(1)</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.5%; border-right: 1px solid black;">&#160;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: auto; border-right: 1px solid black; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Printing and miscellaneous expenses</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:5.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">(1)</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.5%; border-right: 1px solid black;">&#160;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: auto; border-right: 1px solid black; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total</b></p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 5.6%; text-align: right;"><b>(1)</b></td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.5%; border-right: 1px solid black;">&#160;</td>
		</tr>

</tbody></table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">(1) These fees are calculated based on the securities offered and the number of issuances and accordingly cannot be estimated at this time.&#160;An estimate of the various expenses in connection with the sale and distribution of the securities being offered will be included in the applicable prospectus supplement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Item 15. Indemnification of Directors and Officers.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our Articles of Incorporation provide for the indemnification of a present or former director or officer to the fullest extent authorized by Nevada law. &#160;Such indemnification shall include, but not necessarily be limited to, expenses, including attorney's fees reasonably incurred or suffered by such officer or director.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Under certain circumstances, Chapter 78 of the NRS also provides for mandatory and discretionary indemnification, as applicable, of any person who is a director, officer, employee or agent of the Company.&#160; Nevada law provides that we may indemnify such individuals if they have not have breached their fiduciary duties under Chapter 78 of the NRS or if such person has acted in good faith and in a manner which he or she reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal action or proceeding, had no reasonable cause to believe his or her conduct was unlawful.&#160; Nevada law also provides that we must indemnify any &#160;person who is a director, officer, employee or agent of the Company, to the extent that the person is successful on the merits or otherwise in the defense of any threatened, pending or completed action, suit or proceeding brought against such person because such person is or was a director, officer, employee or agent of the Company, against expenses actually and reasonably incurred by the person in connection with defending the action, including, without limitation, attorney&#8217;s fees.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Item 16.</b>&#160;<b>Exhibits</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:1.7%;">&#160;</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">(a)</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The exhibits listed in the following table have been filed as part of this registration statement.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 100%; margin-left: 0pt; margin-right: 0pt;">

		<tbody><tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b>Exhibit</b>&#160;<br/>
			<b>Number</b></p>
			</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 87%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b>Description of Exhibit</b></p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 87%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">1.1*</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: top; width: 87%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Form of Underwriting Agreement.</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: top; width: 87%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">1.2</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: top; width: 87%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><a href="ex_888634.htm" style="-sec-extract:exhibit;">At The Market Offering Agreement between Comstock Inc. and Titan Partners Group LLC, a division of American Capital Partners, LLC, dated November 21, 2025.</a></td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: top; width: 87%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">4.1</p>
			</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: top; width: 87%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1120970/000112097022000052/exhibit31_restatedxartofinc.htm" style="-sec-extract:exhibit;">Amended and Restated Articles of Incorporation of&#160;Comstock Inc. (Previously filed with the Commission on June 2, 2022 as Exhibit 3.1 to the Company&#8217;s Form 8-K and incorporated herein by reference)</a></p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 87%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">4.2</p>
			</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: top; width: 87%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1120970/000112097022000052/exhibit32lodebylaws.htm" style="-sec-extract:exhibit;">Amended and Restated Bylaws of Comstock Inc. (Previously filed with the Commission&#160;on June 2, 2022&#160;as Exhibit 3.2 to the Company&#8217;s Form 8-K and incorporated herein by reference)</a></p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 87%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">4.3</p>
			</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: bottom; width: 87%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><a href="ex_869179.htm" style="-sec-extract:exhibit;">Form of Indenture for Debt Securities</a></p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 87%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">4.4*</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: top; width: 87%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Form of Note</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: top; width: 87%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">4.5*</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: top; width: 87%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Form of Warrant Agreement</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: top; width: 87%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">4.6*</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: top; width: 87%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Form of Rights Agreement</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: top; width: 87%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">4.7*</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: top; width: 87%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Form of Unit Agreement</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: top; width: 87%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">5.1</p>
			</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: top; width: 87%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><a href="ex_879511.htm" style="-sec-extract:exhibit;">Opinion of McDonald Carano LLP, Reno, Nevada, relating to the base prospectus and sales agreement prospectus supplement.</a></p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: top; width: 87%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">23.1</p>
			</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: top; width: 87%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><a href="ex_879511.htm" style="-sec-extract:exhibit;">Consent of McDonald Carano LLP, Reno, Nevada (included in Exhibit 5.1).</a></p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: top; width: 87%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">23.2</p>
			</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: top; width: 87%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><a href="ex_869506.htm" style="-sec-extract:exhibit;">Consent of Assure CPA, LLC</a></p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: top; width: 87%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">23.3</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: top; width: 87%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><a href="ex_875602.htm" style="-sec-extract:exhibit;">Consent of Behre Dolbear &amp; Company (USA) Inc.</a></td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: top; width: 87%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">24.1</p>
			</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: top; width: 87%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><a href="#poa" style="-sec-extract:exhibit;">Powers of Attorney of Directors and Certain Officers of the Registrant (included on the signature page hereof).</a></p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: top; width: 87%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">25.1**</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: top; width: 87%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Statement of Eligibility and Qualification under the Trust Indenture Act of 1939 on Form T-1</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: top; width: 87%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">107</p>
			</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: top; width: 87%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><a href="ex_869180.htm" style="-sec-extract:exhibit;">Filing Fee&#160;Table</a></p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-indent: -9pt; text-align: justify;">* To be filed by amendment or as an exhibit to a document to be incorporated by reference herein in connection with an offering of securities, if applicable.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-indent: -9pt; text-align: justify;">** To be filed in accordance with the requirements of Section 305(b)(2) of the Trust Indenture Act.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: Times New Roman;">II-1</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Item 17.</b>&#160;<b>Undertakings</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 27pt;">(a) The undersigned registrant hereby undertakes:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">(1) To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 36pt;text-indent:36pt;">(i) to include any prospectus required by Section 10(a)(3) of the Securities Act;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 72pt;">(ii) to reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in the &#8220;Calculation of Registration Fee&#8221; table in the effective registration statement;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 72pt;">(iii) to include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement; provided, however, that paragraphs (i), (ii) and (iii) above do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Securities and Exchange Commission by the registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference in the registration statement, or is contained in a form of prospectus filed pursuant to Rule 424(b) that is part of the registration statement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">(2) That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">(3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">(4) That, for the purpose of determining liability under the Securities Act to any purchaser:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 36pt;text-indent:36pt;">(i) If the registrant is relying on Rule 430B:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 72pt;text-indent:36pt;">A) Each prospectus filed by the registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement; and</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 72pt;text-indent:36pt;">(B) Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii), or (x) for the purpose of providing the information required by section 10(a) of the Securities Act shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date; or</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 36pt;text-indent:36pt;">(ii) If the registrant is subject to Rule 430C, each prospectus filed pursuant to Rule 424(b) as part of a registration statement relating to an offering, other than registration statements relying on Rule 430B or other than prospectuses filed in reliance on Rule 430A, shall be deemed to be part of and included in the registration statement as of the date it is first used after effectiveness. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such date of first use.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: Times New Roman;">II-2</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">(5) That, for the purpose of determining liability of the registrant under the Securities Act to any purchaser in the initial distribution of the securities, the undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this Registration Statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 36pt;text-indent:36pt;">(i) Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 36pt;text-indent:36pt;">(ii) Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 36pt;text-indent:36pt;">(iii) The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 36pt;text-indent:36pt;">(iv) Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 72pt;text-indent:36pt;">(b) The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the registrant&#8217;s annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan&#8217;s annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 72pt;text-indent:36pt;">(c) Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 72pt;text-indent:36pt;">(d) The undersigned registrant hereby undertakes to file an application for the purpose of determining the eligibility of the trustee to act under subsection (a) of section 310 of the Trust Indenture Act (&#8220;Act&#8221;) in accordance with the rules and regulations prescribed by the Commission under Section 305(b)(2) of the Act.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: Times New Roman;">II-3</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>SIGNATURES</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:18pt;">Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Virginia City, Nevada, on November 21, 2025.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td colspan="2" style="vertical-align:middle;width:1.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>COMSTOCK INC.</b></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:1.9%;">&#160;</td>
			<td style="vertical-align:middle;width:44.5%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:1.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">By:</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:middle;width:44.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">/s/ Corrado De Gasperis</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:1.9%;">&#160;</td>
			<td style="vertical-align:middle;width:44.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Corrado De Gasperis</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:1.9%;">&#160;</td>
			<td style="vertical-align:middle;width:44.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Executive Chairman &amp; Chief Executive Officer</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:1.9%;">&#160;</td>
			<td style="vertical-align:middle;width:44.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">(Principal Executive Officer)</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: Times New Roman;">II-4</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><a id="poa" href="#"></a>POWER OF ATTORNEY</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:18pt;">KNOW ALL PERSONS BY THESE PRESENTS, that each individual whose signature appears below hereby constitutes and appoints Corrado De Gasperis as his or her true and lawful agent, proxy and attorney-in-fact, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to (i) act on, sign and file with the Securities and Exchange Commission any and all amendments to this registration statement (which includes any additional registration statement under Rule 462(b)) together with all schedules and exhibits thereto, (ii) act on, sign and file with the Securities and Exchange Commission any and all exhibits to this registration statement and any and all exhibits and schedules thereto, (iii) act on, sign and file any and all such certificates, applications, registration statements, notices, reports, instruments, agreements and other documents necessary or appropriate in connection with the registration or qualification under foreign and state securities laws of the securities described in this registration statement or any amendment thereto, or obtain an exemption therefrom, in connection with the offerings described therein and (iv) take any and all such actions which may be necessary or appropriate in connection therewith, granting unto such agents, proxies and attorneys-in-fact, and each of them individually, full power and authority to do and perform each and every act and thing necessary or appropriate to be done, as fully for all intents and purposes as he might or could do in person, and hereby approving, ratifying and confirming all that such agents, proxies and attorneys-in-fact, any of them or any of his or their substitute or substitutes may lawfully do or cause to be done by virtue hereof.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:18pt;">Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:11.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Name</b></p>
			</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:27.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Title</b></p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:6.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Date</b></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:11.6%;">&#160;</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:27.3%;">&#160;</td>
			<td style="vertical-align:top;width:6.9%;">&#160;</td>
		</tr>
		<tr>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:11.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">/s/ Corrado De Gasperis</p>
			</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:27.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Executive Chairman &amp; Chief Executive Officer and Director</p>
			</td>
			<td style="vertical-align:top;width:6.9%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:11.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Corrado De Gasperis</p>
			</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:27.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Principal Executive Officer)</p>
			</td>
			<td style="vertical-align:top;width:6.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">November 21, 2025</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:11.6%;">&#160;</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:27.3%;">&#160;</td>
			<td style="vertical-align:top;width:6.9%;">&#160;</td>
		</tr>
		<tr>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:11.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">/s/ Judd Merrill</p>
			</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:27.3%;">&#160;</td>
			<td style="vertical-align:top;width:6.9%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:11.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Judd Merrill</p>
			</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:27.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Chief Financial Officer (Principal Financial Officer)</p>
			</td>
			<td style="vertical-align: top; width: 6.9%; text-align: center;">November 21, 2025</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:11.6%;">&#160;</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:27.3%;">&#160;</td>
			<td style="vertical-align:top;width:6.9%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 11.6%; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">/s/ Matthew J. Bieberly</p>
			</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:27.3%;">&#160;</td>
			<td style="vertical-align:top;width:6.9%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:11.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Matthew J. Bieberly</p>
			</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:27.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Chief Accounting Officer (Principal Accounting Officer)</p>
			</td>
			<td style="vertical-align: top; width: 6.9%; text-align: center;">November 21, 2025</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:11.6%;">&#160;</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:27.3%;">&#160;</td>
			<td style="vertical-align:top;width:6.9%;">&#160;</td>
		</tr>
		<tr>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:11.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">/s/ Leo M. Drozdoff</p>
			</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:27.3%;">&#160;</td>
			<td style="vertical-align:top;width:6.9%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:11.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Leo M. Drozdoff</p>
			</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:27.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Director</p>
			</td>
			<td style="vertical-align: top; width: 6.9%; text-align: center;">November 21, 2025</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:11.6%;">&#160;</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:27.3%;">&#160;</td>
			<td style="vertical-align:top;width:6.9%;">&#160;</td>
		</tr>
		<tr>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:11.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">/s/ William J. Nance</p>
			</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:27.3%;">&#160;</td>
			<td style="vertical-align:top;width:6.9%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:11.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">William J. Nance</p>
			</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:27.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Director</p>
			</td>
			<td style="vertical-align: top; width: 6.9%; text-align: center;">November 21, 2025</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:11.6%;">&#160;</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:27.3%;">&#160;</td>
			<td style="vertical-align:top;width:6.9%;">&#160;</td>
		</tr>
		<tr>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:11.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">/s/ Walter A. Marting Jr.</p>
			</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:27.3%;">&#160;</td>
			<td style="vertical-align:top;width:6.9%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:11.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Walter A. Marting Jr.</p>
			</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:27.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Director</p>
			</td>
			<td style="vertical-align: top; width: 6.9%; text-align: center;">November 21, 2025</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:11.6%;">&#160;</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:27.3%;">&#160;</td>
			<td style="vertical-align:top;width:6.9%;">&#160;</td>
		</tr>
		<tr>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:11.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">/s/ Dr. Guez J. Salinas</p>
			</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:27.3%;">&#160;</td>
			<td style="vertical-align:top;width:6.9%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:11.6%;">Dr. Guez J. Salinas</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:27.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Director</p>
			</td>
			<td style="vertical-align: top; width: 6.9%; text-align: center;">November 21, 2025</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:11.6%;">&#160;</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:27.3%;">&#160;</td>
			<td style="vertical-align:top;width:6.9%;">&#160;</td>
		</tr>
		<tr>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:11.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">/s/ Kristin M. Slanina</p>
			</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:27.3%;">&#160;</td>
			<td style="vertical-align:top;width:6.9%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:11.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Kristin M. Slanina</p>
			</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:27.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Director</p>
			</td>
			<td style="vertical-align: top; width: 6.9%; text-align: center;">November 21, 2025</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:11.6%;">&#160;</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:27.3%;">&#160;</td>
			<td style="vertical-align:top;width:6.9%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:11.6%;">&#160;</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:27.3%;">&#160;</td>
			<td style="vertical-align:top;width:6.9%;">&#160;</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">II-5</div>
</div>
</div>
</div>


</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.2
<SEQUENCE>2
<FILENAME>ex_888634.htm
<DESCRIPTION>EXHIBIT 1.2
<TEXT>
<html><head>
	<title>ex_888634.htm</title>
	<!-- Generated by ThunderDome Portal - 11/18/2025 10:50:24 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;">
<p style="margin: 0px 0pt; text-align: right; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt"><b>Exhibit 1.2</b></font></p>

<p style="margin: 0px 0pt; text-align: left; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>COMSTOCK INC.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Common Stock</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">($0.000666 par value per share)</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>AT THE MARKET OFFERING AGREEMENT</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">November 21, 2025</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Titan Partners Group LLC,</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">a division of American Capital Partners, LLC</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">4 World Trade Center, 49th Floor</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">New York, NY 10007</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Ladies and Gentlemen:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Comstock Inc., a corporation formed under the laws of the State of Nevada (the &#8220;<u>Company</u>&#8221;), proposes, subject to the terms and conditions stated herein, to issue and sell from time to time to or through Titan Partners Group LLC, a division of American Capital Partners, LLC (the &#8220;<u>Agent</u>&#8221;), as sales agent, shares (the &#8220;<u>Shares</u>&#8221;<i>) </i>of the Company&#8217;s common stock, $0.000666 par value per share (the &#8220;<u>Common Stock</u>&#8221;), on the terms and subject to the conditions set forth in Section 2 of this Agreement (the &#8220;<u>Agreement</u>&#8221;).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">The Company has prepared and filed not earlier than three years prior to the date hereof, or will prepare and file, with the Securities and Exchange Commission (the &#8220;<u>Commission</u>&#8221;) a registration statement on Form S-3, and such amendments to such registration statement as may have been or will be required to the date of this Agreement, under the Securities Act of 1933, as amended (the &#8220;<u>1933 Act</u>&#8221;) and the rules and regulations of the Commission under the 1933 Act (the &#8220;<u>1933 Act Regulations</u>&#8221;). Such registration statement, at any given time, including the amendments, the exhibits and schedules thereto at such time, the documents incorporated or deemed to be incorporated by reference therein pursuant to Item 12 of Form S-3 under the 1933 Act at such time and the documents and information otherwise deemed to be a part thereof or included therein by Rule 430B under the 1933 Act (the &#8220;<u>Rule 430B Information</u>&#8221;) or otherwise pursuant to the 1933 Act Regulations at such time, is herein called the &#8220;<u>Registration Statement</u>.&#8221; Any registration statement filed pursuant to Rule 462(b) of the 1933 Act Regulations is herein called the &#8220;<u>Rule 462(b) Registration Statement</u>&#8221; and, after such filing, the term &#8220;<u>Registration Statement</u>&#8221; shall include the Rule 462(b) Registration Statement. The Registration Statement at the time it shall become effective is herein called the &#8220;<u>Initial Registration Statement</u>&#8221;. The prospectus in the form in which it appeared in the Initial Registration Statement is herein called the &#8220;<u>Base Prospectus</u>.&#8221; Promptly after execution and delivery of this Agreement, the Company will prepare and file with the Commission a prospectus supplement to the Base Prospectus relating to the Shares and the offering thereof in accordance with the provisions of Rule 430B (&#8220;<u>Rule 430B</u>&#8221;) and Rule 424(b) (&#8220;<u>Rule 424(b)</u>&#8221;) of the 1933 Act Regulations. Such supplemental form of prospectus (including the Base Prospectus as so supplemented), in the form filed with the Commission pursuant to Rule 424(b) under the 1933 Act is herein called the &#8220;<u>Prospectus</u>.&#8221; Any reference herein to the Base Prospectus, or the Prospectus shall be deemed to refer to and include the documents incorporated by reference therein pursuant to Item 12 of Form S-3 under the 1933 Act as of the date of such prospectus.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">For the purposes of this Agreement:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Applicable Time</u>&#8221; means, with respect to any Shares, the time of sale of such Shares pursuant to this Agreement; the Prospectus and the applicable Issuer Free Writing Prospectus(es) issued at or prior to such Applicable Time, taken together (collectively, and, with respect to any Shares, together with the public offering price of such Shares, the &#8220;<u>General Disclosure Package</u>&#8221;) as of each Applicable Time and each Settlement Date, will not include any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; and each applicable Issuer Free Writing Prospectus will not conflict with the information contained in the Registration Statement, the Prospectus Supplement or the Prospectus and each such Issuer Free Writing Prospectus, as supplemented by and taken together with the General Disclosure Package as of such Applicable Time, will not include any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Issuer Free Writing Prospectus</u>&#8221; means any &#8220;issuer free writing prospectus,&#8221; as defined in Rule 433 of the 1933 Act Regulations (&#8220;<u>Rule 433</u>&#8221;), including without limitation any &#8220;free writing prospectus&#8221; (as defined in Rule 405 of the 1933 Act Regulations (&#8220;<u>Rule 405</u>&#8221;)) relating to the Shares that is (i) required to be filed with the Commission by the Company, (ii) a &#8220;road show that is a written communication&#8221; within the meaning of Rule 433(d)(8)(i), whether or not required to be filed with the Commission, or (iii) exempt from filing with the Commission pursuant to Rule 433(d)(5)(i) because it contains a description of the Shares or of the offering that does not reflect the final terms, in each case in the form filed or required to be filed with the Commission or, if not required to be filed, in the form retained in the Company&#8217;s records pursuant to Rule 433(g).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Issuer General Use Free Writing Prospectus</u>&#8221; means any Issuer Free Writing Prospectus that is intended for general distribution to prospective investors (other than a &#8220;bona fide electronic road show,&#8221; as defined in Rule 433).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Issuer Limited Use Free Writing Prospectus</u>&#8221; means any Issuer Free Writing Prospectus that is not an Issuer General Use Free Writing Prospectus.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Offering</u>&#8221; means the offering and sale of the Shares.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>SEC Reports</u>&#8221; means all reports, schedules, forms, statements and other documents required to be filed by the Company under the 1933 Act and the 1934 Act, including pursuant to Section 13(a) or 15(d) thereof, for the two years preceding the date hereof (or such shorter period as the Company was required by law or regulation to file such material).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Statutory Prospectus</u>&#8221; means the Base Prospectus, as amended and supplemented immediately prior to the Applicable Time, including any document incorporated by reference therein and any prospectus supplement deemed to be a part thereof, including the final prospectus supplement dated the date hereof. For purposes of this definition, Rule 430B Information contained in a form of prospectus that is deemed retroactively to be a part of the Registration Statement shall be considered to be included in the Statutory Prospectus as of the actual time that form of prospectus is filed with the Commission pursuant to Rule 424(b) under the 1933 Act.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">All references in this Agreement to financial statements and schedules and other information which is &#8220;described&#8221;, &#8220;contained,&#8221; &#8220;included&#8221; or &#8220;stated&#8221; (or other references of like import) in the Registration Statement, the Base Prospectus, or the Prospectus shall be deemed to mean and include all such financial statements and schedules and other information incorporated or deemed incorporated by reference in the Registration Statement, the Base Prospectus, or the Prospectus, as the case may be, prior to the execution and delivery of this Agreement; and all references in this Agreement to amendments or supplements to the Registration Statement, the Base Prospectus, or the Prospectus shall be deemed to mean and include the filing of any document under the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder (collectively, the &#8220;<u>1934 Act</u>&#8221;), incorporated or deemed to be incorporated by reference in the Registration Statement, the Base Prospectus, or the Prospectus, as the case may be, at or after the execution and delivery of this Agreement. The Company&#8217;s obligations under this Agreement to furnish, provide, deliver or make available (and all other references of like import) copies of any report or statement shall be deemed satisfied if the same is filed with the Commission through its Electronic Data Gathering, Analysis and Retrieval system (except that, upon the Agent&#8217;s request, the Company shall provide a printed copy of the Registration Statement and of any amendment or supplement thereto with conformed signatures in PDF format).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Section 1.&nbsp;&nbsp;&nbsp;&nbsp;<u>Representations and Warranties</u>. The Company represents and warrants to the Agent that as of the date of this Agreement, and except as set forth in the SEC Reports, any applicable Registration Statement Amendment Date (as defined in Section 3 below), each Company Periodic Report Date (as defined in Section 3 below), each Applicable Time and each Settlement Date (as defined in Section 2 below), unless such representation or warranty specifies a different time:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(i)&nbsp;&nbsp;&nbsp;&nbsp; <u>Registration Statement and Prospectuses</u>. The Company meets the requirements for use of Form S-3 under the 1933 Act subject to General Instruction I.B.1 of Form S-3 or, if applicable, General Instruction I.B.6 of Form S-3 with respect to the aggregate market value of securities sold pursuant to this offering and during the 12 month period immediately prior to such time that this representation is made or deemed to be made. No stop order suspending the effectiveness of the Registration Statement or any post-effective amendment thereto has been issued by the Commission under the 1933 Act, no order preventing or suspending the use of any preliminary prospectus or the Prospectus has been issued by the Commission and no proceedings for any of those purposes have been instituted by the Commission or are pending or, to the Company&#8217;s knowledge, contemplated by the Commission. The Company has complied with each request (if any) from the Commission for additional information.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">Each of the Registration Statement and any post-effective amendment thereto, at the time it became or will become effective, complied and will comply in all material respects with the requirements of the 1933 Act and the 1933 Act Regulations. The Prospectus and any amendment or supplement thereto, at the time each was filed with the Commission, complied in all material respects with the requirements of the 1933 Act and the 1933 Act Regulations.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">The documents incorporated or deemed to be incorporated by reference in the Registration Statement and the Prospectus, when they were filed with the Commission, complied in all material respects with the requirements of the 1934 Act and the rules and regulations of the Commission under the 1934 Act (the &#8220;<u>1934 Act Regulations</u>&#8221;); and any further documents so filed and incorporated by reference in the Registration Statement and the Prospectus, when such documents are filed with the Commission, will comply in all material respects to the requirements of the 1934 Act Regulations.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(ii)&nbsp;&nbsp;&nbsp;&nbsp; <u>Accurate Disclosure</u>. Neither the Registration Statement nor any amendment thereto, at its effective time, at each Company Periodic Report Date, at each Applicable Time and at each Settlement Date, contained, contains or will contain an untrue statement of a material fact or omitted, omits or will omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading. As of the Applicable Time, none of (A) the General Disclosure Package and (B) any individual Issuer Limited Use Free Writing Prospectus, when considered together with the General Disclosure Package, included, includes or will include an untrue statement of a material fact or omitted, omits or will omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. Neither the Prospectus nor any amendment or supplement thereto (including any prospectus wrapper), as of its issue date, at the time of any filing with the Commission pursuant to Rule 424(b), at each Company Periodic Report Date, at each Applicable Time and at each Settlement Date, included, includes or will include an untrue statement of a material fact or omitted, omits or will omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. The documents incorporated or deemed to be incorporated by reference in the Registration Statement, the General Disclosure Package and the Prospectus, at the time the Registration Statement became effective or when such documents incorporated by reference were filed with the Commission, as the case may be, when read together with the other information in the Registration Statement, the General Disclosure Package or the Prospectus, as the case may be, did not and will not include an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">The representations and warranties in this subsection shall not apply to statements in or omissions from the Registration Statement (or any amendment thereto), the General Disclosure Package or the Prospectus (or any amendment or supplement thereto) made in reliance upon and in conformity with written information furnished to the Company by the Agent expressly for use therein.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(iii)&nbsp;&nbsp;&nbsp;&nbsp; <u>Issuer Free Writing Prospectuses</u>. No Issuer Free Writing Prospectus conflicts or will conflict with the information contained in the Registration Statement, any Statutory Prospectus or the Prospectus, including any document incorporated by reference therein, and any preliminary or other prospectus deemed to be a part thereof that has not been superseded or modified.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(iv)&nbsp;&nbsp;&nbsp;&nbsp; <u>Stock Exchange Listing</u>. The shares of Common Stock have been approved for listing on the NYSE American (the &#8220;<u>Exchange</u>&#8221;), and the Company has taken no action intended to result in, or likely to have the effect of, delisting the shares of Common Stock from the Exchange, nor has the Company received any written notification that the Exchange is contemplating terminating such listing except as described in the Registration Statement, the General Disclosure Package and the Prospectus. The Company will promptly submit a Supplemental Listing Application with the Exchange for at least such number of Shares as shall be specified by the Agent after due consultation with the Company, following the execution of this Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(v)&nbsp;&nbsp;&nbsp;&nbsp; <u>Disclosure of Agreements</u>. The agreements and documents incorporated or deemed to be incorporated by reference and as described in the Registration Statement, the General Disclosure Package and the Prospectus conform in all material respects to the descriptions thereof contained or incorporated by reference therein and there are no agreements or other documents required by the 1933 Act and the 1933 Act Regulations to be described in the Registration Statement, the General Disclosure Package and the Prospectus or to be filed with the Commission as exhibits to the Registration Statement or to be incorporated by reference in the Registration Statement, the General Disclosure Package or the Prospectus, that have not been so described or filed or incorporated by reference. Each agreement or other instrument that is incorporated by reference in the Registration Statement, the General Disclosure Package and the Prospectus, has been duly authorized and validly executed by the Company, is in full force and effect in all material respects and is enforceable against the Company and, to the Company&#8217;s knowledge, the other parties thereto, in accordance with its terms, except (x) as such enforceability may be limited by bankruptcy, insolvency, reorganization or similar laws affecting creditors&#8217; rights generally, (y) as enforceability of any indemnification or contribution provision may be limited under the federal and state securities laws, and (z) that the remedy of specific performance and injunctive and other forms of equitable relief may be subject to the equitable defenses and to the discretion of the court before which any proceeding therefor may be brought. None of such agreements or instruments has been assigned by the Company, and the Company is not in default thereunder and, to the Company&#8217;s knowledge, no event has occurred that, with the lapse of time or the giving of notice, or both, would constitute a default thereunder, except for any default which would not reasonably be expected to result in a Material Adverse Effect (as defined below). To the Company&#8217;s knowledge, performance by the Company of the material provisions of such agreements or instruments will not result in a violation of any existing applicable law, rule, regulation, judgment, order or decree of any governmental agency or court, domestic or foreign, having jurisdiction over the Company or any of its assets or businesses (each, a &#8220;<u>Governmental Entity</u>&#8221;), including, without limitation, those relating to environmental laws and regulations, except for any violation which would not reasonably be expected to result in a Material Adverse Effect.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(vi)&nbsp;&nbsp;&nbsp;&nbsp; <u>Prior Securities Transactions</u>. Subsequent to the date of the latest audited financial statements included or incorporated by reference in the Registration Statement, the General Disclosure Package and the Prospectus, and except as may otherwise be indicated or contemplated herein or disclosed in the Registration Statement, the General Disclosure Package and the Prospectus, the Company has not: (i) issued any securities or incurred any liability or obligation, direct or contingent, for borrowed money; or (ii) declared or paid any dividend or made any other distribution on or in respect to its capital stock. For the last three years, no securities of the Company have been sold by the Company or by or on behalf of, or for the benefit of, any person or persons controlling, controlled by or under common control with the Company, except as disclosed or incorporated by reference in the Registration Statement, the General Disclosure Package and the Prospectus.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(vii)&nbsp;&nbsp;&nbsp;&nbsp; <u>Regulations</u>. The disclosures in the Registration Statement, the General Disclosure Package and the Prospectus concerning the effects of material applicable federal, state, local and all foreign regulation on the Offering and the Company&#8217;s business as currently conducted are correct in all material respects and no other such regulations are required to be disclosed in the Registration Statement, the General Disclosure Package and the Prospectus which are not so disclosed.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(viii)&nbsp;&nbsp;&nbsp;&nbsp; <u>No Other Distribution of Offering Materials</u>. The Company has not, directly or indirectly, distributed and will not distribute any offering material in connection with the Offering other than the General Disclosure Package, the Prospectus and other materials, if any, permitted under the 1933 Act and consistent with Section 3(a) below.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(ix)&nbsp;&nbsp;&nbsp;&nbsp; <u>No Material Adverse Change in Business</u>. Except as otherwise stated therein, since the respective dates as of which information is given in the Registration Statement, the General Disclosure Package or the Prospectus, (i) there has not been any material change in the capital stock (other than the issuance of shares of Common Stock upon exercise of stock options and warrants described as outstanding in, and the grant of options and awards under the Company&#8217;s existing stock-based compensation plans (the &#8220;<u>Company Stock Plans</u>&#8221;) described in, and the issuance of any stock upon the conversion of Company securities described in the Registration Statement, the General Disclosure Package and the Prospectus, and the repurchase or retirement of shares of capital stock pursuant to agreements providing for an option to repurchase or a right of first refusal on behalf of the Company pursuant to the Company&#8217;s repurchase rights), any material increase in short-term debt or long-term debt of the Company, or any dividend or distribution of any kind declared, set aside for payment, paid or made by the Company on any class of capital stock, or any material adverse change, or any development that would reasonably be expected to result in a material adverse change, in or affecting the business, properties, management, financial position, stockholders&#8217; equity or results of operations of the Company, whether or not arising in the ordinary course of business (a &#8220;<u>Material Adverse Effect</u>&#8221;); (ii) the Company has not entered into any transaction or agreement (other than in the ordinary course of business) that is material to the Company or incurred any liability or obligation, direct or contingent, that is material to the Company; and (iii) the Company has not sustained any loss or interference with its business that is material to the Company and that is either from fire, explosion, flood or other calamity, whether or not covered by insurance, or from any labor disturbance or dispute or any action, order or decree of any court or arbitrator or governmental or regulatory authority, except in each case as otherwise disclosed in the Registration Statement, the General Disclosure Package and the Prospectus.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(x)&nbsp;&nbsp;&nbsp;&nbsp; <u>Disclosures in Commission Filings</u>. Since January 1, 2023, (i) none of the SEC Reports contained any untrue statement of a material fact or omitted to state any material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; and (ii) the Company has made all filings with the Commission required under the 1934 Act and the rules and regulations of the Commission promulgated thereunder (the &#8220;<u>1934 Act Regulations</u>&#8221;).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(xi)&nbsp;&nbsp;&nbsp;&nbsp; <u>Independent Accountants</u>. Assure CPA LLP (the &#8220;<u>Auditor</u>&#8221;), whose report is filed with the Commission as part of the Registration Statement, the General Disclosure Package and the Prospectus, is an independent registered public accounting firm as required by the 1933 Act, the 1933 Act Regulations, the 1934 Act, the 1934 Act Regulations and the Public Company Accounting Oversight Board (United States).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(xii)&nbsp;&nbsp;&nbsp;&nbsp; <u>Financial Statements; Non-GAAP Financial Measures</u>. The financial statements (including the related notes thereto) of the Company included or incorporated by reference in the Registration Statement, the General Disclosure Package and the Prospectus, together with the related schedules and notes, comply as to form in all material respects with Regulation S-X under the 1933 Act and present fairly, in all material respects, the financial position of the Company and its consolidated Subsidiaries (as defined below) at the dates indicated and the statement of operations, statement of changes in stockholders&#8217; equity and statement of cash flows of the Company and its consolidated Subsidiaries for the periods specified; said financial statements have been prepared in conformity with U.S. generally accepted accounting principles (&#8220;<u>GAAP</u>&#8221;) applied on a consistent basis throughout the periods covered thereby, except in the case of unaudited interim financial statements, which are subject to normal year-end adjustments and do not contain certain footnotes as permitted by the applicable rules of the Commission, and any supporting schedules, if any, present fairly, in all material respects, the information required to be stated therein. The summary financial information, if any, and other financial data included or incorporated by reference in the Registration Statement, the General Disclosure Package and the Prospectus has been derived from the accounting records of the Company and present fairly, in all material respects, the information shown therein and have been compiled on a basis consistent with that of the audited financial statements included therein. Except as included therein, no historical or pro forma financial statements or supporting schedules are required to be included or incorporated by reference in the Registration Statement, the General Disclosure Package or the Prospectus under the 1933 Act or the 1933 Act Regulations. All disclosures contained in the Registration Statement, the General Disclosure Package or the Prospectus, or incorporated by reference therein, regarding &#8220;non-GAAP financial measures&#8221; (as such term is defined by the rules and regulations of the Commission) comply in all material respects with Regulation G of the 1934 Act, and Item 10 of Regulation S-K, to the extent applicable. The interactive data in eXtensible Business Reporting Language included or incorporated by reference in the Registration Statement, the General Disclosure Package and the Prospectus fairly presents the information called for in all material respects and has been prepared in accordance with the Commission&#8217;s rules and guidelines applicable thereto.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(xiii)&nbsp;&nbsp;&nbsp;&nbsp; <u>Solvency</u>. Based on the consolidated financial condition of the Company as of the date hereof, after giving effect to the receipt by the Company of the proceeds from the sale of the Shares hereunder, (i) the fair saleable value of the Company&#8217;s assets exceeds the amount that will be required to be paid on or in respect of the Company&#8217;s existing debts and other liabilities (including known contingent liabilities) as they mature, (ii) the Company&#8217;s assets do not constitute unreasonably small capital to carry on its business as now conducted and as proposed to be conducted including its capital needs taking into account the particular capital requirements of the business conducted by the Company, consolidated and projected capital requirements and capital availability thereof, and (iii) the current cash flow of the Company, together with the proceeds the Company would receive, were it to liquidate all of its assets, after taking into account all anticipated uses of the cash, would be sufficient to pay all amounts on or in respect of its liabilities when such amounts are required to be paid. The Company does not intend to incur debts beyond its ability to pay such debts as they mature (taking into account the timing and amounts of cash to be payable on or in respect of its debt). The Company has no knowledge of any facts or circumstances which lead it to believe that it will file for reorganization or liquidation under the bankruptcy or reorganization laws of any jurisdiction within one year from the date hereof.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(xiv)&nbsp;&nbsp;&nbsp;&nbsp; <u>Authorized Capital; Options, etc</u>. The Company had, at the date or dates indicated in the Registration Statement, the General Disclosure Package and the Prospectus, the duly authorized, issued and outstanding capitalization as set forth therein. Except as set forth in, or contemplated by, the Registration Statement, the General Disclosure Package and the Prospectus, there are no stock options, warrants, or other rights to purchase or otherwise acquire any authorized, but unissued shares of Common Stock of the Company or any security convertible or exercisable into shares of Common Stock of the Company, or any contracts or commitments to issue or sell shares of Common Stock or any such options, warrants, rights or convertible securities.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(xv)&nbsp;&nbsp;&nbsp;&nbsp; <u>Outstanding Securities</u>. All issued and outstanding securities of the Company issued prior to the transactions contemplated by this Agreement have been duly authorized and validly issued and are fully paid and non-assessable; the holders thereof have no rights of rescission or similar rights with respect thereto or put rights, and are not subject to personal liability by reason of being such holders; and none of such securities were issued in violation of the preemptive rights, rights of first refusal or rights of participation of any holders of any security of the Company or similar contractual rights granted by the Company. The authorized shares of Common Stock conform in all material respects to all statements relating thereto contained in the Registration Statement, the General Disclosure Package and the Prospectus. The offers and sales of the outstanding shares of Common Stock were at all relevant times either registered under the 1933 Act and the applicable state securities or &#8220;blue sky&#8221; laws or, based in part on the representations and warranties of the purchasers of such Shares, exempt from such registration requirements.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(xvi)&nbsp;&nbsp;&nbsp;&nbsp; <u>Securities Sold Pursuant to this Agreement</u>. The Shares have been duly authorized for issuance and sale and, when issued and paid for in accordance with this Agreement, will be validly issued, fully paid and non-assessable; the holders thereof are not and will not be subject to personal liability by reason of being such holders; the Shares are not and will not be subject to the preemptive rights of any holders of any security of the Company or similar contractual rights granted by the Company; and all corporate action required to be taken for the authorization, issuance and sale of the Shares has been duly and validly taken. The Shares conform in all material respects to all statements with respect thereto contained in or incorporated into the Registration Statement, the General Disclosure Package and the Prospectus.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(xvii)&nbsp;&nbsp;&nbsp;&nbsp; <u>Registration Rights</u>. Except as disclosed in the Registration Statement, the General Disclosure Package and the Prospectus, no holders of any securities of the Company or any rights exercisable for or convertible or exchangeable into securities of the Company have the right to require the Company to register any such securities of the Company under the 1933 Act or to include any such securities in a registration statement to be filed by the Company.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(xviii)&nbsp;&nbsp;&nbsp;&nbsp; <u>Validity and Binding Effect of Agreements</u>. This Agreement has been duly and validly authorized by the Company, and, when executed and delivered, will constitute, the valid and binding agreement of the Company, enforceable against the Company in accordance with its terms, except: (i) as such enforceability may be limited by bankruptcy, insolvency, reorganization or similar laws affecting creditors&#8217; rights generally; (ii) as enforceability of any indemnification or contribution provision may be limited under the federal and state securities laws; and (iii) that the remedy of specific performance and injunctive and other forms of equitable relief may be subject to the equitable defenses and to the discretion of the court before which any proceeding therefor may be brought.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(xix)&nbsp;&nbsp;&nbsp;&nbsp; <u>No Conflicts, etc.</u> Neither the Company nor any Subsidiary is (A) in violation of its charter, by-laws or similar organizational document, (B) in default in the performance or observance of any obligation, agreement, covenant or condition contained in any contract, indenture, mortgage, deed of trust, loan or credit agreement, note, lease or other agreement or instrument to which the Company or any Subsidiary is a party or by which either of them may be bound or to which any of the properties or assets of the Company or any Subsidiary is subject (collectively, &#8220;<u>Agreements and Instruments</u>&#8221;), except for such defaults that would not, individually or in the aggregate, result in a Material Adverse Effect, or (C) in violation of any law, statute, rule, regulation, judgment, order, writ or decree of any arbitrator, court, governmental body, regulatory body, administrative agency or other authority, body or agency having jurisdiction over the Company or its Subsidiaries or any of their respective properties, assets or operations (each, a &#8220;<u>Governmental Entity</u>&#8221;), except for such violations that would not, individually or in the aggregate, result in a Material Adverse Effect. The execution, delivery and performance of this Agreement and the consummation of the transactions contemplated herein and in the Registration Statement, the General Disclosure Package and the Prospectus (including the issuance and sale of the Shares and the use of the proceeds from the sale of the Shares as described therein under the caption &#8220;Use of Proceeds&#8221;) and compliance by the Company with its obligations hereunder have been duly authorized by all necessary corporate action and do not and will not, whether with or without the giving of notice or passage of time or both, conflict with or constitute a breach of, or default or Repayment Event (as defined below) under, or result in the creation or imposition of any lien, charge or encumbrance upon any properties or assets of the Company or its Subsidiaries pursuant to, the Agreements and Instruments (except for such conflicts, breaches, defaults or Repayment Events or liens, charges or encumbrances that would not, individually or in the aggregate, result in a Material Adverse Effect), nor will such action result in any violation of the provisions of the charter, by-laws or similar organizational document of the Company or its Subsidiaries or any law, statute, rule, regulation, judgment, order, writ or decree of any Governmental Entity. As used herein, a &#8220;<u>Repayment Event</u>&#8221; means any event or condition which gives the holder of any note, debenture or other evidence of indebtedness (or any person acting on such holder&#8217;s behalf) the right to require the repurchase, redemption or repayment of all or a portion of such indebtedness by the Company or its Subsidiaries.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(xx)&nbsp;&nbsp;&nbsp;&nbsp; <u>No Defaults; Violations</u>. No material default exists in the due performance and observance of any term, covenant or condition of any material license, contract, indenture, mortgage, deed of trust, note, loan or credit agreement, or any other agreement or instrument evidencing an obligation for borrowed money, or any other material agreement or instrument to which the Company is a party or by which the Company may be bound or to which any of the properties or assets of the Company is subject. The Company is not (i) in violation of any term or provision of its Charter or by-laws, or (ii) to the Company&#8217;s knowledge, in violation of any franchise, license, permit, applicable law, rule, regulation, judgment or decree of any Governmental Entity, except in the cases of clause (i) for such violations which would not, individually or in the aggregate, reasonably be expected to result in a Material Adverse Effect.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(xxi)&nbsp;&nbsp;&nbsp;&nbsp; <u>Conduct of Business</u>. The Company has all requisite corporate power and authority, and has all necessary authorizations, approvals, orders, licenses, certificates and permits of and from all governmental regulatory officials and bodies that it needs as of the date hereof to conduct its business purpose as described in the Registration Statement, the General Disclosure Package and the Prospectus.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(xxii)&nbsp;&nbsp;&nbsp;&nbsp; <u>Transactions Contemplated Herein</u>. The Company has all corporate power and authority to enter into this Agreement and to carry out the provisions and conditions hereof, and all consents, authorizations, approvals and orders required in connection therewith have been obtained. No consent, authorization or order of, and no filing with, any court, government agency or other body is required for the valid issuance, sale and delivery of the Shares and the consummation of the transactions and agreements contemplated by this Agreement and as contemplated by the Registration Statement, the General Disclosure Package and the Prospectus, except with respect to applicable federal and state securities laws and the rules and regulations of the Exchange and the Financial Industry Regulatory Authority, Inc. (&#8220;<u>FINRA</u>&#8221;).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(xxiii)&nbsp;&nbsp;&nbsp;&nbsp; <u>D&amp;O Questionnaires</u>. To the Company&#8217;s knowledge, all information contained in the questionnaires (the &#8220;<u>Questionnaires</u>&#8221;) most recently completed by each of the Company&#8217;s directors and officers (the &#8220;<u>Insiders</u>&#8221;), as supplemented by all information concerning the Company&#8217;s directors, officers and principal shareholders as described in the Registration Statement, the General Disclosure Package and the Prospectus, is true and correct in all material respects and the Company has not become aware of any information which would cause the information disclosed in the Questionnaires to become materially inaccurate and incorrect.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(xxiv)&nbsp;&nbsp;&nbsp;&nbsp; <u>Litigation; Governmental Proceedings</u>. There is no action, suit, inquiry, notice of violation, proceeding or investigation pending or, to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their respective properties before or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state, county, local or foreign) (collectively, an &#8220;<u>Legal Action</u>&#8221;) which (i) adversely affects or challenges the legality, validity or enforceability of this Agreement or the Shares or (ii) could, if there were an unfavorable decision, have or reasonably be expected to result in a Material Adverse Effect. Neither the Company nor any Subsidiary, nor, to the Company&#8217;s knowledge, any director or officer thereof, is or has been the subject of any Legal Action involving a claim of violation of or liability under federal or state securities laws or a claim of breach of fiduciary duty. There has not been, and to the knowledge of the Company, there is not pending or contemplated, any investigation by the Commission involving the Company or any current or former director or officer of the Company. The Commission has not issued any stop order or other order suspending the effectiveness of any registration statement filed by the Company or any Subsidiary under the 1934 Act or the 1933 Act.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(xxv)&nbsp;&nbsp;&nbsp;&nbsp; <u>Good Standing</u>. The Company has been duly organized and is validly existing and in good standing under the laws of its jurisdiction of organization, is duly qualified to do business and is in good standing in each jurisdiction in which its ownership or lease of property or the conduct of its business requires such qualification, and has all power and authority necessary to own or hold its properties and to conduct the business in which it is engaged, except where the failure to be so qualified or in good standing or have such power or authority would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. Other than as disclosed in Exhibit 21.1 of the Company&#8217;s most recent Annual Report on Form 10-K, the Company does not have any direct or indirect Subsidiaries and does not own or control, directly or indirectly, any corporation, association or other entity. It is understood and agreed that Bioleum Corporation, a Nevada corporation, is not a Subsidiary of the Company.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(xxvi)&nbsp;&nbsp;&nbsp;&nbsp; <u>Insurance</u>. The Company and its Subsidiaries carry or are entitled to the benefits of insurance, with financially sound and reputable insurers, in such amounts and covering such risks as is generally maintained by companies of established repute engaged in the same or similar business, and all such insurance is in full force and effect. The Company has no reason to believe that it or its Subsidiaries will not be able (A) to renew its existing insurance coverage as and when such policies expire or (B) to obtain comparable coverage from similar institutions as may be necessary or appropriate to conduct its business as now conducted and at a cost that would not result in a Material Adverse Effect. Neither of the Company nor its Subsidiaries has been denied any insurance coverage which it has sought or for which it has applied.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(xxvii)&nbsp;&nbsp;&nbsp;&nbsp; <u>Finder</u><u>&#8217;</u><u>s Fees</u>. Except as disclosed in the Registration Statement, the General Disclosure Package and the Prospectus, there are no contracts, agreements or understandings between the Company and any person that would give rise to a valid claim against the Company or the Agent for a brokerage commission, finder&#8217;s fee or other like payment in connection with the Offering.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(xxviii)&nbsp;&nbsp;&nbsp;&nbsp; <u>Payments Within Twelve Months</u>. Except as described in the Registration Statement, the General Disclosure Package and the Prospectus, the Company has not made any direct or indirect payments (in cash, securities or otherwise) to: (i) any person, as a finder&#8217;s fee, consulting fee or otherwise, in consideration of such person raising capital for the Company or introducing to the Company persons who raised or provided capital to the Company; (ii) any FINRA member; or (iii) any person or entity that has any direct or indirect affiliation or association with any FINRA member, within the twelve months prior to the date of this Agreement, other than the payment to the Agent as provided hereunder in connection with the Offering.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(xxix)&nbsp;&nbsp;&nbsp;&nbsp; <u>Use of Proceeds</u>. The Company will use the net proceeds received by it from the sale of the Shares in all material respects in the manner specified in the Registration Statement, the General Disclosure Package and the Prospectus under the heading &#8220;Use of Proceeds.&#8221;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(xxx)&nbsp;&nbsp;&nbsp;&nbsp; <u>FINRA Affiliation</u>. No officer, director or any beneficial owner of 10% or more of the Company&#8217;s unregistered securities has any direct or indirect affiliation or association with any FINRA member (as determined in accordance with the rules and regulations of FINRA) that is participating in the Offering. The Company will advise the Agent and the Agent&#8217;s counsel if it learns that any officer, director or owner of 10% or more of (i) the Company&#8217;s outstanding shares of Common Stock or (ii) any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock is or becomes an affiliate or associated person of a FINRA member firm.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(xxxi)&nbsp;&nbsp;&nbsp;&nbsp; <u>Information</u>. All information provided by the Company in its FINRA questionnaire to Agent&#8217;s counsel specifically for use by Agent&#8217;s counsel in connection with its Public Offering System filings (and related disclosure) with FINRA is true, correct and complete in all material respects.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(xxxii)&nbsp;&nbsp;&nbsp;&nbsp; <u>Foreign Corrupt Practices Act</u>. None of the Company, its Subsidiaries or, to the knowledge of the Company, any director, officer, agent, employee, affiliate or other person acting on behalf of the Company or its Subsidiaries is aware of or has taken any action, directly or indirectly, that would result in a violation by such persons of the Foreign Corrupt Practices Act of 1977, as amended, and the rules and regulations thereunder (the &#8220;<u>FCPA</u>&#8221;), including, without limitation, making use of the mails or any means or instrumentality of interstate commerce corruptly in furtherance of an offer, payment, promise to pay or authorization of the payment of any money, or other property, gift, promise to give, or authorization of the giving of anything of value to any &#8220;foreign official&#8221; (as such term is defined in the FCPA) or any foreign political party or official thereof or any candidate for foreign political office, in contravention of the FCPA and the Company has and, to the knowledge of the Company, its affiliates have conducted their businesses in compliance with the FCPA and have instituted and maintain policies and procedures designed to ensure, and which are reasonably expected to continue to ensure, continued compliance therewith.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(xxxiii)&nbsp;&nbsp;&nbsp;&nbsp; <u>Compliance with OFAC</u>. None of the Company, its Subsidiaries or, to the knowledge of the Company, any director, officer, agent, employee, affiliate or representative of the Company or its Subsidiaries is an individual or entity (&#8220;<u>Person</u>&#8221;) currently the subject or target of any sanctions administered or enforced by the United States Government, including, without limitation, the U.S. Department of the Treasury&#8217;s Office of Foreign Assets Control, the United Nations Security Council, the European Union, His Majesty&#8217;s Treasury, or other relevant sanctions authority (collectively, &#8220;<u>Sanctions</u>&#8221;), nor is the Company located, organized or resident in a country or territory that is the subject of Sanctions; and the Company will not directly or indirectly use the proceeds of the sale of the Shares, or lend, contribute or otherwise make available such proceeds to any Subsidiary, joint venture partners or other Person, to fund any activities of or business with any Person, or in any country or territory, that, at the time of such funding, is the subject of Sanctions or in any other manner that will result in a violation by any Person (including any Person participating in the transaction, whether as underwriter, advisor, investor or otherwise) of Sanctions.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(xxxiv)&nbsp;&nbsp;&nbsp;&nbsp; <u>Forward-Looking Statements</u>. No forward-looking statement (within the meaning of Section 27A of the 1933 Act and Section 21E of the 1934 Act) contained in any of the Registration Statement, General Disclosure Package or Prospectus has been made or reaffirmed without a reasonable basis or has been disclosed other than in good faith.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(xxxv)&nbsp;&nbsp;&nbsp;&nbsp; <u>Money Laundering Laws</u>. To the Company&#8217;s knowledge after due inquiry, the operations of the Company and its Subsidiaries are and have been conducted at all times in compliance with applicable financial recordkeeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the money laundering statutes of all applicable jurisdictions, the rules and regulations thereunder and any related or similar rules, regulations or guidelines, issued, administered or enforced by any Governmental Entity (collectively, the &#8220;<u>Money Laundering Laws</u>&#8221;); and no action, suit or proceeding by or before any Governmental Entity involving the Company or its Subsidiaries with respect to the Money Laundering Laws is pending or, to the knowledge of the Company, threatened.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(xxxvi)&nbsp;&nbsp;&nbsp;&nbsp; <u>Cybersecurity</u>. (i)(x) There has been no material security breach or other compromise of or relating to any of the Company&#8217;s or any Subsidiary&#8217;s information technology and computer systems, networks, hardware, software, data (including the data of its respective customers, employees, suppliers, vendors and any third party data maintained by or on behalf of it), equipment or technology (collectively, &#8220;<u>IT Systems and Data</u>&#8221;) and (y) the Company and the Subsidiaries have not been notified of, and has no knowledge of any event or condition that would reasonably be expected to result in, any security breach or other compromise to its IT Systems and Data; (ii) the Company and the Subsidiaries are presently in material compliance with all applicable laws or statutes and all judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory authority, internal policies and contractual obligations relating to the privacy and security of IT Systems and Data and to the protection of such IT Systems and Data from unauthorized use, access, misappropriation or modification, except as would not, individually or in the aggregate, have a Material Adverse Effect; (iii) the Company and the Subsidiaries have implemented and maintained commercially reasonable safeguards to maintain and protect its material confidential information and the integrity, continuous operation, redundancy and security of all IT Systems and Data; and (iv) the Company and the Subsidiaries have implemented backup and disaster recovery technology consistent with industry standards and practices.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(xxxvii)&nbsp;&nbsp;&nbsp;&nbsp; <u>Privacy and Data Protection</u>. The Company and its Subsidiaries have operated their business in a manner compliant in all material respects with all United States federal, state, local and non-United States privacy, data security and data protection laws and regulations applicable to the Company&#8217;s collection, use, transfer, protection, disposal, disclosure, handling, storage and analysis of personal data. The Company and its Subsidiaries have been and are in compliance in all material respects with internal policies and procedures designed to ensure the integrity and security of the data collected, handled or stored in connection with its business; the Company and its Subsidiaries have been and are in compliance in all material respects with internal policies and procedures designed to ensure compliance with health care laws that govern privacy and data security and take, and have taken reasonably appropriate steps designed to assure compliance with such policies and procedures. The Company and its Subsidiaries have taken reasonable steps to maintain the confidentiality of its personally identifiable information, protected health information, consumer information and other confidential information of the Company, its Subsidiaries and any third parties in its possession (&#8220;<u>Sensitive Company Data</u>&#8221;). The IT Systems and Data used or held for use by the Company and its Subsidiaries are adequate and operational for, in accordance with their documentation and functional specifications, the business of the Company and its Subsidiaries as now operated and as currently proposed to be conducted as described in the Registration Statement, the General Disclosure Package and the Prospectus. The Company and its Subsidiaries have used reasonable efforts to establish, and have established, commercially reasonable disaster recovery and security plans, procedures and facilities for the business consistent with industry standards and practices in all material respects, including, without limitation, for the IT Systems and Data held or used by or for the Company and its Subsidiaries. To the knowledge of the Company, the Company and its Subsidiaries have not suffered or incurred any security breaches, compromises or incidents with respect to any Company IT Systems and Data, except where such breaches, compromises or incidents would not reasonably be expected to, individually or in the aggregate, result in a Material Adverse Effect; and to the knowledge of the Company, there has been no unauthorized or illegal use of or access to any IT Systems and Data or Sensitive Company Data by any unauthorized third party. The Company and its Subsidiaries have not been required to notify any individual of any information security breach, compromise or incident involving Sensitive Company Data.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(xxxviii)&nbsp;&nbsp;&nbsp;&nbsp; <u>Bank Holding Company Act</u>. Neither the Company nor any of its Subsidiaries or affiliates is subject to the Bank Holding Company Act of 1956, as amended (the &#8220;<u>BHCA</u>&#8221;) and to regulation by the Board of Governors of the Federal Reserve System (the &#8220;<u>Federal Reserve</u>&#8221;). Neither the Company nor any of its Subsidiaries or affiliates owns or controls, directly or indirectly, five percent (5%) or more of the outstanding shares of any class of voting securities or twenty-five percent (25%) or more of the total equity of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its Subsidiaries or affiliates exercises a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(xxxix)&nbsp;&nbsp;&nbsp;&nbsp; <u>Possession of Licenses and Permits</u>. The Company and its Subsidiaries possess such permits, licenses, approvals, consents and other authorizations (collectively, &#8220;<u>Governmental Licenses</u>&#8221;) issued by the appropriate Governmental Entities necessary to conduct the business now operated by them, except where the failure so to possess would not, individually or in the aggregate, result in a Material Adverse Effect. The Company and its Subsidiaries are in compliance with the terms and conditions of all Governmental Licenses, except where the failure so to comply would not, individually or in the aggregate, result in a Material Adverse Effect. The Company has fulfilled and performed all of its material obligations with respect to the Governmental Licenses and, to the knowledge of the Company, no event has occurred which allows, or after notice or lapse of time would allow, revocation or termination thereof or results in any other material impairment of the rights of the Company as a holder of any permit, except where the failure to so fulfill or perform, or the occurrence of such event, would not, individually or in the aggregate, result in a Material Adverse Effect. All of the Governmental Licenses are valid and in full force and effect, except where the invalidity of such Governmental Licenses or the failure of such Governmental Licenses to be in full force and effect would not, individually or in the aggregate, result in a Material Adverse Effect. Neither the Company nor its Subsidiaries has received any notice of proceedings relating to the revocation or modification of any Governmental Licenses which, individually or in the aggregate, if the subject of an unfavorable decision, ruling or finding, would result in a Material Adverse Effect.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(xl)&nbsp;&nbsp;&nbsp;&nbsp; <u>Officers</u><u>&#8217;</u><u> Certificate</u>. Any certificate signed by any duly authorized officer of the Company and delivered to the Agent or to Agent&#8217;s counsel shall be deemed a representation and warranty by the Company to the Agent as to the matters covered thereby.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(xli)&nbsp;&nbsp;&nbsp;&nbsp; <u>Business Relationships</u>. There are no business relationships or related party transactions involving the Company or any other person required to be described in the Registration Statement, the General Disclosure Package and the Prospectus that have not been described as required.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(xlii)&nbsp;&nbsp;&nbsp;&nbsp; <u>Subsidiaries</u>. Each subsidiary of the Company (each, a &#8220;<u>Subsidiary</u>&#8221; and, collectively, the &#8220;<u>Subsidiaries</u>&#8221;) has been duly organized and is validly existing in good standing under the laws of the jurisdiction of its incorporation or organization, has corporate or similar power and authority to own, lease and operate its properties and to conduct its business as described in the Registration Statement, the General Disclosure Package and the Prospectus and is duly qualified to transact business and is in good standing in each jurisdiction in which such qualification is required, whether by reason of the ownership or leasing of property or the conduct of business, except where the failure to be so qualified or to be in good standing would not result in a Material Adverse Effect. Except as otherwise disclosed in the Registration Statement, the General Disclosure Package and the Prospectus, all of the issued and outstanding capital stock of each Subsidiary has been duly authorized and validly issued, is fully paid and non-assessable and is owned by the Company, directly or through Subsidiaries, free and clear of any security interest, mortgage, pledge, lien, encumbrance, claim or equity. None of the outstanding shares of capital stock of any Subsidiary was issued in violation of the preemptive or similar rights of any securityholder of such Subsidiary. The only Subsidiaries of the Company are the entities listed on Exhibit 21.1 of the Company&#8217;s most recent Annual Report on Form 10-K, it being understood and agreed that Bioleum Corporation, a Nevada corporation, is not a Subsidiary of the Company.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(xliii)&nbsp;&nbsp;&nbsp;&nbsp; <u>No Relationships with Customers and Suppliers</u>. No relationship, direct or indirect, exists between or among the Company on the one hand, and the directors, officers, 5% or greater stockholders, of the Company or any of the Company&#8217;s affiliates on the other hand, which is required to be described in the Registration Statement, the General Disclosure Package or the Prospectus or a document incorporated by reference therein and which is not so described.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(xliv)&nbsp;&nbsp;&nbsp;&nbsp; <u>No Loans or Advances to Affiliates</u>. There are no outstanding loans, advances (except normal advances for business expenses in the ordinary course of business) or guarantees or indebtedness by the Company to or for the benefit of any of the officers or directors of the Company, any other affiliates of the Company or any of their respective immediate family members, except as disclosed in the Registration Statement, the General Disclosure Package and the Prospectus.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(xlv)&nbsp;&nbsp;&nbsp;&nbsp; <u>Accounting Controls and Disclosure Controls</u>. Except as disclosed in the Registration Statement, the General Disclosure Package and the Prospectus, the Company and each of its Subsidiaries maintain effective internal control over financial reporting (as defined under Rule 13a-15 and 15d-15 under the 1934 Act Regulations) and a system of internal accounting controls designed to provide reasonable assurances that (A) transactions are executed in accordance with management&#8217;s general or specific authorization; (B) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain accountability for assets; (C) access to assets is permitted only in accordance with management&#8217;s general or specific authorization; (D) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences; and (E) the interactive data in eXtensible Business Reporting Language included or incorporated by reference in the Registration Statement, the General Disclosure Package and the Prospectus fairly presents the information called for in all material respects and is prepared in accordance with the Commission&#8217;s rules and guidelines applicable thereto. Except as described in the Registration Statement, the General Disclosure Package and the Prospectus, since the end of the Company&#8217;s most recent audited fiscal year, there has been (1) no material weakness in the Company&#8217;s internal control over financial reporting (whether or not remediated) and (2) no change in the Company&#8217;s internal control over financial reporting that has materially adversely affected, or is reasonably likely to materially adversely affect, the Company&#8217;s internal control over financial reporting. Except as described in the Registration Statement, the General Disclosure Package and the Prospectus, the Company and each of its Subsidiaries maintain an effective system of disclosure controls and procedures (as defined in Rule 13a-15 and Rule 15d-15 under the 1934 Act Regulations) that are designed to ensure that information required to be disclosed by the Company in the reports that it files or submits under the 1934 Act is recorded, processed, summarized and reported, within the time periods specified in the Commission&#8217;s rules and forms, and is accumulated and communicated to the Company&#8217;s management, including its principal executive officer or officers and principal financial officer or officers, as appropriate, to allow timely decisions regarding required disclosure.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(xlvi)&nbsp;&nbsp;&nbsp;&nbsp; <u>Compliance with the Sarbanes-Oxley Act of 2002</u>. There is and has been no failure on the part of the Company or any of the Company&#8217;s directors or officers, in their capacities as such, to comply in all material respects with any applicable provision of the Sarbanes-Oxley Act of 2002 and the rules and regulations promulgated in connection therewith, with which the Company is required to comply, including Section 402 related to loans.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(xlvii)&nbsp;&nbsp;&nbsp;&nbsp; <u>No Investment Company Status</u>. Neither the Company nor any Subsidiary is required, and upon the issuance and sale of the Shares as herein contemplated and the application of the net proceeds therefrom as described in the Registration Statement, the General Disclosure Package and the Prospectus will not be required, to register as an &#8220;investment company&#8221; under the Investment Company Act of 1940, as amended.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(xlviii)&nbsp;&nbsp;&nbsp;&nbsp; <u>No Labor Disputes</u>. No labor dispute with the employees of the Company or its Subsidiaries exists or, to the knowledge of the Company, is imminent, and the Company is not aware of any existing or imminent labor disturbance by the employees of any of its or its Subsidiaries&#8217; principal suppliers, manufacturers, customers or contractors, which, in either case, could reasonably result in a Material Adverse Effect.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(xlix)&nbsp;&nbsp;&nbsp;&nbsp; <u>Patents and Trademarks</u>. (i) The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks, trademark applications, service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights and similar rights necessary or material for use in connection with their respective businesses and which the failure to so have could reasonably be expected to have a Material Adverse Effect (collectively, the &#8220;<u>Intellectual Property Rights</u>&#8221;); (ii) neither the Company nor any Subsidiary has received a notice (written or otherwise) that any of the Intellectual Property Rights violates or infringes upon the rights of any Person; (iii) all such Intellectual Property Rights are enforceable and to the knowledge of the Company there is no existing infringement by another Person of any of the Intellectual Property Rights, except where the failure to be so enforceable or for such infringements as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect; and (iv) the Company and its Subsidiaries have taken all commercially appropriate security measures to protect the secrecy, confidentiality and value of all of their intellectual properties, except where failure to do so could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(l)&nbsp;&nbsp;&nbsp;&nbsp; <u>Payment of Taxes</u>. All United States federal income tax returns of the Company and its Subsidiaries required by law to be filed have been filed and all taxes shown by such returns or otherwise assessed, which are due and payable, have been paid, except assessments against which appeals have been or will be promptly taken and as to which adequate reserves have been provided in conformity with GAAP. The United States federal income tax returns of the Company through the fiscal year ended December 31, 2024 have been settled and no assessment in connection therewith has been made against the Company. The Company and its Subsidiaries have filed all other tax returns that are required to have been filed by them pursuant to applicable foreign, state, local or other law except insofar as the failure to file such returns would not result in a Material Adverse Effect, and have paid all taxes due pursuant to such returns or pursuant to any assessment received by the Company and its Subsidiaries, except for such taxes, if any, as are being contested in good faith and as to which adequate reserves have been established by the Company. The charges, accruals and reserves on the books of the Company in respect of any income and corporation tax liability for any years not finally determined are, in conformity with GAAP, adequate to meet any assessments or re-assessments for additional income tax for any years not finally determined, except to the extent of any inadequacy that would not result in a Material Adverse Effect.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(li)&nbsp;&nbsp;&nbsp;&nbsp; <u>ERISA Compliance</u>. The Company and its Subsidiaries and any &#8220;employee benefit plan&#8221; (as defined under the Employee Retirement Income Security Act of 1974, as amended, and the regulations and published interpretations thereunder (collectively, &#8220;<u>ERISA</u>&#8221;)) established or maintained by the Company, its Subsidiaries or their ERISA Affiliates (as defined below) are in compliance in all material respects with ERISA. &#8220;<u>ERISA Affiliate</u>&#8221; means, with respect to the Company or any of its Subsidiaries, any member of any group of organizations described in Sections 414(b), (c), (m) or (o) of the Internal Revenue Code of 1986, as amended, and the regulations and published interpretations thereunder (the &#8220;<u>Code</u>&#8221;) of which the Company or such Subsidiary is a member. No &#8220;reportable event&#8221; (as defined under ERISA) has occurred or is reasonably expected to occur with respect to any &#8220;employee benefit plan&#8221; established or maintained by the Company, its Subsidiaries or any of their ERISA Affiliates. No &#8220;employee benefit plan&#8221; established or maintained by the Company, its Subsidiaries or any of their ERISA Affiliates, if such &#8220;employee benefit plan&#8221; were terminated, would have any &#8220;amount of unfunded benefit liabilities&#8221; (as defined under ERISA). Neither the Company, its Subsidiaries nor any of their ERISA Affiliates has incurred or reasonably expects to incur any liability under (i) Title IV of ERISA with respect to termination of, or withdrawal from, any &#8220;employee benefit plan&#8221; or (ii) Sections 412, 4971, 4975 or 4980B of the Code. Each employee benefit plan established or maintained by the Company, its Subsidiaries or any of their ERISA Affiliates that is intended to be qualified under Section 401(a) of the Code is so qualified and nothing has occurred, whether by action or failure to act, which would cause the loss of such qualification.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(lii)&nbsp;&nbsp;&nbsp;&nbsp; <u>Environmental Laws</u>. The Company and its Subsidiaries are (i) in compliance in all material respects with any and all applicable foreign, federal, state and local laws and regulations relating to the protection of human health and safety, the environment or hazardous or toxic substances or wastes, pollutants or contaminants (&#8220;<u>Environmental Laws</u>&#8221;), (ii) have received all material permits, licenses or other approvals required of them under applicable Environmental Laws to conduct their respective businesses and (iii) are in compliance in all material respects with all terms and conditions of any such permit, license or approval.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(liii)&nbsp;&nbsp;&nbsp;&nbsp; <u>Title to Property</u>. The Company and its Subsidiaries have good and marketable title to all real property owned by them and good title to all other properties owned by them, in each case, free and clear of all mortgages, pledges, liens, security interests, restrictions or encumbrances of any kind except such as (A) are described in the Registration Statement, the General Disclosure Package and the Prospectus or (B) do not, individually or in the aggregate, materially affect the value of such property and do not materially interfere with the use made and proposed to be made of such property by the Company or its Subsidiaries; and all of the leases and subleases material to the business of the Company and its Subsidiaries, considered as one enterprise, and under which the Company or its Subsidiaries holds properties described in the Registration Statement, the General Disclosure Package or the Prospectus, are in full force and effect, and neither the Company nor any such Subsidiary has any notice of any material claim of any sort that has been asserted by anyone adverse to the rights of the Company or any Subsidiary under any of the leases or subleases mentioned above, or affecting or questioning the rights of the Company or such Subsidiary to the continued possession of the leased or subleased premises under any such lease or sublease.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(liv)&nbsp;&nbsp;&nbsp;&nbsp; <u>Contracts Affecting Capital</u>. There are no transactions, arrangements or other relationships between and/or among the Company, any of its affiliates (as such term is defined in Rule 405 of the 1933 Act Regulations) and any unconsolidated entity, including, but not limited to, any structured finance, special purpose or limited purpose entity that could reasonably be expected to materially affect the Company&#8217;s or any of its Subsidiaries&#8217; liquidity or the availability of or requirements for their capital resources required to be described or incorporated by reference in the Registration Statement, the General Disclosure Package and the Prospectus which have not been described or incorporated by reference as required.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(lv)&nbsp;&nbsp;&nbsp;&nbsp; <u>Company Not Ineligible Issuer</u>. At the time of filing the Registration Statement and any post-effective amendment thereto, at the earliest time thereafter that the Company or another offering participant made a bona fide offer (within the meaning of Rule 164(h)(2) of the 1933 Act Regulations) of the Shares and at the date hereof, the Company was not and is not an &#8220;ineligible issuer,&#8221; as defined in Rule 405, without taking account of any determination by the Commission pursuant to Rule 405 that it is not necessary that the Company be considered an ineligible issuer.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(lvi)&nbsp;&nbsp;&nbsp;&nbsp; <u>Industry Data</u>. The statistical and market-related data included in each of the Registration Statement, the General Disclosure Package and the Prospectus are based on or derived from sources that the Company reasonably and in good faith believes are reliable and accurate or represent the Company&#8217;s good faith estimates that are made on the basis of data derived from such sources.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(lvii)&nbsp;&nbsp;&nbsp;&nbsp; <u>Margin Securities</u>. The Company owns no &#8220;margin securities&#8221; as that term is defined in Regulation U of the Board of Governors of the Federal Reserve Board, and none of the proceeds of Offering will be used, directly or indirectly, for the purpose of purchasing or carrying any margin security, for the purpose of reducing or retiring any indebtedness which was originally incurred to purchase or carry any margin security or for any other purpose which might cause any of the shares of Common Stock to be considered a &#8220;purpose credit&#8221; within the meanings of Regulation T, U or X of the Federal Reserve Board.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(lviii)&nbsp;&nbsp;&nbsp;&nbsp; <u>1934 Act Reports</u>. The Company has filed in a timely manner all reports required to be filed pursuant to Sections 13(a), 13(e), 14 and 15(d) of the 1934 Act during the preceding two years (except to the extent that Section 15(d) requires reports to be filed pursuant to Sections 13(d) and 13(g) of the 1934 Act, which shall be governed by the next clause of this sentence); and the Company has filed in a timely manner all reports required to be filed pursuant to Sections 13(d) and 13(g) of the 1934 Act since January 1, 2023, except where the failure to timely file could not reasonably be expected, individually or in the aggregate, to result in a Material Adverse Effect.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(lix)&nbsp;&nbsp;&nbsp;&nbsp; <u>Minute Books</u>. The minute books of the Company have been made available to the Agent and counsel for the Agent, and such books (i) contain a complete summary of all meetings and actions of the board of directors (including each board committee) and stockholders of the Company (or analogous governing bodies and interest holders, as applicable), and each of its Subsidiaries since the time of its respective incorporation or organization through the date of the latest meeting and action, and (ii) accurately in all material respects reflect all transactions referred to in such minutes. There are no material transactions, agreements, dispositions or other actions of the Company that are not properly approved and/or accurately and fairly recorded in the minute books of the Company, as applicable.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(lx)&nbsp;&nbsp;&nbsp;&nbsp; <u>Integration</u>. Neither the Company, nor any of its affiliates, nor any person acting on its or their behalf has, directly or indirectly, made any offers or sales of any security or solicited any offers to buy any security, under circumstances that would cause the Offering to be integrated with prior offerings by the Company for purposes of the 1933 Act that would require the registration of any such securities under the 1933 Act.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(lxi)&nbsp;&nbsp;&nbsp;&nbsp; <u>No Stabilization</u>. Neither the Company nor, to its knowledge, any of its employees, directors or stockholders (without the consent of the Agent) has taken or shall take, directly or indirectly, any action designed to or that has constituted or that might reasonably be expected to cause or result in, under Regulation M of the 1934 Act, or otherwise, stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Shares.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(lxii)&nbsp;&nbsp;&nbsp;&nbsp; <u>Confidentiality and Non-Competition</u>. To the Company&#8217;s knowledge, no director, officer, key employee or consultant of the Company is subject to any confidentiality, non-disclosure, non-competition agreement or non-solicitation agreement with any employer or prior employer that could reasonably be expected to materially affect his ability to be and act in his respective capacity of the Company or be expected to result in a Material Adverse Effect.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(lxiii)&nbsp;&nbsp;&nbsp;&nbsp; <u>Summaries of Law</u>. The statements set forth in the Registration Statement, the General Disclosure Package and the Prospectus under the caption &#8220;Description of Capital Stock&#8221; and with respect to legal proceedings set forth in the note to the financial statements titled &#8220;Litigation&#8221; or under &#8220;Item 3. Legal Proceedings&#8221; or &#8220;Item 1. Legal Proceedings&#8221; in the most recently filed Annual Report on Form 10-K or Quarterly Report on 10-Q, as applicable, as updated by any subsequent report filed pursuant to the 1934 Act, insofar as such statements purport to constitute summaries of the terms of the statutes, rules or regulations, legal or governmental proceedings, agreements or documents referred to therein, are accurate summaries of the terms of such statutes, rules or regulations, legal or governmental proceedings, agreements or documents in all material respects.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(lxiv)&nbsp;&nbsp;&nbsp;&nbsp; <u>Accuracy of Exhibits</u>. There are no contracts or other documents that are required by the 1933 Act to be described in the Prospectus or filed as exhibits to the Registration Statement, or that are required by the 1934 Act to be filed as exhibits to a document incorporated by reference into the Prospectus, that have not been so described in the Prospectus or filed as exhibits to the Registration Statement or such incorporated document.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(lxv)&nbsp;&nbsp;&nbsp;&nbsp;<u> Stock Option Plans</u>. The Company has not knowingly granted, and there is no and has been no Company policy or practice to knowingly grant, stock options prior to, or otherwise knowingly coordinate the grant of stock options with, the release or other public announcement of material information regarding the Company or its Subsidiaries or their financial results or prospects.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(lxvi)&nbsp;&nbsp;&nbsp;&nbsp;<u> Board of Directors</u>. The Company&#8217;s board of directors is comprised of the persons set forth in the SEC Reports. The qualifications of the persons serving as board members and the overall composition of the Company&#8217;s board of directors comply with the Sarbanes-Oxley Act of 2002 and the rules promulgated thereunder applicable to the Company and the rules of the NYSE American. At least one member of the Company&#8217;s board of directors qualifies as a &#8220;financial expert&#8221; as such term is defined under the Sarbanes-Oxley Act of 2002 and the rules promulgated thereunder and the rules of the NYSE American. In addition, at least a majority of the persons serving on the Company&#8217;s board of directors qualify as &#8220;independent&#8221; as defined under the rules of the NYSE American.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(lxvii)&nbsp;&nbsp;&nbsp;&nbsp;<u> No Contract Termination</u>. Neither the Company nor any of its subsidiaries has sent or received any communication regarding termination of, or intent not to renew, any of the contracts or agreements referred to or described in the Registration Statement, the General Disclosure Package or the Prospectus, and no such termination or non-renewal has been threatened by the Company or any of its subsidiaries or, to the Company&#8217;s knowledge, any other party to any such contract or agreement, which threat of termination or non-renewal has not been rescinded as of the date hereof.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(lxviii)&nbsp;&nbsp;&nbsp;&nbsp;<u> Mineral Information</u>. The Dayton Consolidated Project is the only resource project currently material to the Company in which the Company or its Subsidiaries have an interest. The information contained in, related to or derived from the Technical Report Summary for the Dayton Consolidated Project dated November 30, 2022, prepared by Behre Dolbear &amp; Company (USA), Inc., an independent consulting firm, is based on or derived from sources that the Company reasonably believes to be reliable and accurate in all material respects and represent its good faith estimate that is made on the basis of data derived from such sources, and the Company has obtained the written consent to the use of such data from such sources to the extent required, except as disclosed in the public record. The Company is in compliance, in all material respects, with the provisions of Regulation S-K 1300 of the 1933 Act to the extent applicable to the Company, and has filed all technical reports required to be filed pursuant thereto and made all disclosures required by Regulation S-K 1300 and there has been no material change of which the Company is or reasonably should be aware that would materially disaffirm or materially change any aspect of the Technical Report Summary or that would require the filing of a new technical report summary under in accordance with Regulation S-K 1300.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(lxix)&nbsp;&nbsp;&nbsp;&nbsp;<u> Actively-Traded Security</u>. The Common Stock is an &#8220;actively-traded security&#8221; excepted from the requirements of Rule 101 of Regulation M under the 1934 Act by Rule 101(c)(1) thereunder.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(lxx)&nbsp;&nbsp;&nbsp;&nbsp; <u>Sales Agency Agreement</u>. The Company is not currently party to any other sales agency agreements or other similar arrangements with any agent or any other representative in respect of at the market offerings of the Company&#8217;s Common Stock.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Section 2.&nbsp;&nbsp;&nbsp;&nbsp;<u>Sale and Delivery of Shares</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;Subject to the terms and conditions set forth herein, the Company agrees to issue and sell exclusively through the Agent acting as sales agent from time to time, and the Agent agrees to use its commercially reasonable efforts to sell as sales agent for the Company, the Shares. Sales of the Shares, if any, through the Agent acting as sales agent may be made in negotiated transactions or transactions that are deemed to be &#8220;at-the-market offerings&#8221; as defined in Rule 415 under the 1933 Act, including sales made directly on the Exchange, or sales made to or through a market maker other than on an exchange or through an electronic communications network.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;The Shares are to be sold on a daily basis or otherwise as shall be agreed to by the Company and the Agent on that trading day (other than a day on which the Exchange is scheduled to close prior to its regular weekday closing time, each, a &#8220;<u>Trading Day</u>&#8221;) that the Company has satisfied its obligations under Section 6 of this Agreement and that the Company has instructed the Agent to make such sales (&#8220;<u>Sales Notice</u>&#8221;). For the avoidance of doubt, the foregoing limitation shall not apply to sales solely to employees or security holders of the Company or its Subsidiaries, or to a trustee or other person acquiring such securities for the accounts of such persons in which the Agent is acting for the Company in a capacity other than as Agent under this Agreement. On any Trading Day, the Company may transmit such Sales Notice by instructing the Agent by telephone (confirmed promptly by email, which confirmation will be promptly acknowledged by the Agent) as to the maximum number of Shares to be sold by the Agent on such Trading Day (in any event not in excess of the number available for issuance under the Prospectus and the currently effective Registration Statement), the minimum price per Share at which such Shares may be sold and any other limitations specified by the Company and mutually agreed by the Agent. Subject to the terms and conditions hereof, the Agent shall use its commercially reasonable efforts to sell as sales agent all of the Shares so designated by the Company. The Company and the Agent each acknowledge and agree that (A) there can be no assurance that the Agent will be successful in selling the Shares, (B) the Agent will incur no liability or obligation to the Company or any other person or entity if they do not sell Shares for any reason other than a failure by the Agent to use its commercially reasonable efforts consistent with its normal trading and sales practices and applicable law and regulations to sell such Shares as required by this Agreement, and (C) the Agent shall be under no obligation to purchase Shares on a principal basis pursuant to this Agreement unless the Company and the Agent enter into a separate written agreement setting forth the terms of such sale.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding the foregoing, the Company shall not authorize the issuance and sale of, and the Agent as sales agent shall not be obligated to use its commercially reasonable efforts to sell, any Shares (i) at a price lower than the minimum price per share therefor authorized from time to time, or (ii) in a number in excess of the number of Shares authorized from time to time to be issued and sold under this Agreement, in each case, by the Company&#8217;s board of directors, or a duly authorized committee thereof, and notified to the Agent in writing. In addition, the Company may, upon notice to the Agent, suspend the offering of the Shares or the Agent may, upon notice to the Company, suspend the offering of the Shares with respect to which the Agent is acting as sales agent for any reason and at any time; <i>provided</i>, <i>however</i>, that such suspension or termination shall not affect or impair the parties&#8217; respective obligations with respect to the Shares sold hereunder prior to the giving of such notice. Any notice given pursuant to the preceding sentence may be given by telephone (confirmed promptly by email, which confirmation will be promptly acknowledged).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;The gross sales price of any Shares sold pursuant to this Agreement by the Agent acting as sales agent of the Company shall be the market price prevailing at the time of sale for shares of the Company&#8217;s Common Stock sold by the Agent on the Exchange or otherwise, at prices relating to prevailing market prices or at negotiated prices. The compensation payable to the Agent for sales of Shares with respect to which the Agent acts as sales agent shall be 3.0% of the gross sales price of the Shares sold pursuant to this Agreement. The remaining proceeds, after further deduction for any transaction fees imposed by any governmental, regulatory or self-regulatory organization in respect of such sales, shall constitute the net proceeds to the Company for such Shares (the &#8220;<u>Net Proceeds</u>&#8221;). The Agent shall notify the Company as promptly as practicable if any deduction referenced in the preceding sentence will be required.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(e)&nbsp;&nbsp;&nbsp;&nbsp;If acting as a sales agent hereunder, the Agent shall provide written confirmation to the Company following the close of trading on the Exchange, each day in which Shares are sold under this Agreement setting forth the number of Shares sold on such day, the aggregate gross sales proceeds of the Shares, the Net Proceeds to the Company and the compensation payable by the Company to such Agent with respect to such sales.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(f)&nbsp;&nbsp;&nbsp;&nbsp;Under no circumstances shall the aggregate offering price or number, as the case may be, of Shares sold pursuant to this Agreement, exceed the aggregate offering price or number, as the case may be, of shares of Common Stock (i) available for issuance under the Prospectus and the then currently effective Registration Statement (including any limit set forth in General Instruction I.B.6 thereof, if applicable), (ii) authorized but unissued (less shares of Common Stock issuable upon exercise, conversion or exchange of any outstanding securities of the Company or otherwise reserved from the Company&#8217;s authorized capital stock) or (iii) authorized from time to time to be issued and sold under this Agreement by the Company&#8217;s board of directors, or a duly authorized committee thereof. Notwithstanding anything to the contrary contained herein, the parties hereto agree that compliance with the foregoing limitations on the aggregate offering price or number, as the case may be, of Shares sold pursuant to this Agreement shall be the sole responsibility of the Company and that the Agent shall have no obligation in connection with such compliance. In addition, under no circumstances shall any Shares with respect to which the Agent acts as sales agent be sold at a price lower than the minimum price therefor authorized from time to time by the Company&#8217;s board of directors, or a duly authorized committee thereof, and notified to the Agent in writing.<i> </i></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(g)&nbsp;&nbsp;&nbsp;&nbsp;Settlement for sales of the Shares pursuant to this Section 2 will occur on the second trading day following the date on which such sales are made, unless another date shall be agreed to by the Company and the Agent (each such day, a &#8220;<u>Settlement Date</u>&#8221;). On each Settlement Date, the Shares sold through the Agent for settlement on such date shall be delivered by the Company to the Agent against payment of the Net Proceeds from the sale of such Shares. Settlement for all Shares shall be effected by book-entry delivery of Shares to the Agent&#8217;s account at The Depository Trust Company against payments by the Agent of the Net Proceeds from the sale of such Shares in same day funds delivered to an account designated by the Company. If the Company shall default on its obligation to deliver Shares on any Settlement Date, the Company shall (i) indemnify and hold the Agent harmless against any loss, claim or damage arising from or as a result of such default by the Company and (ii) pay the Agent any commission to which it would otherwise be entitled absent such default.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(h)&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding any other provision of this Agreement, the Company and the Agent agree that no sales of Shares shall take place, and the Company shall not request the sale of any Shares that would be sold, and the Agent shall not be obligated to sell any Shares, during any period in which the Company is, or could be deemed to be, in possession of material non-public information.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(i)&nbsp;&nbsp;&nbsp;&nbsp;At each Applicable Time, Settlement Date, Registration Statement Amendment Date (as defined below), Company Periodic Report Date (as defined below) and at each time of delivery of a Sales Notice, the Company shall be deemed to have affirmed each representation and warranty contained in this Agreement. Any obligation of the Agent to use its commercially reasonable efforts to sell the Shares on behalf of the Company as sales agent shall be subject to the continuing accuracy of the representations and warranties of the Company herein, to the performance by the Company of its obligations hereunder and to the continuing satisfaction of the additional conditions specified in Section 6 of this Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Section 3.&nbsp;&nbsp;&nbsp;&nbsp;<u>Covenants.</u> The Company agrees with the Agent:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;During any period when the delivery of a prospectus is required in connection with the offering or sale of Shares (whether physically or through compliance with Rule 153 or 172, or in lieu thereof, a notice referred to in Rule 173(a) under the 1933 Act), (i) to make no further amendment or any supplement to the Registration Statement or the Prospectus prior to any Settlement Date which shall be disapproved by the Agent promptly after reasonable notice thereof and to advise the Agent, promptly after it receives notice thereof, of the time when any amendment to the Registration Statement has been filed or becomes effective or any amendment or supplement to the Prospectus has been filed and to furnish the Agent with copies thereof, (ii) to file promptly all other materials required to be filed by the Company with the Commission pursuant to Rule 433(d) under the 1933 Act, (iii) to file promptly all reports and any definitive proxy or information statements required to be filed by the Company with the Commission pursuant to Section 13(a), 13(c), 14 or 15(d) of the 1934 Act, (iv) to advise the Agent, promptly after it receives notice thereof, of the issuance by the Commission of any stop order or of any order preventing or suspending the use of the Prospectus or other prospectus in respect of the Shares, of the suspension of the qualification of the Shares for offering or sale in any jurisdiction, of the initiation or threatening of any proceeding for any such purpose, or of any request by the Commission for the amending or supplementing of the form of the Registration Statement or the Prospectus or for additional information, and (v) in the event of the issuance of any such stop order or of any such order preventing or suspending the use of the Prospectus in respect of the Shares or suspending any such qualification, to promptly use its commercially reasonable efforts to obtain the withdrawal of such order; and in the event of any such issuance of a notice of objection, promptly to take such reasonable steps as may be necessary to permit offers and sales of the Shares by the Agent, which may include, without limitation, amending the Registration Statement or filing a new registration statement, at the Company&#8217;s expense (references herein to the Registration Statement shall include any such amendment or new registration statement).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;Promptly from time to time to take such action as the Agent may reasonably request to qualify the Shares for offering and sale under the securities laws of such jurisdictions as the Agent may request and to comply with such laws so as to permit the continuance of sales and dealings therein in such jurisdictions for as long as may be necessary to complete the sale of the Shares, <i>provided</i> that in connection therewith the Company shall not be required to qualify as a foreign corporation or to file a general consent to service of process in any jurisdiction; and to promptly advise the Agent of the receipt by the Company of any notification with respect to the suspension of the qualification of the Shares for offer or sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;During any period when the delivery of a prospectus is required (whether physically or through compliance with Rules 153 or 172, or in lieu thereof, a notice referred to in Rule 173(a) under the 1933 Act) in connection with the offering or sale of Shares, the Company will make available to the Agent, as soon as practicable after the execution of this Agreement, and thereafter from time to time furnish to the Agent, copies of the most recent Prospectus in such quantities and at such locations as the Agent may reasonably request for the purposes contemplated by the 1933 Act. During any period when the delivery of a prospectus is required (whether physically or through compliance with Rules 153 or 172, or in lieu thereof, a notice referred to in Rule 173(a) under the 1933 Act) in connection with the offering or sale of Shares, and if at such time any event shall have occurred as a result of which the Prospectus as then amended or supplemented would include an untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made when such Prospectus is delivered, not misleading, or, if for any other reason it shall be necessary during such same period to amend or supplement the Prospectus or to file under the 1934 Act any document incorporated by reference in the Prospectus in order to comply with the 1933 Act or the 1934 Act, to notify the Agent and to file such document and to prepare and furnish without charge to the Agent as many written and electronic copies as the Agent may from time to time reasonably request of an amended Prospectus or a supplement to the Prospectus which will correct such statement or omission or effect such compliance.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;To make generally available to its securityholders as soon as practicable, but in any event not later than sixteen months after the effective date of the Registration Statement (as defined in Rule 158(c) under the 1933 Act), an earnings statement of the Company and its Subsidiaries (which need not be audited) complying with Section 11(a) of the 1933 Act and the rules and regulations of the Commission thereunder (including, at the option of the Company, Rule 158).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(e)&nbsp;&nbsp;&nbsp;&nbsp;To use the Net Proceeds received by it from the sale of the Shares pursuant to this Agreement in the manner specified in the General Disclosure Package and the Prospectus.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(f)&nbsp;&nbsp;&nbsp;&nbsp;In connection with the offering and sale of the Shares, the Company will file with the Exchange all documents and notices, and make all certifications, required by the Exchange of companies that have securities that are listed or quoted on the Exchange and will maintain such listings or quotations.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(g)&nbsp;&nbsp;&nbsp;&nbsp;To not take, directly or indirectly, and to cause its affiliates to refrain from taking, any action designed to cause or result in, or that has constituted or might reasonably be expected to constitute, under the 1934 Act or otherwise, the stabilization or manipulation of the price of any securities of the Company to facilitate the sale or resale of the Shares.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(h)&nbsp;&nbsp;&nbsp;&nbsp;At each Applicable Time, each Settlement Date, each Registration Statement Amendment Date (as defined below), each Company Periodic Report Date (as defined below) and at each time of delivery of a Sales Notice, the Company shall be deemed to have affirmed each representation, warranty, covenant and other agreement contained in this Agreement. In each Annual Report on Form 10-K or Quarterly Report on Form 10-Q filed by the Company in respect of any quarter in which sales of Shares were made by or through the Agent under this Agreement (each date on which any such document is filed, and any date on which an amendment to any such document is filed, a &#8220;<u>Company Periodic Report Date</u>&#8221;), the Company shall set forth with regard to such quarter the number of Shares sold through the Agent under this Agreement and the Net Proceeds received by the Company with respect to sales of Shares pursuant to this Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(i)&nbsp;&nbsp;&nbsp;&nbsp;Upon commencement of the offering of Shares under this Agreement and promptly after each (i) date the Registration Statement or the Prospectus shall be amended, supplemented or replaced (other than (1) by an amendment, supplement or replacement providing solely for the determination of the terms of the Shares, (2) in connection with the filing of a prospectus supplement that contains solely the information set forth in Section 3(h), (3) in connection with the filing of any current reports on Form 8-K (other than any current reports on Form 8-K which contain financial statements, supporting schedules or other financial data, including any current report on Form 8-K under Item 2.02 of such form that is considered &#8220;filed&#8221; under the 1934 Act) or (4) by a prospectus supplement relating to the offering of other securities (including, without limitation, other shares of Common Stock)) (each such date, a &#8220;<u>Registration Statement Amendment Date</u>&#8221;) and (ii) Company Periodic Report Date (such commencement or recommencement date and each such date referred to in (i) and (ii), a &#8220;<u>Representation Date</u>&#8221;), the Company will furnish or cause to be furnished forthwith to the Agent a certificate dated the date of effectiveness of such amendment or the date of filing with the Commission of such supplement or other document, as the case may be, in a form reasonably satisfactory to the Agent to the effect that the statements contained in the certificate referred to in Section 6(f) of this Agreement which were last furnished to the Agent are true and correct at the time of such amendment, supplement or filing, as the case may be, as though made at and as of such time (except that such statements shall be deemed to relate to the Registration Statement, the General Disclosure Package and the Prospectus as amended and supplemented to such time) or, in lieu of such certificate, a certificate of the same tenor as the certificate referred to in said Section 6(f), but modified as necessary to relate to the Registration Statement and the Prospectus as amended and supplemented, or to the document incorporated by reference into the Prospectus, to the time of delivery of such certificate. As used in this paragraph, to the extent there shall be an Applicable Time on or following the date referred to in clause (i) above, promptly shall be deemed to be on or prior to the next succeeding Applicable Time.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(j)&nbsp;&nbsp;&nbsp;&nbsp;Upon commencement of the offering of Shares under this Agreement and within five (5) Trading Days after each Representation Date, the Company will furnish or cause to be furnished to the Agent and to counsel to the Agent the written opinion and negative assurance representation of Company Counsel (as defined below), or other counsel reasonably satisfactory to the Agent, in a form and substance reasonably satisfactory to the Agent and its counsel; <i>provided</i>, <i>however</i>, that if Company Counsel has previously furnished to the Agent such written opinion and negative assurance in the form previously agreed between the Company and the Agent, then Company Counsel may, in respect of any future Representation Date, furnish the Agent with a letter signed by such counsel (each, a &#8220;<u>Reliance Letter</u>&#8221;) in lieu of such opinion and negative assurance of such counsel to the effect that the Agent may rely on the prior opinion and negative assurance of such counsel delivered pursuant to this Section 3(j) to the same extent as if it were dated the date of such Reliance Letter (except that statements in such prior opinion and negative assurance shall be deemed to relate to the Registration Statement and the Prospectus as amended or supplemented to the date of such Reliance Letter); <i>provided</i>, <i>further</i>, that with respect to any opinion and negative representation letter required to be delivered pursuant to this Section 3(j) in connection with a Representation Date, no Sales Notice shall be delivered by the Company on or after such Representation Date until such opinion and representation letter have been furnished to the Agent and to counsel to the Agent. The requirement to furnish or cause to be furnished an opinion (but not with respect to a negative assurance representation) under this Section 3(j) shall be waived for any Representation Date other than a Representation Date on which the Company files its Annual Report on Form 10-K, unless the Agent reasonably requests such deliverable required by this Section 3(j) in connection with a Representation Date, upon which request such deliverable shall be deliverable hereunder. Further, the requirement to furnish or cause to be furnished an opinion and a negative assurance representation letter under this Section 3(j) shall be waived for such Representation Date occurring on a date on which no Sales Notice pursuant to this Agreement has been delivered by the Company or is pending, <i>provided</i> that if the Company subsequently decides to sell Shares following any such Representation Date when the Company relied on such waiver and did not provide the Agent an opinion and a negative assurance representation letter pursuant to this Section 3(j), then before the Company instructs the Agent to sell Shares pursuant to this Agreement, the Company shall provide the Agent such opinion and negative assurance representation letter.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(k)&nbsp;&nbsp;&nbsp;&nbsp;Upon commencement of the offering of Shares under this Agreement and within five (5) Trading Days after each Representation Date, the Company will furnish or cause to be furnished to the Agent and to counsel to the Agent the written opinion of Nevada Counsel (as defined below), or other Nevada counsel reasonably satisfactory to the Agent, in a form and substance reasonably satisfactory to the Agent and its counsel; <i>provided</i>, <i>however</i>, that if Nevada Counsel has previously furnished to the Agent such written opinion in the form previously agreed between the Company and the Agent, then Nevada Counsel may, in respect of any future Representation Date, furnish the Agent with a letter signed by such counsel (each, a &#8220;<u>Nevada Reliance Letter</u>&#8221;) in lieu of such opinion of such counsel to the effect that the Agent may rely on the prior opinion of such counsel delivered pursuant to this Section 3(k) to the same extent as if it were dated the date of such Nevada Reliance Letter (except that statements in such prior opinion shall be deemed to relate to the Registration Statement and the Prospectus as amended or supplemented to the date of such Nevada Reliance Letter); <i>provided</i>, <i>further</i>, that with respect to any opinion required to be delivered pursuant to this Section 3(k) in connection with a Representation Date, no Sales Notice shall be delivered by the Company on or after such Representation Date until such opinion has been furnished to the Agent and to counsel to the Agent. The requirement to furnish or cause to be furnished an opinion under this Section 3(k) shall be waived for any Representation Date other than a Representation Date on which the Company files its Annual Report on Form 10-K, unless the Agent reasonably requests such deliverable required by this Section 3(k) in connection with a Representation Date, upon which request such deliverable shall be deliverable hereunder. Further, the requirement to furnish or cause to be furnished an opinion under this Section 3(k) shall be waived for such Representation Date occurring on a date on which no Sales Notice pursuant to this Agreement has been delivered by the Company or is pending, <i>provided</i> that if the Company subsequently decides to sell Shares following any such Representation Date when the Company relied on such waiver and did not provide the Agent an opinion pursuant to this Section 3(k), then before the Company instructs the Agent to sell Shares pursuant to this Agreement, the Company shall provide the Agent such opinion.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(l)&nbsp;&nbsp;&nbsp;&nbsp;Upon commencement of the offering of Shares under this Agreement and within five (5) Trading Days after each Representation Date, the Company will cause the Auditor (or other independent accountants satisfactory to the Agent) to furnish to the Agent a letter, dated the date of effectiveness of such amendment or the date of filing of such supplement or other document with the Commission, as the case may be, in form reasonably satisfactory to the Agent and its counsel, of the same tenor as the letter referred to in Section 6(d) hereof, but modified as necessary to relate to the Registration Statement, the General Disclosure Package and the Prospectus, as amended and supplemented, or to the document incorporated by reference into the Prospectus, to the date of such letter; <i>provided</i> that with respect to any letter required to be delivered pursuant to this Section 3(l) in connection with a Representation Date, no Sales Notice shall be delivered by the Company on or after such Representation Date until such letter has been furnished to the Agent. The requirement to furnish or cause to be furnished a letter under this Section 3(l) shall be waived for any Representation Date other than a Representation Date on which the Company files its Annual Report on Form 10-K, unless the Agent reasonably requests such deliverable required by this Section 3(l) in connection with a Representation Date, upon which request such deliverable shall be deliverable hereunder. Further, the requirement to furnish or cause to be furnished letter under this Section 3(l) shall be waived for such Representation Date occurring on a date on which no Sales Notice pursuant to this Agreement has been delivered by the Company or is pending, <i>provided</i> that if the Company subsequently decides to sell Shares following any such Representation Date when the Company relied on such waiver and did not provide the Agent a letter pursuant to this Section 3(l), then before the Company instructs the Agent to sell Shares pursuant to this Agreement, the Company shall provide the Agent such letter.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(m)&nbsp;&nbsp;&nbsp;&nbsp;The Company consents to the Agent trading in the Company&#8217;s Common Stock for the Agent&#8217;s own account and for the accounts of its clients at the same time as sales of Shares occur pursuant to this Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(n)&nbsp;&nbsp;&nbsp;&nbsp;The Company will cooperate timely with any reasonable due diligence review conducted by the Agent or its counsel from time to time in connection with the transactions contemplated hereby, including, without limitation, and upon reasonable notice, providing information and making available documents and appropriate corporate officers, during regular business hours and at the Company&#8217;s principal offices, as the Agent may reasonably request.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(o)&nbsp;&nbsp;&nbsp;&nbsp;Without the prior written consent of the Agent, during each period commencing on the second Trading Day immediately prior to the date on which the Company has provided a Sales Notice to the Company pursuant to Section 2(b) and ending on the close of business of the second Trading Day immediately following the Settlement Date of the last Shares sold pursuant to such Sales Notice, the Company will not, (A) offer, pledge, announce the intention to sell, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant for the sale of, lend or otherwise transfer or dispose of, directly or indirectly, any shares of Common Stock or securities convertible into or exchangeable or exercisable for or repayable with Common Stock, or file any registration statement under the 1933 Act with respect to any of the foregoing (other than a shelf registration statement under Rule 415 under the 1933 Act, a registration statement on Form S-8 or post-effective amendment to the Registration Statement) or (B) enter into any swap or other agreement or any transaction that transfers in whole or in part, directly or indirectly, any of the economic consequence of ownership of the Common Stock, or any securities convertible into or exchangeable or exercisable for or repayable with Common Stock, whether any such swap or transaction described in clause (A) or (B) above is to be settled by delivery of Common Stock or such other securities, in cash or otherwise. The foregoing sentence shall not apply to (w) the Shares to be offered and sold through the Agent pursuant to this Agreement, (x) equity incentive awards approved by the board of directors of the Company or the compensation committee thereof or the issuance of Common Stock upon exercise thereof, (y) Shares or securities convertible into or exchangeable for Shares as consideration for mergers, acquisitions, other business combinations, joint ventures or strategic alliances occurring after the date of this Agreement which are not used for capital raising purposes and (z) Shares issuable upon exercise or conversion of outstanding warrants or other derivative securities.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(p)&nbsp;&nbsp;&nbsp;&nbsp;Upon commencement of the offering of the Shares under this Agreement (and upon the recommencement of the offering of the Shares under this Agreement following the termination of a suspension of sales hereunder lasting more than 30 Trading Days), and at each Representation Date for which no waiver is applicable pursuant to this Agreement, the Company will conduct a due diligence session, in form and substance, reasonably satisfactory to the Agent, which shall include representatives of management, Company Counsel and then-responsible independent accountants. The Company shall cooperate timely with any reasonable due diligence request from or review conducted by the Agent or its agents from time to time in connection with the transactions contemplated by this Agreement, including, without limitation, providing information and available documents and access to appropriate corporate officers and the Company&#8217;s agents during regular business hours, and timely furnishing or causing to be furnished such certificates, letters and opinions from the Company, its officers and its agents, as the Agent may reasonably request. The Company shall reimburse the Agent for Agent&#8217;s counsel&#8217;s reasonable and documented out-of-pocket fees incurred in connection with each such Representation Date plus any incidental reasonable and documented out-of-pocket expenses incurred by the Agent in connection therewith.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(q)&nbsp;&nbsp;&nbsp;&nbsp;If to the knowledge of the Company, the conditions set forth in Section 6 shall not have been satisfied as of the applicable Settlement Date, the Company will offer to any person who has agreed to purchase Shares from the Company as the result of an offer to purchase solicited by the Agent the right to refuse to purchase and pay for such Shares.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(r)&nbsp;&nbsp;&nbsp;&nbsp;Each acceptance by the Company of an offer to purchase the Shares hereunder shall be deemed to be an affirmation to the Agent that the representations and warranties of the Company contained in or made pursuant to this Agreement are true and correct as of the date of such acceptance as though made at and as of such date, and an undertaking that such representations and warranties will be true and correct as of the Settlement Date for the Shares relating to such acceptance or as of the time of delivery relating to such sale, as the case may be, as though made at and as of such date (except that such representations and warranties shall be deemed to relate to the Registration Statement and the Prospectus as amended and supplemented relating to such Shares).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(s)&nbsp;&nbsp;&nbsp;&nbsp;The Company shall ensure that there are at all times sufficient shares of Common Stock to provide for the issuance, free of any preemptive rights, out of its authorized but unissued shares of Common Stock or shares of Common Stock held in treasury, of the maximum aggregate number of Shares authorized for issuance by the Company&#8217;s board of directors pursuant to the terms of this Agreement. The Company will use its commercially reasonable efforts to cause the Shares to be listed for trading on the Trading Market and to maintain such listing.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(t)&nbsp;&nbsp;&nbsp;&nbsp;<u>Obligation Under 1934 Act</u>. During any period when the delivery of a prospectus relating to the Shares is required (including in circumstances where such requirement may be satisfied pursuant to Rule 172, 173 or any similar rule) to be delivered under the 1933 Act, the Company will file all documents required to be filed with the Commission pursuant to the 1934 Act within the time periods required by the 1934 Act and the regulations thereunder.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(u)&nbsp;&nbsp;&nbsp;&nbsp;The Company shall cooperate with the Agent and use its commercially reasonable efforts to permit the Shares to be eligible for clearance and settlement through the facilities of DTC.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(v)&nbsp;&nbsp;&nbsp;&nbsp;The Company will, at any time during the term of this Agreement, as supplemented from time to time, advise the Agent immediately after it shall have received notice or obtained knowledge thereof, of any information or fact that would alter or affect any opinion, certificate, letter and other document provided to the Agent pursuant to Section 6 herein.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(w)&nbsp;&nbsp;&nbsp;&nbsp;If any sales are made pursuant to this Agreement which are not made in &#8220;at the market&#8221; offerings as defined in Rule 415, the Company shall file a Prospectus Supplement describing the terms of such transaction, the amount of Shares sold, the price thereof, the Agent&#8217;s compensation, and such other information as may be required pursuant to Rule 424 and Rule 430B, as applicable, within the time required by Rule 424.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(x)&nbsp;&nbsp;&nbsp;&nbsp;To the extent that the Registration Statement is not available for the sales of the Shares as contemplated by this Agreement, the Company shall file a new registration statement with respect to any additional shares of Common Stock necessary to complete such sales of the Shares and shall cause such registration statement to become effective as promptly as practicable. After the effectiveness of any such registration statement, all references to &#8220;<u>Registration Statement</u>&#8221; included in this Agreement shall be deemed to include such new registration statement, including all documents incorporated by reference therein pursuant to Item 12 of Form S-3, and all references to &#8220;<u>Base Prospectus</u>&#8221; included in this Agreement shall be deemed to include the final form of base prospectus, including all documents incorporated therein by reference, included in any such registration statement at the time such registration statement became effective.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Section 4.&nbsp;&nbsp;&nbsp;&nbsp;<u>Free Writing Prospectus</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;(i) The Company represents and agrees that, without the prior consent of the Agent, it has not made and will not make any offer relating to the Shares that would constitute a &#8220;free writing prospectus&#8221; as defined in Rule 405 under the 1933 Act; and</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 54pt;">(ii)&nbsp;&nbsp;&nbsp;&nbsp; the Agent represents and agrees that, without the prior consent of the Company, it has not made and will not make any offer relating to the Shares that would constitute a free writing prospectus required to be filed with the Commission.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;The Company has complied and will comply with the requirements of Rule 433 under the 1933 Act applicable to any Issuer Free Writing Prospectus (including any free writing prospectus identified in Section 4(a) hereof), including timely filing with the Commission or retention where required and legending.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Section 5.&nbsp;&nbsp;&nbsp;&nbsp;<u>Payment of Expenses</u>. The Company agrees to pay the costs and expenses incident to the performance of its obligations under this Agreement, whether or not the transactions contemplated hereby are consummated, including without limitation: (i) the preparation, printing or reproduction and filing with the Commission of the Registration Statement (including financial statements and exhibits thereto), the Prospectus and each Issuer Free Writing Prospectus, and each amendment or supplement to any of them; (ii) the printing (or reproduction) and delivery (including postage, air freight charges and charges for counting and packaging) of such copies of the Registration Statement, the Prospectus, and each Issuer Free Writing Prospectus, and all amendments or supplements to any of them, as may, in each case, be reasonably requested for use in connection with the offering and sale of the Shares; (iii) the preparation, printing, authentication, issuance and delivery of certificates for the Shares, including any stamp or transfer taxes in connection with the original issuance and sale of the Shares; (iv) the printing (or reproduction) and delivery of this Agreement, any blue sky memorandum and all other agreements or documents printed (or reproduced) and delivered in connection with the offering of the Shares; (v) the registration of the Shares under the 1934 Act, if applicable, and the listing of the Shares on the trading market; (vi) any registration or qualification of the Shares for offer and sale under the securities or blue sky laws of the several states (including filing fees and the reasonable and documented out-of-pocket fees and expenses of counsel for the Agent relating to such registration and qualification); (vii) the transportation and other expenses incurred by or on behalf of Company representatives in connection with presentations to prospective purchasers of the Shares; (viii) the fees and expenses of the Company&#8217;s accountants and the fees and expenses of counsel (including local and special counsel) for the Company; (ix) the filing fee under FINRA Rule 5110; (x) the reasonable and documented out-of-pocket fees and expenses of the Agent&#8217;s counsel (excluding any periodic due diligence fees provided for under Section 3(p)), which shall be paid upon the execution of this agreement; and (xi) all other costs and expenses incident to the performance by the Company of its obligations hereunder.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Section 6.&nbsp;&nbsp;&nbsp;&nbsp;<u>Conditions of Agent</u><u>&#8217;</u><u>s Obligation</u>. The obligations of the Agent hereunder shall be subject, in the Agent&#8217;s discretion, to the condition that all representations and warranties and other statements of the Company herein or in certificates of any officer of the Company delivered pursuant to the provisions hereof are true and correct as of the time of the execution of this Agreement and as of each Registration Statement Amendment Date, Company Periodic Report Date, Applicable Time, Settlement Date and time of delivery of a Sales Notice, to the condition that the Company shall have performed all of its obligations hereunder theretofore to be performed, and the following additional conditions:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;The Initial Registration Statement shall have been declared effective by the Commission and the Prospectus Supplement shall have been filed with the Commission pursuant to Rule 424(b) under the 1933 Act, any other material required to be filed by the Company pursuant to Rule 433(d) under the 1933 Act shall have been filed with the Commission within the applicable time periods prescribed for such filings by Rule 433; no stop order suspending the effectiveness of the Registration Statement or any part thereof shall have been issued and no proceeding for that purpose shall have been initiated or threatened by the Commission and no notice of objection of the Commission to the use of the form of the Registration Statement or any post-effective amendment thereto pursuant to Rule 401(g)(2) under the 1933 Act shall have been received; no stop order suspending or preventing the use of the Prospectus or any Issuer Free Writing Prospectus shall have been initiated or threatened by the Commission; and all requests for additional information on the part of the Commission shall have been complied with to the reasonable satisfaction of the Agent.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;On every date specified in Section 3(j) hereof and on such other dates as reasonably requested by the Agent, the Agent shall have received the written opinion or opinions and negative assurance statement of Foley &amp; Lardner LLP (&#8220;<u>Company Counsel</u>&#8221;), counsel for the Company, dated as of such date and in form and substance reasonably satisfactory to the Agent.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;On every date specified in Section 3(k) hereof and on such other dates as reasonably requested by the Agent, the Agent shall have received the written opinion or opinions of McDonald Carano LLP (&#8220;<u>Nevada Counsel</u>&#8221;), Nevada counsel for the Company, dated as of such date and in form and substance reasonably satisfactory to the Agent.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;On every date specified in Section 3(l) hereof and on such other dates as reasonably requested by the Agent, the Company shall have requested and caused the Auditor (or other independent accountants satisfactory to the Agent) to have furnished to the Agent letters (which may refer to letters previously delivered to the Agent), dated as of such date, in form and substance satisfactory in all respects to the Agent.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(e)&nbsp;&nbsp;&nbsp;&nbsp;Prior to commencement of the offering of Shares under this Agreement (and upon the recommencement of the offering of the Shares under this Agreement following the termination of a suspension of sales hereunder lasting more than 30 Trading Days), the Agent shall have received a certificate, signed on behalf of the Company by its corporate Secretary, in form and substance satisfactory to the Agent and its counsel.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(f)&nbsp;&nbsp;&nbsp;&nbsp;On every date specified in Section 3(i) hereof and on such other dates as reasonably requested by the Agent, the Company shall have furnished or caused to be furnished to the Agent a certificate of the Company signed by the Chief Executive Officer or the President and the principal financial or accounting officer of the Company, dated as of such date, to the effect that the signers of such certificate have carefully examined the Registration Statement, the Prospectus, any Prospectus Supplement and any documents incorporated by reference therein and any supplements or amendments thereto and this Agreement and that:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt; text-align: justify;">(i)&nbsp;&nbsp;&nbsp;&nbsp; the representations and warranties of the Company in this Agreement are true and correct on and as of such date with the same effect as if made on such date and the Company has complied with all the agreements and satisfied all the conditions on its part to be performed or satisfied at or prior to such date;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt; text-align: justify;">(ii)&nbsp;&nbsp;&nbsp;&nbsp; no stop order suspending the effectiveness of the Registration Statement or any notice objecting to its use has been issued and no proceedings for that purpose have been instituted or, to the Company&#8217;s knowledge, threatened; and</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt; text-align: justify;">(iii)&nbsp;&nbsp;&nbsp;&nbsp; since the date of the most recent financial statements included in the Registration Statement, the Prospectus and the Incorporated Documents, there has been no Material Adverse Effect on the condition (financial or otherwise), earnings, business or properties of the Company and its Subsidiaries, taken as a whole, whether or not arising from transactions in the ordinary course of business, except as set forth in or contemplated in the Registration Statement and the Prospectus.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(g)&nbsp;&nbsp;&nbsp;&nbsp;Since the date of the latest audited financial statements then included or incorporated by reference in the General Disclosure Package and the Prospectus, no Material Adverse Effect shall have occurred.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(h)&nbsp;&nbsp;&nbsp;&nbsp;The Company shall have complied with the provisions of Section 3(c) hereof with respect to the timely furnishing of prospectuses.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(i)&nbsp;&nbsp;&nbsp;&nbsp;On such dates as reasonably requested by the Agent, the Company shall have conducted due diligence sessions, in form and substance satisfactory to the Agent.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(j)&nbsp;&nbsp;&nbsp;&nbsp;All filings with the Commission required by Rule 424 under the 1933 Act to have been filed by each Applicable Time or related Settlement Date shall have been made within the applicable time period prescribed for such filing by Rule 424 (without reliance on Rule 424(b)(8)).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(k)&nbsp;&nbsp;&nbsp;&nbsp;The Company shall have paid the required Commission filing fees relating to the Shares within the time period required by Rule 456(b)(1)(i) of the 1933 Act without regard to the proviso therein and otherwise in accordance with Rules 456(b) and 457(r) of the 1933 Act and, if applicable, shall have updated the &#8220;Calculation of Registration Fee&#8221; table in accordance with Rule 456(b)(1)(ii) either in a post-effective amendment to the Registration Statement or on the cover page of a prospectus filed pursuant to Rule 424(b).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(l)&nbsp;&nbsp;&nbsp;&nbsp;On or prior to the date the Company instructs the Agent to make sales of Shares pursuant to a Sales Notice, the Company shall have filed with the Exchange one or more Supplemental Listing Applications sufficient to facilitate the listing of such Shares on the Exchange, and on or prior to any Settlement Date, the Shares being delivered shall have received approval for listing on the Exchange, subject only to notice of issuance, if applicable; and, in each case, satisfactory evidence of such actions shall have been provided to the Agent by such applicable time.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(m)&nbsp;&nbsp;&nbsp;&nbsp;FINRA shall not have raised any objection with respect to the fairness and reasonableness of the terms and arrangements under this Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(n)&nbsp;&nbsp;&nbsp;&nbsp;Prior to any Settlement Date, the Company shall have furnished to the Agent such further information, documents or certificates as the Agent may reasonably request.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Section 7.&nbsp;&nbsp;&nbsp;&nbsp;<u>Indemnification</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;The Company will indemnify and hold harmless the Agent against any losses, claims, damages or liabilities, to which the Agent may become subject, under the 1933 Act or otherwise, insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based upon an untrue statement or alleged untrue statement of a material fact contained in the Registration Statement, the Base Prospectus, the Prospectus Supplement or the Prospectus or any amendment or supplement thereto, any Issuer Free Writing Prospectus or any &#8220;issuer information&#8221; filed or required to be filed pursuant to Rule 433(d) under the 1933 Act, or arise out of or are based upon the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, and will reimburse the Agent for any legal or other expenses reasonably incurred and documented by the Agent in connection with investigating or defending any such action or claim as such expenses are incurred; <i>provided</i>, <i>however</i>, that the Company shall not be liable in any such case to the extent that any such loss, claim, damage or liability arises out of or is based upon an untrue statement or alleged untrue statement or omission or alleged omission made in the Registration Statement, the Base Prospectus, the Prospectus Supplement or the Prospectus, or any amendment or supplement thereto, or any Issuer Free Writing Prospectus, in reliance upon and in strict conformity with written information furnished to the Company by the Agent expressly for use therein.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;The Agent will indemnify and hold harmless the Company against any losses, claims, damages or liabilities to which the Company may become subject, under the 1933 Act or otherwise, insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based upon an untrue statement or alleged untrue statement of a material fact contained in the Registration Statement, the Base Prospectus, the Prospectus Supplement or the Prospectus, or any amendment or supplement thereto, or any Issuer Free Writing Prospectus, or arise out of or are based upon the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, in each case to the extent, but only to the extent, that such untrue statement or alleged untrue statement or omission or alleged omission was made in the Registration Statement, the Base Prospectus, the Prospectus Supplement or the Prospectus, or any such amendment or supplement thereto, or any Issuer Free Writing Prospectus, in reliance upon and in strict conformity with written information furnished to the Company by the Agent expressly for use therein; and will reimburse the Company for any legal or other expenses reasonably incurred by the Company in connection with investigating or defending any such action or claim as such expenses are incurred.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;Promptly after receipt by an indemnified party under subsection (a) or (b) above of notice of the commencement of any action, such indemnified party shall, if a claim in respect thereof is to be made against the indemnifying party under such subsection, notify the indemnifying party in writing of the commencement thereof; but the omission so to notify the indemnifying party shall not relieve it from any liability which it may have to any indemnified party otherwise than under such subsection except and then only to the extent such indemnifying party is materially prejudiced thereby. In case any such action shall be brought against any indemnified party and it shall notify the indemnifying party of the commencement thereof, the indemnifying party shall be entitled to participate therein and, to the extent that it shall wish, jointly with any other indemnifying party similarly notified, to assume the defense thereof, with counsel satisfactory to such indemnified party (who shall not, except with the consent of the indemnified party, be counsel to the indemnifying party), and, after notice from the indemnifying party to such indemnified party of its election so to assume the defense thereof, the indemnifying party shall not be liable to such indemnified party under this Section 7 for any legal expenses of other counsel or any other expenses, in each case subsequently incurred by such indemnified party, in connection with the defense thereof other than reasonable costs of investigation. No indemnifying party shall, without the written consent of the indemnified party, effect the settlement or compromise of, or consent to the entry of any judgment with respect to, any pending or threatened action or claim in respect of which indemnification or contribution may be sought hereunder (whether or not the indemnified party is an actual or potential party to such action or claim) unless such settlement, compromise or judgment (i) includes an unconditional release of the indemnified party from all liability arising out of such action or claim and (ii) does not include a statement as to or an admission of fault, culpability or a failure to act, by or on behalf of any indemnified party.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;If the indemnification provided for in this Section 7 is unavailable to hold harmless an indemnified party under subsection (a) or (b) above in respect of any losses, claims, damages or liabilities (or actions in respect thereof) referred to therein, then each indemnifying party shall contribute to the amount paid or payable by such indemnified party as a result of such losses, claims, damages or liabilities (or actions in respect thereof) in such proportion as is appropriate to reflect the relative benefits received by the Company on the one hand and the Agent on the other from the offering of the Shares to which such loss, claim, damage or liability (or action in respect thereof) relates. If, however, the allocation provided by the immediately preceding sentence is not permitted by applicable law, then each indemnifying party shall contribute to such amount paid or payable by such indemnified party in such proportion as is appropriate to reflect not only such relative benefits but also the relative fault of the Company on the one hand and the Agent on the other in connection with the statements or omissions which resulted in such losses, claims, damages or liabilities (or actions in respect thereof), as well as any other relevant equitable considerations. The relative benefits received by the Company on the one hand and the Agent on the other shall be deemed to be in the same proportion as the total net proceeds from the offering (before deducting expenses) received by the Company bear to the total commissions received by the Agent. The relative fault shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by the Company on the one hand or the Agent on the other and the parties&#8217; relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission. The Company and the Agent agree that it would not be just and equitable if contribution pursuant to this subsection (d) were determined by pro rata allocation or by any other method of allocation which does not take account of the equitable considerations referred to above in this subsection (d). The amount paid or payable by an indemnified party as a result of the losses, claims, damages or liabilities (or actions in respect thereof) referred to above in this subsection (d) shall be deemed to include any legal or other expenses reasonably incurred by such indemnified party in connection with investigating or defending any such action or claim. Notwithstanding the provisions of this subsection (d), the Agent shall not be required to contribute any amount in excess of the amount by which the total compensation received by the Agent with respect to sales of the Shares sold by them to the public exceeds the amount of any damages which the Agent have otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the 1933 Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(e)&nbsp;&nbsp;&nbsp;&nbsp;The obligations of the Company under this Section 7 shall be in addition to any liability which the Company may otherwise have and shall extend, upon the same terms and conditions, to the directors, officers, employees, attorneys and agents of the Agent and to each person, if any, who controls the Agent within the meaning of the 1933 Act and each broker dealer affiliate of the Agent; and the obligations of the Agent under this Section 7 shall be in addition to any liability which the Agent may otherwise have and shall extend, upon the same terms and conditions, to each director, officer, employee, attorney and agent of the Company and to each person, if any, who controls the Company within the meaning of the 1933 Act.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Section 8.&nbsp;&nbsp;&nbsp;&nbsp;<u>Representations, Warranties and Agreements to Survive Delivery</u>. The respective indemnities, agreements, representations, warranties and other statements of the Company and the Agent, as set forth in this Agreement or made by or on behalf of them, respectively, pursuant to this Agreement, shall remain in full force and effect, regardless of any investigation (or any statement as to the results thereof) made by or on behalf of the Agent or any controlling person of the Agent, or the Company, or any officer or director or controlling person of the Company, and shall survive delivery of and payment for the Shares.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Section 9.&nbsp;&nbsp;&nbsp;&nbsp;<u>No Advisory or Fiduciary Relationship</u>. The Company acknowledges and agrees that (i) the Agent is acting solely in the capacity of an arm&#8217;s length contractual counterparty to the Company with respect to the offering of Shares contemplated hereby (including in connection with determining the terms of such offering) and (ii) the Agent has not assumed an advisory or fiduciary responsibility in favor of the Company with respect to the offering contemplated hereby or the process leading thereto (irrespective of whether the Agent has advised or is currently advising the Company on other matters) or any other obligation to the Company except the obligations expressly set forth in this Agreement and (iii) the Company has consulted its own legal and financial advisors to the extent it deemed appropriate. The Company agrees that it will not claim that the Agent has rendered advisory services of any nature or respect, or owes a fiduciary or similar duty to the Company, in connection with such transaction or the process leading thereto.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Section 10.&nbsp;&nbsp;&nbsp;&nbsp;<u>Termination</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;The Company shall have the right, by giving written notice as hereinafter specified, to terminate this Agreement in its sole discretion at any time upon ten (10) days&#8217; prior written notice. Any such termination shall be without liability of any party to any other party, except that (i) with respect to any pending sale through the Agent for the Company, the obligations of the Company, including in respect of compensation of the Agent, shall remain in full force and effect notwithstanding such termination; and (ii) the provisions of Section 1, Section 5, Section 7, Section 8, Section 10(e), Section 14, Section 15 and Section 16 of this Agreement shall remain in full force and effect notwithstanding such termination.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;The Agent shall have the right, by giving written notice as hereinafter specified, to terminate this Agreement in its sole discretion at any time upon ten (10) days&#8217; prior written notice. Any such termination shall be without liability of any party to any other party except that the provisions of Section 1, Section 5, Section 7, Section 8, Section 10(e), Section 14, Section 15 and Section 16 of this Agreement shall remain in full force and effect notwithstanding such termination.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;Unless earlier terminated pursuant to this Section 10, this Agreement shall automatically terminate upon the issuance and sale of all of the Shares by the Agent on the terms and subject to the conditions set forth herein except any termination pursuant to this clause (c) shall in all cases be deemed to provide that Section 1, Section 5, Section 7, Section 8, Section 10(e), Section 14, Section 15 and Section 16 of this Agreement shall remain in full force and effect.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;This Agreement shall remain in full force and effect until and unless terminated pursuant to Section 10(a), (b) or (c) above or otherwise by mutual agreement of the parties; <i>provided</i> that any such termination by mutual agreement or pursuant to this clause (c) shall in all cases be deemed to provide that Section 1, Section 5, Section 7, Section 8, Section 14 and Section 15 of this Agreement shall remain in full force and effect.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(e)&nbsp;&nbsp;&nbsp;&nbsp;Any termination of this Agreement shall be effective on the date specified in such notice of termination; <i>provided</i> that such termination shall not be effective until the close of business on the date of receipt of such notice by the Agent or the Company, as the case may be. If such termination shall occur prior to the Settlement Date for any sale of Shares, such sale shall settle in accordance with the provisions of Section 2(g) hereof.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Section 11.&nbsp;&nbsp;&nbsp;&nbsp;<u>Notices</u>. All statements, requests, notices and agreements hereunder shall be in writing, and if to the Agent shall be delivered or sent by mail, telex or facsimile transmission to:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Titan Partners Group LLC,</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">a division of American Capital Partners, LLC</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">4 World Trade Center, 49th Floor</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">New York, NY 10007</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Attention: Adam Sands</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">E-mail: notices@titanpartnersgrp.com</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">and if to the Company to:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Comstock Inc.</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">117 American Flat Road</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Virginia City, NV 89440</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Attention: Corrado De Gasperis</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Email: degasperis@comstock.com</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">With a copy to:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Foley &amp; Lardner LLP</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">777 E. Wisconsin Avenue</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Milwaukee, WI 53202</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Attention: Clyde Tinnen</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Email: ctinnen@foley.com</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Any such statements, requests, notices or agreements shall take effect upon receipt thereof.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Section 12.&nbsp;&nbsp;&nbsp;&nbsp;<u>Parties</u>. This Agreement shall be binding upon, and inure solely to the benefit of, the Agent and the Company and, to the extent provided in Sections 7 and 8 hereof, the officers, directors, employees, attorneys and agents of the Company and the Agent and each person who controls the Company or the Agent, and their respective heirs, executors, administrators, successors and assigns, and no other person shall acquire or have any right under or by virtue of this Agreement. No purchaser of Shares through the Agent shall be deemed a successor or assign by reason merely of such purchase.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Section 13.&nbsp;&nbsp;&nbsp;&nbsp;<u>Time of the Essence</u>. Time shall be of the essence of this Agreement. As used herein, the term &#8220;business day&#8221; shall mean any day when the Commission&#8217;s office in Washington, D.C. is open for business.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Section 14.&nbsp;&nbsp;&nbsp;&nbsp;<u>Amendments; Waivers</u>. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument signed, in the case of an amendment, by the Company and the Agent. No waiver of any default with respect to any provision, condition or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement hereof, nor shall any delay or omission of any party to exercise any right hereunder in any manner impair the exercise of any such right.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Section 15.&nbsp;&nbsp;&nbsp;&nbsp;<u>Waiver of Jury Trial</u>. The Company and the Agent hereby irrevocably waive, to the fullest extent permitted by applicable law, any and all right to jury trial by jury in any legal proceeding arising out of or relating to this Agreement or the transactions contemplated hereby.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Section 16.&nbsp;&nbsp;&nbsp;&nbsp;<u>Governing Law</u>. THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK WITHOUT REFERENCE TO ITS PRINCIPLES OF CONFLICTS OF LAW.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Section 17.&nbsp;&nbsp;&nbsp;&nbsp;<u>Counterparts</u>. This Agreement may be executed by any one or more of the parties hereto and thereto in any number of counterparts, each of which shall be deemed to be an original, but all such respective counterparts shall together constitute one and the same instrument. This Agreement may be delivered by any party by facsimile or other electronic transmission.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Section 18.&nbsp;&nbsp;&nbsp;&nbsp;<u>Severability</u>. The invalidity or unenforceability of any Section, paragraph or provision of this Agreement shall not affect the validity or enforceability of any other Section, paragraph or provision hereof. If any Section, paragraph or provision of this Agreement is for any reason determined to be invalid or unenforceable, there shall be deemed to be made such minor changes (and only such minor changes) as are necessary to make it valid and enforceable.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Section 19.&nbsp;&nbsp;&nbsp;&nbsp;<u>Recognition of the U.S. Special Resolution Regimes</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;In the event that the Agent becomes subject to a proceeding under a U.S. Special Resolution Regime, the transfer from the Agent of this Agreement, and any interest and obligation in or under this Agreement, will be effective to the same extent as the transfer would be effective under the U.S. Special Resolution Regime if this Agreement, and any such interest and obligation, were governed by the laws of the United States or a state of the United States.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;In the event that the Agent or a BHC Act Affiliate of the Agent becomes subject to a proceeding under a U.S. Special Resolution Regime, Default Rights under this Agreement that may be exercised against the Agent are permitted to be exercised to no greater extent than such Default Rights could be exercised under the U.S. Special Resolution Regime if this Agreement were governed by the laws of the United States or a state of the United States.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">For purposes of this Section 19:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>BHC Act Affiliate</u>&#8221; has the meaning assigned to the term &#8220;affiliate&#8221; in, and shall be interpreted in accordance with, 12 U.S.C. &#167; 1841(k).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Default Right</u>&#8221; has the meaning assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R. &#167;&#167; 252.81, 47.2 or 382.1, as applicable.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>U.S. Special Resolution Regime</u>&#8221; means each of (i) the Federal Deposit Insurance Act and the regulations promulgated thereunder and (ii) Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">If the foregoing is in accordance with your understanding of our agreement, please sign and return to the Company a counterpart hereof, whereupon this instrument, along with all counterparts, will become a binding agreement between the Agent and the Company in accordance with its terms.</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Very truly yours,</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Comstock Inc.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 100%;">

		<tr>
			<td style="width: 48px;">By:</td>
			<td style="width: 256px; border-bottom: 1px solid rgb(0, 0, 0);">/s/&nbsp;Corrado De Gasperis</td>
			<td style="width: 2372px;">&nbsp;</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Name:&nbsp; &nbsp; &nbsp;Corrado De Gasperis &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Title:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Executive Chairman and Chief Executive Officer</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Accepted as of the date hereof:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Titan Partners Group LLC,</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">a division of American Capital Partners, LLC</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 100%;">

		<tr>
			<td style="width: 46px;">By:</td>
			<td style="width: 255px; border-bottom: 1px solid rgb(0, 0, 0);">/s/ Adam Sands</td>
			<td style="width: 2375px;">&nbsp;</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Name:&nbsp; &nbsp; Adam Sands &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Title:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Authorized Representative</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.3
<SEQUENCE>3
<FILENAME>ex_869179.htm
<DESCRIPTION>EXHIBIT 4.3
<TEXT>
<html><head>
	<title>ex_869179.htm</title>

	<!-- Generated by ThunderDome Portal - 10/27/2025 9:31:31 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;">
<p style="margin: 0px 0pt; text-align: right; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt"><b>Exhibit 4.3</b></font></p>

<p style="margin: 0px 0pt; text-align: left; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>COMSTOCK INC.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<hr style="text-align: center; height: 1px; color: #000000; background-color: #000000; width: 25%; border: none; margin: 3pt auto">
<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>INDENTURE</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Dated as of</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>_________ __, ____</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<hr style="text-align: center; height: 1px; color: #000000; background-color: #000000; width: 25%; border: none; margin: 3pt auto">
<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>DEBT SECURITIES</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<hr style="text-align: center; height: 1px; color: #000000; background-color: #000000; width: 25%; border: none; margin: 3pt auto">
<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Trustee</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">INDENTURE dated as of&nbsp;<u>&nbsp;</u><u>&nbsp;</u><u>&nbsp;</u><u>&nbsp;</u><u>&nbsp;</u><u>&nbsp;</u><u>&nbsp;</u><u>&nbsp;</u><u>&nbsp;</u><u>&nbsp;</u><u>&nbsp;</u><u>&nbsp;</u><u>&nbsp;</u><u>&nbsp;</u><u>&nbsp;</u><u>&nbsp;</u><u>&nbsp;</u><u>&nbsp;</u><u>&nbsp;</u><u>&nbsp;</u><u>&nbsp;</u>&nbsp;<u>&nbsp;</u><u>&nbsp;</u><u>&nbsp;</u><u>&nbsp;</u>, &nbsp;<u>&nbsp;</u><u>&nbsp;</u><u>&nbsp;</u><u>&nbsp;</u><u>&nbsp;</u><u>&nbsp;</u><u>&nbsp;</u><u>&nbsp;</u>, among Comstock Inc., a Nevada corporation (the &#8220;Company&#8221;), and&nbsp;<u>&nbsp;</u><u>&nbsp;</u><u>&nbsp;</u><u>&nbsp;</u><u>&nbsp;</u><u>&nbsp;</u><u>&nbsp;</u><u>&nbsp;</u><u>&nbsp;</u><u>&nbsp;</u><u>&nbsp;</u><u>&nbsp;</u><u>&nbsp;</u><u>&nbsp;</u><u>&nbsp;</u><u>&nbsp;</u><u>&nbsp;</u><u>&nbsp;</u><u>&nbsp;</u><u>&nbsp;</u><u>&nbsp;</u>, as trustee (the &#8220;Trustee&#8221;).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>WITNESSETH:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">WHEREAS, the Company has duly authorized the execution and delivery of this Indenture to provide for the issuance of unsecured debentures, notes, bonds or other evidences of indebtedness (the &#8220;Securities&#8221;) in an unlimited aggregate principal amount to be issued from time to time in one or more series as provided in this Indenture; and</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">WHEREAS, all things necessary to make this Indenture a valid and legally binding agreement of the Company, in accordance with its terms, have been done.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">NOW, THEREFORE, THIS INDENTURE WITNESSETH:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">That, in consideration of the premises and the purchase of the Securities by the Holders thereof for the equal and proportionate benefit of all of the present and future Holders of the Securities, each party agrees and covenants as follows:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>ARTICLE I</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><u>DEFINITIONS</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">For all purposes of this Indenture, except as otherwise expressly provided or unless the context otherwise requires:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the terms defined in this Article have the meanings assigned to them in this Article and include the plural as well as the singular;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;unless otherwise defined in this Indenture or the context otherwise requires, all terms used herein without definition which are defined in the Trust Indenture Act, either directly or by reference therein, have the meanings assigned to them therein;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the words &#8220;herein,&#8221; &#8220;hereof&#8221; and &#8220;hereunder&#8221; and other words of similar import refer to this Indenture as a whole and not to any particular Article, Section or other subdivision; and</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;references to &#8220;Article&#8221; or &#8220;Section&#8221; or other subdivision herein are references to an Article, Section or other subdivision of the Indenture, unless the context otherwise requires.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 1.01&nbsp;&nbsp;&nbsp;&nbsp;<u>Definitions</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Unless the context otherwise requires, the terms defined in this Section 1.01 shall for all purposes of this Indenture have the meanings hereinafter set forth:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Affiliate:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The term &#8220;Affiliate,&#8221; with respect to any specified Person shall mean any other Person directly or indirectly controlling or controlled by or under direct or indirect common control with such specified Person.&nbsp;&nbsp;For the purposes of this definition, &#8220;control&#8221; when used with respect to any specified Person means the power to direct the management and policies of such Person, directly or indirectly, whether through the ownership of voting securities, by contract or otherwise; and the terms &#8220;controlling&#8221; and &#8220;controlled&#8221; have meanings correlative to the foregoing.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Authenticating Agent:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The term &#8220;Authenticating Agent&#8221; shall have the meaning assigned to it in Section 11.09.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Board of Directors:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The term &#8220;Board of Directors&#8221; shall mean either the board of directors of the Company&nbsp;&nbsp;or the executive or any other committee of that board duly authorized to act in respect hereof.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Board Resolution:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The term &#8220;Board Resolution&#8221; shall mean a copy of a resolution or resolutions certified by the Secretary or an Assistant Secretary of the Company to have been duly adopted by the Board of Directors (or by a committee of the Board of Directors to the extent that any such other committee has been authorized by the Board of Directors to establish or approve the matters contemplated) and to be in full force and effect on the date of such certification and delivered to the Trustee.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Business Day:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The term &#8220;Business Day,&#8221; when used with respect to any Place of Payment or any other particular location referred to in this Indenture or in the Securities, shall mean each Monday, Tuesday, Wednesday, Thursday and Friday which is not a day on which banking institutions in that Place of Payment or other location are authorized or obligated by law or executive order to close.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Capital Stock:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The term &#8220;Capital Stock&#8221; shall mean:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;in the case of a corporation, corporate stock;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;in the case of an association or business entity, any and all shares, interests, participations, rights or other equivalents (however designated) of corporate stock;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;in the case of a partnership or limited liability company, partnership interests (whether general or limited) or membership interests; and</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any other interest or participation that confers on a Person the right to receive a share of the profits and losses of, or distributions of assets of, the issuing Person, but excluding from all of the foregoing any debt securities convertible into Capital Stock, whether or not such debt securities include any right of participation with Capital Stock.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Code:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The term &#8220;Code&#8221; shall mean the Internal Revenue Code of 1986, as amended.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Company:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The term &#8220;Company&#8221; shall mean the Person named as the &#8220;Company&#8221; in the first paragraph of this Indenture until a successor Person shall have become such pursuant to the applicable provisions of this Indenture, and thereafter &#8220;Company&#8221; shall mean such successor Person.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Company Order:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The term &#8220;Company Order&#8221; shall mean a written order signed in the name of the Company by the Executive Chairman of the Board of Directors, Chief Executive Officer, Principal Financial Officer, President, Treasurer, Assistant Treasurer, Controller, Assistant Controller, Secretary or Assistant Secretary of the Company, and delivered to the Trustee.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Corporate Trust Office:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The term &#8220;Corporate Trust Office,&#8221; or other similar term, shall mean the principal office of the Trustee at which at any particular time its corporate trust business shall be administered, which office at the date hereof is located at [&nbsp;&nbsp;&nbsp;&nbsp;], Attention: Corporate Trust Services Division, [address], or such other address as the Trustee may designate from time to time by notice to the Holders and the Company, or the principal corporate trust officer of any successor Trustee (or such other address as such successor Trustee may designate from time to time by notice to the Holders and the Company).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Currency:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The term &#8220;Currency&#8221; shall mean U.S. Dollars or Foreign Currency.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Default:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The term &#8220;Default&#8221; shall have the meaning assigned to it in Section&nbsp;11.03.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Defaulted Interest:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The term &#8220;Defaulted Interest&#8221; shall have the same meaning assigned to it in Section&nbsp;3.08(b).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Depositary:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The term &#8220;Depositary&#8221; shall mean, with respect to the Securities of any series issuable in whole or in part in the form of one or more Global Securities, each Person designated as Depositary by the Company pursuant to Section 3.01 until one or more successor Depositaries shall have become such pursuant to the applicable provisions of this Indenture, and thereafter &#8220;Depositary&#8221; shall mean or include each Person who is then a Depositary hereunder, and if at any time there is more than one such Person, &#8220;Depositary&#8221; as used with respect to the Securities of any such series shall mean the Depositary with respect to the Securities of that series.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Designated Currency:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The term &#8220;Designated Currency&#8221; shall have the same meaning assigned to it in Section&nbsp;3.12.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Discharged:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The term &#8220;Discharged&#8221; shall have the meaning assigned to it in Section 12.03.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>DTC:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The term &#8220;DTC&#8221; shall mean The Depository Trust Company, Inc. and its successors.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Event of Default:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The term &#8220;Event of Default&#8221; shall have the meaning specified in Section 7.01.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Exchange Act:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The term &#8220;Exchange Act&#8221; shall mean the United States Securities Exchange Act of 1934, and the rules and regulations promulgated by the SEC thereunder and any statute successor thereto, in each case as amended from time to time.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Exchange Rate:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The term &#8220;Exchange Rate&#8221; shall have the meaning assigned to it in Section 7.01.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Floating Rate Security:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The term &#8220;Floating Rate Security&#8221; shall mean a Security that provides for the payment of interest at a variable rate determined periodically by reference to an interest rate index specified pursuant to Section 3.01.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Foreign Currency:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The term &#8220;Foreign Currency&#8221; shall mean a currency issued by the government of any country other than the United States or a composite currency, the value of which is determined by reference to the values of the currencies of any group of countries.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>GAAP:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The term &#8220;GAAP,&#8221; with respect to any computations required or permitted hereunder, shall mean generally accepted accounting principles in effect in the United States as in effect from time to time; provided, however, if the Company is required by the SEC to adopt (or is permitted to adopt and so adopts) a different accounting framework, including but not limited to the International Financial Reporting Standards, &#8220;GAAP&#8221; shall mean such new accounting framework as in effect from time to time, including, without limitation, in each case, those accounting principles set forth in the opinions and pronouncements of the Accounting Principles Board of the American Institute of Certified Public Accountants and statements and pronouncements of the Financial Accounting Standards Board or in such other statements by such other entity as approved by a significant segment of the accounting profession.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Global Security:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The term &#8220;Global Security&#8221; shall mean any Security that evidences all or part of a series of Securities, issued in fully-registered certificated form to the Depositary for such series in accordance with Section 3.03 and bearing the legend prescribed in Section 3.03(g).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Holder; Holder of Securities:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The terms &#8220;Holder&#8221; and &#8220;Holder of Securities&#8221; are defined under &#8220;Securityholder; Holder of Securities; Holder.&#8221;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Indebtedness:</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The term &#8220;Indebtedness&#8221; shall mean any and all obligations of a Person for money borrowed which, in accordance with GAAP, would be reflected on the balance sheet of such Person as a liability on the date as of which Indebtedness is to be determined.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Indenture:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The term &#8220;Indenture&#8221; or &#8220;this Indenture&#8221; shall mean this instrument as originally executed or as it may from time to time be supplemented or amended by one or more indentures supplemental hereto entered into pursuant to the applicable provisions hereof, including, for all purposes of this instrument and any such supplemental indenture, the provisions of the Trust Indenture Act that are deemed to be a part of and govern this instrument and any such supplemental indenture, respectively. The term &#8220;Indenture&#8221; shall also include the terms of particular series of Securities established as contemplated by Section 3.01; provided, however, that if at any time more than one Person is acting as Trustee under this Indenture due to the appointment of one or more separate Trustees for any one or more separate series of Securities, &#8220;Indenture&#8221; shall mean, with respect to such series of Securities for which any such Person is Trustee, this instrument as originally executed or as it may from time to time be supplemented or amended by one or more indentures supplemental hereto entered into pursuant to the applicable provisions hereof and shall include the terms of particular series of Securities for which such Person is Trustee established as contemplated by Section 3.01, exclusive, however, of any provisions or terms which relate solely to other series of Securities for which such Person is not Trustee, regardless of when such terms or provisions were adopted, and exclusive of any provisions or terms adopted by means of one or more indentures supplemental hereto executed and delivered after such person had become such Trustee, but to which such person, as such Trustee, was not a party; provided, further that in the event that this Indenture is supplemented or amended by one or more indentures supplemental hereto which are only applicable to certain series of Securities, the term &#8220;Indenture&#8221; for a particular series of Securities shall only include the supplemental indentures applicable thereto.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Individual Securities:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The term &#8220;Individual Securities&#8221; shall have the meaning specified in Section 3.01(p).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Interest:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The term &#8220;interest&#8221; shall mean, unless the context otherwise requires, interest payable on any Securities, and with respect to an Original Issue Discount Security that by its terms bears interest only after Maturity, interest payable after Maturity.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Interest Payment Date:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The term &#8220;Interest Payment Date&#8221; shall mean, with respect to any Security, the Stated Maturity of an installment of interest on such Security.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Mandatory Sinking Fund Payment:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The term &#8220;Mandatory Sinking Fund Payment&#8221; shall have the meaning assigned to it in Section 5.01(b).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Maturity:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The term &#8220;Maturity,&#8221; with respect to any Security, shall mean the date on which the principal of such Security shall become due and payable as therein and herein provided, whether by declaration, call for redemption or otherwise.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Members:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The term &#8220;Members&#8221; shall have the meaning assigned to it in Section 3.03(i).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Officer</b>&#8217;<b>s Certificate:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The term &#8220;Officer&#8217;s Certificate&#8221; shall mean a certificate signed by any of the Chairman of the Board of Directors, Chief Executive Officer, Chief Financial Officer, the President Treasurer, an Assistant Treasurer, the Controller, the Secretary or an Assistant Secretary of the Company and delivered to the Trustee.&nbsp;&nbsp;Each such certificate shall include the statements provided for in Section 16.01 if and to the extent required by the provisions of Section 16.01.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Opinion of Counsel:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The term &#8220;Opinion of Counsel&#8221; shall mean an opinion in writing signed by one or more legal counsel, who may be an employee of or of counsel to the Company, or may be one or more other counsel that meets the requirements provided for in Section 16.01.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Optional Sinking Fund Payment:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The term &#8220;Optional Sinking Fund Payment&#8221; shall have the meaning assigned to it in Section 5.01(b).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Original Issue Discount Security:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The term &#8220;Original Issue Discount Security&#8221; shall mean any Security that is issued with &#8220;original issue discount&#8221; within the meaning of Section 1273(a) of the Code, or any successor provision, and the regulations thereunder and any other Security designated by the Company as issued with original issue discount for United States federal income tax purposes.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Outstanding:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The term &#8220;Outstanding,&#8221; when used with respect to Securities means, as of the date of determination, all Securities theretofore authenticated and delivered under this Indenture, except:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Securities theretofore canceled by the Trustee or delivered to the Trustee for cancellation;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Securities or portions thereof for which payment or redemption money in the necessary amount has been theretofore deposited with the Trustee or any Paying Agent (other than the Company) in trust or set aside and segregated in trust by the Company (if the Company shall act as its own Paying Agent) for the Holders of such Securities or Securities as to which the Company&#8217;s obligations have been Discharged; provided, however, that if such Securities or portions thereof are to be redeemed, notice of such redemption has been duly given pursuant to this Indenture or provision therefor satisfactory to the Trustee has been made; and</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Securities that have been paid pursuant to Section 3.07(b) or in exchange for or in lieu of which other Securities have been authenticated and delivered pursuant to this Indenture, other than any such Securities in respect of which there shall have been presented to a Responsible Officer of the Trustee proof satisfactory to it that such Securities are held by a protected purchaser in whose hands such Securities are valid obligations of the Company;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">provided, however, that in determining whether the Holders of the requisite principal amount of Securities of a series Outstanding have performed any action hereunder, Securities owned by the Company or any other obligor upon the Securities of such series or any Affiliate of the Company or of such other obligor shall be disregarded and deemed not to be Outstanding, except that, in determining whether the Trustee shall be protected in relying upon any such action, only Securities of such series that a Responsible Officer of the Trustee actually knows to be so owned shall be so disregarded.&nbsp;&nbsp;Securities so owned that have been pledged in good faith may be regarded as Outstanding if the pledgee establishes to the satisfaction of the Trustee the pledgee&#8217;s right to act with respect to such Securities and that the pledgee is not the Company or any other obligor upon such Securities or any Affiliate of the Company or of such other obligor.&nbsp;&nbsp;In determining whether the Holders of the requisite principal amount of Outstanding Securities of a series have performed any action hereunder, the principal amount of an Original Issue Discount Security that shall be deemed to be Outstanding for such purpose shall be the amount of the principal thereof that would be due and payable as of the date of such determination upon a declaration of acceleration of the Maturity thereof pursuant to Section 7.02 and the principal amount of a Security denominated in a Foreign Currency that shall be deemed to be Outstanding for such purpose shall be the amount calculated pursuant to Section 3.11(b).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Paying Agent:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The term &#8220;Paying Agent&#8221; shall have the meaning assigned to it in Section 6.02(a).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Person:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The term &#8220;Person&#8221; shall mean an individual, a corporation, a limited liability company, a partnership, an association, a joint stock company, a trust, an unincorporated organization or a government or an agency or political subdivision thereof.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Place of Payment:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The term &#8220;Place of Payment&#8221; shall mean, when used with respect to the Securities of any series, the place or places where the principal of and premium, if any, and interest on the Securities of that series are payable as specified pursuant to Section 3.01.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Predecessor Security:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The term &#8220;Predecessor Security&#8221; shall mean, with respect to any Security, every previous Security evidencing all or a portion of the same Indebtedness as that evidenced by such particular Security, and, for the purposes of this definition, any Security authenticated and delivered under Section 3.07 in lieu of a lost, destroyed or stolen Security shall be deemed to evidence the same Indebtedness as the lost, destroyed or stolen Security.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Record Date:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The term &#8220;Record Date&#8221; shall mean, with respect to any interest payable on any Security on any Interest Payment Date, the close of business on any date specified in such Security for the payment of interest pursuant to Section 3.01.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Redemption Date:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The term &#8220;Redemption Date&#8221; shall mean, when used with respect to any Security to be redeemed, in whole or in part, the date fixed for such redemption by or pursuant to this Indenture and the terms of such Security, which, in the case of a Floating Rate Security, unless otherwise specified pursuant to Section 3.01, shall be an Interest Payment Date only.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Redemption Price:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The term &#8220;Redemption Price,&#8221; when used with respect to any Security to be redeemed, in whole or in part, shall mean the price at which it is to be redeemed pursuant to the terms of the applicable Security and this Indenture.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Register:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The term &#8220;Register&#8221; shall have the meaning assigned to it in Section 3.05(a).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Registrar:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The term &#8220;Registrar&#8221; shall have the meaning assigned to it in Section 3.05(a).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Responsible Officers:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The term &#8220;Responsible Officers&#8221; of the Trustee hereunder shall mean any trust officer, any assistant trust officer or any other officer associated with the corporate trust department of the Trustee customarily performing functions similar to those performed by any of the above designated officers, and also means, with respect to a particular corporate trust matter, any other officer of the Trustee to whom such matter is referred because of such person&#8217;s knowledge of and familiarity with the particular subject and who shall have direct responsibility for the administration of this Indenture.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>SEC:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The term &#8220;SEC&#8221; shall mean the United States Securities and Exchange Commission, as constituted from time to time.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Securities Act:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The term &#8220;Securities Act&#8221; shall mean the United States Securities Act of 1933 and the rules and regulations promulgated by the SEC thereunder and any statute successor thereto, in each case as amended from time to time.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Security:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The term &#8220;Security&#8221; or &#8220;Securities&#8221; shall have the meaning stated in the recitals and shall more particularly mean one or more of the Securities duly authenticated by the Trustee and delivered pursuant to the provisions of this Indenture.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Security Custodian:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The term &#8220;Security Custodian&#8221; shall mean the custodian with respect to any Global Security appointed by the Depositary, or any successor Person thereto, and shall initially be the Paying Agent.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Securityholder; Holder of Securities; Holder:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The term &#8220;Securityholder,&#8221; &#8220;Holder of Securities&#8221; or &#8220;Holder,&#8221; shall mean the Person in whose name Securities shall be registered in the Register kept for that purpose hereunder.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Senior Indebtedness:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The term &#8220;Senior Indebtedness&#8221; means the principal of (and premium, if any) and unpaid interest on (x) Indebtedness of the Company, whether outstanding on the date hereof or thereafter created, incurred, assumed or guaranteed, for money borrowed other than (a) any Indebtedness of the Company which when incurred, and without respect to any election under Section 1111(b) of the U.S. Federal Bankruptcy Code (Title 11 of the United States Code), was without recourse to the Company, (b) any Indebtedness of the Company to any of its Subsidiaries, (c) Indebtedness to any employee of the Company, (d) any liability for taxes, (e) Trade Payables and (f) any Indebtedness of the Company which is expressly subordinate in right of payment to any other Indebtedness of the Company, and (y) renewals, extensions, modifications and refundings of any such Indebtedness.&nbsp;&nbsp;For purposes of the foregoing and the definition of &#8220;Senior Indebtedness,&#8221; the phrase &#8220;subordinated in right of payment&#8221; means debt subordination only and not lien subordination, and accordingly, (i) unsecured indebtedness shall not be deemed to be subordinated in right of payment to secured indebtedness merely by virtue of the fact that it is unsecured, and (ii) junior liens, second liens and other contractual arrangements that provide for priorities among Holders of the same or different issues of indebtedness with respect to any collateral or the proceeds of collateral shall not constitute subordination in right of payment. This definition may be modified or superseded by a supplemental indenture.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Special Record Date:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The term &#8220;Special Record Date&#8221; shall have the meaning assigned to it in Section&nbsp;3.08(b)(i).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Stated Maturity:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The term &#8220;Stated Maturity,&#8221; when used with respect to any Security or any installment of interest thereon, shall mean the date specified in such Security as the fixed date on which the principal (or any portion thereof) of or premium, if any, on such Security or such installment of interest is due and payable.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Subsidiary:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The term &#8220;Subsidiary,&#8221; when used with respect to any Person, shall mean:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any corporation, limited liability company, association or other business entity of which more than 50% of the total voting power of shares of Capital Stock entitled (without regard to the occurrence of any contingency and after giving effect to any voting agreement or stockholders&#8217; agreement that effectively transfers voting power) to vote in the election of directors, managers or trustees of the corporation, limited liability company, association or other business entity is at the time owned or controlled, directly or indirectly, by that Person or one or more of the other Subsidiaries of that Person (or a combination thereof); and</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any partnership (i) the sole general partner or the managing general partner of which is such Person or a Subsidiary of such Person or (ii) the only general partners of which are that Person or one or more Subsidiaries of that Person (or any combination thereof).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Successor Company:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The term &#8220;Successor Company&#8221; shall have the meaning assigned to it in Section 3.06(i).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Trade Payables:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The term &#8220;Trade Payables&#8221; means accounts payable or any other Indebtedness or monetary obligations to trade creditors created or assumed by the Company or any Subsidiary of the Company in the ordinary course of business (including guarantees thereof or instruments evidencing such liabilities).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Trust Indenture Act; TIA:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The term &#8220;Trust Indenture Act&#8221; or &#8220;TIA&#8221; shall mean the Trust Indenture Act of 1939, as amended, and the rules and regulations thereunder as in effect on the date of this Indenture, except as provided in Section 14.06 and except to the extent any amendment to the Trust Indenture Act expressly provides for application of the Trust Indenture Act as in effect on another date.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Trustee:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The term &#8220;Trustee&#8221; shall mean the Person named as the &#8220;Trustee&#8221; in the first paragraph of this Indenture until a successor Trustee shall have become such with respect to one or more series of Securities pursuant to the applicable provisions of this Indenture, and thereafter &#8220;Trustee&#8221; shall mean or include each Person who is then a Trustee hereunder, and if at any time there is more than one such Person, &#8220;Trustee&#8221; as used with respect to the Securities of any series shall mean the Trustee with respect to Securities of that series.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>U.S. Dollars:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The term &#8220;U.S. Dollars&#8221; shall mean such currency of the United States as at the time of payment shall be legal tender for the payment of public and private debts.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>U.S. Government Obligations:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The term &#8220;U.S. Government Obligations&#8221; shall have the meaning assigned to it in Section 12.03.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>United States:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The term &#8220;United States&#8221; shall mean the United States of America (including the States and the District of Columbia), its territories and its possessions and other areas subject to its jurisdiction.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>ARTICLE II</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><u>FORMS OF SECURITIES</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Section 2.01&nbsp;&nbsp;&nbsp;&nbsp;<u>Terms of the Securities</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;The Securities of each series shall be substantially in the form set forth in a Company Order or in one or more indentures supplemental hereto, and shall have such appropriate insertions, omissions, substitutions and other variations as are required or permitted by this Indenture, and may have such letters, numbers or other marks of identification or designation and such legends or endorsements placed thereon as the Company may deem appropriate and as are not inconsistent with the provisions of this Indenture, or as may be required to comply with any law or with any rule or regulation made pursuant thereto or with any rule or regulation of any securities exchange on which any series of the Securities may be listed or of any automated quotation system on which any such series may be quoted, or to conform to usage, all as determined by the officers executing such Securities as conclusively evidenced by their execution of such Securities.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;The terms and provisions of the Securities shall constitute, and are hereby expressly made, a part of this Indenture, and, to the extent applicable, the Company and the Trustee, by their execution and delivery of this Indenture expressly agree to such terms and provisions and to be bound thereby.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Section 2.02&nbsp;&nbsp;&nbsp;&nbsp;<u>Form of Trustee</u><u>&#8217;</u><u>s Certificate of Authentication</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;Only such of the Securities as shall bear thereon a certificate substantially in the form of the Trustee&#8217;s certificate of authentication hereinafter recited, executed by the Trustee by manual signature, shall be valid or become obligatory for any purpose or entitle the Holder thereof to any right or benefit under this Indenture.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;Each Security shall be dated the date of its authentication, except that any Global Security shall be dated as of the date specified as contemplated in Section 3.01.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(c)&nbsp;&nbsp;&nbsp;&nbsp;The form of the Trustee&#8217;s certificate of authentication to be borne by the Securities shall be substantially as follows:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">TRUSTEE&#8217;S CERTIFICATE OF AUTHENTICATION</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">This is one of the Securities of the series designated therein referred to in the within-mentioned Indenture.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: bottom; width: 47%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td colspan="2" rowspan="1" style="vertical-align: bottom; width: 3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;],&nbsp;&nbsp;as Trustee</p>
			</td>
			<td rowspan="1" style="vertical-align: bottom; width: 20%;">&nbsp;</td>
		</tr>
		<tr>
			<td colspan="2" style="vertical-align: bottom; width: 47%;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 30%;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 20%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: bottom; width: 47%;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">By:</p>
			</td>
			<td style="vertical-align: bottom; width: 30%; border-bottom: 1px solid black;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 20%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: bottom; width: 47%;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align: bottom; width: 30%;">Authorized Signatory</td>
			<td style="vertical-align: bottom; width: 20%;">&nbsp;</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 2.03&nbsp;&nbsp;&nbsp;&nbsp;<u>Form of Trustee</u><u>&#8217;</u><u>s Certificate of Authentication by an Authenticating Agent</u>.&nbsp;&nbsp;If at any time there shall be an Authenticating Agent appointed with respect to any series of Securities, then the Trustee&#8217;s Certificate of Authentication by such Authenticating Agent to be borne by Securities of each such series shall be substantially as follows:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">TRUSTEE&#8217;S CERTIFICATE OF AUTHENTICATION</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">This is one of the Securities of the series designated therein referred to in the within-mentioned Indenture.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: bottom; width: 40%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td colspan="2" rowspan="1" style="vertical-align: bottom; width: 3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;],&nbsp;&nbsp;as Trustee</p>
			</td>
			<td style="vertical-align: bottom; width: 27%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: bottom; width: 40%;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 3%;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 30%;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 27%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: bottom; width: 40%;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 3%;">By:</td>
			<td style="vertical-align: bottom; width: 30%;">[<u>NAME OF AUTHENTICATION AGENT</u>]</td>
			<td style="vertical-align: bottom; width: 27%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: bottom; width: 40%;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 3%;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 30%;">as Authenticating Agent</td>
			<td style="vertical-align: bottom; width: 27%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: bottom; width: 40%;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 3%;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 30%;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 27%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: bottom; width: 40%;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 3%;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 30%;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 27%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: bottom; width: 40%;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">By:</p>
			</td>
			<td style="vertical-align: bottom; width: 30%; border-bottom: 1px solid black;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 27%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: bottom; width: 40%;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align: bottom; width: 30%;">Authorized Signatory</td>
			<td style="vertical-align: bottom; width: 27%;">&nbsp;</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>ARTICLE III</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><u>THE DEBT SECURITIES</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 3.01&nbsp;&nbsp;&nbsp;&nbsp;<u>Amount Unlimited; Issuable in Series</u>.&nbsp;&nbsp; The aggregate principal amount of Securities that may be authenticated and delivered under this Indenture is unlimited.&nbsp;&nbsp;The Securities may be issued in one or more series.&nbsp;&nbsp;There shall be set forth in a Company Order or in one or more indentures supplemental hereto, prior to the issuance of Securities of any series:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;the title of the Securities of the series (which shall distinguish the Securities of such series from the Securities of all other series, except to the extent that additional Securities of an existing series are being issued);</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;the aggregate principal amount of the Securities of the series and any limit upon the aggregate principal amount of the Securities of the series that may be authenticated and delivered under this Indenture (except for Securities authenticated and delivered upon transfer of, or in exchange for, or in lieu of, other Securities of such series pursuant to Section 3.04, 3.06, 3.07, 4.06, or 14.05);</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(c)&nbsp;&nbsp;&nbsp;&nbsp;whether the Securities will be issued as registered Securities and any restrictions on the exchange of one form of Securities for another and on the offer, sale and delivery of the Securities;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(d)&nbsp;&nbsp;&nbsp;&nbsp;the dates on which or periods during which the Securities of the series may be issued, and the dates on, or the range of dates within, which the principal of and premium, if any, on the Securities of such series are or may be payable or the method by which such date or dates shall be determined or extended;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(e)&nbsp;&nbsp;&nbsp;&nbsp;the rate or rates at which the Securities of the series shall bear interest, if any, or the method by which such rate or rates shall be determined, whether such interest shall be payable in cash or additional Securities of the same series or shall accrue and increase the aggregate principal amount outstanding of such series (including if such Securities were originally issued at a discount), the date or dates from which such interest shall accrue, or the method by which such date or dates shall be determined, the Interest Payment Dates on which any such interest shall be payable, and the Record Dates for the determination of Holders to whom interest is payable on such Interest Payment Dates or the method by which such date or dates shall be determined, the right, if any, to extend or defer interest payments and the duration of such extension or deferral;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(f)&nbsp;&nbsp;&nbsp;&nbsp;if the Securities do not bear interest, the dates on which the Company will furnish to the Trustee the names and addresses of the Holders of Securities;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(g)&nbsp;&nbsp;&nbsp;&nbsp;if other than U.S. Dollars, the Foreign Currency in which Securities of the series shall be denominated or in which payment of the principal of, premium, if any, or interest on the Securities of the series shall be payable and any other terms concerning such payment;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(h)&nbsp;&nbsp;&nbsp;&nbsp;if the amount of payment of principal of, premium, if any, or interest on the Securities of the series may be determined with reference to an index, formula or other method including, but not limited to, an index based on a Currency or Currencies other than that in which the Securities are stated to be payable, the manner in which such amounts shall be determined;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(i)&nbsp;&nbsp;&nbsp;&nbsp;if the principal of, premium, if any, or interest on Securities of the series are to be payable, at the election of the Company or a Holder thereof, in a Currency other than that in which the Securities are denominated or stated to be payable without such election, the period or periods within which, and the terms and conditions upon which, such election may be made and the time and the manner of determining the exchange rate between the Currency in which the Securities are denominated or payable without such election and the Currency in which the Securities are to be paid if such election is made;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(j)&nbsp;&nbsp;&nbsp;&nbsp;the designation of the original currency determination agent, if any;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(k)&nbsp;&nbsp;&nbsp;&nbsp;the place or places, if any, in addition to or instead of the Corporate Trust Office of the Trustee where the principal of, premium, if any, and interest on Securities of the series shall be payable, and where Securities of any series may be presented for registration of transfer, exchange or conversion, and the place or places where notices and demands to or upon the Company in respect of the Securities of such series may be made;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(l)&nbsp;&nbsp;&nbsp;&nbsp;the price or prices at which, the period or periods within which or the date or dates on which, and the terms and conditions upon which Securities of the series may be redeemed, in whole or in part, at the option of the Company, if the Company is to have that option;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(m)&nbsp;&nbsp;&nbsp;&nbsp;the obligation or right, if any, of the Company to redeem, purchase or repay Securities of the series pursuant to any sinking fund, amortization or analogous provisions or at the option of a Holder thereof and the price or prices at which, the period or periods within which or the date or dates on which, the Currency or Currencies in which and the terms and conditions upon which Securities of the series shall be redeemed, purchased or repaid, in whole or in part, pursuant to such obligation;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(n)&nbsp;&nbsp;&nbsp;&nbsp;if the Currency in which the Securities will be issuable is U.S. Dollars, the denominations in which Securities of the series shall be issuable, if other than minimum denominations of $1,000 or any integral multiple thereof;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(o)&nbsp;&nbsp;&nbsp;&nbsp;if other than the principal amount thereof, the portion of the principal amount of the Securities of the series which shall be payable upon declaration of acceleration of the Maturity thereof pursuant to Section 7.02;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(p)&nbsp;&nbsp;&nbsp;&nbsp;the guarantors, if any, of the Securities of the series, and the extent of the guarantees (including provisions relating to seniority, subordination and the release of the guarantors), if any, and any additions or changes to permit or facilitate guarantees of such Securities;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(q)&nbsp;&nbsp;&nbsp;&nbsp;whether the Securities of the series are to be issued as Original Issue Discount Securities and the amount of discount with which such Securities may be issued;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(r)&nbsp;&nbsp;&nbsp;&nbsp;whether and under what circumstances the Company will pay additional amounts to non-United States Holders in respect of any tax assessment or government charge;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(s)&nbsp;&nbsp;&nbsp;&nbsp;provisions, if any, for the defeasance of Securities of the series in whole or in part and any addition or change in the provisions related to satisfaction and discharge;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(t)&nbsp;&nbsp;&nbsp;&nbsp;whether the Securities of the series are to be issued in whole or in part in the form of one or more Global Securities and, in such case, the Depositary and global exchange agent for such Global Security or Global Securities, the terms and conditions, if any, upon which interests in such Global Security or Global Securities may be exchanged in whole or in part for the individual securities represented thereby in definitive form registered in the name or names of Persons other than such Depositary or a nominee or nominees thereof (&#8220;Individual Securities&#8221;), and whether such Global Security or Global Securities shall be permanent or temporary;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(u)&nbsp;&nbsp;&nbsp;&nbsp;if the Securities are to be issuable initially in the form of a temporary Global Security, the circumstances (if any in addition to those set forth in Section 3.04) under which the temporary Global Security can be exchanged for definitive Securities and whether the definitive Securities will be registered Securities, bearer Securities or will be in global form and provisions relating to the payment of interest in respect of any portion of a Global Security payable in respect of an Interest Payment Date prior to the exchange date;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(v)&nbsp;&nbsp;&nbsp;&nbsp;the date as of which any bearer Securities and any Global Security of the series shall be dated if other than the original issuance of the first Security of the series to be issued;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(w)&nbsp;&nbsp;&nbsp;&nbsp;the form of the Securities of the series;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(x)&nbsp;&nbsp;&nbsp;&nbsp;if the Securities of the series are to be convertible into or exchangeable for any securities or property of any Person (including the Company), the terms and conditions upon which such Securities will be so convertible or exchangeable, and any additions or changes, if any, to permit or facilitate such conversion or exchange;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(y)&nbsp;&nbsp;&nbsp;&nbsp;whether the Securities of such series are subject to subordination and the terms of such subordination;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(z)&nbsp;&nbsp;&nbsp;&nbsp;whether the Securities will be secured or unsecured;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(aa)&nbsp;&nbsp;&nbsp;&nbsp;any restriction or condition on the transferability of the Securities of such series;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(bb)&nbsp;&nbsp;&nbsp;&nbsp;any addition or change in the provisions related to compensation and reimbursement of the Trustee which applies to Securities of such series;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(cc)&nbsp;&nbsp;&nbsp;&nbsp;any addition or change in the provisions related to supplemental indentures set forth in Sections 14.01, 14.02 and 14.04 which applies to Securities of such series;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(dd)&nbsp;&nbsp;&nbsp;&nbsp;provisions, if any, granting special rights to Holders upon the occurrence of specified events;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(ee)&nbsp;&nbsp;&nbsp;&nbsp;any addition to or change in the Events of Default which applies to any Securities of the series and any change in the right of&nbsp;&nbsp;the Trustee or the requisite Holders of such Securities to declare the principal amount thereof due and payable pursuant to Section 7.02 and any addition or change in the provisions set forth in Article VII which applies to Securities of the series;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(ff)&nbsp;&nbsp;&nbsp;&nbsp;any addition to or change in the covenants set forth in Article VI which applies to Securities of the series; and</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(gg)&nbsp;&nbsp;&nbsp;&nbsp;any other terms of the Securities of such series (which terms shall not be inconsistent with the provisions of the TIA, but may modify, amend, supplement or delete any of the terms of this Indenture with respect to such series).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">All Securities of any one series shall be substantially identical, except as to denomination and except as may otherwise be provided herein or set forth in a Company Order or in one or more indentures supplemental hereto.&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 3.02&nbsp;&nbsp;&nbsp;&nbsp;<u>Denominations</u>.&nbsp;&nbsp; In the absence of any specification pursuant to Section 3.01 with respect to Securities of any series, the Securities of such series shall be issuable only as Securities in minimum denominations of $1,000 and any integral multiple thereof, and shall be payable only in U.S. Dollars.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Section 3.03&nbsp;&nbsp;&nbsp;&nbsp;<u>Execution, Authentication, Delivery and Dating</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;The Securities shall be executed in the name and on behalf of the Company by the manual or facsimile signature of its Chairman of the Board of Directors, its Chief Executive Officer, President, or Treasurer.&nbsp;&nbsp;If the Person whose signature is on a Security no longer holds that office at the time the Security is authenticated and delivered, the Security shall nevertheless be valid.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;At any time and from time to time after the execution and delivery of this Indenture, the Company may deliver Securities of any series executed by the Company to the Trustee for authentication, together with a Company Order for the authentication and delivery of such Securities and, if required pursuant to Section 3.01, a supplemental indenture or Company Order setting forth the terms of the Securities of a series.&nbsp;&nbsp;The Trustee shall thereupon authenticate and deliver such Securities without any further action by the Company.&nbsp;&nbsp;The Company Order shall specify the amount of Securities to be authenticated and the date on which the original issue of Securities is to be authenticated.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(c)&nbsp;&nbsp;&nbsp;&nbsp;In authenticating the first Securities of any series and accepting the additional responsibilities under this Indenture in relation to such Securities the Trustee shall receive, and (subject to Section 11.02) shall be fully protected in relying upon an Officer&#8217;s Certificate and an Opinion of Counsel, each prepared in accordance with Section 16.01 stating that the conditions precedent, if any, provided for in the Indenture have been complied with.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(d)&nbsp;&nbsp;&nbsp;&nbsp;The Trustee shall have the right to decline to authenticate and deliver the Securities under this Section 3.03 if the issue of the Securities pursuant to this Indenture will affect the Trustee&#8217;s own rights, duties or immunities under the Securities and this Indenture or otherwise in a manner which is not reasonably acceptable to the Trustee.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(e)&nbsp;&nbsp;&nbsp;&nbsp;Each Security shall be dated the date of its authentication, except as otherwise provided pursuant to Section 3.01 with respect to the Securities of such series.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(f)&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding the provisions of Section 3.01 and of this Section 3.03, if all of the Securities of any series are not to be originally issued at the same time, then the documents required to be delivered pursuant to this Section 3.03 must be delivered only once prior to the authentication and delivery of the first Security of such series.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(g)&nbsp;&nbsp;&nbsp;&nbsp;If the Company shall establish pursuant to Section 3.01 that the Securities of a series are to be issued in whole or in part in the form of one or more Global Securities, then the Company shall execute and the Trustee shall authenticate and deliver one or more Global Securities that (i) shall represent an aggregate amount equal to the aggregate principal amount of the Outstanding Securities of such series to be represented by such Global Securities, (ii) shall be registered, if in registered form, in the name of the Depositary for such Global Security or Global Securities or the nominee of such Depositary, (iii) shall be delivered by the Trustee to such Depositary or pursuant to such Depositary&#8217;s instruction and (iv) shall bear a legend substantially to the following effect:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#8220;THIS SECURITY IS A GLOBAL SECURITY WITHIN THE MEANING OF THE INDENTURE HEREINAFTER REFERRED TO AND IS REGISTERED IN THE NAME OF THE DEPOSITARY OR A NOMINEE OF THE DEPOSITARY, WHICH MAY BE TREATED BY THE COMPANY, THE TRUSTEE AND ANY AGENT THEREOF AS OWNER AND HOLDER OF THIS SECURITY FOR ALL PURPOSES.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF [THE DEPOSITARY] TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF [THE NOMINEE OF THE DEPOSITARY] OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF [THE DEPOSITARY] (AND ANY PAYMENT HEREON IS MADE TO [THE NOMINEE OF THE DEPOSITARY] OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF [THE DEPOSITARY]), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL SINCE THE REGISTERED OWNER HEREOF, [THE NOMINEE OF THE DEPOSITARY], HAS AN INTEREST HEREIN.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">TRANSFERS OF THIS GLOBAL SECURITY SHALL BE LIMITED TO TRANSFERS IN WHOLE, BUT NOT IN PART, BY THE DEPOSITARY TO A NOMINEE OF THE DEPOSITARY, OR BY A NOMINEE OF THE DEPOSITARY TO THE DEPOSITARY OR ANOTHER NOMINEE OF THE DEPOSITARY, OR BY THE DEPOSITARY OR ANY SUCH NOMINEE TO A SUCCESSOR DEPOSITARY OR A NOMINEE OF SUCH SUCCESSOR DEPOSITARY.&#8221;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The aggregate principal amount of each Global Security may from time to time be increased or decreased by adjustments made on the records of the Security Custodian, as provided in this Indenture.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(h)&nbsp;&nbsp;&nbsp;&nbsp;Each Depositary designated pursuant to Section 3.01 for a Global Security in registered form must, at the time of its designation and at all times while it serves as such Depositary, be a clearing agency registered under the Exchange Act and any other applicable statute or regulation.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(i)&nbsp;&nbsp;&nbsp;&nbsp;Members of, or participants in, the Depositary (&#8220;Members&#8221;) shall have no rights under this Indenture with respect to any Global Security held on their behalf by the Depositary or by the Security Custodian under such Global Security, and the Depositary may be treated by the Company, the Trustee, the Paying Agent and the Registrar and any of their agents as the absolute owner of such Global Security for all purposes whatsoever.&nbsp;&nbsp;Notwithstanding the foregoing, nothing herein shall prevent the Company, the Trustee, the Paying Agent or the Registrar or any of their agents from giving effect to any written certification, proxy or other authorization furnished by the Depositary or impair, as between the Depositary and its Members, the operation of customary practices of the Depositary governing the exercise of the rights of an owner of a beneficial interest in any Global Security.&nbsp;&nbsp;The Holder of a Global Security may grant proxies and otherwise authorize any Person, including Members and Persons that may hold interests through Members, to take any action that a Holder is entitled to take under this Indenture or the Securities.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(j)&nbsp;&nbsp;&nbsp;&nbsp;No Security shall be entitled to any benefit under this Indenture or be valid or obligatory for any purpose unless there appears on such Security a certificate of authentication substantially in one of the forms provided for herein duly executed by the Trustee or by an Authenticating Agent by manual or facsimile signature of an authorized signatory of the Trustee, and such certificate upon any Security shall be conclusive evidence, and the only evidence, that such Security has been duly authenticated and delivered hereunder and is entitled to the benefits of this Indenture.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 3.04&nbsp;&nbsp;&nbsp;&nbsp;<u>Temporary Securities</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;Pending the preparation of definitive Securities of any series, the Company may execute, and upon Company Order the Trustee shall authenticate and deliver, temporary Securities that are printed, lithographed, typewritten, mimeographed or otherwise reproduced, in any authorized denomination, substantially of the tenor of the definitive Securities in lieu of which they are issued, in registered form and with such appropriate insertions, omissions, substitutions and other variations as the officers executing such Securities may determine, as conclusively evidenced by their execution of such Securities.&nbsp;&nbsp;Any such temporary Security may be in the form of one or more Global Securities, representing all or a portion of the Outstanding Securities of such series.&nbsp;&nbsp;Every such temporary Security shall be executed by the Company and shall be authenticated and delivered by the Trustee upon the same conditions and in substantially the same manner, and with the same effect, as the definitive Security or Securities in lieu of which it is issued.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;If temporary Securities of any series are issued, the Company will cause definitive Securities of such series to be prepared without unreasonable delay.&nbsp;&nbsp;After the preparation of definitive Securities of such series, the temporary Securities of such series shall be exchangeable for definitive Securities of such series upon surrender of such temporary Securities at the office or agency of the Company in a Place of Payment for such series, without charge to the Holder.&nbsp;&nbsp;Upon surrender for cancellation of any one or more temporary Securities of any series, the Company shall execute and the Trustee shall authenticate and deliver in exchange therefor a like principal amount of definitive Securities of the same series of authorized denominations and of like tenor.&nbsp;&nbsp;Until so exchanged, the temporary Securities of any series shall in all respects be entitled to the same benefits under this Indenture as definitive Securities of such series.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(c)&nbsp;&nbsp;&nbsp;&nbsp;Upon any exchange of a portion of a temporary Global Security for a definitive Global Security or for the Individual Securities represented thereby pursuant to this Section 3.04 or Section 3.06, the temporary Global Security shall be endorsed by the Trustee to reflect the reduction of the principal amount evidenced thereby, whereupon the principal amount of such temporary Global Security shall be reduced for all purposes by the amount so exchanged and endorsed.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 3.05&nbsp;&nbsp;&nbsp;&nbsp;<u>Registrar and Paying Agent</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;The Company will keep, at an office or agency to be maintained by it in a Place of Payment where Securities may be presented for registration or presented and surrendered for registration of transfer or of exchange, and where Securities of any series that are convertible or exchangeable may be surrendered for conversion or exchange, as applicable (the &#8220;Registrar&#8221;), a security register for the registration and the registration of transfer or of exchange of the Securities (the registers maintained in such office and in any other office or agency of the Company in a Place of Payment being herein sometimes collectively referred to as the &#8220;Register&#8221;), as in this Indenture provided, which Register shall at all reasonable times be open for inspection by the Trustee.&nbsp;&nbsp;Such Register shall be in written form or in any other form capable of being converted into written form within a reasonable time.&nbsp;&nbsp;The Company may have one or more co-Registrars; the term &#8220;Registrar&#8221; includes any co-registrar.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;The Company shall enter into an appropriate agency agreement with any Registrar or co-Registrar not a party to this Indenture.&nbsp;&nbsp;The agreement shall implement the provisions of this Indenture that relate to such agent.&nbsp;&nbsp;The Company shall notify the Trustee of the name and address of each such agent.&nbsp;&nbsp;If the Company fails to maintain a Registrar for any series, the Trustee shall act as such and shall be entitled to appropriate compensation therefor pursuant to Section 11.01.&nbsp;&nbsp;The Company or any Affiliate thereof may act as Registrar, co-Registrar or transfer agent.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(c)&nbsp;&nbsp;&nbsp;&nbsp;The Company hereby appoints the Trustee at its Corporate Trust Office as Registrar in connection with the Securities and this Indenture, until such time as another Person is appointed as such.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 3.06&nbsp;&nbsp;&nbsp;&nbsp;<u>Transfer and Exchange</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;Transfer.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Upon surrender for registration of transfer of any Security of any series at the Registrar, the Company shall execute, and the Trustee or any Authenticating Agent shall authenticate and deliver, in the name of the designated transferee, one or more new Securities of the same series for like aggregate principal amount of any authorized denomination or denominations.&nbsp;&nbsp;The transfer of any Security shall not be valid as against the Company or the Trustee unless registered at the Registrar at the request of the Holder, or at the request of his, her or its attorney duly authorized in writing.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding any other provision of this Section 3.06, unless and until it is exchanged in whole or in part for the Individual Securities represented thereby, a Global Security representing all or a portion of the Securities of a series may not be transferred except as a whole by the Depositary for such series to a nominee of such Depositary or by a nominee of such Depositary to such Depositary or another nominee of such Depositary or by such Depositary or any such nominee to a successor Depositary for such series or a nominee of such successor Depositary.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Exchange.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;At the option of the Holder, Securities of any series (other than a Global Security, except as set forth below) may be exchanged for other Securities of the same series for like aggregate principal amount of any authorized denomination or denominations, upon surrender of the Securities to be exchanged at the Registrar.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Whenever any Securities are so surrendered for exchange, the Company shall execute, and the Trustee shall authenticate and deliver, the Securities that the Holder making the exchange is entitled to receive.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Exchange of Global Securities for Individual Securities.&nbsp;&nbsp;Except as provided below, owners of beneficial interests in Global Securities will not be entitled to receive Individual Securities.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Individual Securities shall be issued to all owners of beneficial interests in a Global Security in exchange for such interests if: (A) at any time the Depositary for the Securities of a series notifies the Company that it is unwilling or unable to continue as Depositary for the Securities of such series or if at any time the Depositary for the Securities of such series shall no longer be eligible under Section 3.03(h) and, in each case, a successor Depositary is not appointed by the Company within 90 days of such notice, or (B) the Company executes and delivers to the Trustee and the Registrar an Officer&#8217;s Certificate stating that such Global Security shall be so exchangeable.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">In connection with the exchange of an entire Global Security for Individual Securities pursuant to this Section 3.06(c), such Global Security shall be deemed to be surrendered to the Trustee for cancellation, and the Company shall execute, and the Trustee, upon receipt of a Company Order for the authentication and delivery of Individual Securities of such series, will authenticate and deliver to each beneficial owner identified by the Depositary in exchange for its beneficial interest in such Global Security, an equal aggregate principal amount of Individual Securities of authorized denominations.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The owner of a beneficial interest in a Global Security will be entitled to receive an Individual Security in exchange for such interest if an Event of Default has occurred and is continuing.&nbsp;&nbsp;Upon receipt by the Security Custodian and Registrar of instructions from the Holder of a Global Security directing the Security Custodian and Registrar to (x) issue one or more Individual Securities in the amounts specified to the owner of a beneficial interest in such Global Security and (y) debit or cause to be debited an equivalent amount of beneficial interest in such Global Security, subject to the rules and regulations of the Depositary:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(A)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the Security Custodian and Registrar shall notify the Company and the Trustee of such instructions, identifying the owner and amount of such beneficial interest in such Global Security;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(B)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the Company shall promptly execute and the Trustee, upon receipt of a Company Order for the authentication and delivery of Individual Securities of such series, shall authenticate and deliver to such beneficial owner Individual Securities in an equivalent amount to such beneficial interest in such Global Security; and</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(C)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the Security Custodian and Registrar shall decrease such Global Security by such amount in accordance with the foregoing.&nbsp;&nbsp;In the event that the Individual Securities are not issued to each such beneficial owner promptly after the Registrar has received a request from the Holder of a Global Security to issue such Individual Securities, the Company expressly acknowledges, with respect to the right of any Holder to pursue a remedy pursuant to Section 7.07 hereof, the right of any beneficial Holder of Securities to pursue such remedy with respect to the portion of the Global Security that represents such beneficial Holder&#8217;s Securities as if such Individual Securities had been issued.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If specified by the Company pursuant to Section 3.01 with respect to a series of Securities, the Depositary for such series of Securities may surrender a Global Security for such series of Securities in exchange in whole or in part for Individual Securities of such series on such terms as are acceptable to the Company and such Depositary.&nbsp;&nbsp;Thereupon, the Company shall execute, and the Trustee shall authenticate and deliver, without service charge,</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(A)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to each Person specified by such Depositary a new Individual Security or new Individual Securities of the same series, of any authorized denomination as requested by such Person in aggregate principal amount equal to and in exchange for such Person&#8217;s beneficial interest in the Global Security; and</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(B)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to such Depositary a new Global Security in a denomination equal to the difference, if any, between the principal amount of the surrendered Global Security and the aggregate principal amount of Individual Securities delivered to Holders thereof.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In any exchange provided for in Section 3.06(c)(i) through (iii), the Company will execute and the Trustee will authenticate and deliver Individual Securities in registered form in authorized denominations.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Upon the exchange in full of a Global Security for Individual Securities, such Global Security shall be canceled by the Trustee.&nbsp;&nbsp;Individual Securities issued in exchange for a Global Security pursuant to this Section 3.06 shall be registered in such names and in such authorized denominations as the Depositary for such Global Security, pursuant to instructions from its direct or indirect participants or otherwise, shall instruct the Trustee.&nbsp;&nbsp;The Trustee shall deliver such Securities to the Persons in whose names such Securities are so registered.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All Securities issued upon any registration of transfer or exchange of Securities shall be valid obligations of the Company evidencing the same debt, and entitled to the same benefits under this Indenture, as the Securities surrendered for such registration of transfer or exchange.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Every Security presented or surrendered for registration of transfer, or for exchange or payment shall (if so required by the Company, the Trustee or the Registrar) be duly endorsed, or be accompanied by a written instrument or instruments of transfer in form satisfactory to the Company, the Trustee and the Registrar, duly executed by the Holder thereof or by his, her or its attorney duly authorized in writing.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No service charge will be made for any registration of transfer or exchange of Securities.&nbsp;&nbsp;The Company or the Trustee may require payment of a sum sufficient to cover any tax, assessment or other governmental charge that may be imposed in connection with any registration of transfer or exchange of Securities, other than those expressly provided in this Indenture to be made at the Company&#8217;s own expense or without expense or charge to the Holders.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company shall not be required to (i) register, transfer or exchange Securities of any series during a period beginning at the opening of business 15 days before the day of the transmission of a notice of redemption of Securities of such series selected for redemption under Section 4.03 and ending at the close of business on the day of such transmission, or (ii) register, transfer or exchange any Security so selected for redemption in whole or in part, except the unredeemed portion of any Security being redeemed in part.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prior to the due presentation for registration of transfer or exchange of any Security, the Company, the Trustee, the Paying Agent, the Registrar, any co-Registrar or any of their agents may deem and treat the Person in whose name a Security is registered as the absolute owner of such Security (whether or not such Security shall be overdue and notwithstanding any notation of ownership or other writing thereon) for all purposes whatsoever, and none of the Company, the Trustee, the Paying Agent, the Registrar, any co-Registrar or any of their agents shall be affected by any notice to the contrary.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In case a successor Company (&#8220;Successor Company&#8221;) has executed an indenture supplemental hereto with the Trustee pursuant to Article XIV, any of the Securities authenticated or delivered pursuant to such transaction may, from time to time, at the request of the Successor Company, be exchanged for other Securities executed in the name of the Successor Company with such changes in phraseology and form as may be appropriate, but otherwise identical to the Securities surrendered for such exchange and of like principal amount; and the Trustee, upon Company Order of the Successor Company, shall authenticate and deliver Securities as specified in such order for the purpose of such exchange.&nbsp;&nbsp;If Securities shall at any time be authenticated and delivered in any new name of a Successor Company pursuant to this Section 3.06 in exchange or substitution for or upon registration of transfer of any Securities, such Successor Company, at the option of the Holders but without expense to them, shall provide for the exchange of all Securities at the time Outstanding for Securities authenticated and delivered in such new name.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each Holder of a Security agrees to indemnify the Company and the Trustee against any liability that may result from the transfer, exchange or assignment of such Holder&#8217;s Security in violation of any provision of this Indenture and/or applicable United States federal or state securities laws.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Trustee shall have no obligation or duty to monitor, determine or inquire as to compliance with any restrictions on transfer imposed under this Indenture or under applicable law with respect to any transfer of any interest in any Security other than to require delivery of such certificates and other documentation or evidence as are expressly required by, and to do so if and when expressly required by the terms of, this Indenture, and to examine the same to determine substantial compliance as to form with the express requirements hereof.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neither the Trustee nor any agent of the Trustee shall have any responsibility for any actions taken or not taken by the Depositary.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Section 3.07&nbsp;&nbsp;&nbsp;&nbsp;<u>Mutilated, Destroyed, Lost and Stolen Securities</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If (i) any mutilated Security is surrendered to the Trustee at its Corporate Trust Office or (ii) the Company and the Trustee receive evidence to their satisfaction of the destruction, loss or theft of any Security, and there is delivered to the Company and the Trustee security or indemnity satisfactory to them to save each of them and any Paying Agent harmless, and neither the Company nor the Trustee receives notice that such Security has been acquired by a protected purchaser, then the Company shall execute and upon Company Order the Trustee shall authenticate and deliver, in exchange for or in lieu of any such mutilated, destroyed, lost or stolen Security, a new Security of the same series and of like tenor, form, terms and principal amount, bearing a number not contemporaneously outstanding, that neither gain nor loss in interest shall result from such exchange or substitution.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In case any such mutilated, destroyed, lost or stolen Security has become or is about to become due and payable, the Company in its discretion may, instead of issuing a new Security, pay the amount due on such Security in accordance with its terms.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Upon the issuance of any new Security under this Section 3.07, the Company may require the payment of a sum sufficient to cover any tax or other governmental charge that may be imposed in respect thereto and any other expenses (including the fees and expenses of the Trustee) connected therewith.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Every new Security of any series issued pursuant to this Section 3.07 shall constitute an original additional contractual obligation of the Company, whether or not the mutilated, destroyed, lost or stolen Security shall be at any time enforceable by anyone, and shall be entitled to all the benefits of this Indenture equally and proportionately with any and all other Securities of that series duly issued hereunder.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The provisions of this Section 3.07 are exclusive and shall preclude (to the extent lawful) all other rights and remedies with respect to the replacement or payment of mutilated, destroyed, lost or stolen Securities.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Section 3.08&nbsp;&nbsp;&nbsp;&nbsp;<u>Payment of Interest; Interest Rights Preserved</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest on any Security that is payable and is punctually paid or duly provided for on any Interest Payment Date shall be paid to the Person in whose name such Security (or one or more Predecessor Securities) is registered at the close of business on the Record Date for such interest notwithstanding the cancellation of such Security upon any transfer or exchange subsequent to the Record Date.&nbsp;&nbsp;Payment of interest on Securities shall be made at the Corporate Trust Office (except as otherwise specified pursuant to Section 3.01) or, at the option of the Company, by check mailed to the address of the Person entitled thereto as such address shall appear in the Register or, in accordance with arrangements satisfactory to the Trustee, by wire transfer to an account designated by the Holder.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any interest on any Security that is payable but is not punctually paid or duly provided for on any Interest Payment Date (herein called &#8220;Defaulted Interest&#8221;) shall forthwith cease to be payable to the Holder on the relevant Record Date by virtue of his, her or its having been such a Holder, and such Defaulted Interest may be paid by the Company, at its election in each case, as provided in Section 3.08(b)(i) or (ii):</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company may elect to make payment of any Defaulted Interest to the Persons in whose names such Securities (or their respective Predecessor Securities) are registered at the close of business on a special record date for the payment of such Defaulted Interest (a &#8220;Special Record Date&#8221;), which shall be fixed in the following manner.&nbsp;&nbsp;The Company shall notify the Trustee in writing of the amount of Defaulted Interest proposed to be paid on each such Security and the date of the proposed payment, and at the same time the Company shall deposit with the Trustee an amount of money equal to the aggregate amount proposed to be paid in respect of such Defaulted Interest or shall make arrangements satisfactory to the Trustee for such deposit prior to the date of the proposed payment, such money when deposited to be held in trust for the benefit of the Persons entitled to such Defaulted Interest as provided in this Section 3.08(b)(i).&nbsp;&nbsp;Thereupon the Trustee shall fix a Special Record Date for the payment of such Defaulted Interest which shall be not more than 15 calendar days and not less than 10 calendar days prior to the date of the proposed payment and not less than 10 calendar days after the receipt by the Trustee of the notice of the proposed payment.&nbsp;&nbsp;The Trustee shall promptly notify the Company of such Special Record Date and, in the name and at the expense of the Company, shall cause notice of the proposed payment of such Defaulted Interest and the Special Record Date therefor to be mailed, first-class postage prepaid, to the Holders of such Securities at their addresses as they appear in the Register, not less than 10 calendar days prior to such Special Record Date.&nbsp;&nbsp;Notice of the proposed payment of such Defaulted Interest and the Special Record Date therefor having been mailed as aforesaid, such Defaulted Interest shall be paid to the Persons in whose names such Securities (or their respective Predecessor Securities) are registered at the close of business on such Special Record Date and shall no longer be payable pursuant to Section 3.08(b)(ii).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company may make payment of any Defaulted Interest on Securities in any other lawful manner not inconsistent with the requirements of any securities exchange on which such Securities may be listed, and upon such notice as may be required by such exchange, if, after notice given by the Company to the Trustee of the proposed payment pursuant to this clause, such manner of payment shall be deemed practicable by the Trustee.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject to the provisions set forth herein relating to Record Dates, each Security delivered pursuant to any provision of this Indenture in exchange or substitution for, or upon registration of transfer of, any other Security shall carry all the rights to interest accrued and unpaid, and to accrue, which were carried by such other Security.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 3.09&nbsp;&nbsp;&nbsp;&nbsp;<u>Cancellation</u>.&nbsp; Unless otherwise specified pursuant to Section 3.01 for Securities of any series, all Securities surrendered for payment, redemption, registration of transfer or exchange or credit against any sinking fund or otherwise shall, if surrendered to any Person other than the Trustee, be delivered to the Trustee for cancellation and shall be promptly canceled by it and, if surrendered to the Trustee, shall be promptly canceled by it.&nbsp;&nbsp;The Company may at any time deliver to the Trustee for cancellation any Securities previously authenticated and delivered hereunder that the Company may have acquired in any manner whatsoever, and all Securities so delivered shall be promptly canceled by the Trustee.&nbsp;&nbsp;No Securities shall be authenticated in lieu of or in exchange for any Securities canceled as provided in this Section 3.09, except as expressly permitted by this Indenture.&nbsp;&nbsp;The Trustee shall dispose of all canceled Securities held by it in accordance with its then customary procedures and deliver a certificate of such disposal to the Company upon its request therefor.&nbsp;&nbsp;The acquisition of any Securities by the Company shall not operate as a redemption or satisfaction of the Indebtedness represented thereby unless and until such Securities are surrendered to the Trustee for cancellation.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 3.10&nbsp;&nbsp;&nbsp;&nbsp;<u>Computation of Interest</u>.&nbsp; Except as otherwise specified pursuant to Section 3.01 for Securities of any series, interest on the Securities of each series shall be computed on the basis of a 360-day year of twelve 30-day months.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Section 3.11&nbsp;&nbsp;&nbsp;&nbsp;<u>Currency of Payments in Respect of Securities</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except as otherwise specified pursuant to Section 3.01 for Securities of any series, payment of the principal of and premium, if any, and interest on Securities of such series will be made in U.S. Dollars.&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For purposes of any provision of the Indenture where the Holders of Outstanding Securities may perform an action that requires that a specified percentage of the Outstanding Securities of all series perform such action and for purposes of any decision or determination by the Trustee of amounts due and unpaid for the principal of and premium, if any, and interest on the Securities of all series in respect of which moneys are to be disbursed ratably, the principal of and premium, if any, and interest on the Outstanding Securities denominated in a Foreign Currency will be the amount in U.S. Dollars based upon exchange rates, determined as specified pursuant to Section 3.01 for Securities of such series, as of the date for determining whether the Holders entitled to perform such action have performed it or as of the date of such decision or determination by the Trustee, as the case may be.&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any decision or determination to be made regarding exchange rates shall be made by an agent appointed by the Company; provided, that such agent shall accept such appointment in writing and the terms of such appointment shall, in the opinion of the Company at the time of such appointment, require such agent to make such determination by a method consistent with the method provided pursuant to Section 3.01 for the making of such decision or determination.&nbsp;&nbsp;All decisions and determinations of such agent regarding exchange rates shall, in the absence of manifest error, be conclusive for all purposes and irrevocably binding upon the Company, the Trustee and all Holders of the Securities.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 3.12&nbsp;&nbsp;&nbsp;&nbsp;<u>Judgments</u>.&nbsp; The Company may provide pursuant to Section 3.01 for Securities of any series that (a) the obligation, if any, of the Company to pay the principal of, premium, if any, and interest on the Securities of any series in a Foreign Currency or U.S. Dollars (the &#8220;Designated Currency&#8221;) as may be specified pursuant to Section 3.01 is of the essence and agrees that, to the fullest extent possible under applicable law, judgments in respect of such Securities shall be given in the Designated Currency; (b) the obligation of the Company to make payments in the Designated Currency of the principal of and premium, if any, and interest on such Securities shall, notwithstanding any payment in any other Currency (whether pursuant to a judgment or otherwise), be discharged only to the extent of the amount in the Designated Currency that the Holder receiving such payment may, in accordance with normal banking procedures, purchase with the sum paid in such other Currency (after any premium and cost of exchange) on the business day in the country of issue of the Designated Currency or in the international banking community (in the case of a composite currency) immediately following the day on which such Holder receives such payment; (c) if the amount in the Designated Currency that may be so purchased for any reason falls short of the amount originally due, the Company shall pay such additional amounts as may be necessary to compensate for such shortfall; and (d) any obligation of the Company not discharged by such payment shall be due as a separate and independent obligation and, until discharged as provided herein, shall continue in full force and effect.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 3.13&nbsp;&nbsp;&nbsp;&nbsp;<u>CUSIP Numbers</u>.&nbsp; The Company in issuing any Securities may use CUSIP, ISIN or other similar numbers, if then generally in use, and thereafter with respect to such series, the Trustee may use such numbers in any notice of redemption or exchange with respect to such series provided that any such notice may state that no representation is made as to the correctness of such numbers either as printed on the Securities or as contained in any notice of a redemption and that reliance may be placed only on the other identification numbers printed on the Securities, and any such redemption shall not be affected by any defect in or omission of such numbers.&nbsp;&nbsp;The Company will promptly notify the Trustee in writing of any change in the CUSIP, ISIN or other similar numbers.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>ARTICLE IV</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><u>REDEMPTION OF SECURITIES</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 4.01&nbsp;&nbsp;&nbsp;&nbsp;<u>Applicability of Right of Redemption</u>. Redemption of Securities (other than pursuant to a sinking fund, amortization or analogous provision) permitted by the terms of any series of Securities shall be made (except as otherwise specified pursuant to Section 3.01 for Securities of any series) in accordance with this Article; provided, however, that if any such terms of a series of Securities shall conflict with any provision of this Article, the terms of such series shall govern.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Section 4.02&nbsp;&nbsp;&nbsp;&nbsp;<u>Selection of Securities to be Redeemed</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If the Company shall at any time elect to redeem all or any portion of the Securities of a series then Outstanding, it shall at least 30 days prior to the Redemption Date fixed by the Company (unless a shorter period shall be satisfactory to the Trustee) notify the Trustee of such Redemption Date and of the principal amount of Securities to be redeemed, and thereupon the Trustee shall select, by lot or in such other manner as the Trustee shall deem appropriate and which may provide for the selection for redemption of a portion of the principal amount of any Security of such series; provided that the unredeemed portion of the principal amount of any Security shall be in an authorized denomination (which shall not be less than the minimum authorized denomination) for such Security.&nbsp;&nbsp;In any case where more than one Security of such series is registered in the same name, the Trustee may treat the aggregate principal amount so registered as if it were represented by one Security of such series.&nbsp;&nbsp;The Trustee shall, as soon as practicable, notify the Company in writing of the Securities and portions of Securities so selected.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For all purposes of this Indenture, unless the context otherwise requires, all provisions relating to the redemption of Securities shall relate, in the case of any Security redeemed or to be redeemed only in part, to the portion of the principal amount of such Security that has been or is to be redeemed.&nbsp;&nbsp;If the Company shall so direct, Securities registered in the name of the Company, any Affiliate or any Subsidiary thereof shall not be included in the Securities selected for redemption.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Section 4.03&nbsp;&nbsp;&nbsp;&nbsp;<u>Notice of Redemption</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notice of redemption shall be given by the Company or, at the Company&#8217;s request, by the Trustee in the name and at the expense of the Company, not less than 30 nor more than 60 days prior to the Redemption Date (unless a shorter period shall be satisfactory to the Trustee and, in the case of a redemption in connection with a defeasance or discharge under Article XII or otherwise, such period may be longer than 60 days), to the Holders of Securities of any series to be redeemed in whole or in part pursuant to this Article, in the manner provided in Section 16.04.&nbsp;&nbsp;Any notice so given shall be conclusively presumed to have been duly given, whether or not the Holder receives such notice.&nbsp;&nbsp;Failure to give such notice, or any defect in such notice to the Holder of any Security of a series designated for redemption, in whole or in part, shall not affect the sufficiency of any notice of redemption with respect to the Holder of any other Security of such series.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All notices of redemption shall identify the Securities to be redeemed (including CUSIP, ISIN or other similar numbers, if available) and shall state:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;such election by the Company to redeem Securities of such series pursuant to provisions contained in this Indenture or the terms of the Securities of such series or a supplemental indenture establishing such series, if such be the case;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the Redemption Date;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the Redemption Price;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;if less than all Outstanding Securities of any series are to be redeemed, the identification (and, in the case of partial redemption, the principal amounts) of the Securities of such series to be redeemed;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;that on the Redemption Date the Redemption Price will become due and payable upon each such Security to be redeemed, and that, if applicable, interest thereon shall cease to accrue on and after said date;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(vi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the Place or Places of Payment where such Securities are to be surrendered for payment of the Redemption Price; and</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(vii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;that the redemption is for a sinking fund, if such is the case;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 4.04&nbsp;&nbsp;&nbsp;&nbsp;<u>Deposit of Redemption Price</u>.&nbsp;&nbsp;On or prior to 11:00 a.m., New York City time, on the Redemption Date for any Securities, the Company shall deposit with the Trustee or with a Paying Agent (or, if the Company is acting as its own Paying Agent, segregate and hold in trust as provided in Section 6.03) an amount of money in the Currency in which such Securities are denominated (except as provided pursuant to Section 3.01) sufficient to pay the Redemption Price of such Securities or any portions thereof that are to be redeemed on that date.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 4.05&nbsp;&nbsp;&nbsp;&nbsp;<u>Securities Payable on Redemption Date</u>.&nbsp; Notice of redemption having been given as aforesaid, any Securities to be redeemed shall, on the Redemption Date, become due and payable at the Redemption Price and from and after such date (unless the Company shall Default in the payment of the Redemption Price) such Securities shall cease to bear interest.&nbsp;&nbsp;Upon surrender of any such Security for redemption in accordance with said notice, such Security shall be paid by the Company at the Redemption Price; provided, however, that (unless otherwise provided pursuant to Section 3.01) installments of interest that have a Stated Maturity on or prior to the Redemption Date for such Securities shall be payable according to the terms of such Securities and the provisions of Section 3.08.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">If any Security called for redemption shall not be so paid upon surrender thereof for redemption, the principal thereof and premium, if any, thereon shall, until paid, bear interest from the Redemption Date at the rate prescribed therefor in the Security.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 4.06&nbsp;&nbsp;&nbsp;&nbsp;<u>Securities Redeemed in Part</u>.&nbsp;&nbsp;Any Security that is to be redeemed only in part shall be surrendered at the Corporate Trust Office or such other office or agency of the Company as is specified pursuant to Section 3.01 with, if the Company, the Registrar or the Trustee so requires, due endorsement by, or a written instrument of transfer in form satisfactory to the Company, the Registrar and the Trustee duly executed by the Holder thereof or his, her or its attorney duly authorized in writing, and the Company shall execute, and the Trustee shall authenticate and deliver to the Holder of such Security without service charge, a new Security or Securities of the same series, of like tenor and form, of any authorized denomination as requested by such Holder in aggregate principal amount equal to and in exchange for the unredeemed portion of the principal of the Security so surrendered; except that if a Global Security is so surrendered, the Company shall execute, and the Trustee shall authenticate and deliver to the Depositary for such Global Security, without service charge, a new Global Security in a denomination equal to and in exchange for the unredeemed portion of the principal of the Global Security so surrendered.&nbsp;&nbsp;In the case of a Security providing appropriate space for such notation, at the option of the Holder thereof, the Trustee, in lieu of delivering a new Security or Securities as aforesaid, may make a notation on such Security of the payment of the redeemed portion thereof.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>ARTICLE V</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><u>SINKING FUNDS</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Section 5.01&nbsp;&nbsp;&nbsp;&nbsp;<u>Applicability of Sinking Fund</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Redemption of Securities permitted or required pursuant to a sinking fund for the retirement of Securities of a series by the terms of such series of Securities shall be made in accordance with such terms of such series of Securities and this Article, except as otherwise specified pursuant to Section 3.01 for Securities of such series, provided, however, that if any such terms of a series of Securities shall conflict with any provision of this Article, the terms of such series shall govern.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The minimum amount of any sinking fund payment provided for by the terms of Securities of any series is herein referred to as a &#8220;Mandatory Sinking Fund Payment,&#8221; and any payment in excess of such minimum amount provided for by the terms of Securities of any series is herein referred to as an &#8220;Optional Sinking Fund Payment.&#8221;&nbsp;&nbsp;If provided for by the terms of Securities of any series, the cash amount of any Mandatory Sinking Fund Payment may be subject to reduction as provided in Section 5.02.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 5.02&nbsp;&nbsp;&nbsp;&nbsp;<u>Mandatory Sinking Fund Obligation</u>.&nbsp;&nbsp; The Company may, at its option, satisfy any Mandatory Sinking Fund Payment obligation, in whole or in part, with respect to a particular series of Securities by (a) delivering to the Trustee Securities of such series in transferable form theretofore purchased or otherwise acquired by the Company or redeemed at the election of the Company pursuant to Section 4.03 or (b) receiving credit for Securities of such series (not previously so credited) acquired by the Company and theretofore delivered to the Trustee.&nbsp;&nbsp;The Trustee shall credit such Mandatory Sinking Fund Payment obligation with an amount equal to the Redemption Price specified in such Securities for redemption through operation of the sinking fund and the amount of such Mandatory Sinking Fund Payment shall be reduced accordingly.&nbsp;&nbsp;If the Company shall elect to so satisfy any Mandatory Sinking Fund Payment obligation, it shall deliver to the Trustee not less than 45 days prior to the relevant sinking fund payment date an Officer&#8217;s Certificate, which shall designate the Securities (and portions thereof, if any) so delivered or credited and which shall be accompanied by such Securities (to the extent not theretofore delivered) in transferable form.&nbsp;&nbsp;In case of the failure of the Company, at or before the time so required, to give such notice and deliver such Securities the Mandatory Sinking Fund Payment obligation shall be paid entirely in moneys.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 5.03&nbsp;&nbsp;&nbsp;&nbsp;<u>Optional Redemption at Sinking Fund Redemption Price</u>.&nbsp;&nbsp;In addition to the sinking fund requirements of Section 5.02, to the extent, if any, provided for by the terms of a particular series of Securities, the Company may, at its option, make an Optional Sinking Fund Payment with respect to such Securities.&nbsp;&nbsp;Unless otherwise provided by such terms, (a) to the extent that the right of the Company to make such Optional Sinking Fund Payment shall not be exercised in any year, it shall not be cumulative or carried forward to any subsequent year, and (b) such optional payment shall operate to reduce the amount of any Mandatory Sinking Fund Payment obligation as to Securities of the same series.&nbsp;&nbsp;If the Company intends to exercise its right to make such optional payment in any year it shall deliver to the Trustee not less than 45 days prior to the relevant sinking fund payment date an Officer&#8217;s Certificate stating that the Company will exercise such optional right, and specifying the amount which the Company will pay on or before the next succeeding sinking fund payment date.&nbsp;&nbsp;Such Officer&#8217;s Certificate shall also state that no Event of Default has occurred and is continuing.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Section 5.04&nbsp;&nbsp;&nbsp;&nbsp;<u>Application of Sinking Fund Payment</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If the sinking fund payment or payments made in funds pursuant to either Section 5.02 or 5.03 with respect to a particular series of Securities plus any unused balance of any preceding sinking fund payments made in funds with respect to such series shall exceed $50,000 (or a lesser sum if the Company shall so request, or such equivalent sum for Securities denominated other than in U.S. Dollars), it shall be applied by the Trustee on the sinking fund payment date next following the date of such payment, unless the date of such payment shall be a sinking fund payment date, in which case such payment shall be applied on such sinking fund payment date, to the redemption of Securities of such series at the redemption price specified pursuant to Section 4.03(b).&nbsp;&nbsp;The Trustee shall select, in the manner provided in Section 4.02, for redemption on such sinking fund payment date, a sufficient principal amount of Securities of such series to absorb said funds, as nearly as may be, and shall, at the expense and in the name of the Company, thereupon cause notice of redemption of the Securities to be given in substantially the manner provided in Section 4.03(a) for the redemption of Securities in part at the option of the Company, except that the notice of redemption shall also state that the Securities are being redeemed for the sinking fund.&nbsp;&nbsp;Any sinking fund moneys not so applied by the Trustee to the redemption of Securities of such series shall be added to the next sinking fund payment received in funds by the Trustee and, together with such payment, shall be applied in accordance with the provisions of this Section 5.04.&nbsp;&nbsp;Any and all sinking fund moneys held by the Trustee on the last sinking fund payment date with respect to Securities of such series, and not held for the payment or redemption of particular Securities of such series, shall be applied by the Trustee to the payment of the principal of the Securities of such series at Maturity.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On or prior to each sinking fund payment date, the Company shall pay to the Trustee a sum equal to all interest accrued to but not including the date fixed for redemption on Securities to be redeemed on such sinking fund payment date pursuant to this Section 5.04.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Trustee shall not redeem any Securities of a series with sinking fund moneys or mail any notice of redemption of Securities of such series by operation of the sinking fund during the continuance of a Default in payment of interest on any Securities of such series or of any Event of Default (other than an Event of Default occurring as a consequence of this Section 5.04) of which a Responsible Officer of the Trustee has actual knowledge, except that if the notice of redemption of any Securities of such series shall theretofore have been mailed in accordance with the provisions hereof, the Trustee shall redeem such Securities if funds sufficient for that purpose shall be deposited with the Trustee in accordance with the terms of this Article V.&nbsp;&nbsp;Except as aforesaid, any moneys in the sinking fund at the time any such Default or Event of Default shall occur and any moneys thereafter paid into the sinking fund shall, during the continuance of such Default or Event of Default, be held as security for the payment of all the Securities of such series; provided, however, that in case such Default or Event of Default shall have been cured or waived as provided herein, such moneys shall thereafter be applied on the next sinking fund payment date on which such moneys are required to be applied pursuant to the provisions of this Section 5.04.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>ARTICLE VI</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><u>PARTICULAR COVENANTS OF THE COMPANY</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The Company hereby covenants and agrees as follows:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 6.01&nbsp;&nbsp;&nbsp;&nbsp;<u>Payments of Securities</u>.&nbsp;&nbsp; The Company will duly and punctually pay the principal of and premium, if any, on each series of Securities, and the interest which shall have accrued thereon, at the dates and place and in the manner provided in the Securities and in this Indenture.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Section 6.02&nbsp;&nbsp;&nbsp;&nbsp;<u>Paying Agent</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company will maintain in each Place of Payment for any series of Securities, if any, an office or agency where Securities may be presented or surrendered for payment, where Securities of such series may be surrendered for registration of transfer or exchange and where notices and demands to or upon the Company in respect of the Securities and this Indenture may be served (the &#8220;Paying Agent&#8221;).&nbsp;&nbsp;The Company will give prompt written notice to the Trustee of the location, and any change in the location, of such office or agency.&nbsp;&nbsp;If at any time the Company shall fail to maintain any such required office or agency or shall fail to furnish the Trustee with the address thereof, such presentations, surrenders, notices and demands may be made or served at the Corporate Trust Office of the Trustee, and the Company hereby appoints the Trustee as Paying Agent to receive all presentations, surrenders, notices and demands.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company may also from time to time designate different or additional offices or agencies where the Securities of any series may be presented or surrendered for any or all such purposes (in or outside of such Place of Payment), and may from time to time rescind any such designations; provided, however, that no such designation or rescission shall in any manner relieve the Company of its obligations described in Section 6.02(a).&nbsp;&nbsp;The Company will give prompt written notice to the Trustee of any such additional designation or rescission of designation and of any change in the location of any such different or additional office or agency.&nbsp;&nbsp;The Company shall enter into an appropriate agency agreement with any Paying Agent not a party to this Indenture.&nbsp;&nbsp;The agreement shall implement the provisions of this Indenture that relate to such agent.&nbsp;&nbsp;The Company shall notify the Trustee of the name and address of each such agent.&nbsp;&nbsp;The Company or any Affiliate thereof may act as Paying Agent.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Section 6.03&nbsp;&nbsp;&nbsp;&nbsp;<u>To Hold Payment in Trust</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If the Company or an Affiliate thereof shall at any time act as Paying Agent with respect to any series of Securities, then, on or before the date on which the principal of and premium, if any, or interest on any of the Securities of that series by their terms or as a result of the calling thereof for redemption shall become payable, the Company or such Affiliate will segregate and hold in trust for the benefit of the Holders of such Securities or the Trustee a sum sufficient to pay such principal and premium, if any, or interest which shall have so become payable until such sums shall be paid to such Holders or otherwise disposed of as herein provided, and will notify the Trustee of its action or failure to act in that regard.&nbsp;&nbsp;Upon any proceeding under any federal bankruptcy laws with respect to the Company or any Affiliate thereof, if the Company or such Affiliate is then acting as Paying Agent, the Trustee shall replace the Company or such Affiliate as Paying Agent.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If the Company shall appoint, and at the time have, a Paying Agent for the payment of the principal of and premium, if any, or interest on any series of Securities, then prior to 11:00 a.m., New York City time, on the date on which the principal of and premium, if any, or interest on any of the Securities of that series shall become payable as aforesaid, whether by their terms or as a result of the calling thereof for redemption, the Company will deposit with such Paying Agent a sum sufficient to pay such principal and premium, if any, or interest, such sum to be held in trust for the benefit of the Holders of such Securities or the Trustee, and (unless such Paying Agent is the Trustee), the Company or any other obligor of such Securities will promptly notify the Trustee of its payment or failure to make such payment.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If the Paying Agent shall be other than the Trustee, the Company will cause such Paying Agent to execute and deliver to the Trustee an instrument in which such Paying Agent shall agree with the Trustee, subject to the provisions of this Section 6.03, that such Paying Agent shall:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;hold all moneys held by it for the payment of the principal of and premium, if any, or interest on the Securities of that series in trust for the benefit of the Holders of such Securities until such sums shall be paid to such Holders or otherwise disposed of as herein provided;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;give to the Trustee notice of any Default by the Company or any other obligor upon the Securities of that series in the making of any payment of the principal of and premium, if any, or interest on the Securities of that series; and</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;at any time during the continuance of any such Default, upon the written request of the Trustee, pay to the Trustee all sums so held in trust by such Paying Agent.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Anything in this Section 6.03 to the contrary notwithstanding, the Company may at any time, for the purpose of obtaining a release, satisfaction or discharge of this Indenture or for any other reason, pay or cause to be paid to the Trustee all sums held in trust by the Company or by any Paying Agent other than the Trustee as required by this Section 6.03, such sums to be held by the Trustee upon the same trusts as those upon which such sums were held by the Company or such Paying Agent.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any money deposited with the Trustee or any Paying Agent, or then held by the Company, in trust for the payment of the principal of and premium, if any, or interest on any Security of any series and remaining unclaimed for two years after such principal and premium, if any, or interest has become due and payable shall be paid to the Company upon Company Order along with any interest that has accumulated thereon as a result of such money being invested at the direction of the Company, or (if then held by the Company) shall be discharged from such trust, and the Holder of such Security shall thereafter, as an unsecured general creditor, look only to the Company for payment of such amounts without interest thereon, and all liability of the Trustee or such Paying Agent with respect to such trust money, and all liability of the Company as trustee thereof, shall thereupon cease; provided, however, that the Trustee or such Paying Agent before being required to make any such repayment, may at the expense of the Company cause to be published once, in a newspaper published in the English language, customarily published on each Business Day and of general circulation in The City of New York, notice that such money remains unclaimed and that, after a date specified therein, which shall not be less than 30 days from the date of such publication, any unclaimed balance of such money then remaining will be repaid to the Company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 6.04&nbsp;&nbsp;&nbsp;&nbsp;<u>Merger, Consolidation and Sale of Assets</u>.&nbsp;&nbsp;Except as otherwise provided as contemplated by Section 3.01 with respect to any series of Securities:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company will not consolidate with any other entity or accept a merger of any other entity into the Company or permit the Company to be merged into any other entity, or sell other than for cash or lease all or substantially all its assets to another entity, or purchase all or substantially all the assets of another entity, unless (i) either the Company shall be the continuing entity, or the successor, transferee or lessee entity (if other than the Company) shall expressly assume, by indenture supplemental hereto, executed and delivered by such entity prior to or simultaneously with such consolidation, merger, sale or lease, the due and punctual payment of the principal of and interest and premium, if any, on all the Securities, according to their tenor, and the due and punctual performance and observance of all other obligations to the Holders and the Trustee under this Indenture or under the Securities to be performed or observed by the Company; and (ii) immediately after such consolidation, merger, sale, lease or purchase the Company or the successor, transferee or lessee entity (if other than the Company) would not be in Default in the performance of any covenant or condition of this Indenture.&nbsp;&nbsp;A purchase by a Subsidiary of all or substantially all of the assets of another entity shall not be deemed to be a purchase of such assets by the Company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Upon any consolidation with or merger into any other entity, or any sale other than for cash, or any conveyance or lease of all or substantially all of the assets of the Company in accordance with this Section 6.04, the successor entity formed by such consolidation or into or with which the Company is merged or to which the Company is sold or to which such conveyance, transfer or lease is made shall succeed to, and be substituted for, and may exercise every right and power of, the Company under this Indenture with the same effect as if such successor entity had been named as the Company herein, and thereafter, except in the case of a lease, the predecessor Company shall be relieved of all obligations and covenants under this Indenture and the Securities, and from time to time such entity may exercise each and every right and power of the Company under this Indenture, in the name of the Company, or in its own name; and any act or proceeding by any provision of this Indenture required or permitted to be done by the Board of Directors or any officer of the Company may be done with like force and effect by the like board or officer of any entity that shall at the time be the successor of the Company hereunder.&nbsp;&nbsp;In the event of any such sale or conveyance, but not any such lease, the Company (or any successor entity which shall theretofore have become such in the manner described in this Section 6.04) shall be discharged from all obligations and covenants under this Indenture and the Securities and may thereupon be dissolved and liquidated.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 6.05&nbsp;&nbsp;&nbsp;&nbsp;<u>Compliance Certificate</u>.&nbsp;&nbsp;Except as otherwise provided as contemplated by Section 3.01 with respect to any series of Securities, the Company shall furnish to the Trustee annually, within 120 days after the end of each fiscal year, a brief certificate from the principal executive officer, principal financial officer, principal accounting officer and/or treasurer as to his or her knowledge of the Company&#8217;s compliance with all conditions and covenants under this Indenture (which compliance shall be determined without regard to any period of grace or requirement of notice provided under this Indenture) and, in the event of any Default, specifying each such Default and the nature and status thereof of which such person may have knowledge.&nbsp;&nbsp;Such certificates need not comply with Section 16.01 of this Indenture.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 6.06&nbsp;&nbsp;&nbsp;&nbsp;<u>Conditional Waiver by Holders of Securities</u>.&nbsp;&nbsp;Anything in this Indenture to the contrary notwithstanding, the Company may fail or omit in any particular instance to comply with a covenant or condition set forth herein with respect to any series of Securities if the Company shall have obtained and filed with the Trustee, prior to the time of such failure or omission, evidence (as provided in Article VIII) of the consent of the Holders of a majority in aggregate principal amount of the Securities of such series at the time Outstanding, either waiving such compliance in such instance or generally waiving compliance with such covenant or condition, but no such waiver shall extend to or affect such covenant or condition except to the extent so expressly waived, or impair any right consequent thereon and, until such waiver shall have become effective, the obligations of the Company and the duties of the Trustee in respect of any such covenant or condition shall remain in full force and effect.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 6.07&nbsp;&nbsp;&nbsp;&nbsp;<u>Statement by Officers as to Default</u>.&nbsp;&nbsp;The Company shall deliver to the Trustee as soon as possible and in any event within 30 days after the Company becomes aware of the occurrence of any Event of Default or an event which, with the giving of notice or the lapse of time or both, would constitute an Event of Default, an Officer&#8217;s Certificate setting forth the details of such Event of Default or Default and the action which the Company proposes to take with respect thereto.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>ARTICLE VII</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><u>REMEDIES OF TRUSTEE AND SECURITYHOLDERS</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 7.01&nbsp;&nbsp;&nbsp;&nbsp;<u>Events of Default</u>.&nbsp;&nbsp;Except where otherwise indicated by the context or where the term is otherwise defined for a specific purpose, the term &#8220;Event of Default&#8221; as used in this Indenture with respect to Securities of any series shall mean one of the following described events unless it is either inapplicable to a particular series or it is specifically deleted or modified in the manner contemplated in Section 3.01:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the failure of the Company to pay any installment of interest on any Security of such series when and as the same shall become payable, which failure shall have continued unremedied for a period of 90 days;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the failure of the Company to pay the principal of (and premium, if any, on) any Security of such series, when and as the same shall become payable, whether at Maturity as therein expressed, by call for redemption (otherwise than pursuant to a sinking fund), by declaration as authorized by this Indenture or otherwise;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the failure of the Company to pay a sinking fund installment, if any, when and as the same shall become payable by the terms of a Security of such series;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the failure of the Company, subject to the provisions of Section 6.06, to perform any covenants or agreements contained in this Indenture (including any indenture supplemental hereto pursuant to which the Securities of such series were issued as contemplated by Section 3.01) (other than a covenant or agreement which has been expressly included in this Indenture solely for the benefit of a series of Securities other than that series and other than a covenant or agreement a default in the performance of which is elsewhere in this Section 7.01 specifically addressed), which failure shall not have been remedied, or without provision deemed to be adequate for the remedying thereof having been made, for a period of 90 days after written notice shall have been given to the Company by the Trustee or shall have been given to the Company and the Trustee by Holders of 25% or more in aggregate principal amount of the Securities of such series then Outstanding, specifying such failure, requiring the Company to remedy the same and stating that such notice is a &#8220;Notice of Default&#8221; hereunder;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the entry by a court having jurisdiction in the premises of a decree or order for relief in respect of the Company in an involuntary case under the federal bankruptcy laws, as now or hereafter constituted, or any other applicable federal or state bankruptcy, insolvency or other similar law now or hereafter in effect, or appointing a receiver, liquidator, assignee, custodian, trustee or sequestrator (or similar official) of the Company or of substantially all the property of the Company or ordering the winding-up or liquidation of its affairs and such decree or order shall remain unstayed and in effect for a period of 90 consecutive days;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the commencement by the Company of a voluntary case under the federal bankruptcy laws, as now or hereafter constituted, or any other applicable federal or state bankruptcy, insolvency or other similar law now or hereafter in effect, or the consent by the Company to the entry of an order for relief in an involuntary case under any such law, or the consent by the Company to the appointment of or taking possession by a receiver, liquidator, assignee, trustee, custodian or sequestrator (or similar official) of the Company or of substantially all the property of the Company or the making by it of an assignment for the benefit of creditors or the admission by it in writing of its inability to pay its debts generally as they become due, or the taking of corporate action by the Company in furtherance of any action; or</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the occurrence of any other Event of Default with respect to Securities of such series as provided in Section 3.01;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">provided, however, that no event described in Section 7.01(d) or (other than with respect to a payment default) Section 7.01(g) shall constitute an Event of Default hereunder until a Responsible Officer of the Trustee&#8217;s has actual knowledge thereof or until a written notice of any such event is received by the Trustee at the Corporate Trust Office, and such notice refers to the facts underlying such event, the Securities generally, the Company and the Indenture.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Notwithstanding the foregoing provisions of this Section 7.01, to the extent elected by the Company, the sole remedy for an Event of Default relating to the failure to comply with the reporting obligations specified in Section 10.02, and for any failure to comply with the requirements of &#167; 314(a)(1) of the TIA, shall for the first 60 days after the occurrence of such an Event of Default consist exclusively of the right to receive additional interest on the Securities at an annual rate equal to 0.25% of the principal amount of the Securities. The additional interest will accrue on all outstanding Securities from and including the date on which an Event of Default relating to a failure to comply with the reporting obligations specified in Section 10.02 first occurs to but not including the 60th day thereafter (or such earlier date on which the Event of Default relating to the reporting obligations shall have been cured or waived). On such 60th day (or earlier, if the Event of Default relating to the reporting obligations is cured or waived prior to such 60th day), such additional interest will cease to accrue and, if the Event of Default relating to the reporting obligations has not been cured or waived prior to such 60th day, the Securities shall be subject to an acceleration of maturity as provided in Section 7.02(a).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The provisions of the immediately preceding paragraph will not affect the rights of Holders in the event of the occurrence of any other Event of Default; provided, however, that in no event will the rate of additional interest accruing pursuant to the immediately preceding paragraph at any time exceed 1.00% per annum, in the aggregate. In the event the Company does not elect to pay additional interest upon an Event of Default in accordance with the immediately preceding paragraph, the Securities shall be subject to an acceleration of maturity as provided in Section 7.02(a). If the Company elects to pay additional interest as the sole remedy for an Event of Default relating to the failure to comply with the reporting obligations specified in Section 10.02, and for any failure to comply with the requirements of &#167; 314(a)(1) of the TIA in accordance with the immediately preceding paragraph, the Company shall notify all Holders and the Trustee and Paying Agent of such election on or before the close of business on the date on which such Event of Default first occurs.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Notwithstanding the foregoing provisions of this Section 7.01, if the principal or any premium or interest on any Security is payable in a Currency other than U.S. Dollars and such Currency is not available to the Company for making payment thereof due to the imposition of exchange controls or other circumstances beyond the control of the Company, the Company will be entitled to satisfy its obligations to Holders of the Securities by making such payment in U.S. Dollars in an amount equal to U.S. Dollars equivalent of the amount payable in such other Currency, as determined by the Company&#8217;s agent in accordance with Section 3.11(c) hereof by reference to the noon buying rate in The City of New York for cable transfers for such Currency (&#8220;Exchange Rate&#8221;), as such Exchange Rate is reported or otherwise made available by the Federal Reserve Bank of New York on the date of such payment, or, if such rate is not then available, on the basis of the most recently available Exchange Rate.&nbsp;&nbsp;Notwithstanding the foregoing provisions of this Section 7.01, any payment made under such circumstances in U.S. Dollars where the required payment is in a Currency other than U.S. Dollars will not constitute an Event of Default under this Indenture.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Section 7.02&nbsp;&nbsp;&nbsp;&nbsp;<u>Acceleration; Rescission and Annulment</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except as otherwise provided as contemplated by Section 3.01 with respect to any series of Securities, if any one or more of the above-described Events of Default (other than an Event of Default specified in Section 7.01(e) or 7.01(f)) shall happen with respect to Securities of any series at the time Outstanding, then, and in each and every such case, during the continuance of any such Event of Default, the Trustee or the Holders of 25% or more in principal amount of the Securities of such series then Outstanding may declare the principal (or, if the Securities of that series are Original Issue Discount Securities, such portion of the principal amount as may be specified in the terms of that series) of and all accrued but unpaid interest, if any, on all the Securities of such series then Outstanding to be due and payable immediately by a notice in writing to the Company (and to the Trustee if given by Holders), and upon any such declaration such principal amount (or specified amount) shall become immediately due and payable.&nbsp;&nbsp;If an Event of Default specified in Section 7.01(e) or 7.01(f) occurs and is continuing, then in every such case, the principal amount of all of the Securities of that series then Outstanding shall automatically, and without any declaration or any other action on the part of the Trustee or any Holder, become due and payable immediately.&nbsp;&nbsp;Upon payment of such amounts in the Currency in which such Securities are denominated (subject to Section 7.01 and except as otherwise provided pursuant to Section 3.01), all obligations of the Company in respect of the payment of principal of and interest on the Securities of such series shall terminate.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The provisions of Section 7.02(a), however, are subject to the condition that, at any time after the principal of all the Securities of such series, to which any one or more of the above-described Events of Default is applicable, shall have been so declared to be due and payable, and before a judgment or decree for payment of the money due has been obtained by the Trustee as hereinafter provided in this Article VII, the Event of Default giving rise to such declaration of acceleration shall, without further act, be deemed to have been waived, and such declaration and its consequences shall, without further act, be deemed to have been rescinded and annulled, if:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the Company has paid or deposited with the Trustee or Paying Agent a sum in the Currency in which such Securities are denominated (subject to Section 7.01 and except as otherwise provided pursuant to Section 3.01) sufficient to pay:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(A)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;all amounts owing the Trustee and any predecessor trustee hereunder under Section 11.01(a) (provided, however, that all sums payable under this Section 7.02(b)(i)(A) shall be paid in U.S. Dollars);</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(B)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;all arrears of interest, if any, upon all the Securities of such series (with interest, to the extent that interest thereon shall be legally enforceable, on any overdue installment of interest at the rate borne by such Securities at the rate or rates prescribed therefor in such Securities); and</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(C)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the principal of and premium, if any, on any Securities of such series that have become due otherwise than by such declaration of acceleration and interest thereon; and</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;every other Default and Event of Default with respect to Securities of that series, other than the non-payment of the principal of Securities of that series which have become due solely by such declaration of acceleration, have been cured or waived as provided in Section 7.06.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No such rescission shall affect any subsequent default or impair any right consequent thereon.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For all purposes under this Indenture, if a portion of the principal of any Original Issue Discount Securities shall have been accelerated and declared due and payable pursuant to the provisions hereof, then, from and after such declaration, unless such declaration has been rescinded and annulled, the principal amount of such Original Issue Discount Securities shall be deemed, for all purposes hereunder, to be such portion of the principal thereof as shall be due and payable as a result of such acceleration, and payment of such portion of the principal thereof as shall be due and payable as a result of such acceleration, together with interest, if any, thereon and all other amounts owing thereunder, shall constitute payment in full of such Original Issue Discount Securities.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 7.03&nbsp;&nbsp;&nbsp;&nbsp;<u>Other Remedies</u>.&nbsp;&nbsp;If the Company shall fail for a period of 90 days to pay any installment of interest on the Securities of any series or shall fail to pay the principal of and premium, if any, on any of the Securities of such series when and as the same shall become due and payable, whether at Maturity, or by call for redemption (other than pursuant to the sinking fund), by declaration as authorized by this Indenture, or otherwise, or shall fail to make any required sinking fund payment as to a series of Securities when and as the same shall become due and payable, then, upon demand of the Trustee, the Company will pay to the Paying Agent for the benefit of the Holders of Securities of such series then Outstanding the whole amount which then shall have become due and payable on all the Securities of such series, with interest on the overdue principal and premium, if any, and (so far as the same may be legally enforceable) on the overdue installments of interest at the rate borne by the Securities of such series, and all amounts owing the Trustee and any predecessor trustee hereunder under Section 11.01(a).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">In case the Company shall fail forthwith to pay such amounts upon such demand, the Trustee, in its own name and as trustee of an express trust, shall be entitled and empowered to institute any action or proceeding at law or in equity for the collection of the sums so due and unpaid, and may prosecute any such action or proceeding to judgment or final decree, and may enforce any such judgment or final decree against the Company or any other obligor upon the Securities of such series, and collect the moneys adjudged or decreed to be payable out of the property of the Company or any other obligor upon the Securities of such series, wherever situated, in the manner provided by law.&nbsp;&nbsp;Every recovery of judgment in any such action or other proceeding, subject to the payment to the Trustee of all amounts owing the Trustee and any predecessor trustee hereunder under Section 11.01(a), shall be for the ratable benefit of the Holders of such series of Securities which shall be the subject of such action or proceeding.&nbsp;&nbsp;All rights of action upon or under any of the Securities or this Indenture may be enforced by the Trustee without the possession of any of the Securities and without the production of any thereof at any trial or any proceeding relative thereto.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 7.04&nbsp;&nbsp;&nbsp;&nbsp;<u>Trustee as Attorney-in-Fact</u>.&nbsp;&nbsp;The Trustee is hereby appointed, and each and every Holder of the Securities, by receiving and holding the same, shall be conclusively deemed to have appointed the Trustee, the true and lawful attorney-in-fact of such Holder, with authority to make or file (whether or not the Company shall be in Default in respect of the payment of the principal of, or interest on, any of the Securities), in its own name and as trustee of an express trust or otherwise as it shall deem advisable, in any receivership, insolvency, liquidation, bankruptcy, reorganization or other judicial proceeding relative to the Company or any other obligor upon the Securities or to their respective creditors or property, any and all claims, proofs of claim, proofs of debt, petitions, consents, other papers and documents and amendments of any thereof, as may be necessary or advisable in order to have the claims of the Trustee and any predecessor trustee hereunder and of the Holders of the Securities allowed in any such proceeding and to collect and receive any moneys or other property payable or deliverable on any such claim, and to execute and deliver any and all other papers and documents and to do and perform any and all other acts and things, as it may deem necessary or advisable in order to enforce in any such proceeding any of the claims of the Trustee and any predecessor trustee hereunder and of any of such Holders in respect of any of the Securities; and any receiver, assignee, trustee, custodian or debtor in any such proceeding is hereby authorized, and each and every taker or Holder of the Securities, by receiving and holding the same, shall be conclusively deemed to have authorized any such receiver, assignee, trustee, custodian or debtor, to make any such payment or delivery only to or on the order of the Trustee, and to pay to the Trustee any amount due it and any predecessor trustee hereunder under Section 11.01(a); provided, however, that nothing herein contained shall be deemed to authorize or empower the Trustee to consent to or accept or adopt, on behalf of any Holder of Securities, any plan of reorganization or readjustment affecting the Securities or the rights of any Holder thereof, or to authorize or empower the Trustee to vote in respect of the claim of any Holder of any Securities in any such proceeding.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 7.05&nbsp;&nbsp;&nbsp;&nbsp;<u>Priorities</u>.&nbsp;&nbsp;Any moneys or properties collected by the Trustee with respect to a series of Securities under this Article VII shall be applied in the following order, at the date or dates fixed by the Trustee for the distribution of such moneys or properties and, in the case of the distribution of such moneys or properties on account of the Securities of any series, upon presentation of the Securities of such series, and stamping thereon the payment, if only partially paid, and upon surrender thereof, if fully paid:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">First: To the payment of all amounts due to the Trustee and any predecessor trustee hereunder under Section 11.01(a).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Second: Subject to Article XV, in case the principal of the Outstanding Securities of such series shall not have become due and be unpaid, to the payment of interest on the Securities of such series, in the chronological order of the Maturity of the installments of such interest, with interest (to the extent that such interest has been collected by the Trustee) upon the overdue installments of interest at the rate borne by such Securities, such payments to be made ratably to the Persons entitled thereto.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Third: Subject to Article XV, in case the principal of the Outstanding Securities of such series shall have become due, by declaration or otherwise, to the payment of the whole amount then owing and unpaid upon the Securities of such series for principal and premium, if any, and interest, with interest on the overdue principal and premium, if any, and (to the extent that such interest has been collected by the Trustee) upon overdue installments of interest at the rate borne by the Securities of such series, and in case such moneys shall be insufficient to pay in full the whole amounts so due and unpaid upon the Securities of such series, then to the payment of such principal and premium, if any, and interest without preference or priority of principal and premium, if any, over interest, or of interest over principal and premium, if any, or of any installment of interest over any other installment of interest, or of any Security of such series over any other Security of such series, ratably to the aggregate of such principal and premium, if any, and accrued and unpaid interest.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Any surplus then remaining shall be paid to the Company or as directed by a court of competent jurisdiction.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 7.06&nbsp;&nbsp;&nbsp;&nbsp;<u>Control by Securityholders; Waiver of Past Defaults</u>.&nbsp;&nbsp;The Holders of a majority in principal amount of the Securities of any series at the time Outstanding may direct the time, method and place of conducting any proceeding for any remedy available to the Trustee hereunder, or of exercising any trust or power hereby conferred upon the Trustee with respect to the Securities of such series, provided, however, that, subject to the provisions of Sections 11.01 and 11.02, the Trustee shall have the right to decline to follow any such direction if the Trustee being advised by counsel determines that the action so directed may not lawfully be taken or would be unduly prejudicial to Holders not joining in such direction or would involve the Trustee in personal liability.&nbsp;&nbsp;Prior to any declaration accelerating the Maturity of the Securities of any series, the Holders of a majority in aggregate principal amount of such series of Securities at the time Outstanding may on behalf of the Holders of all of the Securities of such series waive any past Default or Event of Default hereunder and its consequences except a Default in the payment of interest or any premium on or the principal of the Securities of such series.&nbsp;&nbsp;Upon any such waiver the Company, the Trustee and the Holders of the Securities of such series shall be restored to their former positions and rights hereunder, respectively; but no such waiver shall extend to any subsequent or other Default or Event of Default or impair any right consequent thereon.&nbsp;&nbsp;Whenever any Default or Event of Default hereunder shall have been waived as permitted by this Section 7.06, said Default or Event of Default shall for all purposes of the Securities of such series and this Indenture be deemed to have been cured and to be not continuing.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 7.07&nbsp;&nbsp;&nbsp;&nbsp;<u>Limitation on Suits</u>.&nbsp;&nbsp;No Holder of any Security of any series shall have any right to institute any action, suit or proceeding at law or in equity for the execution of any trust hereunder or for the appointment of a receiver or for any other remedy hereunder, in each case with respect to an Event of Default with respect to such series of Securities, unless such Holder previously shall have given to the Trustee written notice of one or more of the Events of Default herein specified with respect to such series of Securities, and unless also the Holders of 25% in principal amount of the Securities of such series then Outstanding shall have requested the Trustee in writing to take action in respect of the matter complained of, and unless also there shall have been offered to the Trustee security and reasonable indemnity against the costs, expenses and liabilities to be incurred therein or thereby, and the Trustee, for 60 days after receipt of such notification, request and offer of indemnity, shall have neglected or refused to institute any such action, suit or proceeding; and such notification, request and offer of indemnity are hereby declared in every such case to be conditions precedent to any such action, suit or proceeding by any Holder of any Security of such series; it being understood and intended that no one or more of the Holders of Securities of such series shall have any right in any manner whatsoever by his, her, its or their action to enforce any right hereunder, except in the manner herein provided, and that every action, suit or proceeding at law or in equity shall be instituted, had and maintained in the manner herein provided and for the equal benefit of all Holders of the Outstanding Securities of such series; provided, however, that nothing in this Indenture or in the Securities of such series shall affect or impair the obligation of the Company, which is absolute and unconditional, to pay the principal of, premium, if any, and interest on the Securities of such series to the respective Holders of such Securities at the respective due dates in such Securities stated, or affect or impair the right, which is also absolute and unconditional, of such Holders to institute suit to enforce the payment thereof.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 7.08&nbsp;&nbsp;&nbsp;&nbsp;<u>Undertaking for Costs</u>.&nbsp;&nbsp;All parties to this Indenture and each Holder of any Security, by such Holder&#8217;s acceptance thereof, shall be deemed to have agreed that any court may in its discretion require, in any action, suit or proceeding for the enforcement of any right or remedy under this Indenture, or in any action, suit or proceeding against the Trustee for any action taken or omitted by it as Trustee, the filing by any party litigant in such action, suit or proceeding of an undertaking to pay the costs of such action, suit or proceeding, and that such court may in its discretion assess reasonable costs, including reasonable attorneys&#8217; fees and expenses, against any party litigant in such action, suit or proceeding, having due regard to the merits and good faith of the claims or defenses made by such party litigant; provided, however, that the provisions of this Section 7.08 shall not apply to any action, suit or proceeding instituted by the Trustee, to any action, suit or proceeding instituted by any one or more Holders of Securities holding in the aggregate more than 10% in principal amount of the Securities of any series Outstanding, or to any action, suit or proceeding instituted by any Holder of Securities of any series for the enforcement of the payment of the principal of or premium, if any, or the interest on, any of the Securities of such series, on or after the respective due dates expressed in such Securities.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 7.09&nbsp;&nbsp;&nbsp;&nbsp;<u>Remedies Cumulative</u>.&nbsp;&nbsp;No remedy herein conferred upon or reserved to the Trustee or to the Holders of Securities of any series is intended to be exclusive of any other remedy or remedies, and each and every remedy shall be cumulative and shall be in addition to every other remedy given hereunder or now or hereafter existing at law or in equity or by statute.&nbsp;&nbsp;No delay or omission of the Trustee or of any Holder of the Securities of any series to exercise any right or power accruing upon any Default or Event of Default shall impair any such right or power or shall be construed to be a waiver of any such Default or Event of Default or an acquiescence therein; and every power and remedy given by this Article VII to the Trustee and to the Holders of Securities of any series, respectively, may be exercised from time to time and as often as may be deemed expedient by the Trustee or by the Holders of Securities of such series, as the case may be.&nbsp;&nbsp;In case the Trustee or any Holder of Securities of any series shall have proceeded to enforce any right under this Indenture and the proceedings for the enforcement thereof shall have been discontinued or abandoned because of waiver or for any other reason or shall have been adjudicated adversely to the Trustee or to such Holder of Securities, then and in every such case the Company, the Trustee and the Holders of the Securities of such series shall severally and respectively be restored to their former positions and rights hereunder, and thereafter all rights, remedies and powers of the Trustee and the Holders of the Securities of such series shall continue as though no such proceedings had been taken, except as to any matters so waived or adjudicated.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>ARTICLE VIII</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><u>CONCERNING THE SECURITYHOLDERS</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 8.01&nbsp;&nbsp;&nbsp;&nbsp;<u>Evidence of Action of Securityholders</u>.&nbsp;&nbsp;Whenever in this Indenture it is provided that the Holders of a specified percentage or a majority in aggregate principal amount of the Securities or of any series of Securities may take any action (including the making of any demand or request, the giving of any notice, consent or waiver or the taking of any other action), the fact that at the time of taking any such action the Holders of such specified percentage or majority have joined therein may be evidenced by (a) any instrument or any number of instruments of similar tenor executed by Securityholders in person, by an agent or by a proxy appointed in writing, including through an electronic system for tabulating consents operated by the Depositary for such series or otherwise (such action becoming effective, except as herein otherwise expressly provided, when such instruments or evidence of electronic consents are delivered to the Trustee and, where it is hereby expressly required, to the Company), or (b) by the record of the Holders of Securities voting in favor thereof at any meeting of Securityholders duly called and held in accordance with the provisions of Article IX, or (c) by a combination of such instrument or instruments and any such record of such a meeting of Securityholders.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 8.02&nbsp;&nbsp;&nbsp;&nbsp;<u>Proof of Execution or Holding of Securities</u>.&nbsp;&nbsp;Proof of the execution of any instrument by a Securityholder or his, her or its agent or proxy and proof of the holding by any Person of any of the Securities shall be sufficient if made in the following manner:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The fact and date of the execution by any Person of any such instrument may be proved (i) by the certificate of any notary public or other officer in any jurisdiction who, by the laws thereof, has power to take acknowledgments or proof of deeds to be recorded within such jurisdiction, that the Person who signed such instrument did acknowledge before such notary public or other officer the execution thereof, or (ii) by the affidavit of a witness of such execution sworn to before any such notary or other officer.&nbsp;&nbsp;Where such execution is by a Person acting in other than his or her individual capacity, such certificate or affidavit shall also constitute sufficient proof of his or her authority.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The ownership of Securities of any series shall be proved by the Register of such Securities or by a certificate of the Registrar for such series.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The record of any Holders&#8217; meeting shall be proved in the manner provided in Section 9.06.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Trustee may require such additional proof of any matter referred to in this Section 8.02 as it shall deem appropriate or necessary, so long as the request is a reasonable one.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If the Company shall solicit from the Holders of Securities of any series any action, the Company may, at its option fix in advance a record date for the determination of Holders of Securities entitled to take such action, but the Company shall have no obligation to do so.&nbsp;&nbsp;Any such record date shall be fixed at the Company&#8217;s discretion.&nbsp;&nbsp;If such a record date is fixed, such action may be sought or given before or after the record date, but only the Holders of Securities of record at the close of business on such record date shall be deemed to be Holders of Securities for the purpose of determining whether Holders of the requisite proportion of Outstanding Securities of such series have authorized or agreed or consented to such action, and for that purpose the Outstanding Securities of such series shall be computed as of such record date.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 8.3&nbsp;&nbsp;&nbsp;&nbsp;<u>Persons Deemed Owners</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company, the Trustee and any agent of the Company or the Trustee may treat the Person in whose name any Security is registered as the owner of such Security for the purpose of receiving payment of principal of and premium, if any, and (subject to Section 3.08) interest, if any, on, such Security and for all other purposes whatsoever, whether or not such Security be overdue, and neither the Company, the Trustee nor any agent of the Company or the Trustee shall be affected by notice to the contrary.&nbsp;&nbsp;All payments made to any Holder, or upon his, her or its order, shall be valid, and, to the extent of the sum or sums paid, effectual to satisfy and discharge the liability for moneys payable upon such Security.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;None of the Company, the Trustee, any Paying Agent or the Registrar will have any responsibility or liability for any aspect of the records relating to or payments made on account of beneficial ownership interests in a Global Security or for maintaining, supervising or reviewing any records relating to such beneficial ownership interests.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 8.04&nbsp;&nbsp;&nbsp;&nbsp;<u>Effect of Consents</u>.&nbsp;&nbsp;After an amendment, supplement, waiver or other action becomes effective as to any series of Securities, a consent to it by a Holder of such series of Securities is a continuing consent conclusive and binding upon such Holder and every subsequent Holder of the same Securities or portion thereof, and of any Security issued upon the transfer thereof or in exchange therefor or in place thereof, even if notation of the consent is not made on any such Security.&nbsp;&nbsp;&nbsp;An amendment, supplement or waiver becomes effective in accordance with its terms and thereafter binds every Holder.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>ARTICLE IX</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><u>SECURITYHOLDERS</u></b><u>&#8217;</u><b><u> MEETINGS</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 9.01&nbsp;&nbsp;&nbsp;&nbsp;<u>Purposes of Meetings</u>.&nbsp;&nbsp;A meeting of Securityholders of any or all series may be called at any time and from time to time pursuant to the provisions of this Article IX for any of the following purposes:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to give any notice to the Company or to the Trustee, or to give any directions to the Trustee, or to consent to the waiving of any Default or Event of Default hereunder and its consequences, or to take any other action authorized to be taken by Securityholders pursuant to any of the provisions of Article VIII;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to remove the Trustee and nominate a successor trustee pursuant to the provisions of Article XI;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to consent to the execution of an Indenture or of indentures supplemental hereto pursuant to the provisions of Section 14.02; or</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to take any other action authorized to be taken by or on behalf of the Holders of any specified aggregate principal amount of the Securities of any one or more or all series, as the case may be, under any other provision of this Indenture or under applicable law.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 9.02&nbsp;&nbsp;&nbsp;&nbsp;<u>Call of Meetings by Trustee</u>.&nbsp;&nbsp;The Trustee may at any time call a meeting of all Securityholders of all series that may be affected by the action proposed to be taken, to take any action specified in Section 9.01, to be held at such time and at such place as the Trustee shall determine.&nbsp;&nbsp;Notice of every meeting of the Securityholders of a series, setting forth the time and the place of such meeting and in general terms the action proposed to be taken at such meeting, shall be mailed to Holders of Securities of such series at their addresses as they shall appear on the Register of the Company.&nbsp;&nbsp;Such notice shall be mailed not less than 20 nor more than 90 days prior to the date fixed for the meeting.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 9.03&nbsp;&nbsp;&nbsp;&nbsp;<u>Call of Meetings by Company or Securityholders</u>.&nbsp;&nbsp;In case at any time the Company or the Holders of at least 10% in aggregate principal amount of the Securities of a series (or of all series, as the case may be) then Outstanding that may be affected by the action proposed to be taken, shall have requested the Trustee to call a meeting of Securityholders of such series (or of all series), by written request setting forth in reasonable detail the action proposed to be taken at the meeting, and the Trustee shall not have mailed the notice of such meeting within 20 days after receipt of such request, then the Company or such Securityholders may determine the time and the place for such meeting and may call such meeting to take any action authorized in Section 9.01, by mailing notice thereof as provided in Section 9.02.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 9.04&nbsp;&nbsp;&nbsp;&nbsp;<u>Qualifications for Voting</u>.&nbsp;&nbsp;To be entitled to vote at any meeting of Securityholders, a Person shall (a) be a Holder of one or more Securities affected by the action proposed to be taken at the meeting or (b) be a Person appointed by an instrument in writing as proxy by a Holder of one or more such Securities.&nbsp;&nbsp;The only Persons who shall be entitled to be present or to speak at any meeting of Securityholders shall be the Persons entitled to vote at such meeting and their counsel and any representatives of the Trustee and its counsel and any representatives of the Company and its counsel.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Section 9.05&nbsp;&nbsp;&nbsp;&nbsp;<u>Regulation of Meetings</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding any other provisions of this Indenture, the Trustee may make such reasonable regulations as it may deem advisable for any meeting of Securityholders, in regard to proof of the holding of Securities and of the appointment of proxies, and in regard to the appointment and duties of inspectors of votes, the submission and examination of proxies, certificates and other evidence of the right to vote, and such other matters concerning the conduct of the meeting as it shall deem fit.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Trustee shall, by an instrument in writing, appoint a temporary chairman of the meeting, unless the meeting shall have been called by the Company or by Securityholders as provided in Section 9.03, in which case the Company or the Securityholders calling the meeting, as the case may be, shall in like manner appoint a temporary chair.&nbsp;&nbsp;A permanent chairman and a permanent secretary of the meeting shall be elected by majority vote of the meeting.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;At any meeting of Securityholders of a series, each Securityholder of such series of such Securityholder&#8217;s proxy shall be entitled to one vote for each $1,000 principal amount of Securities of such series Outstanding held or represented by him; provided, however, that no vote shall be cast or counted at any meeting in respect of any Security challenged as not Outstanding and ruled by the chairman of the meeting to be not Outstanding.&nbsp;&nbsp;The chairman of the meeting shall have no right to vote other than by virtue of Securities of such series held by him or her or instruments in writing as aforesaid duly designating him or her as the Person to vote on behalf of other Securityholders.&nbsp;&nbsp;At any meeting of the Securityholders duly called pursuant to the provisions of Section 9.02 or 9.03 the presence of Persons holding or representing Securities in an aggregate principal amount sufficient to take action upon the business for the transaction of which such meeting was called shall be necessary to constitute a quorum, and any such meeting may be adjourned from time to time by a majority of those present, whether or not constituting a quorum, and the meeting may be held as so adjourned without further notice.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 9.06&nbsp;&nbsp;&nbsp;&nbsp;<u>Voting</u>.&nbsp;&nbsp;The vote upon any resolution submitted to any meeting of Securityholders of a series shall be by written ballots on which shall be subscribed the signatures of the Holders of Securities of such series or of their representatives by proxy and the principal amounts of the Securities of such series held or represented by them.&nbsp;&nbsp;The permanent chairman of the meeting shall appoint two inspectors of votes who shall count all votes cast at the meeting for or against any resolution and who shall make and file with the secretary of the meeting their verified written reports in duplicate of all votes cast at the meeting.&nbsp;&nbsp;A record in duplicate of the proceedings of each meeting of Securityholders shall be prepared by the secretary of the meeting and there shall be attached to said record the original reports of the inspectors of votes on any vote by ballot taken thereat and affidavits by one or more Persons having knowledge of the facts setting forth a copy of the notice of the meeting and showing that said notice was mailed as provided in Section 9.02.&nbsp;&nbsp;The record shall show the principal amounts of the Securities voting in favor of or against any resolution.&nbsp;&nbsp;The record shall be signed and verified by the affidavits of the permanent chairman and secretary of the meeting and one of the duplicates shall be delivered to the Company and the other to the Trustee to be preserved by the Trustee.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Any record so signed and verified shall be conclusive evidence of the matters therein stated.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 9.07&nbsp;&nbsp;&nbsp;&nbsp;<u>No Delay of Rights by Meeting</u>.&nbsp;&nbsp;Nothing contained in this Article IX shall be deemed or construed to authorize or permit, by reason of any call of a meeting of Securityholders of any series or any rights expressly or impliedly conferred hereunder to make such call, any hindrance or delay in the exercise of any right or rights conferred upon or reserved to the Trustee or to the Securityholders of such series under any of the provisions of this Indenture or of the Securities of such series.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>ARTICLE X</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><u>REPORTS BY THE COMPANY AND THE TRUSTEE AND</u></b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><u>SECURITYHOLDERS</u></b><u>&#8217;</u><b><u> LISTS</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Section 10.01&nbsp;&nbsp;&nbsp;&nbsp;<u>Reports by Trustee</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Trustee shall transmit to Holders such reports concerning the Trustee and its actions under this Indenture as may be required pursuant to the Trust Indenture Act at the times and in the manner pursuant thereto.&nbsp;&nbsp;If required by Section 313(a) of the Trust Indenture Act, the Trustee shall, within 60 days after each anniversary following the date of this Indenture deliver to Holders a brief report which complies with the provisions of such Section 313(a).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Trustee shall, at the time of the transmission to the Holders of Securities of any report pursuant to the provisions of this Section 10.01, file a copy of such report with each stock exchange upon which the Securities are listed, if any, and also with the SEC in respect of a Security listed and registered on a national securities exchange, if any.&nbsp;&nbsp;The Company agrees to notify the Trustee when, as and if the Securities become listed on any stock exchange or any delisting thereof.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company will reimburse the Trustee for all expenses incurred in the preparation and transmission of any report pursuant to the provisions of this Section 10.01 and of Section 10.02.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 10.02&nbsp;&nbsp;&nbsp;&nbsp;<u>Reports by the Company</u>.&nbsp;&nbsp;The Company shall file with the Trustee and the SEC, and transmit to Holders, such information, documents and other reports, and such summaries thereof, as may be required pursuant to the Trust Indenture Act at the times and in the manner provided in the Trust Indenture Act; provided that, unless available on EDGAR (or any replacement thereof), any such information, documents or reports required to be filed with the SEC pursuant to Section 13 or 15(d) of the Exchange Act shall be delivered to the Trustee within 30 days after the same is filed with the SEC.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Delivery of such reports, information and documents to the Trustee is for informational purposes only and the Trustee&#8217;s receipt of such shall not constitute constructive notice of any information contained therein or determinable from information contained therein, including the Company&#8217;s compliance with any of its covenants hereunder (as to which the Trustee is entitled to rely exclusively on Officer&#8217;s Certificates).&nbsp;&nbsp;Notwithstanding any provisions hereunder to the contrary, the foregoing provisions of this Section 10.02 are subject, in their entirety, to the provisions of Section 7.01.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 10.03&nbsp;&nbsp;&nbsp;&nbsp;<u>Securityholders</u><u>&#8217;</u><u> Lists</u>.&nbsp;&nbsp;The Company covenants and agrees that it will furnish or cause to be furnished to the Trustee:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;semi-annually, within 15 days after each Record Date, but in any event not less frequently than semi-annually, a list in such form as the Trustee may reasonably require of the names and addresses of the Holders of Securities to which such Record Date applies, as of such Record Date, and</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;at such other times as the Trustee may request in writing, within 30 days after receipt by the Company of any such request, a list of similar form and content as of a date not more than 15 days prior to the time such list is furnished;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">provided, however, that so long as the Trustee shall be the Registrar, such lists shall not be required to be furnished.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>ARTICLE XI</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><u>CONCERNING THE TRUSTEE</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 11.01&nbsp;&nbsp;&nbsp;&nbsp;<u>Rights of Trustees; Compensation and Indemnity</u>.&nbsp;&nbsp;The Trustee accepts the trusts created by this Indenture upon the terms and conditions hereof, including the following, to all of which the parties hereto and the Holders from time to time of the Securities agree:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Trustee shall be entitled to such compensation as the Company and the Trustee shall from time to time agree in writing for all services rendered by it hereunder (including in any agent capacity in which it acts).&nbsp;&nbsp;The compensation of the Trustee shall not be limited by any provision of law in regard to the compensation of a trustee of an express trust.&nbsp;&nbsp;The Company shall reimburse the Trustee promptly upon its request for all reasonable out-of-pocket expenses, disbursements and advances incurred or made by the Trustee (including the reasonable expenses and disbursements of its agents and counsel), except any such expense, disbursement or advance as may be attributable to its own negligence, bad faith or willful misconduct.&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The Company also agrees to indemnify each of the Trustee and any predecessor Trustee hereunder for, and to hold it harmless against, any and all loss, liability, damage, claim or expense incurred without its own negligence, bad faith or willful misconduct, arising out of or in connection with the acceptance or administration of the trust or trusts hereunder and the performance of its duties (including in any agent capacity in which it acts), as well as the costs and expenses of defending itself against any claim or liability in connection with the exercise or performance of any of its powers or duties hereunder, except those attributable to its negligence, willful misconduct or bad faith.&nbsp;&nbsp;The Trustee shall notify the Company promptly of any claim for which it may seek indemnity. The Company shall defend the claim and the Trustee shall cooperate in the defense. The Trustee may have one separate counsel of its selection and the Company shall pay the reasonable fees and expenses of such counsel. The Company need not pay for any settlement made without its consent, which consent shall not be unreasonably withheld.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">As security for the performance of the obligations of the Company under this Section 11.01(a), the Trustee shall have a lien upon all property and funds held or collected by the Trustee as such, except funds held in trust by the Trustee to pay principal of and interest on any Securities.&nbsp;&nbsp;Notwithstanding any provisions of this Indenture to the contrary, the obligations of the Company to compensate and indemnify the Trustee under this Section 11.01(a) shall survive the resignation or removal of the Trustee, the termination of this Indenture and any satisfaction and discharge under Article XII.&nbsp;&nbsp;When the Trustee incurs expenses or renders services after an Event of Default specified in Section 7.01(e) or (f) occurs, the expenses and compensation for the services are intended to constitute expenses of administration under any applicable federal or state bankruptcy, insolvency or similar laws.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Trustee may execute any of the trusts or powers hereof and perform any duty hereunder either directly or by its agents and attorneys and shall not be responsible for any misconduct or negligence on the part of any agent or attorney appointed with due care by it hereunder.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Trustee shall not be responsible in any manner whatsoever for the correctness of the recitals herein or in the Securities (except its certificates of authentication thereon) contained, all of which are made solely by the Company; and the Trustee shall not be responsible or accountable in any manner whatsoever for or with respect to the validity or execution or sufficiency of this Indenture or of the Securities (except its certificates of authentication thereon), and the Trustee makes no representation with respect thereto, except that the Trustee represents that it is duly authorized to execute and deliver this Indenture, authenticate the Securities and perform its obligations hereunder and that the statements made by it in a Statement of Eligibility on Form T-1 supplied to the Company are true and accurate, subject to the qualifications set forth therein.&nbsp;&nbsp;The Trustee shall not be accountable for the use or application by the Company of any Securities, or the proceeds of any Securities, authenticated and delivered by the Trustee in conformity with the provisions of this Indenture.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Trustee may consult with counsel of its selection, and, to the extent permitted by Section 11.02, any Opinion of Counsel shall be full and complete authorization and protection in respect of any action taken or suffered by the Trustee hereunder in good faith and in accordance with such Opinion of Counsel.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Trustee, to the extent permitted by Section 11.02, may rely upon the certificate of the Secretary or one of the Assistant Secretaries of the Company as to the adoption of any Board Resolution or resolution of the stockholders of the Company, and any request, direction, order or demand of the Company mentioned herein shall be sufficiently evidenced by, and whenever in the administration of this Indenture the Trustee shall deem it desirable that a matter be proved or established prior to taking, suffering or omitting any action hereunder, the Trustee may rely upon, an Officer&#8217;s Certificate of the Company (unless other evidence in respect thereof be herein specifically prescribed).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject to Section 11.04, the Trustee or any agent of the Trustee, in its individual or any other capacity, may become the owner or pledgee of Securities and, subject to Sections 310(b) and 311 of the Trust Indenture Act, may otherwise deal with the Company with the same rights it would have had if it were not the Trustee or such agent.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Money held by the Trustee in trust hereunder need not be segregated from other funds except to the extent required by law.&nbsp;&nbsp;The Trustee shall be under no liability for interest on any money received by it hereunder except as otherwise agreed in writing with the Company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any action taken by the Trustee pursuant to any provision hereof at the request or with the consent of any Person who at the time is the Holder of any Security shall be conclusive and binding in respect of such Security upon all future Holders thereof or of any Security or Securities which may be issued for or in lieu thereof in whole or in part, whether or not such Security shall have noted thereon the fact that such request or consent had been made or given.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject to the provisions of Section 11.02, the Trustee may conclusively rely and shall be protected in acting or refraining from acting upon any resolution, certificate, statement, instrument, opinion, report, notice, request, consent, order, approval, bond, debenture or other paper or document reasonably believed by it to be genuine and to have been signed or presented by the proper party or parties.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject to the provisions of Section 11.02, the Trustee shall not be under any obligation to exercise any of the rights or powers vested in it by this Indenture at the request, order or direction of any of the Holders of the Securities, pursuant to any provision of this Indenture, unless one or more of the Holders of the Securities shall have offered to the Trustee security or indemnity satisfactory to it against the costs, expenses and liabilities which may be incurred by it therein or thereby.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject to the provisions of Section 11.02, the Trustee shall not be liable for any action taken or omitted by it in good faith and believed by it to be authorized or within its discretion or within the rights or powers conferred upon it by this Indenture.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject to the provisions of Section 11.02, the Trustee shall not be deemed to have knowledge or notice of any Default or Event of Default unless a Responsible Officer of the Trustee has actual knowledge thereof or unless the Holders of not less than 25% of the Outstanding Securities notify the Trustee thereof.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(m)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject to the provisions of Section 11.02 (a), the Trustee shall not be bound to make any investigation into the facts or matters stated in any resolution, certificate, statement, instrument, opinion, report, notice, request, direction, consent, order, bond, debenture, note, other evidence of Indebtedness or other paper or document, but the Trustee, may, but shall not be required to, make further inquiry or investigation into such facts or matters as it may see fit.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(n)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The rights, privileges, protections, immunities and benefits given to the Trustee, including, without limitation, its right to be indemnified, are extended to, and shall be enforceable by, the Trustee in each of its capacities hereunder.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 11.02&nbsp;&nbsp;&nbsp;&nbsp;<u>Duties of Trustee</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If one or more of the Events of Default specified in Section 7.01 with respect to the Securities of any series shall have happened, then, during the continuance thereof, the Trustee shall, with respect to such Securities, exercise such of the rights and powers vested in it by this Indenture, and shall use the same degree of care and skill in their exercise, as a prudent person would exercise or use under the circumstances in the conduct of such person&#8217;s own affairs.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;None of the provisions of this Indenture shall be construed as relieving the Trustee from liability for its own negligent action, negligent failure to act, or its own willful misconduct, except that, anything in this Indenture contained to the contrary notwithstanding,</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;unless and until an Event of Default specified in Section 7.01 with respect to the Securities of any series shall have happened which at the time is continuing,</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(A)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the Trustee undertakes to perform such duties and only such duties with respect to the Securities of that series as are specifically set out in this Indenture, and no implied covenants or obligations shall be read into this Indenture against the Trustee, whose duties and obligations shall be determined solely by the express provisions of this Indenture; and</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(B)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the Trustee may conclusively rely, as to the truth of the statements and the correctness of the opinions expressed therein, in the absence of bad faith on the part of the Trustee, upon certificates and opinions furnished to it pursuant to the express provisions of this Indenture; but in the case of any such certificates or opinions which, by the provisions of this Indenture, are specifically required to be furnished to the Trustee, the Trustee shall be under a duty to examine the same to determine whether or not they conform to the requirements of this Indenture (but need not confirm or investigate the accuracy of mathematical calculations or other facts, statements, opinions or conclusions stated therein);</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the Trustee shall not be liable to any Holder of Securities or to any other Person for any error of judgment made in good faith by a Responsible Officer or Officers of the Trustee, unless it shall be proved that the Trustee was negligent in ascertaining the pertinent facts; and</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the Trustee shall not be liable to any Holder of Securities or to any other Person with respect to any action taken or omitted to be taken by it in good faith, in accordance with the direction of Securityholders given as provided in Section 7.06, relating to the time, method and place of conducting any proceeding for any remedy available to it or exercising any trust or power conferred upon it by this Indenture.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;None of the provisions of this Indenture shall require the Trustee to expend or risk its own funds or otherwise to incur any financial liability in the performance of any of its duties hereunder, or in the exercise of any of its rights or powers, if it shall have reasonable grounds for believing that repayment of such funds or adequate indemnity against such risk or liability is not reasonably assured to it.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Whether or not herein expressly so provided, every provision of this Indenture relating to the conduct or affecting the liability of or affording protection to the Trustee shall be subject to the provisions of this Section 11.02.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 11.03&nbsp;&nbsp;&nbsp;&nbsp;<u>Notice of Defaults</u>.&nbsp;&nbsp;Within 90 days after the occurrence thereof, and if known to the Trustee, the Trustee shall give to the Holders of the Securities of a series notice of each Default or Event of Default with respect to the Securities of such series known to the Trustee, by transmitting such notice to Holders at their addresses as the same shall then appear on the Register of the Company, unless such Default shall have been cured or waived before the giving of such notice (the term &#8220;Default&#8221; being hereby defined to be the events specified in Section 7.01, which are, or after notice or lapse of time or both would become, Events of Default as defined in Section 7.01).&nbsp;&nbsp;Except in the case of a Default or Event of Default in payment of the principal of, premium, if any, or interest on any of the Securities of such series when and as the same shall become payable, or to make any sinking fund payment as to Securities of the same series, the Trustee shall be protected in withholding such notice, if and so long as a Responsible Officer or Responsible Officers of the Trustee in good faith determines that the withholding of such notice is in the interests of the Holders of the Securities of such series.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Section 11.04&nbsp;&nbsp;&nbsp;&nbsp;<u>Eligibility; Disqualification</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Trustee shall at all times satisfy the requirements of TIA Section 310(a).&nbsp;&nbsp;The Trustee shall have a combined capital and surplus of at least $50 million as set forth in its most recent published annual report of condition, and shall have a Corporate Trust Office.&nbsp;&nbsp;If at any time the Trustee shall cease to be eligible in accordance with the provisions of this Section 11.04, it shall resign immediately in the manner and with the effect hereinafter specified in this Article XI.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Trustee shall comply with TIA Section 310(b); provided, however, that there shall be excluded from the operation of TIA Section 310(b)(i) any indenture or indentures under which other securities or certificates of interest or participation in other securities of the Company are outstanding if the requirements for such exclusion set forth in TIA Section 310(b)(i) are met.&nbsp;&nbsp;If the Trustee has or shall acquire a conflicting interest within the meaning of Section 310(b) of the Trust Indenture Act, the Trustee shall either eliminate such interest or resign, to the extent and in the manner provided by, and subject to the provisions of, the Trust Indenture Act and this Indenture.&nbsp;&nbsp;If Section 310(b) of the Trust Indenture Act is amended any time after the date of this Indenture to change the circumstances under which a Trustee shall be deemed to have a conflicting interest with respect to the Securities of any series or to change any of the definitions in connection therewith, this Section 11.04 shall be automatically amended to incorporate such changes.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 11.05&nbsp;&nbsp;&nbsp;&nbsp;<u>Registration and Notice; Removal</u>.&nbsp;&nbsp;The Trustee, or any successor to it hereafter appointed, may at any time resign and be discharged of the trusts hereby created with respect to any one or more or all series of Securities by giving to the Company notice in writing.&nbsp;&nbsp;Such resignation shall take effect upon the appointment of a successor Trustee and the acceptance of such appointment by such successor Trustee.&nbsp;&nbsp;Any Trustee hereunder may be removed with respect to any series of Securities at any time by the filing with such Trustee and the delivery to the Company of an instrument or instruments in writing signed by the Holders of a majority in principal amount of the Securities of such series then Outstanding, specifying such removal and the date when it shall become effective.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">If at any time:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(a) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the Trustee shall fail to comply with the provisions of TIA Section 310(b) after written request therefor by the Company or by any Holder who has been a bona fide Holder of a Security for at least six months (or, if it is a shorter period, the period since the initial issuance of the Securities of such series),</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the Trustee shall cease to be eligible under Section 11.04 and shall fail to resign after written request therefor by the Company or by any Holder who has been a bona fide Holder of a Security for at least six months (or, if it is a shorter period, the period since the initial issuance of the Securities of such series), or</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the Trustee shall become incapable of acting or shall be adjudged bankrupt or insolvent or a receiver of the Trustee or of its property shall be appointed or any public officer shall take charge or control of the Trustee or of its property or affairs for the purpose of rehabilitation, conservation or liquidation,</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">then, in any such case, (i) the Company by written notice to the Trustee may remove the Trustee and appoint a successor Trustee with respect to all Securities, or (ii) subject to TIA Section 315(e), any Securityholder who has been a bona fide Holder of a Security for at least six months (or, if it is a shorter period, the period since the initial issuance of the Securities of such series) may, on behalf of himself and all others similarly situated, petition any court of competent jurisdiction for the removal of the Trustee with respect to all Securities and the appointment of a successor Trustee or Trustees.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Upon its resignation or removal, any Trustee shall be entitled to the payment of reasonable compensation for the services rendered hereunder by such Trustee and to the payment of all reasonable expenses incurred hereunder and all moneys then due to it hereunder.&nbsp;&nbsp;The Trustee&#8217;s rights to indemnification provided in Section 11.01(a) shall survive its resignation or removal.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Section 11.06&nbsp;&nbsp;&nbsp;&nbsp;<u>Successor Trustee by Appointment</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In case at any time the Trustee shall resign, or shall be removed (unless the Trustee shall be removed as provided in Section 11.04(b), in which event the vacancy shall be filled as provided in Section 11.04(b)), or shall become incapable of acting, or shall be adjudged bankrupt or insolvent, or if a receiver of the Trustee or of its property shall be appointed, or if any public officer shall take charge or control of the Trustee or of its property or affairs for the purpose of rehabilitation, conservation or liquidation with respect to the Securities of one or more series, a successor Trustee with respect to the Securities of that or those series (it being understood that any such successor Trustee may be appointed with respect to the Securities of one or more or all of such series and that at any time there shall be only one Trustee with respect to the Securities of any series) may be appointed by the Holders of a majority in principal amount of the Securities of that or those series then Outstanding, by an instrument or instruments in writing signed in duplicate by such Holders and filed, one original thereof with the Company and the other with the successor Trustee; but, until a successor Trustee shall have been so appointed by the Holders of Securities of that or those series as herein authorized, the Company, or, in case all or substantially all the assets of the Company shall be in the possession of one or more custodians or receivers lawfully appointed, or of trustees in bankruptcy or reorganization proceedings (including a trustee or trustees appointed under the provisions of the federal bankruptcy laws, as now or hereafter constituted), or of assignees for the benefit of creditors, such receivers, custodians, trustees or assignees, as the case may be, by an instrument in writing, shall appoint a successor Trustee with respect to the Securities of such series.&nbsp;&nbsp;Subject to the provisions of Sections 11.04 and 11.05, upon the appointment as aforesaid of a successor Trustee with respect to the Securities of any series, the Trustee with respect to the Securities of such series shall cease to be Trustee hereunder.&nbsp;&nbsp;After any such appointment other than by the Holders of Securities of that or those series, the Person making such appointment shall forthwith cause notice thereof to be mailed to the Holders of Securities of such series at their addresses as the same shall then appear on the Register of the Company but any successor Trustee with respect to the Securities of such series so appointed shall, immediately and without further act, be superseded by a successor Trustee appointed by the Holders of Securities of such series in the manner prescribed above, if such appointment be made prior to the expiration of one year from the date of the mailing of such notice by the Company, or by such receivers, trustees or assignees.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If any Trustee with respect to the Securities of one or more series shall resign or be removed and a successor Trustee shall not have been appointed by the Company or by the Holders of the Securities of such series or, if any successor Trustee so appointed shall not have accepted its appointment within 30 days after such appointment shall have been made, the resigning Trustee at the expense of the Company may apply to any court of competent jurisdiction for the appointment of a successor Trustee.&nbsp;&nbsp;If in any other case a successor Trustee shall not be appointed pursuant to the foregoing provisions of this Section 11.06 within three months after such appointment might have been made hereunder, the Holder of any Security of the applicable series or any retiring Trustee at the expense of the Company may apply to any court of competent jurisdiction to appoint a successor Trustee.&nbsp;&nbsp;Such court may thereupon, in any such case, after such notice, if any, as such court may deem proper and prescribe, appoint a successor Trustee.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any successor Trustee appointed hereunder with respect to the Securities of one or more series shall execute, acknowledge and deliver to its predecessor Trustee and to the Company, or to the receivers, trustees, assignees or court appointing it, as the case may be, an instrument accepting such appointment hereunder, and thereupon such successor Trustee, without any further act, deed or conveyance, shall become vested with all the authority, rights, powers, trusts, immunities, duties and obligations with respect to such series of such predecessor Trustee with like effect as if originally named as Trustee hereunder, and such predecessor Trustee, upon payment of its charges and disbursements then unpaid, shall thereupon become obligated to pay over, and such successor Trustee shall be entitled to receive, all moneys and properties held by such predecessor Trustee as Trustee hereunder, subject nevertheless to its lien provided for in Section 11.01(a).&nbsp;&nbsp;Nevertheless, on the written request of the Company or of the successor Trustee or of the Holders of at least 10% in principal amount of the Securities of such series then Outstanding, such predecessor Trustee, upon payment of its said charges and disbursements, shall execute and deliver an instrument transferring to such successor Trustee upon the trusts herein expressed all the rights, powers and trusts of such predecessor Trustee and shall assign, transfer and deliver to the successor Trustee all moneys and properties held by such predecessor Trustee, subject nevertheless to its lien provided for in Section 11.01(a); and, upon request of any such successor Trustee, the Company shall make, execute, acknowledge and deliver any and all instruments in writing for more fully and effectually vesting in and confirming to such successor Trustee all such authority, rights, powers, trusts, immunities, duties and obligations.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 11.07&nbsp;&nbsp;&nbsp;&nbsp;<u>Successor Trustee by Merger</u>.&nbsp;&nbsp;Any Person into which the Trustee or any successor to it in the trusts created by this Indenture shall be merged or converted, or any Person with which it or any successor to it shall be consolidated, or any Person resulting from any merger, conversion or consolidation to which the Trustee or any such successor to it shall be a party, or any Person to which the Trustee or any successor to it shall sell or otherwise transfer all or substantially all of the corporate trust business of the Trustee, shall be the successor Trustee under this Indenture without the execution or filing of any paper or any further act on the part of any of the parties hereto; provided that such Person shall be otherwise qualified and eligible under this Article.&nbsp;&nbsp;In case at the time such successor to the Trustee shall succeed to the trusts created by this Indenture with respect to one or more series of Securities, any of such Securities shall have been authenticated but not delivered by the Trustee then in office, any successor to such Trustee may adopt the certificate of authentication of any predecessor Trustee, and deliver such Securities so authenticated; and in case at that time any of the Securities shall not have been authenticated, any successor to the Trustee may authenticate such Securities either in the name of any predecessor hereunder or in the name of the successor Trustee; and in all such cases such certificates shall have the full force which it is anywhere in the Securities or in this Indenture provided that the certificate of the Trustee shall have; provided, however, that the right to adopt the certificate of authentication of any predecessor Trustee or authenticate Securities in the name of any predecessor Trustee shall apply only to its successor or successors by merger, conversion or consolidation.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 11.08&nbsp;&nbsp;&nbsp;&nbsp;<u>Right to Rely on Officer</u><u>&#8217;</u><u>s Certificate</u>.&nbsp;&nbsp;Subject to Section 11.02, and subject to the provisions of Section 16.01 with respect to the certificates required thereby, whenever in the administration of the provisions of this Indenture the Trustee shall deem it necessary or desirable that a matter be proved or established prior to taking or suffering any action hereunder, such matter (unless other evidence in respect thereof be herein specifically prescribed) may, in the absence of negligence, bad faith or willful misconduct on the part of the Trustee, be deemed to be conclusively proved and established by an Officer&#8217;s Certificate with respect thereto delivered to the Trustee, and such Officer&#8217;s Certificate, in the absence of negligence, bad faith or willful misconduct on the part of the Trustee, shall be full warrant to the Trustee for any action taken, suffered or omitted by it under the provisions of this Indenture upon the faith thereof.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 11.09&nbsp;&nbsp;&nbsp;&nbsp;<u>Appointment of Authenticating Agent</u>.&nbsp;&nbsp;The Trustee may appoint an agent (the &#8220;Authenticating Agent&#8221;) acceptable to the Company to authenticate the Securities, and the Trustee shall give written notice of such appointment to all Holders of Securities of the series with respect to which such Authenticating Agent will serve.&nbsp;&nbsp;Unless limited by the terms of such appointment, any such Authenticating Agent may authenticate Securities whenever the Trustee may do so.&nbsp;&nbsp;Each reference in this Indenture to authentication by the Trustee includes authentication by the Authenticating Agent. Securities so authenticated shall be entitled to the benefits of this Indenture and shall be valid and obligatory for all purposes as if authenticated by the Trustee hereunder.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Each Authenticating Agent shall at all times be a corporation organized and doing business and in good standing under the laws of the United States, any State thereof or the District of Columbia, authorized under such laws to act as Authenticating Agent, having a combined capital and surplus of not less than $50,000,000 and subject to supervision or examination by Federal or State authority. If such corporation publishes reports of condition at least annually, pursuant to law or to the requirements of said supervising or examining authority, then for the purposes of this Article XI, the combined capital and surplus of such corporation shall be deemed to be its combined capital and surplus as set forth in its most recent report of condition so published. If at any time an Authenticating Agent shall cease to be eligible in accordance with the provisions of this Article XI, it shall resign immediately in the manner and with the effect specified in this Article XI.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Any corporation into which an Authenticating Agent may be merged or converted or with which it may be consolidated, or any corporation resulting from any merger, conversion or consolidation to which such Authenticating Agent shall be a party, or any corporation succeeding to all or substantially all the corporate agency or corporate trust business of an Authenticating Agent, shall continue to be an Authenticating Agent, provided such corporation shall be otherwise eligible under this Article XI, without the execution or filing of any paper or any further act on the part of the Trustee or the Authenticating Agent.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">An Authenticating Agent may resign at any time by giving written notice thereof to the Trustee and the Company. The Trustee may at any time terminate the agency of an Authenticating Agent by giving written notice thereof to such Authenticating Agent and the Company. Upon receiving such a notice of resignation or upon such a termination, or in case at any time such Authenticating Agent shall cease to be eligible in accordance with the provisions of this Section 11.09, the Trustee may appoint a successor Authenticating Agent which shall be acceptable to the Company and shall give written notice of such appointment to all Holders of Securities of the series with respect to which such Authenticating Agent will serve. Any successor Authenticating Agent upon acceptance of its appointment hereunder shall become vested with all the rights, powers and duties of its predecessor hereunder, with like effect as if originally named as an Authenticating Agent. No successor Authenticating Agent shall be appointed unless eligible under the provisions of this Section 11.09.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The Trustee agrees to pay to each Authenticating Agent from time to time reasonable compensation for its services under this Section 11.09, and the Trustee shall be entitled to be reimbursed for such payments, subject to the provisions of Section 11.01.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Section 11.10&nbsp;&nbsp;&nbsp;&nbsp;<u>Communications by Securityholders with Other Securityholders</u>.&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Holders of Securities may communicate pursuant to Section 312(b) of the Trust Indenture Act with other Holders with respect to their rights under this Indenture or the Securities.&nbsp;&nbsp;The Company, the Trustee, the Registrar and anyone else shall have the protection of Section 312(c) of the Trust Indenture Act with respect to such communications.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>ARTICLE XII</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><u>SATISFACTION AND DISCHARGE; DEFEASANCE</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 12.01&nbsp;&nbsp;&nbsp;&nbsp;<u>Applicability of Article</u>.&nbsp;&nbsp;If, pursuant to Section 3.01, provision is made for the defeasance of Securities of a series and if the Securities of such series are denominated and payable only in U.S. Dollars (except as provided pursuant to Section 3.01), then the provisions of this Article XII shall be applicable except as otherwise specified pursuant to Section 3.01 for Securities of such series.&nbsp;&nbsp;Defeasance provisions, if any, for Securities denominated in a Foreign Currency may be specified pursuant to Section 3.01.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 12.02&nbsp;&nbsp;&nbsp;&nbsp;<u>Satisfaction and Discharge of Indenture</u>.&nbsp;&nbsp;This Indenture, with respect to the Securities of any series (if all series issued under this Indenture are not to be affected), shall, upon Company Order, cease to be of further effect (except as to any surviving rights of registration of transfer or exchange of such Securities herein expressly provided for and rights to receive payments of principal of and premium, if any, and interest on such Securities) and the Trustee, at the expense of the Company, shall execute proper instruments acknowledging satisfaction and discharge of this Indenture, when,</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;either: &nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;all Securities of such series theretofore authenticated and delivered (other than (A) Securities that have been destroyed, lost or stolen and that have been replaced or paid as provided in Section 3.07 and (B) Securities for whose payment money has theretofore been deposited in trust or segregated and held in trust by the Company and thereafter repaid to the Company or discharged from such trust, as provided in Section 6.03) have been delivered to the Trustee for cancellation; or</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;all Securities of such series not theretofore delivered to the Trustee for cancellation,</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(A)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;have become due and payable,</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(B)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;will become due and payable at their Stated Maturity within one year, or</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(C)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;are to be called for redemption within one year under arrangements satisfactory to the Trustee for the giving of notice by the Trustee in the name, and at the expense, of the Company,&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">and in the case of Section 12.02(a)(ii)(A), (B) or (C), the Company has deposited or caused to be deposited with the Trustee or Paying Agent as trust funds in trust for the purpose an amount in the Currency in which such Securities are denominated (except as otherwise provided pursuant to Section 3.01) sufficient to pay and discharge the entire Indebtedness on such Securities for principal and premium, if any, and interest to the date of such deposit (in the case of Securities that have become due and payable) or to the Stated Maturity or Redemption Date, as the case may be;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the Company has paid or caused to be paid all other sums payable hereunder by the Company; and</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the Company has delivered to the Trustee an Officer&#8217;s Certificate and an Opinion of Counsel each stating that all conditions precedent herein provided for relating to the satisfaction and discharge of this Indenture with respect to such series have been complied with.&nbsp;&nbsp;Notwithstanding the satisfaction and discharge of this Indenture, the obligations of the Company to the Trustee under Section 11.01 and, if money shall have been deposited with the Trustee pursuant to Section 12.02(a)(i)(B), the obligations of the Trustee under Section 12.07 and Section 6.03(e) shall survive.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 12.03&nbsp;&nbsp;&nbsp;&nbsp;<u>Defeasance upon Deposit of Moneys or U.S. Government Obligations</u>.&nbsp;&nbsp;At the Company&#8217;s option, either (x) the Company shall be deemed to have been Discharged (as defined below) from its obligations with respect to Securities of any series on the first day after the applicable conditions set forth below have been satisfied or (y) the Company shall cease to be under any obligation to comply with any term, provision or condition set forth in Section 6.04 and Section 10.02 with respect to Securities of any series (and, if so specified pursuant to Section 3.01, any other restrictive covenant added for the benefit of such series pursuant to Section 3.01) at any time after the applicable conditions set forth below have been satisfied (such action under Section 12.03(a) or (b) in no circumstance may be construed as an Event of Default under Section 7.01):</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company shall have deposited or caused to be deposited irrevocably with the Trustee as trust funds in trust, specifically pledged as security for, and dedicated solely to, the benefit of the Holders of the Securities of such series (i) money in an amount, (ii) U.S. Government Obligations (as defined below) that through the payment of interest and principal in respect thereof in accordance with their terms will provide, not later than one day before the due date of any payment, money in an amount, or (iii) a combination of (i) and (ii), sufficient to pay and discharge each installment of principal (including any mandatory sinking fund payments) of and premium, if any, and interest on the Outstanding Securities of such series on the dates such installments of interest or principal and premium are due or applicable Redemption Date, as the case may be;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No Default with respect to the Securities of such series shall have occurred and be continuing on the date of such deposit (other than a Default resulting from the borrowing of funds and the grant of any related liens to be applied to such deposit); and</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company shall have delivered to the Trustee an Opinion of Counsel to the effect that Holders of the Securities of such series will not recognize income, gain or loss for U.S. federal income tax purposes as a result of the Company&#8217;s exercise of its option under this Section 12.03 and will be subject to federal income tax on the same amounts and in the same manner and at the same times as would have been the case if such action had not been exercised and, in the case of the Securities of such series being Discharged accompanied by a ruling to that effect received from or published by the Internal Revenue Service.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">&#8220;Discharged&#8221; means that the Company shall be deemed to have paid and discharged the entire Indebtedness represented by, and obligations under, the Securities of such series and to have satisfied all the obligations under this Indenture relating to the Securities of such series (and the Trustee, at the expense of the Company, shall execute proper instruments acknowledging the same), except (A) the rights of Holders of Securities of such series to receive, from the trust fund described in Section 12.03(a), payment of the principal of and premium, if any, and interest on such Securities when such payments are due, (B) the Company&#8217;s obligations with respect to Securities of such series under Sections 3.04, 3.06, 3.07, 6.02, 12.06 and 12.07 and (C) the rights, powers, trusts, duties and immunities of the Trustee hereunder.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">&#8220;U.S. Government Obligations&#8221; means securities that are (A) direct obligations of the United States for the payment of which its full faith and credit is pledged or (B) obligations of a Person controlled or supervised by and acting as an agency or instrumentality of the United States the timely of payment of which is unconditionally guaranteed as a full faith and credit obligation by the United States, that, in either case under clauses (A) or (B) are not callable or redeemable at the action of the issuer thereof, and shall also include a depositary receipt issued by a bank or trust company as custodian with respect to any such U.S. Government Obligation or a specific payment of interest on or principal of any such U.S. Government Obligation held by such custodian for the account of the holder of a depositary receipt; provided that (except as required by law) such custodian is not authorized to make any deduction from the amount payable to the holder of such depositary receipt from any amount received by the custodian in respect of the U.S. Government Obligation or the specific payment of interest on or principal of the U.S. Government Obligation evidenced by such depositary receipt.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 12.04&nbsp;&nbsp;&nbsp;&nbsp;<u>Repayment to Company</u>.&nbsp;&nbsp;The Trustee and any Paying Agent shall promptly pay to the Company (or to its designee) upon Company Order any excess moneys or U.S. Government Obligations held by them at any time, including any such moneys or obligations held by the Trustee under any escrow trust agreement entered into pursuant to Section 12.06.&nbsp;&nbsp;The provisions of Section 6.03(e) shall apply to any money held by the Trustee or any Paying Agent under this Article XII that remains unclaimed for two years after the Maturity of any series of Securities for which money or U.S. Government Obligations have been deposited pursuant to Section 12.03.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 12.05&nbsp;&nbsp;&nbsp;&nbsp;<u>Indemnity for U.S. Government Obligations</u>.&nbsp;&nbsp;The Company shall pay and shall indemnify the Trustee against any tax, fee or other charge imposed on or assessed against the deposited U.S. Government Obligations or the principal or interest received on such U.S. Government Obligations.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 12.06&nbsp;&nbsp;&nbsp;&nbsp;<u>Deposits to Be Held in Escrow</u>.&nbsp;&nbsp;Any deposits with the Trustee referred to in Section 12.03 shall be irrevocable (except to the extent provided in Sections 12.04 and 12.07) and shall be made under the terms of an escrow trust agreement.&nbsp;&nbsp;If any Outstanding Securities of a series are to be redeemed prior to their Stated Maturity, whether pursuant to any optional redemption provisions or in accordance with any mandatory or optional sinking fund requirement, the applicable escrow trust agreement shall provide therefor and the Company shall make such arrangements as are satisfactory to the Trustee for the giving of notice of redemption by the Trustee in the name, and at the expense, of the Company.&nbsp;&nbsp;The agreement shall provide that, upon satisfaction of any mandatory sinking fund payment requirements, whether by deposit of moneys, application of proceeds of deposited U.S. Government Obligations or, if permitted, by delivery of Securities, the Trustee shall pay or deliver over to the Company as excess moneys pursuant to Section 12.04 all funds or obligations then held under the agreement and allocable to the sinking fund payment requirements so satisfied.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">If Securities of a series with respect to which such deposits are made may be subject to later redemption at the option of the Company or pursuant to optional sinking fund payments, the applicable escrow trust agreement may, at the option of the Company, provide therefor.&nbsp;&nbsp;In the case of an optional redemption in whole or in part, such agreement shall require the Company to deposit with the Trustee on or before the date notice of redemption is given funds sufficient to pay the Redemption Price of the Securities to be redeemed together with all unpaid interest thereon to the Redemption Date.&nbsp;&nbsp;Upon such deposit of funds, the Trustee shall pay or deliver over to the Company as excess funds pursuant to Section 12.04 all funds or obligations then held under such agreement and allocable to the Securities to be redeemed.&nbsp;&nbsp;In the case of exercise of optional sinking fund payment rights by the Company, such agreement shall, at the option of the Company, provide that upon deposit by the Company with the Trustee of funds pursuant to such exercise the Trustee shall pay or deliver over to the Company as excess funds pursuant to Section 12.04 all funds or obligations then held under such agreement for such series and allocable to the Securities to be redeemed.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 12.07&nbsp;&nbsp;&nbsp;&nbsp;<u>Application of Trust Money</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neither the Trustee nor any other Paying Agent shall be required to pay interest on any moneys deposited pursuant to the provisions of this Indenture, except such as it shall agree with the Company in writing to pay thereon.&nbsp;&nbsp;Any moneys so deposited for the payment of the principal of, or premium, if any, or interest on the Securities of any series and remaining unclaimed for two years after the date of the maturity of the Securities of such series or the date fixed for the redemption of all the Securities of such series at the time outstanding, as the case may be, shall be repaid by the Trustee or such other Paying Agent to the Company upon its written request and thereafter, anything in this Indenture to the contrary notwithstanding, any rights of the Holders of Securities of such series in respect of which such moneys shall have been deposited shall be enforceable only against the Company, and all liability of the Trustee or such other Paying Agent with respect to such moneys shall thereafter cease.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject to the provisions of Section 12.07, any moneys which at any time shall be deposited by the Company or on its behalf with the Trustee or any other Paying Agent for the purpose of paying the principal of, premium, if any, and interest on any of the Securities shall be and are hereby assigned, transferred and set over to the Trustee or such other Paying Agent in trust for the respective Holders of the Securities for the purpose for which such moneys shall have been deposited; but such moneys need not be segregated from other funds except to the extent required by law.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 12.08&nbsp;&nbsp;&nbsp;&nbsp;<u>Deposits of Non-U.S. Currencies</u>.&nbsp;&nbsp;Notwithstanding the foregoing provisions of this Article XII, if the Securities of any series are payable in a Currency other than U.S. Dollars, the Currency or the nature of the government obligations to be deposited with the Trustee under the foregoing provisions of this Article XII shall be as set forth in the Officer&#8217;s Certificate or established in the supplemental indenture under which the Securities of such series are issued.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>ARTICLE XIII</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><u>IMMUNITY OF CERTAIN PERSONS</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 13.01&nbsp;&nbsp;&nbsp;&nbsp;<u>No Personal Liability</u>.&nbsp;&nbsp;No recourse shall be had for the payment of the principal of, or the premium, if any, or interest on any Security or for any claim based thereon or otherwise in respect thereof or of the Indebtedness represented thereby, or upon any obligation, covenant or agreement of this Indenture, against any incorporator, stockholder, officer or director, as such, past, present or future, of the Company or of any successor corporation, either directly or through the Company or any successor corporation, whether by virtue of any constitutional provision, statute or rule of law, or by the enforcement of any assessment or penalty or otherwise; it being expressly agreed and understood that this Indenture and the Securities are solely corporate obligations, and that no personal liability whatsoever shall attach to, or be incurred by, any incorporator, stockholder, officer or director, as such, past, present or future, of the Company or of any successor corporation, either directly or through the Company or any successor corporation, because of the incurring of the Indebtedness hereby authorized or under or by reason of any of the obligations, covenants, promises or agreements contained in this Indenture or in any of the Securities, or to be implied herefrom or therefrom, and that all liability, if any, of that character against every such incorporator, stockholder, officer and director is, by the acceptance of the Securities and as a condition of, and as part of the consideration for, the execution of this Indenture and the issue of the Securities expressly waived and released.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>ARTICLE XIV</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><u>SUPPLEMENTAL INDENTURES</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 14.01&nbsp;&nbsp;&nbsp;&nbsp;<u>Without Consent of Securityholders</u>.&nbsp;&nbsp;Except as otherwise provided as contemplated by Section 3.01 with respect to any series of Securities, the Company and the Trustee, at any time and from time to time, may enter into one or more indentures supplemental hereto, in form satisfactory to the Trustee, for any one or more of or all the following purposes:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to add to the covenants and agreements of the Company, to be observed thereafter and during the period, if any, in such supplemental indenture or indentures expressed, and to add Events of Default, in each case for the protection or benefit of the Holders of all or any series of the Securities (and if such covenants, agreements and Events of Default are to be for the benefit of fewer than all series of Securities, stating that such covenants, agreements and Events of Default are expressly being included for the benefit of such series as shall be identified therein), or to surrender any right or power herein conferred upon the Company;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to delete or modify any Events of Default with respect to all or any series of the Securities, the form and terms of which are being established pursuant to such supplemental indenture as permitted in Section 3.01 (and, if any such Event of Default is applicable to fewer than all such series of the Securities, specifying the series to which such Event of Default is applicable), and to specify the rights and remedies of the Trustee and the Holders of such Securities in connection therewith;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to add to or change any of the provisions of this Indenture to provide, change or eliminate any restrictions on the payment of principal of or premium, if any, on Securities; provided that any such action shall not adversely affect the interests of the Holders of Securities of any series in any material respect;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to change or eliminate any of the provisions of this Indenture; provided that any such change or elimination shall become effective only when there is no Outstanding Security of any series created prior to the execution of such supplemental indenture that is entitled to the benefit of such provision and as to which such supplemental indenture would apply;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to evidence the succession of another Person to the Company, or successive successions, and the assumption by such successor of the covenants and obligations of the Company contained in the Securities of one or more series and in this Indenture or any supplemental indenture;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to evidence and provide for the acceptance of appointment hereunder by a successor Trustee with respect to one or more series of Securities and to add to or change any of the provisions of this Indenture as shall be necessary for or facilitate the administration of the trusts hereunder by more than one Trustee, pursuant to the requirements of Section 11.06(c);</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to secure any series of Securities;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to evidence any changes to this Indenture pursuant to Sections 11.05, 11.06 or 11.07 hereof as permitted by the terms thereof;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to cure any ambiguity or to correct or supplement any provision contained herein or in any indenture supplemental hereto which may be defective or inconsistent with any other provision contained herein or in any supplemental indenture or to conform the terms hereof, as amended and supplemented, that are applicable to the Securities of any series to the description of the terms of such Securities in the offering memorandum, prospectus supplement or other offering document applicable to such Securities at the time of initial sale thereof;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to add to or change or eliminate any provision of this Indenture as shall be necessary or desirable in accordance with any amendments to the Trust Indenture Act;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to add guarantors or co-obligors with respect to any series of Securities or to release guarantors from their guarantees of Securities in accordance with the terms of the applicable series of Securities;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to make any change in any series of Securities that does not adversely affect in any material respect the rights of the Holders of such Securities;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(m)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to provide for uncertificated securities in addition to certificated securities;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(n)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to supplement any of the provisions of this Indenture to such extent as shall be necessary to permit or facilitate the defeasance and discharge of any series of Securities; provided that any such action shall not adversely affect the interests of the Holders of Securities of such series or any other series of Securities;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(o)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to prohibit the authentication and delivery of additional series of Securities; or</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(p)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; to establish the form and terms of Securities of any series as permitted in Section 3.01, or to authorize the issuance of additional Securities of a series previously authorized or to add to the conditions, limitations or restrictions on the authorized amount, terms or purposes of issue, authentication or delivery of the Securities of any series, as herein set forth, or other conditions, limitations or restrictions thereafter to be observed.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Subject to the provisions of Section 14.03, the Trustee is authorized to join with the Company in the execution of any such supplemental indenture, to make the further agreements and stipulations which may be therein contained and to accept the conveyance, transfer, assignment, mortgage or pledge of any property or assets thereunder.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Any supplemental indenture authorized by the provisions of this Section 14.01 may be executed by the Company and the Trustee without the consent of the Holders of any of the Securities at the time Outstanding.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 14.02&nbsp;&nbsp;&nbsp;&nbsp;<u>With Consent of Securityholders; Limitations</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;With the consent of the Holders (evidenced as provided in Article VIII) of a majority in aggregate principal amount of the Outstanding Securities of each series affected by such supplemental indenture voting separately, the Company and the Trustee may, from time to time and at any time, enter into an indenture or indentures supplemental hereto for the purpose of adding any provisions to or changing in any manner or eliminating any provisions of this Indenture or of modifying in any manner the rights of the Holders of the Securities of such series to be affected; provided, however, that no such supplemental indenture shall, without the consent of the Holder of each Outstanding Security of each such series affected thereby,</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;extend the Stated Maturity of the principal of, or any installment of interest on, any Security, or reduce the principal amount thereof or the interest thereon or any premium payable upon redemption thereof, or extend the Stated Maturity of, or change the place of payment where, or the Currency in which the principal of and premium, if any, or interest on such Security is denominated or payable, or reduce the amount of the principal of an Original Issue Discount Security that would be due and payable upon a declaration of acceleration of the Maturity thereof pursuant to Section 7.02, or impair the right to institute suit for the enforcement of any payment on or after the Stated Maturity thereof (or, in the case of redemption, on or after the Redemption Date), or materially adversely affect the economic terms of any right to convert or exchange any Security as may be provided pursuant to Section 3.01;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;reduce the percentage in principal amount of the Outstanding Securities of any series, the consent of whose Holders is required for any supplemental indenture, or the consent of whose Holders is required for any waiver of compliance with certain provisions of this Indenture or certain Defaults hereunder and their consequences provided for in this Indenture;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;modify any of the provisions of this Section 14.02, Section 7.06 or Section 6.06, except to increase any such percentage or to provide that certain other provisions of this Indenture cannot be modified or waived without the consent of the Holder of each Outstanding Security affected thereby; provided, however, that this Section 14.02(a)(iii) shall not be deemed to require the consent of any Holder with respect to changes in the references to &#8220;the Trustee&#8221; and concomitant changes in this Section 14.02 and Section 6.06, or the deletion of this proviso, in accordance with the requirements of Sections 11.06 and 14.01(f); or</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;modify, without the written consent of the Trustee, the rights, duties or immunities of the Trustee.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A supplemental indenture that changes or eliminates any provision of this Indenture which has expressly been included solely for the benefit of one or more particular series of Securities or which modifies the rights of the Holders of Securities of such series with respect to such covenant or other provision, shall be deemed not to affect the rights under this Indenture of the Holders of Securities of any other series.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;It shall not be necessary for the consent of the Securityholders under this Section 14.02 to approve the particular form of any proposed supplemental indenture, but it shall be sufficient if such consent shall approve the substance thereof.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company may set a record date for purposes of determining the identity of the Holders of each series of Securities entitled to give a written consent or waive compliance by the Company as authorized or permitted by this Section 14.02.&nbsp;&nbsp;Such record date shall not be more than 30 days prior to the first solicitation of such consent or waiver or the date of the most recent list of Holders furnished to the Trustee prior to such solicitation pursuant to Section 312 of the Trust Indenture Act.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Promptly after the execution by the Company and the Trustee of any supplemental indenture pursuant to the provisions of this Section 14.02, the Company shall mail a notice, setting forth in general terms the substance of such supplemental indenture, to the Holders of Securities at their addresses as the same shall then appear in the Register of the Company.&nbsp;&nbsp;Any failure of the Company to mail such notice, or any defect therein, shall not, however, in any way impair or affect the validity of any such supplemental indenture.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 14.03&nbsp;&nbsp;&nbsp;&nbsp;<u>Trustee Protected</u>.&nbsp;&nbsp;Upon the request of the Company, accompanied by the Officer&#8217;s Certificate and Opinion of Counsel required by Section 16.01 (provided, however, that such Officers&#8217; Certificate or Opinion of Counsel need not be provided in connection with the execution of a supplemental indenture that establishes the terms of a series of Securities pursuant to Section 2.01 hereof) and evidence reasonably satisfactory to the Trustee of consent of the Holders if the supplemental indenture is to be executed pursuant to Section 14.02, the Trustee shall join with the Company in the execution of said supplemental indenture unless said supplemental indenture affects the Trustee&#8217;s own rights, duties or immunities under this Indenture or otherwise, in which case the Trustee may in its discretion, but shall not be obligated to, enter into said supplemental indenture.&nbsp;&nbsp;The Trustee shall be fully protected in relying upon such Officer&#8217;s Certificate and an Opinion of Counsel.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 14.04&nbsp;&nbsp;&nbsp;&nbsp;<u>Effect of Execution of Supplemental Indenture</u>.&nbsp;&nbsp;Upon the execution of any supplemental indenture pursuant to the provisions of this Article XIV, this Indenture shall be deemed to be modified and amended in accordance therewith and, except as herein otherwise expressly provided, the respective rights, limitations of rights, obligations, duties and immunities under this Indenture of the Trustee, the Company and the Holders of all of the Securities or of the Securities of any series affected, as the case may be, shall thereafter be determined, exercised and enforced hereunder subject in all respects to such modifications and amendments, and all the terms and conditions of any such supplemental indenture shall be and be deemed to be part of the terms and conditions of this Indenture for any and all purposes.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 14.05&nbsp;&nbsp;&nbsp;&nbsp;<u>Notation on or Exchange of Securities</u>.&nbsp;&nbsp;Securities of any series authenticated and delivered after the execution of any supplemental indenture pursuant to the provisions of this Article XIV may bear a notation in the form approved by the Trustee as to any matter provided for in such supplemental indenture.&nbsp;&nbsp;If the Company or the Trustee shall so determine, new Securities so modified as to conform, in the opinion of the Trustee and the Board of Directors of the Company, to any modification of this Indenture contained in any such supplemental indenture may be prepared and executed by the Company and authenticated and delivered by the Trustee in exchange for the Securities then Outstanding in equal aggregate principal amounts, and such exchange shall be made without cost to the Holders of the Securities.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 14.06&nbsp;&nbsp;&nbsp;&nbsp;<u>Conformity with TIA</u>.&nbsp;&nbsp;Every supplemental indenture executed pursuant to the provisions of this Article XIV shall conform to the requirements of the Trust Indenture Act as then in effect.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>ARTICLE XV</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><u>SUBORDINATION OF SECURITIES</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 15.01&nbsp;&nbsp;&nbsp;&nbsp;<u>Agreement to Subordinate</u>. In the event a series of Securities is designated as subordinated pursuant to Section 3.01, and except as otherwise provided in a Company Order or in one or more indentures supplemental hereto, the Company, for itself, its successors and assigns, covenants and agrees, and each Holder of Securities of such series by his, her or its acceptance thereof, likewise covenants and agrees, that the payment of the principal of (and premium, if any) and interest, if any, on each and all of the Securities of such series is hereby expressly subordinated, to the extent and in the manner hereinafter set forth, in right of payment to the prior payment in full of all Senior Indebtedness.&nbsp;&nbsp;In the event a series of Securities is not designated as subordinated pursuant to Section 3.01(t), this Article XV shall have no effect upon the Securities.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 15.02&nbsp;&nbsp;&nbsp;&nbsp;<u>Distribution on Dissolution, Liquidation and Reorganization; Subrogation of Securities</u>. Subject to Section 15.01, upon any distribution of assets of the Company upon any dissolution, winding up, liquidation or reorganization of the Company, whether in bankruptcy, insolvency, reorganization or receivership proceedings or upon an assignment for the benefit of creditors or any other marshalling of the assets and liabilities of the Company or otherwise (subject to the power of a court of competent jurisdiction to make other equitable provision reflecting the rights conferred in this Indenture upon the Senior Indebtedness and the holders thereof with respect to the Securities and the holders thereof by a lawful plan of reorganization under applicable bankruptcy law):</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the holders of all Senior Indebtedness shall be entitled to receive payment in full of the principal thereof (and premium, if any) and interest due thereon before the Holders of the Securities are entitled to receive any payment upon the principal (or premium, if any) or interest, if any, on Indebtedness evidenced by the Securities;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any payment or distribution of assets of the Company of any kind or character, whether in cash, property or securities, to which the Holders of the Securities or the Trustee would be entitled except for the provisions of this Article XV shall be paid by the liquidation trustee or agent or other Person making such payment or distribution, whether a trustee in bankruptcy, a receiver or liquidating trustee or otherwise, directly to the holders of Senior Indebtedness or their representative or representatives or to the trustee or trustees under any indenture under which any instruments evidencing any of such Senior Indebtedness may have been issued, ratably according to the aggregate amounts remaining unpaid on account of the principal of (and premium, if any) and interest, if any, on the Senior Indebtedness held or represented by each, to the extent necessary to make payment in full of all Senior Indebtedness remaining unpaid, after giving effect to any concurrent payment or distribution to the holders of such Senior Indebtedness; and</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;in the event that, notwithstanding the foregoing, any payment or distribution of assets of the Company of any kind or character, whether in cash, property or securities prohibited by the foregoing, shall be received by the Trustee or the Holders of the Securities before all Senior Indebtedness is paid in full, such payment or distribution shall be paid over, upon written notice to a Responsible Officer of the Trustee, to the holder of such Senior Indebtedness or his, her or its representative or representatives or to the trustee or trustees under any indenture under which any instrument evidencing any of such Senior Indebtedness may have been issued, ratably as aforesaid, as calculated by the Company, for application to payment of all Senior Indebtedness remaining unpaid until all such Senior Indebtedness shall have been paid in full, after giving effect to any concurrent payment or distribution to the holders of such Senior Indebtedness.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject to the payment in full of all Senior Indebtedness, the Holders of the Securities shall be subrogated to the rights of the holders of Senior Indebtedness (to the extent that distributions otherwise payable to such holder have been applied to the payment of Senior Indebtedness) to receive payments or distributions of cash, property or securities of the Company applicable to Senior Indebtedness until the principal of (and premium, if any) and interest, if any, on the Securities shall be paid in full and no such payments or distributions to the Holders of the Securities of cash, property or securities otherwise distributable to the holders of Senior Indebtedness shall, as between the Company, its creditors other than the holders of Senior Indebtedness, and the Holders of the Securities be deemed to be a payment by the Company to or on account of the Securities. It is understood that the provisions of this Article XV are and are intended solely for the purpose of defining the relative rights of the Holders of the Securities, on the one hand, and the holders of the Senior Indebtedness, on the other hand. Nothing contained in this Article XV or elsewhere in this Indenture or in the Securities is intended to or shall impair, as between the Company, its creditors other than the holders of Senior Indebtedness, and the Holders of the Securities, the obligation of the Company, which is unconditional and absolute, to pay to the Holders of the Securities the principal of (and premium, if any) and interest, if any, on the Securities as and when the same shall become due and payable in accordance with their terms, or to affect the relative rights of the Holders of the Securities and creditors of the Company other than the holders of Senior Indebtedness, nor shall anything herein or in the Securities prevent the Trustee or the Holder of any Security from exercising all remedies otherwise permitted by applicable law upon default under this Indenture, subject to the rights, if any, under this Article XV of the holders of Senior Indebtedness in respect of cash, property or securities of the Company received upon the exercise of any such remedy. Upon any payment or distribution of assets of the Company referred to in this Article XV, the Trustee, subject to the provisions of Section 15.05, shall be entitled to conclusively rely upon a certificate of the liquidating trustee or agent or other person making any distribution to the Trustee for the purpose of ascertaining the Persons entitled to participate in such distribution, the holders of Senior Indebtedness and other indebtedness of the Company, the amount thereof or payable thereon, the amount or amounts paid or distributed thereof and all other facts pertinent thereto or to this Article XV.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 15.03&nbsp;&nbsp;&nbsp;&nbsp;<u>No Payment on Securities in Event of Default on Senior Indebtedness</u>. Subject to Section 15.01, no payment by the Company on account of principal of (or premium, if any), sinking funds or interest, if any, on the Securities shall be made at any time if: (a) a default on Senior Indebtedness exists that permits the holders of such Senior Indebtedness to accelerate its maturity and (b) the default is the subject of judicial proceedings or the Company has received notice of such default. The Company may resume payments on the Securities when full payment of amounts then due for principal of (premium, if any), sinking funds and interest, if any, on Senior Indebtedness has been made or duly provided for in money or money&#8217;s worth.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">In the event that, notwithstanding the foregoing, any payment shall be received by the Trustee when such payment is prohibited by the preceding paragraph of this Section 15.03, such payment shall be held in trust for the benefit of, and shall be paid over or delivered to, the holders of such Senior Indebtedness or their respective representatives, or to the trustee or trustees under any indenture pursuant to which any of such Senior Indebtedness may have been issued, as their respective interests may appear, as calculated by the Company, but only to the extent that the holders of such Senior Indebtedness (or their representative or representatives or a trustee) notify the Trustee in writing within 90 days of such payment of the amounts then due and owing on such Senior Indebtedness and only the amounts specified in such notice to the Trustee shall be paid to the holders of such Senior Indebtedness.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 15.04&nbsp;&nbsp;&nbsp;&nbsp;<u>Payments on Securities Permitted</u>. Subject to Section 15.01, nothing contained in this Indenture or in any of the Securities shall (a) affect the obligation of the Company to make, or prevent the Company from making, at any time except as provided in Sections 15.02 and 15.03, payments of principal of (or premium, if any) or interest, if any, on the Securities or (b) prevent the application by the Trustee of any moneys or assets deposited with it hereunder to the payment of or on account of the principal of (or premium, if any) or interest, if any, on the Securities, unless a Responsible Officer of the Trustee shall have received at its Corporate Trust Office written notice of any fact prohibiting the making of such payment from the Company or from the holder of any Senior Indebtedness or from the trustee for any such holder, together with proof satisfactory to the Trustee of such holding of Senior Indebtedness or of the authority of such trustee more than two Business Days prior to the date fixed for such payment.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 15.05&nbsp;&nbsp;&nbsp;&nbsp;<u>Authorization of Securityholders to Trustee to Effect Subordination</u>.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Subject to Section 15.01, each Holder of Securities by his acceptance thereof authorizes and directs the Trustee on his, her or its behalf to take such action as may be necessary or appropriate to effectuate the subordination as provided in this Article XV and appoints the Trustee his attorney-in-fact for any and all such purposes.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 15.06&nbsp;&nbsp;&nbsp;&nbsp;<u>Notices to Trustee</u>. The Company shall give prompt written notice to a Responsible Officer of the Trustee of any fact known to the Company that would prohibit the making of any payment of monies or assets to or by the Trustee in respect of the Securities of any series pursuant to the provisions of this Article XV.&nbsp;&nbsp;Subject to Section 15.01, notwithstanding the provisions of this Article XV or any other provisions of this Indenture, neither the Trustee nor any Paying Agent (other than the Company) shall be charged with knowledge of the existence of any Senior Indebtedness or of any fact which would prohibit the making of any payment of moneys or assets to or by the Trustee or such Paying Agent, unless and until a Responsible Officer of the Trustee or such Paying Agent shall have received (in the case of a Responsible Officer of the Trustee, at the Corporate Trust Office of the Trustee) written notice thereof from the Company or from the holder of any Senior Indebtedness or from the trustee for any such holder, together with proof satisfactory to the Trustee of such holding of Senior Indebtedness or of the authority of such trustee and, prior to the receipt of any such written notice, the Trustee shall be entitled in all respects conclusively to presume that no such facts exist; provided, however, that if at least two Business Days prior to the date upon which by the terms hereof any such moneys or assets may become payable for any purpose (including, without limitation, the payment of either the principal of (or premium, if any) or interest, if any, on any Security) a Responsible Officer of the Trustee shall not have received with respect to such moneys or assets the notice provided for in this Section 15.06, then, anything herein contained to the contrary notwithstanding, the Trustee shall have full power and authority to receive such moneys or assets and to apply the same to the purpose for which they were received, and shall not be affected by any notice to the contrary which may be received by it within two Business Days prior to such date. The Trustee shall be entitled to rely on the delivery to it of a written notice by a Person representing himself to be a holder of Senior Indebtedness (or a trustee on behalf of such holder) to establish that such a notice has been given by a holder of Senior Indebtedness or a trustee on behalf of any such holder. In the event that the Trustee determines in good faith that further evidence is required with respect to the right of any Person as a holder of Senior Indebtedness to participate in any payment or distribution pursuant to this Article XV, the Trustee may request such Person to furnish evidence to the reasonable satisfaction of the Trustee as to the amount of Senior Indebtedness held by such Person, the extent to which such Person is entitled to participate in such payment or distribution and any other facts pertinent to the rights of such Person under this Article XV and, if such evidence is not furnished, the Trustee may defer any payment to such Person pending judicial determination as to the right of such Person to receive such payment.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 15.07&nbsp;&nbsp;&nbsp;&nbsp;<u>Trustee as Holder of Senior Indebtedness</u>. Subject to Section 15.01, the Trustee in its individual capacity shall be entitled to all the rights set forth in this Article XV in respect of any Senior Indebtedness at any time held by it to the same extent as any other holder of Senior Indebtedness and nothing in this Indenture shall be construed to deprive the Trustee of any of its rights as such holder. Nothing in this Article XV shall apply to claims of, or payments to, the Trustee under or pursuant to Sections 7.05 or 11.01.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 15.08&nbsp;&nbsp;&nbsp;&nbsp;<u>Modifications of Terms of Senior Indebtedness</u>. Subject to Section 15.01, any renewal or extension of the time of payment of any Senior Indebtedness or the exercise by the holders of Senior Indebtedness of any of their rights under any instrument creating or evidencing Senior Indebtedness, including, without limitation, the waiver of default thereunder, may be made or done all without notice to or assent from the Holders of the Securities or the Trustee. No compromise, alteration, amendment, modification, extension, renewal or other change of, or waiver, consent or other action in respect of, any liability or obligation under or in respect of, or of any of the terms, covenants or conditions of any indenture or other instrument under which any Senior Indebtedness is outstanding or of such Senior Indebtedness, whether or not such release is in accordance with the provisions of any applicable document, shall in any way alter or affect any of the provisions of this Article XV or of the Securities relating to the subordination thereof.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 15.09&nbsp;&nbsp;&nbsp;&nbsp;<u>Reliance on Judicial Order or Certificate of Liquidating Agent</u>. Subject to Section 15.01, upon any payment or distribution of assets of the Company referred to in this Article XV, the Trustee and the Holders of the Securities shall be entitled to conclusively rely upon any order or decree entered by any court of competent jurisdiction in which such insolvency, bankruptcy, receivership, liquidation, reorganization, dissolution, winding up or similar case or proceeding is pending, or a certificate of the trustee in bankruptcy, liquidating trustee, custodian, receiver, assignee for the benefit of creditors, agent or other person making such payment or distribution, delivered to the Trustee or to the Holders of Securities, for the purpose of ascertaining the Persons entitled to participate in such payment or distribution, the holders of Senior Indebtedness and other indebtedness of the Company, the amount thereof or payable thereon, the amount or amounts paid or distributed thereon and all other facts pertinent thereto or to this Article XV.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 15.10&nbsp;&nbsp;&nbsp;&nbsp;<u>Satisfaction and Discharge; Defeasance and Covenant Defeasance</u>. Subject to Section 15.01, amounts and U.S. Government Obligations deposited in trust with the Trustee pursuant to and in accordance with Article XII and not, at the time of such deposit, prohibited to be deposited under Sections 15.02 or 15.03 shall not be subject to this Article XV.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 15.11&nbsp;&nbsp;&nbsp;&nbsp;<u>Trustee Not Fiduciary for Holders of Senior Indebtedness</u>.&nbsp;&nbsp;With respect to the holders of Senior Indebtedness, the Trustee undertakes to perform or observe only such of its covenants and obligations as are specifically set forth in this Article XV, and no implied covenants or obligations with respect to the holders of Senior Indebtedness shall be read into this Indenture against the Trustee.&nbsp;&nbsp;The Trustee shall not be deemed to owe any fiduciary duty to the holders of Senior Indebtedness.&nbsp;&nbsp;The Trustee shall not be liable to any such holder if it shall pay over or distribute to or on behalf of Holders of Securities or the Company, or any other Person, moneys or assets to which any holder of Senior Indebtedness shall be entitled by virtue of this Article XV or otherwise.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>ARTICLE XVI</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><u>MISCELLANEOUS PROVISIONS</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 16.01&nbsp;&nbsp;&nbsp;&nbsp;<u>Certificates and Opinions as to Conditions Precedent</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Upon any request or application by the Company to the Trustee to take any action under any of the provisions of this Indenture, the Company shall furnish to the Trustee an Officer&#8217;s Certificate stating that all conditions precedent, if any, provided for in this Indenture relating to the proposed action have been complied with and an Opinion of Counsel stating that in the opinion of such counsel all such conditions precedent have been complied with, except that in the case of any such application or demand as to which the furnishing of such document is specifically required by any provision of this Indenture relating to such particular application or demand, no additional certificate or opinion need be furnished.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each certificate or opinion provided for in this Indenture and delivered to the Trustee with respect to compliance with a condition or covenant provided for in this Indenture (other than the certificates provided pursuant to Section 6.05 of this Indenture) shall include (i) a statement that the Person giving such certificate or opinion has read such covenant or condition; (ii) a brief statement as to the nature and scope of the examination or investigation upon which the statements or opinions contained in such certificate or opinion are based; (iii) a statement that, in the view or opinion of such Person, he or she has made such examination or investigation as is necessary to enable such Person to express an informed view or opinion as to whether or not such covenant or condition has been complied with; and (iv) a statement as to whether or not, in the view or opinion of such Person, such condition or covenant has been complied with.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any certificate, statement or opinion of an officer of the Company may be based, insofar as it relates to legal matters, upon a certificate or opinion of, or representations by, counsel, unless such officer knows, or in the exercise of reasonable care should know, that the certificate or opinion or representations with respect to the matters upon which his or her certificate, statement or opinion is based are erroneous.&nbsp;&nbsp;Any certificate, statement or opinion of counsel may be based, insofar as it relates to factual matters, upon a certificate, statement or opinion of, or representations by, an officer or officers of the Company stating that the information with respect to such factual matters is in the possession of the Company, unless such counsel knows, or in the exercise of reasonable care should know, that the certificate, statement or opinion or representations with respect to such matters are erroneous.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any certificate, statement or opinion of an officer of the Company or of counsel to the Company may be based, insofar as it relates to accounting matters, upon a certificate or opinion of, or representations by, an accountant or firm of accountants, unless such officer or counsel, as the case may be, knows, or in the exercise of reasonable care should know, that the certificate or opinion or representations with respect to the accounting matters upon which his or her certificate, statement or opinion may be based are erroneous.&nbsp;&nbsp;Any certificate or opinion of any firm of independent registered public accountants filed with the Trustee shall contain a statement that such firm is independent.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In any case where several matters are required to be certified by, or covered by an opinion of, any specified Person, it is not necessary that all such matters be certified by, or covered by the opinion of, only one such Person, or that they be so certified or covered by only one document, but one such Person may certify or give an opinion with respect to some matters and one or more other such Persons as to other matters, and any such Person may certify or give an opinion as to such matters in one or several documents.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Where any Person is required to make, give or execute two or more applications, requests, consents, certificates, statements, opinions or other instruments under this Indenture, they may, but need not, be consolidated and form one instrument.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 16.02&nbsp;&nbsp;&nbsp;&nbsp;<u>Trust Indenture Act Controls</u>.&nbsp;&nbsp;If and to the extent that any provision of this Indenture limits, qualifies or conflicts with the duties imposed by, or another provision included in this Indenture which is required to be included in this Indenture by any of the provisions of Sections 310 to 318, inclusive, of the Trust Indenture Act, such imposed duties or incorporated provision shall control.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 16.03&nbsp;&nbsp;&nbsp;&nbsp;<u>Notices to the Company and Trustee</u>.&nbsp;&nbsp;Any notice or demand authorized by this Indenture to be made upon, given or furnished to, or filed with, the Company or the Trustee shall be sufficiently made, given, furnished or filed for all purposes if it shall be mailed, delivered or telefaxed to:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the Company, at 1200 American Flat Rd, Virginia City, NV 89440, Attention: Chief Financial Officer, Facsimile No.: (303) 260-5080 or at such other address or facsimile number as may have been furnished in writing to the Trustee by the Company; and</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the Trustee, at the Corporate Trust Office of the Trustee, Attention: Trust Administrator.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Any such notice, demand or other document shall be in the English language.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 16.04&nbsp;&nbsp;&nbsp;&nbsp;<u>Notices to Securityholders; Waiver</u>.&nbsp;&nbsp;Any notice required or permitted to be given to Securityholders shall be sufficiently given (unless otherwise herein expressly provided),</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;if to Holders, if given in writing by first class mail, postage prepaid, to such Holders at their addresses as the same shall appear on the Register of the Company; provided, that in the event of suspension of regular mail service or by reason of any other cause it shall be impracticable to give notice by mail, then such notification as shall be given with the approval of the Trustee shall constitute sufficient notice for every purpose hereunder; or</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;if a series of notes has been issued in global form through DTC as Depositary, notice may be provided by delivery of such notice to DTC for posting through its &#8220;Legal Notice Service&#8221; (LENS) or a successor system thereof.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Where this Indenture provides for notice in any manner, such notice may be waived in writing by the Person entitled to receive such notice, either before or after the event, and such waiver shall be the equivalent of such notice.&nbsp;&nbsp;Waivers of notice by Holders shall be filed with the Trustee, but such filing shall not be a condition precedent to the validity of any action taken in reliance on such waiver.&nbsp;&nbsp;In any case where notice to Holders is given by mail; neither the failure to mail such notice nor any defect in any notice so mailed to any particular Holder shall affect the sufficiency of such notice with respect to other Holders, and any notice that is mailed in the manner herein provided shall be conclusively presumed to have been duly given.&nbsp;&nbsp;In any case where notice to Holders is given by publication, any defect in any notice so published as to any particular Holder shall not affect the sufficiency of such notice with respect to other Holders, and any notice that is published in the manner herein provided shall be conclusively presumed to have been duly given.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 16.05&nbsp;&nbsp;&nbsp;&nbsp;<u>Legal Holiday</u>.&nbsp;&nbsp;Unless otherwise specified pursuant to Section 3.01, in any case where any Interest Payment Date, Redemption Date or Maturity of any Security of any series shall not be a Business Day at any Place of Payment for the Securities of that series, then payment of principal and premium, if any, or interest need not be made at such Place of Payment on such date, but may be made on the next succeeding Business Day at such Place of Payment with the same force and effect as if made on such Interest Payment Date, Redemption Date or Maturity and no interest shall accrue on such payment for the period from and after such Interest Payment Date, Redemption Date or Maturity, as the case may be, to such Business Day if such payment is made or duly provided for on such Business Day.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 16.06&nbsp;&nbsp;&nbsp;&nbsp;<u>Effects of Headings and Table of Contents</u>.&nbsp;&nbsp;The Article and Section headings herein and the Table of Contents are for convenience only and shall not affect the construction hereof.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 16.07&nbsp;&nbsp;&nbsp;&nbsp;<u>Successors and Assigns</u>.&nbsp;&nbsp;All covenants and agreements in this Indenture by the parties hereto shall bind their respective successors and assigns and inure to the benefit of their permitted successors and assigns, whether so expressed or not.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 16.08&nbsp;&nbsp;&nbsp;&nbsp;<u>Separability Clause</u>.&nbsp;&nbsp;In case any provision in this Indenture or in the Securities shall be invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 16.09&nbsp;&nbsp;&nbsp;&nbsp;<u>Benefits of Indenture</u>.&nbsp;&nbsp;Nothing in this Indenture expressed and nothing that may be implied from any of the provisions hereof is intended, or shall be construed, to confer upon, or to give to, any Person or corporation other than the parties hereto and their successors and the Holders of the Securities any benefit or any right, remedy or claim under or by reason of this Indenture or any covenant, condition, stipulation, promise or agreement hereof, and all covenants, conditions, stipulations, promises and agreements in this Indenture contained shall be for the sole and exclusive benefit of the parties hereto and their successors and of the Holders of the Securities.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 16.10&nbsp;&nbsp;&nbsp;&nbsp;<u>Counterparts; Originals</u>.&nbsp;&nbsp;This Indenture may be executed in any number of counterparts, each of which so executed shall be deemed to be an original, but all such counterparts shall together constitute but one and the same instrument. The exchange of copies of this Indenture and of signature pages by facsimile or PDF transmission shall constitute effective execution and delivery of this Indenture as to the parties hereto and may be used in lieu of the original Indenture for all purposes. Signatures of the parties hereto transmitted by facsimile or PDF shall be deemed to be their original signatures for all purposes.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section 16.11&nbsp;&nbsp;&nbsp;&nbsp;<u>Governing Law; Waiver of Trial by Jury</u>.&nbsp;&nbsp;This Indenture and the Securities shall be deemed to be contracts made under the law of the State of New York, and for all purposes shall be governed by and construed in accordance with the law of said State.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">EACH PARTY HERETO, AND EACH HOLDER OF A SECURITY BY ACCEPTANCE THEREOF, HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS INDENTURE.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">IN WITNESS WHEREOF, the parties have caused this Indenture to be duly executed as of the date first written above.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: bottom; width: 45%;">&nbsp;</td>
			<td colspan="2" rowspan="1" style="vertical-align: bottom; width: 3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">COMSTOCK INC.,</p>
			</td>
			<td style="vertical-align: bottom; width: 17%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: bottom; width: 45%;">&nbsp;</td>
			<td colspan="2" rowspan="1" style="vertical-align: bottom; width: 3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">as Issuer</p>
			</td>
			<td style="vertical-align: bottom; width: 17%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: bottom; width: 45%;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 3%;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 35%;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 17%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: bottom; width: 45%;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">By:</p>
			</td>
			<td style="vertical-align: bottom; width: 35%; border-bottom: 1px solid black;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 17%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: bottom; width: 45%;">&nbsp;</td>
			<td colspan="2" rowspan="1" style="vertical-align: bottom; width: 3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Name:</p>
			</td>
			<td style="vertical-align: bottom; width: 17%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: bottom; width: 45%;">&nbsp;</td>
			<td colspan="2" rowspan="1" style="vertical-align: bottom; width: 3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Title:</p>
			</td>
			<td style="vertical-align: bottom; width: 17%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: bottom; width: 45%;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 3%;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 35%;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 17%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: bottom; width: 45%;">&nbsp;</td>
			<td colspan="2" rowspan="1" style="vertical-align: bottom; width: 3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;],</p>
			</td>
			<td style="vertical-align: bottom; width: 17%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: bottom; width: 45%;">&nbsp;</td>
			<td colspan="2" rowspan="1" style="vertical-align: bottom; width: 3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">as Trustee</p>
			</td>
			<td style="vertical-align: bottom; width: 17%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: bottom; width: 45%;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 3%;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 35%;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 17%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: bottom; width: 45%;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">By:</p>
			</td>
			<td style="vertical-align: bottom; width: 35%; border-bottom: 1px solid black;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 17%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: bottom; width: 45%;">&nbsp;</td>
			<td colspan="2" rowspan="1" style="vertical-align: bottom; width: 3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Name:</p>
			</td>
			<td style="vertical-align: bottom; width: 17%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: bottom; width: 45%;">&nbsp;</td>
			<td colspan="2" rowspan="1" style="vertical-align: bottom; width: 3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Title:</p>
			</td>
			<td style="vertical-align: bottom; width: 17%;">&nbsp;</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>4
<FILENAME>ex_879511.htm
<DESCRIPTION>EXHIBIT 5.1
<TEXT>
<html><head>
	<title>ex_879511.htm</title>
	<!-- Generated by ThunderDome Portal - 11/18/2025 10:50:42 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size:10pt;font-family:'Times New Roman';padding:0in .1in;">
<p style="margin: 0px 0pt; text-align: right; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt"><b>Exhibit 5.1</b></font></p>

<p style="margin: 0px 0pt; text-align: left; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>

<div style="text-align: center;"><img alt="mcdc.jpg" src="mcdc.jpg"></div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">November 21, 2025</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Board of Directors</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Comstock Inc.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">117 American Flat Road</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Virginia City, NV 89440</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Ladies and Gentlemen:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">We have acted as special Nevada counsel to Comstock Inc., a Nevada corporation (the &#8220;<u>Company</u>&#8221;), in connection with the filing by the Company of a Registration Statement on Form S-3 (including the prospectus which is a part thereof, the &#8220;<u>Registration Statement</u>&#8221;), with the Securities and Exchange Commission (the &#8220;<u>Commission</u>&#8221;) relating to the registration under the Securities Act of 1933, as amended (the &#8220;<u>Act</u>&#8221;), of:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;an indeterminate&nbsp;amount and number of the following securities of the Company, which may be offered, issued and sold or delivered from time to time on a delayed or continuous basis pursuant to Rule 415 under the Act for an aggregate initial offering price of up to $200,000,000: (i) shares of common stock of the Company, par value $0.000666 per share (the &#8220;<u>Common Stock</u>&#8221;) which may be issued by the Company independently, together with other Securities (as defined below), and/or upon the conversion, exercise, or exchange of the other Securities described in the Registration Statement (the &#8220;<u>Common Shares</u>&#8221;); (ii) shares of one or more series of preferred stock of the Company, par value $0.000666 per share, (the &#8220;<u>Preferred Stock</u>&#8221;) which may be issued by the Company independently, together with other Securities, and/or upon the conversion, exercise, or exchange of the other Securities described in the Registration Statement (the &#8220;<u>Preferred Shares</u>&#8221;); (iii) debt securities which may be issued in one or more series (the &#8220;<u>Debt Securities</u>&#8221;); (iv) rights to purchase shares of the Common Stock, shares of Preferred Stock, or the other Securities described in the Registration Statement which may be issued in one or more series (the &#8220;<u>Rights</u>&#8221;); (v) warrants to purchase shares of the Common Stock, shares of Preferred Stock, and/or Debt Securities which may be issued in one or more series (the &#8220;<u>Warrants</u>&#8221;); and (vi) units consisting of shares of Common Stock, shares of Preferred Stock, Debt Securities and/or Warrants (the &#8220;<u>Units</u>&#8221;); and</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;the issuance and sale by the Company of shares of Common Stock, having an aggregate offering price of up to $100,000,000 (the &#8220;<u>ATM Shares</u>&#8221;), pursuant to the Registration Statement and the prospectus supplement relating to the ATM Shares filed with the Commission dated as of the date hereof (the &#8220;<u>ATM Prospectus Supplement</u>&#8221;). All of the ATM Shares are to be sold by the Company as described in the ATM Prospectus Supplement, and in accordance with the terms and conditions of the At the Market Offering Agreement referenced in the Prospectus Supplement (the &#8220;<u>Sales Agreement</u>&#8221;). The Common Stock, Preferred Stock, Debt Securities, Rights, Warrants, Units, and ATM Shares are referred to herein each as a &#8220;<u>Security</u>&#8221; and collectively as the &#8220;<u>Securities</u>.&#8221;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">
<div style="margin: 0pt;"><img alt="mcdcfooter.jpg" src="mcdcfooter.jpg"></div>
</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">
<div style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><img alt="mcdcmini.jpg" src="mcdcmini.jpg"></div>

<div style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: right;">Page 2</div>
</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">In connection with this opinion, we have examined originals or copies, certified or otherwise identified to our satisfaction, of: (i) the Articles of Incorporation of the Company, as amended through the date hereof (the &#8220;<u>Articles of Incorporation</u>&#8221;); (ii) the Bylaws of the Company, as amended through the date hereof (the &#8220;<u>Bylaws</u>&#8221;); (iii) certain resolutions of the Board of Directors of the Company relating to the issuance, sale and registration of the Securities; (iv) the Registration Statement; (v) the ATM Prospectus&nbsp;Supplement; and, (vi) the Sale Agreement. In addition, we have examined and relied upon originals or copies, certified or otherwise identified to our satisfaction, of certain other corporate records, documents, instruments and certificates of public officials and of the Company, and we have made such inquiries of officers of the Company and public officials and considered such questions of law as we have deemed necessary for purposes of rendering the opinions set forth herein. We have also relied upon the representations and warranties of the Company contained in those certain documents included as exhibits to the Registration Statement and the ATM Prospectus Supplement. In rendering our opinion, we have made the assumptions that are customary in opinion letters of this kind. We have not verified these assumptions.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">In connection with this opinion, we have assumed the accuracy and completeness of each document submitted to us, the genuineness of all signatures, the legal capacity of natural persons, and the authenticity of all items submitted to us as originals and the conformity with originals of all items submitted to us as copies. In making our examination of documents executed by parties other than the Company, we have assumed that each other party has the power and authority to execute and deliver, and to perform and observe the provisions of, such documents and has duly authorized, executed and delivered such documents, and that such documents constitute the legal, valid and binding obligations of each such party, including the Company. With respect to certain factual matters, we have relied upon certificates of officers of the Company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We have assumed that any indentures relating to the Debt Securities, any warrant agreements relating to the Warrants, any unit agreements relating to the Units, any rights agreements relating to the Rights, any other agreements, instruments, or other documents relating to the offering, issuance, or sale of any Securities and the issuance and sale of the Securities by the Company will not, in each case, violate or constitute a default or breach under: (i) any agreement or instrument to which the Company or its properties is subject; (ii) any law, rule or regulation to which the Company is subject; (iii) any judicial or regulatory order or decree of any governmental authority; or (iv) any consent, approval, license, authorization or validation of, or filing, recording or registration with any governmental authority.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We have further assumed that: (i) the Registration Statement, the ATM Prospectus Supplement, and any amendments thereto will have become effective under the Act and comply with all applicable laws at the time the Securities are offered or issued as contemplated by the Registration Statement and the ATM Prospectus Supplement, as applicable; (ii) an appropriate prospectus supplement, free writing prospectus or term sheet relating to the Securities (other than the ATM Shares) offered thereby will be prepared and filed with the Commission in compliance with the Act and will comply with all applicable laws at the time the Securities (other than the ATM Shares) are offered or issued as contemplated by the Registration Statement; (iii) all Securities will be offered, issued and sold (A) in accordance with and in the manner specified in the Registration Statement, the base prospectus contained therein, the ATM Prospectus Supplement, the relevant prospectus supplement(s), the Articles of Incorporation, the Bylaws and the terms and conditions of the applicable agreements, instruments, and other Securities Documents (as defined below) governing the offer, sale, or issuance of such Securities or the conversion, exchange or exercise thereof, and (B) in compliance with the applicable provisions of the Act, the Trust Indenture Act of 1939, as applicable, and the securities or blue sky laws of various states and in the manner stated in the Registration Statement and the applicable prospectus supplement; and (iv) that the trustee under any indenture shall have been qualified pursuant to the Trust Indenture Act of 1939 at the time the Securities&nbsp;are offered or issued (or such later time as may be permitted pursuant to the rules, regulations, interpretations or positions of the Commission) as contemplated by the Registration Statement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">
<div style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><img alt="mcdcmini.jpg" src="mcdcmini.jpg"></div>

<div style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: right;">Page 3</div>
</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 36pt;">We have also assumed that:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;prior to the time any particular Securities are issued or sold, the Board of Directors of the Company or a duly constituted and acting committee thereof (such Board of Directors or committee thereof being hereinafter collectively referred to as the &#8220;<u>Board</u>&#8221;) will have duly authorized and taken all necessary corporate action in conformity with Nevada law, the Articles of Incorporation and the Bylaws to approve:&nbsp;(i) the pricing, terms, and conditions of the offering, issuance and sale of such Securities and the adequacy of the consideration for such Securities; (ii) the form and terms of all relevant agreements, instruments, or other documents relating to the offering, issuance, or sale of such Securities, including, without limitation, any applicable purchase agreements, underwriting agreement, subscription agreements, warrant agreements, unit agreements or similar agreements with any underwriters or purchasers of Common Shares, Preferred Shares, or other Securities, and any other any other applicable indentures, certificates, instruments, or other documents evidencing any such Securities or governing the offer, sale, or issuance of such Securities or the conversion, exchange or exercise thereof (each a &#8220;<u>Securities Document</u>&#8221; and collectively, the &#8220;<u>Securities Documents</u>&#8221;); (iii) the execution, delivery and performance by the Company of the applicable agreements, instruments and other Securities Documents; and (v) the execution, authentication, issuance and delivery of such Securities by the Company and the relevant certificates or other documents evidencing such Securities, as applicable, either (A) against payment in full of all consideration therefor pursuant to and in accordance with the terms and conditions of the relevant agreements and other Securities Documents governing the offer, sale, or issuance of such Securities; or (B) upon the conversion, exchange or exercise of any other issued and outstanding Security entitling the holder thereof to acquire any such particular Securities and against payment in full of the exercise price or other requisite consideration for such Securities pursuant to and in accordance with the terms and conditions of any such convertible, exchangeable, or exercisable Security and the applicable Securities Document governing the conversion, exchange, or exercise thereof;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;all relevant agreements, instruments, or other Securities Documents relating to the offering, issuance, or sale of any particular Securities will, in each case, have been duly authorized, executed and delivered by the Company and the purchaser, indenture trustee, warrant agent, unit agent, other relevant counter-party or counter-parties to such Securities Documents, as applicable and the obligations of each party to such Securities Documents, as applicable, will constitute valid and binding obligations of such party, enforceable in accordance with their respective terms;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;with respect to any Common Shares or Preferred Shares to be offered or issued (including any Common Shares or Preferred Shares issued or issuable upon the conversion, exercise, or exchanged of any other Security), prior to and at the time of each issuance of any such Common Shares or Preferred Shares, the Company will have a sufficient number of authorized shares of Common Stock or Preferred Stock available for such issuance, as applicable;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">
<div style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><img alt="mcdcmini.jpg" src="mcdcmini.jpg"></div>

<div style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: right;">Page 4</div>
</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;with respect to any series of Preferred Shares to be offered or issued (including any Preferred Shares issued or issuable pursuant to any Securities Documents or upon the conversion, exercise, or exchanged of any other Security), prior to the issuance of such Preferred Shares, (i) the voting powers, designations, preferences, limitations, restrictions, and relative rights of such series of Preferred Stock will&nbsp;have be established by a resolution of the Board pursuant to the provisions contained in the Company&#8217;s then-effective Articles of Incorporation; and (ii) a certificate of designation, in the form prescribed by Nevada law, setting forth such resolution and the authorized number of Preferred Shares for such series of Preferred Stock (each, a &#8220;<u>Certificate of Designation</u>&#8221;) will have been duly signed by an authorized officer of the Company, appropriately filed with the Nevada Secretary of State, and will have become effective in accordance with applicable law; and</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(e)&nbsp;&nbsp;&nbsp;&nbsp;the Sales Agreement has been duly authorized, executed and delivered by the counter-party or counter-parties to such Sales Agreement, and the obligations of each party to Sales Agreement, including the Company, will constitute valid and binding obligations of such party, enforceable in accordance with their respective terms.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Based upon, subject to and limited by the foregoing and the qualifications set forth in subsequent portions of this opinion letter, as of the date hereof, we are of the opinion that:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 39pt; text-align: justify;">1.&nbsp;&nbsp;&nbsp;&nbsp;The Common Shares will be validly issued, fully paid and nonassessable shares of Common Stock, when (A) the Board has taken all necessary corporate action in conformity with Nevada law, the Articles of Incorporation and the Bylaws to approve the issuance of such Common Shares, the pricing and terms of the offering, sale and issuance thereof and related matters, including the terms of any applicable purchase, underwriting or similar agreement and any other relevant Securities Documents governing the offer, sale, or issuance of such Common Shares, and (B) when stock certificates or book entry positions representing such Common Shares have been duly executed, registered in the books and records of the Company and delivered, either (i) against payment of the consideration for such Common Shares (not less than the par value of the Common Stock) as approved by the Board and in accordance with the terms of the applicable definitive purchase, underwriting or similar agreement and other Security Documents governing the offer, sale, or issuance of such Common Shares; or (ii) upon the conversion, exchange or exercise of any other Security entitling the holder thereof to acquire any such Common Shares and against payment in full of the exercise price or other requisite consideration for such Common Shares (not less than the par value of the Common Stock), in accordance with the terms of any such other convertible, exchangeable, or exercisable Security and the applicable Securities Documents governing the conversion, exchange or exercise thereof.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.&nbsp;&nbsp;&nbsp;&nbsp;The Preferred Shares will be validly issued, fully paid and nonassessable shares of Preferred Stock, when (A) the Board has taken all necessary corporate action in conformity with Nevada law, the Articles of Incorporation and the Bylaws to approve the issuance and terms of a particular series of Preferred Shares and the pricing and terms of the offering, sale and issuance thereof and related matters, including (i) the rights, preferences, privileges, restrictions, terms and conditions thereof, (ii) the adoption of a Certificate of Designation for such series of Preferred Shares which has been appropriately filed with the Secretary of State of the State of Nevada and become effective in accordance with applicable law prior to any issuance of such Preferred Shares, and (iii) the terms of any applicable purchase, underwriting or similar agreement and any other applicable Securities Documents governing the offer, sale, or issuance of such Preferred Shares, and (B) when stock certificates or book entry positions representing such Preferred Shares have been duly executed, registered in the books and records of the Company and delivered, either (i) against payment of the consideration therefor (not less than the par value of the Preferred Stock) as approved by the Board and in accordance with the terms of the applicable definitive purchase, underwriting or similar agreement and other Security Documents governing the offer, sale, or&nbsp;issuance of such Preferred Shares; or (ii) upon the conversion, exchange or exercise of any other Security entitling the holder thereof to acquire any such Preferred Shares and against payment in full of the exercise price or other requisite consideration for such Preferred Shares (not less than the par value of the Preferred Stock), in accordance with the terms of any such other convertible, exchangeable, or exercisable Security and the applicable Securities Documents governing the conversion, exchange or exercise thereof.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">
<div style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><img alt="mcdcmini.jpg" src="mcdcmini.jpg"></div>

<div style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: right;">Page 5</div>
</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">3.&nbsp;&nbsp;&nbsp;&nbsp;The Debt Securities will constitute binding obligations of the Company, when (A) the indenture relating to a particular series of such Debt Securities has been duly authorized, executed and delivered by the Company, (B) the Board has taken all necessary corporate action in conformity with Nevada law, the Articles of Incorporation and the Bylaws to approve the issuance and terms of such series of Debt Securities, the terms of the offering thereof and related matters, and (C) such Debt Securities have been duly executed, authenticated, issued and delivered, either (i) in accordance with the indenture, applicable definitive purchase, underwriting or similar agreement approved by the Board against payment of the consideration therefor as provided therein; or (ii) upon the conversion, exchange or exercise of any other Security and against payment of the exercise price or other requisite consideration for such Debt Securities in accordance with the terms of any such other convertible, exchangeable, or exercisable Security and the applicable Securities Documents governing the conversion, exchange or exercise thereof.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">4.&nbsp;&nbsp;&nbsp;&nbsp;The Rights will constitute binding obligations of the Company, when (A) the Board has taken all necessary corporate action in conformity with Nevada law, the Articles of Incorporation and the Bylaws to approve the form, terms, execution and delivery of a rights agreement (including a form of certificate evidencing the Rights and the other relevant Securities Documents governing the offering and issuance thereof), the issuance of the Rights, the terms of the offering thereof (including the consideration for which Common Shares, Preferred Shares or other Securities are to be issued in connection therewith) and related matters, and (B) the certificates evidencing Rights with such terms are duly executed, attested, issued and delivered by duly a authorized officer of the Company against payment of the consideration therefor in accordance with the provisions of the applicable rights agreement, the applicable definitive purchase, underwriting or similar agreement, and the other relevant Securities Documents governing the offering and issuance of such Rights.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">5.&nbsp;&nbsp;&nbsp;&nbsp;The Warrants will constitute binding obligations of the Company, when (A) the Board has taken all necessary corporate action in conformity with Nevada law, the Articles of Incorporation and the Bylaws to approve the form, terms, execution and delivery of a warrant agreement (including a form of certificate evidencing the Warrants and the other relevant Securities Documents governing the offering and issuance thereof), the issuance of such Warrants, the terms of the offering thereof (including the consideration for which Common Shares, Preferred Shares or other Securities are to be issued in connection therewith) and related matters, and (B) the certificates evidencing the Warrants with such terms are duly executed, attested, issued and delivered by a duly authorized officer of the Company against payment of the consideration therefor in accordance with the provisions of the applicable warrant agreement and the applicable definitive purchase, underwriting or similar agreement, and the other relevant Securities Documents governing the offering and issuance of such Warrants.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">6.&nbsp;&nbsp;&nbsp;&nbsp;The Units will constitute binding obligations of the Company, when (A) the Board has taken all necessary corporate action in conformity with Nevada law, the Articles of Incorporation and the Bylaws to approve the form, terms, execution and delivery of a unit agreement (including a form of certificate evidencing the Units and the other relevant Securities Documents governing the offering and&nbsp;issuance thereof), the issuance of the Units, the terms of the offering thereof and related matters, and (B) the certificates evidencing such Units with such terms are duly executed, attested, issued and delivered by a duly authorized officer of the Company against payment of the consideration therefor in accordance with the provisions of the applicable unit agreement, the applicable definitive purchase, underwriting or similar agreement and the other relevant Securities Documents governing the offering and issuance of such Units.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">
<div style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><img alt="mcdcmini.jpg" src="mcdcmini.jpg"></div>

<div style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: right;">Page 6</div>
</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The ATM Shares will be validly issued, fully paid and nonassessable shares of Common Stock, when (A) issued in accordance with the terms and conditions described in the Sales Agreement and the ATM Prospectus Supplement, and (B) when stock certificates or book entry positions representing such ATM Shares have been duly executed, registered in the books and records of the Company and delivered.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We are qualified to practice law in the State of Nevada. The opinions set forth herein are expressly limited to and based exclusively on the general corporate laws of the State of Nevada, and we do not purport to be experts on, or to express any opinion with respect to the applicability or effect of, the laws of any other jurisdiction. We express no opinion herein concerning, and we assume no responsibility as to the laws or judicial decisions related to, or any orders, consents or other authorizations or approvals as may be required by, any federal laws, rules or regulations, including, without limitation, any federal securities or bankruptcy laws, rules or regulations, any state securities or &#8220;blue sky&#8221; laws, rules or regulations or any state laws regarding fraudulent transfers. Our opinion is rendered as of the date hereof, and we assume no obligation to advise you of changes in law or fact (or the effect thereof on the opinions expressed herein) that hereafter may come to our attention.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">This opinion is issued in the State of Nevada. By issuing this opinion, McDonald Carano LLP (i) shall not be deemed to be transacting business in any other state or jurisdiction other than the State of Nevada and (ii) does not consent to the jurisdiction of any state other than the State of Nevada. Any claim or cause of action arising out of the opinions expressed herein must be brought in the State of Nevada. Your acceptance of this opinion shall constitute your agreement to the foregoing.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We hereby consent to the filing of this opinion as part of the Registration Statement and to the reference to our firm therein under the caption &#8220;Legal Matters.&#8221; In giving this consent, we do not admit that we are within the category of persons whose consent is required by Section 7 of the Act or the rules and regulations of the Commission promulgated thereunder.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Sincerely,</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><img alt="mcdcsig.jpg" src="mcdcsig.jpg"></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">MCDONALD CARANO LLP</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>5
<FILENAME>ex_869506.htm
<DESCRIPTION>EXHIBIT 23.2
<TEXT>
<html><head>
	<title>ex_869506.htm</title>
	<!-- Generated by ThunderDome Portal - 11/18/2025 10:51:06 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size:10pt;font-family:'Times New Roman';padding:0in .1in;">
<p style="margin: 0px 0pt; text-align: right; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt"><b>Exhibit 23.2</b></font></p>

<p style="margin: 0px 0pt; text-align: left; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</b></p>

<p style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; margin: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">We hereby consent to the incorporation by reference in the Prospectus constituting a part of this registration statement of our report dated March 6, 2025, relating to the consolidated financial statements of Comstock Inc. (the &#8220;Company&#8221;) appearing in the Company&#8217;s Annual Report on Form&nbsp;10-K&nbsp;for the year ended December&nbsp;31, 2024.&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">We also consent to the reference to us under the caption &#8220;Experts&#8221; in the Prospectus.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">/s/ Assure CPA LLC</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Spokane, Washington</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">November 21, 2025</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.3
<SEQUENCE>6
<FILENAME>ex_875602.htm
<DESCRIPTION>EXHIBIT 23.3
<TEXT>
<html><head>
	<title>ex_875602.htm</title>

	<!-- Generated by ThunderDome Portal - 10/30/2025 6:04:30 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;">
<p style="margin: 0px 0pt; text-align: right; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt"><b>Exhibit 23.3</b></font></p>

<p style="margin: 0px 0pt; text-align: right; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&nbsp;</p>

<div style="text-align: center;"><img alt="header.jpg" src="header.jpg"></div>

<p style="margin: 0px 0pt; text-align: left; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&nbsp;</p>

<p style="margin: 0px 0pt; text-align: left; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">October 22, 2025</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Robert E. Cameron, Ph.D.</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Senior Associate of Behre Dolbear &amp; Company (USA), Inc.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Comstock Inc. Form 10-K Consent Letter</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The undersigned hereby consent to (i) the references to, and the information derived from, the technical report entitled TECHNICAL REPORT SUMMARY DAYTON CONSOLIDATED PROJECT LYON COUNTY, NEVADA, USA dated effective November 30, 2022; and (ii) the references, as applicable, to the undersigned names included in or incorporated by reference in their Annual Report for the Fiscal Year ending December 31, 2024 on Form 10-K and constituting a part of this registration statement, which was filed by Comstock Inc. with the United States Securities and Exchange Commission, and any amendments thereto.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Robert Cameron, Ph.D., a Senior Associate of Behre Dolbear &amp; Company (USA), Inc., is responsible for authoring the Technical Report Summary and has read the Annual Report and consents to references to Robert Cameron, Ph.D. or Behre Dolbear &amp; Company (USA), Inc., as applicable.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 100%;">

		<tr>
			<td style="width: 30%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Original Signed and Sealed by</i></p>

			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Robert E. Cameron, Ph.D., MMSA</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Senior Associate of</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Behre Dolbear &amp; Company (USA), Inc.</p>

			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">October 22, 2025</p>
			</td>
			<td style="width: 70%; vertical-align: middle;">
			<div><img alt="seal.jpg" src="seal.jpg"></div>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Original Signed and Sealed by</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">H. John Head</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Member, Executive Committee</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Behre Dolbear Group, Inc.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">October 22, 2025</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 100%;">

		<tr>
			<td style="width: 30%;">Office: +1 (303) 620 0020</td>
			<td style="width: 70%;">&#8226; <u>inquiry@dolbear.com</u> &#8226; <u>www.dolbear.com</u></td>
		</tr>
		<tr>
			<td colspan="2" style="text-align: justify; width: 30%;">Behre Dolbear Group, Inc. &nbsp; 4255 South Buckley Road, #425 &nbsp; Aurora, Colorado 80013 USA</td>
		</tr>

</table>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>7
<FILENAME>ex_869180.htm
<DESCRIPTION>EXHIBIT FILING FEES
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:ffd="http://xbrl.sec.gov/ffd/2025">
  <head>
    <title>EX-FILING FEES</title>
  </head>
  <body>
    <div style="display: none">
      <ix:header>
        <ix:hidden>
          <ix:nonNumeric name="ffd:FormTp" contextRef="rc" id="ixv-449">S-3</ix:nonNumeric>
          <ix:nonNumeric name="ffd:SubmissnTp" contextRef="rc" id="ixv-450">S-3</ix:nonNumeric>
          <ix:nonNumeric name="ffd:FeeExhibitTp" contextRef="rc" id="ixv-451">EX-FILING FEES</ix:nonNumeric>
          <ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="rc" id="ixv-452">0001120970</ix:nonNumeric>
          <ix:nonNumeric name="dei:EntityRegistrantName" contextRef="rc" id="ixv-453">Comstock Inc.</ix:nonNumeric>
          <ix:nonNumeric name="ffd:OfferingTableNa" contextRef="rc" id="hiddenrcOfferingTableNa" xsi:nil="true"></ix:nonNumeric>
          <ix:nonNumeric name="ffd:OffsetTableNa" contextRef="rc" id="hiddenrcOffsetTableNa">N/A</ix:nonNumeric>
          <ix:nonNumeric name="ffd:CombinedProspectusTableNa" contextRef="rc" id="hiddenrcCombinedProspectusTableNa">N/A</ix:nonNumeric>
          <ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_7" id="ixv-457">0.0001381</ix:nonFraction>
        </ix:hidden>
        <ix:references>
          <link:schemaRef xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd" xlink:type="simple"/>
        </ix:references>
        <ix:resources>
          <xbrli:context id="rc">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0001120970</xbrli:identifier>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-11-21</xbrli:startDate>
              <xbrli:endDate>2025-11-21</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="offrl_1">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0001120970</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                  <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-11-21</xbrli:startDate>
              <xbrli:endDate>2025-11-21</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="offrl_2">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0001120970</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                  <dei:lineNo>2</dei:lineNo>
                </xbrldi:typedMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-11-21</xbrli:startDate>
              <xbrli:endDate>2025-11-21</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="offrl_3">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0001120970</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                  <dei:lineNo>3</dei:lineNo>
                </xbrldi:typedMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-11-21</xbrli:startDate>
              <xbrli:endDate>2025-11-21</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="offrl_4">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0001120970</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                  <dei:lineNo>4</dei:lineNo>
                </xbrldi:typedMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-11-21</xbrli:startDate>
              <xbrli:endDate>2025-11-21</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="offrl_5">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0001120970</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                  <dei:lineNo>5</dei:lineNo>
                </xbrldi:typedMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-11-21</xbrli:startDate>
              <xbrli:endDate>2025-11-21</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="offrl_6">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0001120970</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                  <dei:lineNo>6</dei:lineNo>
                </xbrldi:typedMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-11-21</xbrli:startDate>
              <xbrli:endDate>2025-11-21</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="offrl_7">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0001120970</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                  <dei:lineNo>7</dei:lineNo>
                </xbrldi:typedMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-11-21</xbrli:startDate>
              <xbrli:endDate>2025-11-21</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="offrl_8">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0001120970</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                  <dei:lineNo>8</dei:lineNo>
                </xbrldi:typedMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-11-21</xbrli:startDate>
              <xbrli:endDate>2025-11-21</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:unit id="USD">
            <xbrli:measure>iso4217:USD</xbrli:measure>
          </xbrli:unit>
          <xbrli:unit id="pure">
            <xbrli:measure>xbrli:pure</xbrli:measure>
          </xbrli:unit>
          <xbrli:unit id="Shares">
            <xbrli:measure>xbrli:shares</xbrli:measure>
          </xbrli:unit>
        </ix:resources>
      </ix:header>
    </div>
    <div>
      <table style="width: 99%; font-family: Arial, Helvetica, sans-serif; font-size: 20pt; text-align: center;">
        <tr>
          <td colspan="4" style="padding-bottom: .5em">
            <p>
              <b>Calculation of Filing Fee Tables</b>
            </p>
          </td>
        </tr>
        <tr>
          <td style="padding-bottom: .25em">
            <p>
              <b>
                <ix:nonNumeric name="ffd:FormTp" contextRef="rc" id="ixv-545">S-3</ix:nonNumeric>
              </b>
            </p>
          </td>
        </tr>
        <tr>
          <td style="padding-bottom: .25em">
            <p>
              <b>
                <ix:nonNumeric name="dei:EntityRegistrantName" contextRef="rc" id="ixv-546">Comstock Inc.</ix:nonNumeric>
              </b>
            </p>
          </td>
        </tr>
      </table>
    </div>
    <div style="padding-bottom: 20px;">
      <table style="float: center; width: 100%; text-align: left;  ">
        <tr style="font-family: Arial, Helvetica, sans-serif; font-size: 16px">
          <th style="vertical-align: bottom; text-align: left; word-wrap: break-word">
            <b>Table 1: Newly Registered and Carry Forward Securities</b>
          </th>
          <th style="vertical-align: bottom; word-wrap: break-word; text-align: right;">
            <span style="-sec-ix-hidden: hiddenrcOfferingTableNa">&#9744;Not Applicable</span>
          </th>
        </tr>
      </table>
      <table style="font-family: Arial, Helvetica, sans-serif; float: center; width: 100%; text-align: center; border: 1px solid black; font-size: 16px;">
        <tr style="background-color:#9ADAF6">
          <th style="width: 12%;">
            <!-- BLANK -->
          </th>
          <th style="width: 2%;">
            <!-- BLANK -->
          </th>
          <th style="width: 12%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Security Type</b>
            </p>
          </th>
          <th style="width: 14%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Security Class Title </b>
            </p>
          </th>
          <th style="width: 2%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Fee Calculation or Carry Forward Rule</b>
            </p>
          </th>
          <th style="width: 5%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Amount Registered</b>
            </p>
          </th>
          <th style="width: 15%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Proposed Maximum Offering Price Per Unit</b>
            </p>
          </th>
          <th style="width: 10%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Maximum Aggregate Offering Price</b>
            </p>
          </th>
          <th style="width: 5%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Fee Rate</b>
            </p>
          </th>
          <th style="width: 6%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Amount of Registration Fee</b>
            </p>
          </th>
          <th style="width: 1%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Carry Forward Form Type</b>
            </p>
          </th>
          <th style="width: 7%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Carry Forward File Number</b>
            </p>
          </th>
          <th style="width: 6%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Carry Forward Initial Effective Date</b>
            </p>
          </th>
          <th style="width: 7%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward</b>
            </p>
          </th>
        </tr>
        <tr>
          <td colspan="14" style="text-align: center">
            <b>Newly Registered Securities</b>
          </td>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="offrl_1" format="ixt:booleanfalse" id="ixv-547">Fees to be Paid</ix:nonNumeric>
          </td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="offrl_1" id="ixv-548">Equity</ix:nonNumeric>
          </td>
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="offrl_1" id="ixv-549">Common stock, $0.000666 per share</ix:nonNumeric>
          </td>
          <td style="text-align: center;">
            <ix:nonNumeric name="ffd:Rule457oFlg" contextRef="offrl_1" format="ixt:booleantrue" id="ixv-550">457(o)</ix:nonNumeric>
          </td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">
            <span>$</span>
            <ix:nonFraction name="ffd:MaxOfferingPricPerScty" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_1" id="ixv-551">0.00</ix:nonFraction>
          </td>
          <td style="text-align: right;">
            <span>$</span>
            <ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_1" id="ixv-552">0.00</ix:nonFraction>
          </td>
          <td style="text-align: right;">
            <ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_1" id="ixv-553">0.0001381</ix:nonFraction>
          </td>
          <td style="text-align: right;">
            <span>$</span>
            <ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_1" id="ixv-554">0.00</ix:nonFraction>
          </td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: right;">

	</td>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="offrl_2" format="ixt:booleanfalse" id="ixv-555">Fees to be Paid</ix:nonNumeric>
          </td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="offrl_2" id="ixv-556">Equity</ix:nonNumeric>
          </td>
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="offrl_2" id="ixv-557">Preferred stock, $0.000666 per share</ix:nonNumeric>
          </td>
          <td style="text-align: center;">
            <ix:nonNumeric name="ffd:Rule457oFlg" contextRef="offrl_2" format="ixt:booleantrue" id="ixv-558">457(o)</ix:nonNumeric>
          </td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">
            <span>$</span>
            <ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_2" id="ixv-559">0.00</ix:nonFraction>
          </td>
          <td style="text-align: right;">
            <ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_2" id="ixv-560">0.0001381</ix:nonFraction>
          </td>
          <td style="text-align: right;">
            <span>$</span>
            <ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_2" id="ixv-561">0.00</ix:nonFraction>
          </td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: right;">

	</td>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="offrl_3" format="ixt:booleanfalse" id="ixv-562">Fees to be Paid</ix:nonNumeric>
          </td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="offrl_3" id="ixv-563">Debt</ix:nonNumeric>
          </td>
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="offrl_3" id="ixv-564">Debt securities</ix:nonNumeric>
          </td>
          <td style="text-align: center;">
            <ix:nonNumeric name="ffd:Rule457oFlg" contextRef="offrl_3" format="ixt:booleantrue" id="ixv-565">457(o)</ix:nonNumeric>
          </td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">
            <span>$</span>
            <ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_3" id="ixv-566">0.00</ix:nonFraction>
          </td>
          <td style="text-align: right;">
            <ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_3" id="ixv-567">0.0001381</ix:nonFraction>
          </td>
          <td style="text-align: right;">
            <span>$</span>
            <ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_3" id="ixv-568">0.00</ix:nonFraction>
          </td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: right;">

	</td>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="offrl_4" format="ixt:booleanfalse" id="ixv-569">Fees to be Paid</ix:nonNumeric>
          </td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="offrl_4" id="ixv-570">Other</ix:nonNumeric>
          </td>
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="offrl_4" id="ixv-571">Rights</ix:nonNumeric>
          </td>
          <td style="text-align: center;">
            <ix:nonNumeric name="ffd:Rule457oFlg" contextRef="offrl_4" format="ixt:booleantrue" id="ixv-572">457(o)</ix:nonNumeric>
          </td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">
            <span>$</span>
            <ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_4" id="ixv-573">0.00</ix:nonFraction>
          </td>
          <td style="text-align: right;">
            <ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_4" id="ixv-574">0.0001381</ix:nonFraction>
          </td>
          <td style="text-align: right;">
            <span>$</span>
            <ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_4" id="ixv-575">0.00</ix:nonFraction>
          </td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: right;">

	</td>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="offrl_5" format="ixt:booleanfalse" id="ixv-576">Fees to be Paid</ix:nonNumeric>
          </td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="offrl_5" id="ixv-577">Other</ix:nonNumeric>
          </td>
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="offrl_5" id="ixv-578">Units</ix:nonNumeric>
          </td>
          <td style="text-align: center;">
            <ix:nonNumeric name="ffd:Rule457oFlg" contextRef="offrl_5" format="ixt:booleantrue" id="ixv-579">457(o)</ix:nonNumeric>
          </td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">
            <span>$</span>
            <ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_5" id="ixv-580">0.00</ix:nonFraction>
          </td>
          <td style="text-align: right;">
            <ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_5" id="ixv-581">0.0001381</ix:nonFraction>
          </td>
          <td style="text-align: right;">
            <span>$</span>
            <ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_5" id="ixv-582">0.00</ix:nonFraction>
          </td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: right;">

	</td>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="offrl_6" format="ixt:booleanfalse" id="ixv-583">Fees to be Paid</ix:nonNumeric>
          </td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="offrl_6" id="ixv-584">Other</ix:nonNumeric>
          </td>
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="offrl_6" id="ixv-585">Warrants</ix:nonNumeric>
          </td>
          <td style="text-align: center;">
            <ix:nonNumeric name="ffd:Rule457oFlg" contextRef="offrl_6" format="ixt:booleantrue" id="ixv-586">457(o)</ix:nonNumeric>
          </td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">
            <span>$</span>
            <ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_6" id="ixv-587">0.00</ix:nonFraction>
          </td>
          <td style="text-align: right;">
            <ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_6" id="ixv-588">0.0001381</ix:nonFraction>
          </td>
          <td style="text-align: right;">
            <span>$</span>
            <ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_6" id="ixv-589">0.00</ix:nonFraction>
          </td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: right;">

	</td>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="text-align: left;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: left;">
            <span style="text-indent: 0px; display:inline-block; padding-left: 20px;">
              <ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="offrl_7" id="ixv-590">Other</ix:nonNumeric>
            </span>
          </td>
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="offrl_7" id="ixv-591">Unallocated (Universal) Shelf</ix:nonNumeric>
          </td>
          <td style="text-align: center;">
            <ix:nonNumeric name="ffd:Rule457oFlg" contextRef="offrl_7" format="ixt:booleantrue" id="ixv-592">457(o)</ix:nonNumeric>
          </td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: right;">

	</td>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="offrl_8" format="ixt:booleanfalse" id="ixv-593">Fees to be Paid</ix:nonNumeric>
          </td>
          <td style="text-align: center;">
		1
	</td>
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="offrl_8" id="ixv-594">Unallocated (Universal) Shelf</ix:nonNumeric>
          </td>
          <td style="text-align: left;">

	</td>
          <td style="text-align: center;">
            <ix:nonNumeric name="ffd:Rule457oFlg" contextRef="offrl_8" format="ixt:booleantrue" id="ixv-595">457(o)</ix:nonNumeric>
          </td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">
            <span>$</span>
            <ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_8" id="ixv-596">200,000,000.00</ix:nonFraction>
          </td>
          <td style="text-align: right;">
            <ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_8" id="ixv-597">0.0001381</ix:nonFraction>
          </td>
          <td style="text-align: right;">
            <span>$</span>
            <ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_8" id="ixv-598">27,620.00</ix:nonFraction>
          </td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: right;">

	</td>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="text-align: left;">
		Fees Previously Paid
	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: left;">

	</td>
          <td style="text-align: left;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: right;">

	</td>
        </tr>
        <tr>
          <td colspan="14" style="text-align: center">
            <b>Carry Forward Securities</b>
          </td>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="text-align: left;">
		Carry Forward Securities
	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: left;">

	</td>
          <td style="text-align: left;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: right;">

	</td>
        </tr>
        <tr>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td colspan="3" style="vertical-align: top">
            <p style="margin: 0pt; text-align: right">Total Offering Amounts:</p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td style="vertical-align: top; width: 16%;">
            <p id="MaxAggtOfferingPrice" style="margin: 0pt; text-align: right">
              <span>$</span>
              <ix:nonFraction name="ffd:TtlOfferingAmt" contextRef="rc" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-599">200,000,000.00</ix:nonFraction>
            </p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td style="vertical-align: top; border-bottom: 1px black; width: 16%;">
            <p id="TotalFeeAmt" style="margin: 0pt; text-align: right">
              <span>$</span>
              <ix:nonFraction name="ffd:TtlFeeAmt" contextRef="rc" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-600">27,620.00</ix:nonFraction>
            </p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
        </tr>
        <tr>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td colspan="3" style="vertical-align: top">
            <p style="margin: 0pt; text-align: right">
					Total Fees Previously Paid:
				</p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td style="vertical-align: top">
            <p id="TotalPreviouslyPaidAmt" style="margin: 0pt; text-align: right">
              <span>$</span>
              <ix:nonFraction name="ffd:TtlPrevslyPdAmt" contextRef="rc" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-601">0.00</ix:nonFraction>
            </p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
        </tr>
        <tr>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td colspan="3" style="vertical-align: top">
            <p style="margin: 0pt; text-align: right">
					Total Fee Offsets:
				</p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td style="vertical-align: top">
            <p id="TotalOffsetAmt" style="margin: 0pt; text-align: right">
              <span>$</span>
              <ix:nonFraction name="ffd:TtlOffsetAmt" contextRef="rc" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-602">0.00</ix:nonFraction>
            </p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
        </tr>
        <tr>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td colspan="3" style="vertical-align: top">
            <p style="margin: 0pt; text-align: right">
					Net Fee Due:
				</p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td style="vertical-align: top">
            <p id="NetFeeAmt" style="margin: 0pt; text-align: right">
              <span>$</span>
              <ix:nonFraction name="ffd:NetFeeAmt" contextRef="rc" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-603">27,620.00</ix:nonFraction>
            </p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
        </tr>
      </table>
    </div>
    <div>
      <table style="width: 100%; text-indent: 0px;">
        <tbody>
          <tr style="font-family: Arial, Helvetica, sans-serif; font-size: 16px; vertical-align: top;">
            <td>
              <p style="margin:0pt;text-align:left; margin-bottom: 5px;">
                <b>Offering Note</b>
              </p>
            </td>
            <td/>
          </tr>
        </tbody>
      </table>
    </div>
    <div style="padding-bottom: 20px;">
      <table style="width: 100%; text-indent: 0px;">
        <tr style="font-family: Arial, Helvetica, sans-serif; font-size: 16px; vertical-align: top;">
          <td style="width:10pt;">
            <p style="margin:0pt;text-align:left;">
              <sup style="vertical-align:top;line-height:120%;font-size:10px">1</sup>
            </p>
          </td>
          <td colspan="7" style="white-space: pre-line;">
            <ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="offrl_8" id="ixv-604">(1) We are registering under this registration statement such indeterminate number of shares of common stock and preferred stock, such indeterminate principal amount of debt securities, such indeterminate number of warrants to purchase common stock, preferred stock and/or debt securities, such indeterminate number of units and such indeterminate number of rights, as may be sold by the registrant from time to time, which together shall have an aggregate initial offering price not to exceed $200,000,000. If we issue any debt securities at an original issue discount, then the offering price of such debt securities shall be in such greater principal amount at maturity as shall result in an aggregate offering price not to exceed $200,000,000, less the aggregate dollar amount of all securities previously issued hereunder. We may sell any securities we are registering under this registration statement separately or as units with the other securities we are registering under this registration statement. We will determine, from time to time, the proposed maximum offering price per unit in connection with our issuance of the securities we are registering under this registration statement. The securities we are registering under this registration statement also include such indeterminate number of shares of common stock and preferred stock and amount of debt securities as we may issue upon conversion of or exchange for preferred stock or debt securities that provide for conversion or exchange, upon exercise of warrants or rights or pursuant to the antidilution provisions of any of such securities. In addition, pursuant to Rule 416 under the Securities Act of 1933, as amended (the "Securities Act"), the shares we are registering under this registration statement include such indeterminate number of shares of common stock and preferred stock as may be issuable with respect to the shares we are registering as a result of stock splits, stock dividends or similar transactions. (2) We will determine the proposed maximum aggregate offering price per class of security from time to time in connection with our issuance of the securities we are registering under this registration statement and we are not specifying such price as to each class of security pursuant to General Instruction II.D. of Form S-3 under the Securities Act. (3) Registration fee calculated pursuant to Rule 457(o) under the Securities Act, based on aggregated indeterminate number of securities to be sold by the registrant.</ix:nonNumeric>
          </td>
        </tr>
        <tr>
          <td colspan="7">
            <hr style="width:100%;text-align:left;margin-left:0"/>
          </td>
        </tr>
      </table>
    </div>
    <div style="padding-bottom: 20px;">
      <table style="float: center; width: 100%; text-align: left;  ">
        <tr style="font-family: Arial, Helvetica, sans-serif; font-size: 16px">
          <th style="vertical-align: bottom; text-align: left; word-wrap: break-word">
            <b>Table 2: Fee Offset Claims and Sources</b>
          </th>
          <th style="vertical-align: bottom; word-wrap: break-word; text-align: right;">
            <span style="-sec-ix-hidden: hiddenrcOffsetTableNa">&#9745;Not Applicable</span>
          </th>
        </tr>
      </table>
      <table style="font-family: Arial, Helvetica, sans-serif; font-size: 16px; float: center; width: 100%; text-align: center;  border: 1px solid black;">
        <tr style="background-color:#9ADAF6">
          <th style="width: 10%; text-align: left;">
            <!-- BLANK -->
          </th>
          <th style="width: 8%; text-align: left;">
            <!-- BLANK -->
          </th>
          <th style="width: 16%;">
				Registrant or Filer Name
			</th>
          <th style="width: 6%;">
				Form or Filing Type
			</th>
          <th style="width: 7%;">
				File Number
			</th>
          <th style="width: 6%;">
				Initial Filing Date
			</th>
          <th style="width: 6%;">
				Filing Date
			</th>
          <th style="width: 6%;">
				Fee Offset Claimed
			</th>
          <th style="width: 6%;">
				Security Type Associated with Fee Offset Claimed
			</th>
          <th style="width: 8%;">
				Security Title Associated with Fee Offset Claimed
			</th>
          <th style="width: 6%;">
				Unsold Securities Associated with Fee Offset Claimed
			</th>
          <th style="width: 9%;">
				Unsold Aggregate Offering Amount Associated with Fee Offset Claimed
			</th>
          <th style="width: 6%;">
				Fee Paid with Fee Offset Source
			</th>
        </tr>
        <tr>
          <td colspan="14" style="text-align: center">
            <b>Rules 457(b) and 0-11(a)(2)</b>
          </td>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="text-align: left;">
		Fee Offset Claims
	</td>
          <td>
		N/A
	</td>
          <td style="text-align: left;">
		N/A
	</td>
          <td>
		N/A
	</td>
          <td>
		N/A
	</td>
          <td>
		N/A
	</td>
          <td>
		N/A
	</td>
          <td style="text-align: right;">
		N/A
	</td>
          <td style="text-align: left;">
		N/A
	</td>
          <td style="text-align: left;">
		N/A
	</td>
          <td style="text-align: right;">
		N/A
	</td>
          <td style="text-align: right;">
		N/A
	</td>
          <td style="text-align: right;">
		N/A
	</td>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="text-align: left;">
		Fee Offset Sources
	</td>
          <td>
		N/A
	</td>
          <td style="text-align: left;">
		N/A
	</td>
          <td>
		N/A
	</td>
          <td>
		N/A
	</td>
          <td>
		N/A
	</td>
          <td>
		N/A
	</td>
          <td style="text-align: right;">
		N/A
	</td>
          <td style="text-align: left;">
		N/A
	</td>
          <td style="text-align: left;">
		N/A
	</td>
          <td style="text-align: right;">
		N/A
	</td>
          <td style="text-align: right;">
		N/A
	</td>
          <td style="text-align: right;">
		N/A
	</td>
        </tr>
        <tr>
          <td colspan="14" style="text-align: center">
            <b>Rule 457(p)</b>
          </td>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="text-align: left;">
		Fee Offset Claims
	</td>
          <td>
		N/A
	</td>
          <td style="text-align: left;">
		N/A
	</td>
          <td>
		N/A
	</td>
          <td>
		N/A
	</td>
          <td>
		N/A
	</td>
          <td>
		N/A
	</td>
          <td style="text-align: right;">
		N/A
	</td>
          <td style="text-align: left;">
		N/A
	</td>
          <td style="text-align: left;">
		N/A
	</td>
          <td style="text-align: right;">
		N/A
	</td>
          <td style="text-align: right;">
		N/A
	</td>
          <td style="text-align: right;">
		N/A
	</td>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="text-align: left;">
		Fee Offset Sources
	</td>
          <td>
		N/A
	</td>
          <td style="text-align: left;">
		N/A
	</td>
          <td>
		N/A
	</td>
          <td>
		N/A
	</td>
          <td>
		N/A
	</td>
          <td>
		N/A
	</td>
          <td style="text-align: right;">
		N/A
	</td>
          <td style="text-align: left;">
		N/A
	</td>
          <td style="text-align: left;">
		N/A
	</td>
          <td style="text-align: right;">
		N/A
	</td>
          <td style="text-align: right;">
		N/A
	</td>
          <td style="text-align: right;">
		N/A
	</td>
        </tr>
      </table>
    </div>
    <div style="padding-bottom: 20px;">
      <table style="float: center; width: 100%; text-align: left;  ">
        <tr style="font-family: Arial, Helvetica, sans-serif; font-size: 16px">
          <th style="vertical-align: bottom; text-align: left; word-wrap: break-word">
            <b>Table 3: Combined Prospectuses</b>
          </th>
          <th style="vertical-align: bottom; word-wrap: break-word; text-align: right;">
            <span style="-sec-ix-hidden: hiddenrcCombinedProspectusTableNa">&#9745;Not Applicable</span>
          </th>
        </tr>
      </table>
      <table style="font-family: Arial, Helvetica, sans-serif; font-size: 16px; float: center; width: 100%; border: 1px solid black;">
        <tr style="background-color:#9ADAF6">
          <th style="width: 4%">
            <!-- Note column -->
          </th>
          <th style="width: 14%">
            <p style="margin: 0pt; text-align: center;">
              <b>Security Type</b>
            </p>
          </th>
          <th style="width: 25%">
            <p style="margin: 0pt; text-align: center;">
              <b>Security Class Title</b>
            </p>
          </th>
          <th style="width: 14%">
            <p style="margin: 0pt; text-align: center;">
              <b>Amount of Securities Previously Registered</b>
            </p>
          </th>
          <th style="width: 18%">
            <p style="margin: 0pt; text-align: center;">
              <b>Maximum Aggregate Offering Price of Securities Previously Registered</b>
            </p>
          </th>
          <th style="width: 6%">
            <p style="margin: 0pt; text-align: center;">
              <b>Form Type</b>
            </p>
          </th>
          <th style="width: 10%">
            <p style="margin: 0pt; text-align: center;">
              <b>File Number</b>
            </p>
          </th>
          <th style="width: 8%">
            <p style="margin: 0pt; text-align: center;">
              <b>Initial Effective Date</b>
            </p>
          </th>
        </tr>
        <tr style="background-color:#E7E7E2;">
          <td style="text-align: center;">
		N/A
	</td>
          <td>
		N/A
	</td>
          <td>
		N/A
	</td>
          <td style="text-align: right;">
		N/A
	</td>
          <td style="text-align: right;">
		N/A
	</td>
          <td style="text-align: center;">
		N/A
	</td>
          <td style="text-align: center;">
		N/A
	</td>
          <td style="text-align: center;">
		N/A
	</td>
        </tr>
      </table>
    </div>
  </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>lode-20250630.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome XBRL - 11:11PM UTC 2025-11-20--><xsd:schema xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:currency="http://xbrl.sec.gov/currency/2025" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:ecd="http://xbrl.sec.gov/ecd/2025" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:exch="http://xbrl.sec.gov/exch/2025" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:lode="http://comstock.inc/20250630" xmlns:naics="http://xbrl.sec.gov/naics/2025" xmlns:sic="http://xbrl.sec.gov/sic/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:stpr="http://xbrl.sec.gov/stpr/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-types="http://fasb.org/us-types/2025" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://comstock.inc/20250630">
  <xsd:import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd"/>
  <xsd:import namespace="http://xbrl.sec.gov/ecd/2025" schemaLocation="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd"/>
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xsd:import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd"/>
  <xsd:import namespace="http://xbrl.sec.gov/exch/2025" schemaLocation="https://xbrl.sec.gov/exch/2025/exch-2025.xsd"/>
  <xsd:import namespace="http://xbrl.sec.gov/stpr/2025" schemaLocation="https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"/>
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xsd:import namespace="http://xbrl.sec.gov/currency/2025" schemaLocation="https://xbrl.sec.gov/currency/2025/currency-2025.xsd"/>
  <xsd:import namespace="http://xbrl.sec.gov/naics/2025" schemaLocation="https://xbrl.sec.gov/naics/2025/naics-2025.xsd"/>
  <xsd:import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd"/>
  <xsd:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xsd:import namespace="http://xbrl.org/2020/extensible-enumerations-2.0" schemaLocation="https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd"/>
  <xsd:import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd"/>
  <xsd:import namespace="http://xbrl.sec.gov/sic/2025" schemaLocation="https://xbrl.sec.gov/sic/2025/sic-2025.xsd"/>
  <xsd:import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd"/>
  <xsd:import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd"/>
  <xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lode-20250630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lode-20250630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lode-20250630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="statement-document-and-entity-information" roleURI="http://comstock.inc/20250630/role/statement-document-and-entity-information">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element abstract="true" id="lode_DocumentAndEntityInformation" name="DocumentAndEntityInformation" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="lode_NoteToFinancialStatementDetailsTextual" name="NoteToFinancialStatementDetailsTextual" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="lode_NotesToFinancialStatements" name="NotesToFinancialStatements" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="lode_NotesToFinancialStatementsAbstract" name="NotesToFinancialStatementsAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>lode-20250630_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome XBRL - 11:11PM UTC 2025-11-20--><link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple"/>
  <link:roleRef roleURI="http://comstock.inc/20250630/role/statement-document-and-entity-information" xlink:href="lode-20250630.xsd#statement-document-and-entity-information" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://comstock.inc/20250630/role/statement-document-and-entity-information" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" xlink:type="arc"/>
    <link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" xlink:type="arc"/>
    <link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" xlink:type="arc"/>
    <link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" xlink:type="arc"/>
    <link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" xlink:type="arc"/>
    <link:definitionArc order="12" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntitySmallBusiness" xlink:type="arc"/>
    <link:definitionArc order="13" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" xlink:type="arc"/>
    <link:definitionArc order="14" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" xlink:type="arc"/>
    <link:definitionArc order="15" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" xlink:type="arc"/>
    <link:definitionArc order="16" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCurrentReportingStatus" xlink:type="arc"/>
    <link:definitionArc order="17" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityInteractiveDataCurrent" xlink:type="arc"/>
    <link:definitionArc order="18" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityShellCompany" xlink:type="arc"/>
    <link:definitionArc order="19" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" xlink:type="arc"/>
    <link:definitionArc order="20" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" xlink:type="arc"/>
    <link:definitionArc order="21" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" xlink:type="arc"/>
    <link:definitionArc order="22" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" xlink:type="arc"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>lode-20250630_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome XBRL - 11:11PM UTC 2025-11-20--><link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="lode-20250630.xsd#lode_DocumentAndEntityInformation" xlink:label="lode_DocumentAndEntityInformation" xlink:type="locator"/>
    <link:label xlink:label="lode_DocumentAndEntityInformation-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document And Entity Information</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lode_DocumentAndEntityInformation" xlink:to="lode_DocumentAndEntityInformation-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
    <link:label xlink:label="dei_EntityIncorporationStateCountryCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
    <link:label xlink:label="dei_EntityCentralIndexKey-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
    <link:label xlink:label="dei_AmendmentFlag-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
    <link:label xlink:label="dei_EntityRegistrantName-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">dei_EntityRegistrantName</link:label>
    <link:label xlink:label="dei_EntityRegistrantName-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AccountingPoliciesAbstract-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract-label" xlink:type="arc"/>
    <link:loc xlink:href="lode-20250630.xsd#lode_NotesToFinancialStatements" xlink:label="lode_NotesToFinancialStatements" xlink:type="locator"/>
    <link:label xlink:label="lode_NotesToFinancialStatements-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notes To Financial Statements</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lode_NotesToFinancialStatements" xlink:to="lode_NotesToFinancialStatements-label" xlink:type="arc"/>
    <link:loc xlink:href="lode-20250630.xsd#lode_NotesToFinancialStatementsAbstract" xlink:label="lode_NotesToFinancialStatementsAbstract" xlink:type="locator"/>
    <link:label xlink:label="lode_NotesToFinancialStatementsAbstract-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notes To Financial Statements [Abstract]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lode_NotesToFinancialStatementsAbstract" xlink:to="lode_NotesToFinancialStatementsAbstract-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
    <link:label xlink:label="dei_CityAreaCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">dei_CityAreaCode</link:label>
    <link:label xlink:label="dei_CityAreaCode-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode-label" xlink:type="arc"/>
    <link:loc xlink:href="lode-20250630.xsd#lode_NoteToFinancialStatementDetailsTextual" xlink:label="lode_NoteToFinancialStatementDetailsTextual" xlink:type="locator"/>
    <link:label xlink:label="lode_NoteToFinancialStatementDetailsTextual-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note To Financial Statement Details Textual</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lode_NoteToFinancialStatementDetailsTextual" xlink:to="lode_NoteToFinancialStatementDetailsTextual-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:label xlink:label="dei_EntityDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityDomain" xlink:to="dei_EntityDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:label xlink:label="dei_LegalEntityAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StatementTable-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
    <link:label xlink:label="dei_EntityAddressAddressLine1-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">dei_EntityAddressAddressLine1</link:label>
    <link:label xlink:label="dei_EntityAddressAddressLine1-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" xlink:type="locator"/>
    <link:label xlink:label="dei_EntityInteractiveDataCurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
    <link:label xlink:label="dei_EntityAddressCityOrTown-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">dei_EntityAddressCityOrTown</link:label>
    <link:label xlink:label="dei_EntityAddressCityOrTown-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StatementEquityComponentsAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_EquityComponentDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
    <link:label xlink:label="dei_EntityAddressPostalZipCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">dei_EntityAddressPostalZipCode</link:label>
    <link:label xlink:label="dei_EntityAddressPostalZipCode-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
    <link:label xlink:label="dei_EntityAddressStateOrProvince-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">dei_EntityAddressStateOrProvince</link:label>
    <link:label xlink:label="dei_EntityAddressStateOrProvince-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" xlink:type="locator"/>
    <link:label xlink:label="dei_CurrentFiscalYearEndDate-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StatementLineItems-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:type="locator"/>
    <link:label xlink:label="dei_DocumentFiscalPeriodFocus-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" xlink:type="locator"/>
    <link:label xlink:label="dei_DocumentFiscalYearFocus-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
    <link:label xlink:label="dei_DocumentPeriodEndDate-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
    <link:label xlink:label="dei_EntityEmergingGrowthCompany-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
    <link:label xlink:label="dei_DocumentType-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">dei_DocumentType</link:label>
    <link:label xlink:label="dei_DocumentType-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" xlink:type="locator"/>
    <link:label xlink:label="dei_EntitySmallBusiness-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" xlink:type="locator"/>
    <link:label xlink:label="dei_EntityShellCompany-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PolicyTextBlockAbstract" xlink:label="us-gaap_PolicyTextBlockAbstract" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_PolicyTextBlockAbstract-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_PolicyTextBlockAbstract</link:label>
    <link:label xlink:label="us-gaap_PolicyTextBlockAbstract-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounting Policies</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PolicyTextBlockAbstract" xlink:to="us-gaap_PolicyTextBlockAbstract-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
    <link:label xlink:label="dei_DocumentInformationLineItems-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationLineItems-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
    <link:label xlink:label="dei_DocumentInformationTable-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationTable-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DisclosureTextBlockAbstract-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_DisclosureTextBlockAbstract</link:label>
    <link:label xlink:label="us-gaap_DisclosureTextBlockAbstract-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notes to Financial Statements</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_DisclosureTextBlockAbstract-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" xlink:type="locator"/>
    <link:label xlink:label="dei_EntityFilerCategory-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StatementClassOfStockAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
    <link:label xlink:label="dei_LocalPhoneNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">dei_LocalPhoneNumber</link:label>
    <link:label xlink:label="dei_LocalPhoneNumber-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" xlink:type="locator"/>
    <link:label xlink:label="dei_EntityCurrentReportingStatus-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_TableTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_TableTextBlock</link:label>
    <link:label xlink:label="us-gaap_TableTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notes Tables</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_TableTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
    <link:label xlink:label="dei_EntityTaxIdentificationNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber-label" xlink:type="arc"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>lode-20250630_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome XBRL - 11:11PM UTC 2025-11-20--><link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://comstock.inc/20250630/role/statement-document-and-entity-information" xlink:href="lode-20250630.xsd#statement-document-and-entity-information" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://comstock.inc/20250630/role/statement-document-and-entity-information" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber-2" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType-2" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName-2" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1-2" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown-2" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince-2" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode-2" xlink:type="arc"/>
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode-2" xlink:type="arc"/>
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber-2" xlink:type="arc"/>
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" xlink:type="arc"/>
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntitySmallBusiness" xlink:type="arc"/>
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" xlink:type="arc"/>
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" xlink:type="arc"/>
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" xlink:type="arc"/>
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCurrentReportingStatus" xlink:type="arc"/>
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityInteractiveDataCurrent" xlink:type="arc"/>
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityShellCompany" xlink:type="arc"/>
    <link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" xlink:type="arc"/>
    <link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" xlink:type="arc"/>
    <link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" xlink:type="arc"/>
    <link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" xlink:type="arc"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>header.jpg
<TEXT>
begin 644 header.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 L17AI9@  34T *@    @  0$Q  (
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M *.[O/\ PT?P-_\ G;4?\1#_ /P6"_Z.[O/_  T?P-_^=M7XJT5ZW^K^0_\
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M,5_\M\E]Q^U7_$0__P %@O\ H[N\_P##1_ W_P"=M1_Q$/\ _!8+_H[N\_\
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M,5_\M\E]Q^U7_$0__P %@O\ H[N\_P##1_ W_P"=M1_Q$/\ _!8+_H[N\_\
M#1_ W_YVU?BK11_J_D/_ $)<I_\ #?A/_E7DON#_ %CX@_Z'>;?^'#%?_+?)
M?<?M5_Q$/_\ !8+_ *.[O/\ PT?P-_\ G;4?\1#_ /P6"_Z.[O/_  T?P-_^
M=M7XJT4?ZOY#_P!"7*?_  WX3_Y5Y+[@_P!8^(/^AWFW_APQ7_RWR7W'[5?\
M1#__  6"_P"CN[S_ ,-'\#?_ )VU'_$0_P#\%@O^CN[S_P -'\#?_G;5^*M%
M'^K^0_\ 0ERG_P -^$_^5>2^X/\ 6/B#_H=YM_X<,5_\M\E]Q^U7_$0__P %
M@O\ H[N\_P##1_ W_P"=M1_Q$/\ _!8+_H[N\_\ #1_ W_YVU?BK11_J_D/_
M $)<I_\ #?A/_E7DON#_ %CX@_Z'>;?^'#%?_+?)?<?M5_Q$/_\ !8+_ *.[
MO/\ PT?P-_\ G;4?\1#_ /P6"_Z.[O/_  T?P-_^=M7XJT4?ZOY#_P!"7*?_
M  WX3_Y5Y+[@_P!8^(/^AWFW_APQ7_RWR7W'[5?\1#__  6"_P"CN[S_ ,-'
M\#?_ )VU'_$0_P#\%@O^CN[S_P -'\#?_G;5^*M%'^K^0_\ 0ERG_P -^$_^
M5>2^X/\ 6/B#_H=YM_X<,5_\M\E]Q^U7_$0__P %@O\ H[N\_P##1_ W_P"=
MM1_Q$/\ _!8+_H[N\_\ #1_ W_YVU?BK11_J_D/_ $)<I_\ #?A/_E7DON#_
M %CX@_Z'>;?^'#%?_+?)?<?M5_Q$/_\ !8+_ *.[O/\ PT?P-_\ G;4?\1#_
M /P6"_Z.[O/_  T?P-_^=M7XJT4?ZOY#_P!"7*?_  WX3_Y5Y+[@_P!8^(/^
MAWFW_APQ7_RWR7W'[5?\1#__  6"_P"CN[S_ ,-'\#?_ )VU'_$0_P#\%@O^
MCN[S_P -'\#?_G;5^*M%'^K^0_\ 0ERG_P -^$_^5>2^X/\ 6/B#_H=YM_X<
M,5_\M\E]Q^U7_$0__P %@O\ H[N\_P##1_ W_P"=M1_Q$/\ _!8+_H[N\_\
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M,5_\M\E]Q^U7_$0__P %@O\ H[N\_P##1_ W_P"=M1_Q$/\ _!8+_H[N\_\
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M,5_\M\E]Q^U7_$0__P %@O\ H[N\_P##1_ W_P"=M1_Q$/\ _!8+_H[N\_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M(GA8OVU/VGMZ<5.<'2YO:+EA*,W+EY.62]Z^B^?**_7+QW^PA^S!X7_X)J>
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MR3^1_P#8HRW_ -0Z)_,G$O\ R4.>?]C7'_\ J34"BBBO9/$"BBE4*64,2%+
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M,5W+JA6+[._B7PW\._\ !*/PQ\2O#7B#Q_\ &;]M/XA_#+0/$-CJVJ> +/\
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MQ]E+]Y6HM4?;498:-9RA+D<8U5R'Z?\ _!RU?:5X@^/7[$?C:_6W3XL^./\
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M[77;S1OAUXYU:\U=I+Z+1=/T!KBZTN=+R$CR;]B/XW^"?@9J?[3VI^,M>O\
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M=XBFD\0W2C1C4KVEB(TY5:F'_=<RJQ@OP'L?A/\ %75-*U?7=)^&'Q%U?0]
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M5RG*HK$QIYGSU*5#%5J;<\%&DY47%4Z3E]8YJDZC<E&-",Y5+1E!)2:C^?\
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M3P1POC,17Q>)ROVF(Q-6I7K5/KN8PYZM63G.7)3Q<81YI-OEA&,5>R26@?\
M$'%_UD8_\U$__*?H_P"(.+_K(Q_YJ)_^4_116W^OW%G_ $-O_+'+?_F,P_XA
M_P (_P#0H_\ +_,__FT/^(.+_K(Q_P":B?\ Y3]'_$'%_P!9&/\ S43_ /*?
MHHH_U^XL_P"AM_Y8Y;_\QA_Q#_A'_H4?^7^9_P#S:'_$'%_UD8_\U$__ "GZ
M/^(.+_K(Q_YJ)_\ E/T44?Z_<6?]#;_RQRW_ .8P_P"(?\(_]"C_ ,O\S_\
MFT/^(.+_ *R,?^:B?_E/T?\ $'%_UD8_\U$__*?HHH_U^XL_Z&W_ )8Y;_\
M,8?\0_X1_P"A1_Y?YG_\VA_Q!Q?]9&/_ #43_P#*?H_X@XO^LC'_ )J)_P#E
M/T44?Z_<6?\ 0V_\L<M_^8P_XA_PC_T*/_+_ #/_ .;0_P"(.+_K(Q_YJ)_^
M4_1_Q!Q?]9&/_-1/_P I^BBC_7[BS_H;?^6.6_\ S&'_ !#_ (1_Z%'_ )?Y
MG_\ -H?\0<7_ %D8_P#-1/\ \I^C_B#B_P"LC'_FHG_Y3]%%'^OW%G_0V_\
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MY;_\QA_Q#_A'_H4?^7^9_P#S:'_$'%_UD8_\U$__ "GZ/^(.+_K(Q_YJ)_\
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M_P#-1/\ \I^C_B#B_P"LC'_FHG_Y3]%%'^OW%G_0V_\ +'+?_F,/^(?\(_\
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M<6?]#;_RQRW_ .8P_P"(?\(_]"C_ ,O\S_\ FT/^(.+_ *R,?^:B?_E/T?\
M$'%_UD8_\U$__*?HHH_U^XL_Z&W_ )8Y;_\ ,8?\0_X1_P"A1_Y?YG_\VA_Q
M!Q?]9&/_ #43_P#*?H_X@XO^LC'_ )J)_P#E/T44?Z_<6?\ 0V_\L<M_^8P_
MXA_PC_T*/_+_ #/_ .;0_P"(.+_K(Q_YJ)_^4_1_Q!Q?]9&/_-1/_P I^BBC
M_7[BS_H;?^6.6_\ S&'_ !#_ (1_Z%'_ )?YG_\ -H?\0<7_ %D8_P#-1/\
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D9))=$D?6PHTZ<(4X1Y84X1A"-Y.T8)1BKMMNR25VVWU;9__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>logo02.jpg
<TEXT>
begin 644 logo02.jpg
M_]C_X  02D9)1@ ! @$ 2 !(  #_X0GT17AI9@  34T *@    @ !P$2  ,
M   !  $   $:  4    !    8@$;  4    !    :@$H  ,    !  (   $Q
M  (    4    <@$R  (    4    AH=I  0    !    G    ,@   !(
M 0   $@    !061O8F4@4&AO=&]S:&]P(#<N,  R,#(U.C R.C(X(#$Q.C4R
M.C0Q      .@ 0 #     ?__  "@ @ $     0   1.@ P $     0   #,
M        !@$#  ,    !  8   $:  4    !   !%@$;  4    !   !'@$H
M  ,    !  (   (!  0    !   !)@("  0    !   (Q@        !(
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M!0$! 0$! 0         #  $"! 4&!P@)"@L!  $% 0$! 0$!          $
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MO5?YZ\(224_07UYZ?G9S.B?8\=V3]FZMC9%S6CZ-3!9OL?\ R/<LZ_._QA]
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ME/\ _]G_[0XD4&AO=&]S:&]P(#,N,  X0DE-!"4      !
M        .$))30/M       0 $@    !  $ 2     $  3A"24T$)@
M#@             _@   .$))300-       $    >#A"24T$&0      !
M !XX0DE- _,       D           $ .$))300*       !   X0DE-)Q
M      H  0         !.$))30/T       2 #4    ! "T    &       !
M.$))30/W       <  #_____________________________ ^@  #A"24T$
M         @ !.$))300"       $     #A"24T$"       $     $   )
M   "0      X0DE-!!X       0     .$))300:      -)    !@
M        ,P   1,    * %4 ;@!T &D = !L &4 9  M #$    !
M                  $              1,    S
M  $                         $     $       !N=6QL     @    9B
M;W5N9'-/8FIC     0       %)C=#$    $     %1O<"!L;VYG
M  !,969T;&]N9P          0G1O;6QO;F<    S     %)G:'1L;VYG   !
M$P    9S;&EC97-6;$QS     4]B:F,    !       %<VQI8V4    2
M!W-L:6-E241L;VYG          =G<F]U<$E$;&]N9P         &;W)I9VEN
M96YU;0    Q%4VQI8V5/<FEG:6X    -875T;T=E;F5R871E9     !4>7!E
M96YU;0    I%4VQI8V54>7!E     $EM9R     &8F]U;F1S3V)J8P    $
M      !28W0Q    !     !4;W @;&]N9P          3&5F=&QO;F<
M     $)T;VUL;VYG    ,P    !29VAT;&]N9P   1,    #=7)L5$585
M  $       !N=6QL5$585     $       !-<V=E5$585     $       9A
M;'1486=415A4     0      #F-E;&Q497AT27-(5$U,8F]O; $    (8V5L
M;%1E>'1415A4     0      "6AO<GI!;&EG;F5N=6T    /15-L:6-E2&]R
M>D%L:6=N    !V1E9F%U;'0    )=F5R=$%L:6=N96YU;0    ]%4VQI8V56
M97)T06QI9VX    '9&5F875L=     MB9T-O;&]R5'EP965N=6T    115-L
M:6-E0D=#;VQO<E1Y<&4     3F]N90    ET;W!/=71S971L;VYG
M  IL969T3W5T<V5T;&]N9P         ,8F]T=&]M3W5T<V5T;&]N9P
M   +<FEG:'1/=71S971L;VYG       X0DE-!!$       $! #A"24T$%
M    !     (X0DE-! P     ".(    !    @    !@   &    D    ",8
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M1I2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V)S='5V=WAY>GM\?_V@ , P$
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M_1KK]E3OSO;OK]%G\_\ I[*JJ5XRDDI^@.B=+S<;Z]?6#-?CNJPLFK$;C6P
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M0DE-!"$      %4    ! 0    \ 00!D &\ 8@!E "  4 !H &\ = !O ',
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M(" @(" @(" @"CP_>'!A8VME="!E;F0])W<G/S[_[@ .061O8F4 9(
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M^QV_#%!R 1R0!N]/_C-_Z/;^^O$6#ZQ?7[ZP.#3ON=+H)(IHJ!T:/W:F[O\
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M]5^J/UG'1\UQ;C.O&/F8Q.YC2X[6W5:[?:[\_P#PU2G_ (X__%;7_P"$ZO\
MJKEJX/\ B;9F8.-E_M0L^T5,L+?1F/4:U^W^=_E(_P#XQS/_ "W/_; _]+KO
MNC=/KZ%T.C LN#Z\&HA][@& M;N>ZQS9LV;5Y%]:_KEU?ZW=4'2^E>H,![_3
MQ\6KZ5W_  MWT?I?3]/Z%7_@BT<+_$OUBZEK\S-IQ;")]-K76D']USMU;/\
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J._PO^?\ X->Q+__5]522222222222222222222222222222222227__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>logomd.jpg
<TEXT>
begin 644 logomd.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 L17AI9@  34T *@    @  0$Q  (
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MZ;'8:7:16UM&NT1HN 1[^I^M>(_&SP[!X1UG2?&'AQ5L;EKC;*L0VJ9!\P;
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M[M[N[L7MKJ0Y>:T?RRQ]2.03[XHHH KZ%\%?!NA7:72V<M]-&<H;V3>%/^Z
M ?Q%=/XG\,V'BS0)-'U,RK:R,K'R6"L-IR,'!HHH D\-^'[/PMH%MH^FF4VU
ML&"&5MS<L6.3@=R:P/%WPMT#QCJ\&J7SW=I>P@#S[*149L?=)RIY'8T44 ==
;:PM;VD4+323F- IEEQN? ZG  S^%%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>mcdc.jpg
<TEXT>
begin 644 mcdc.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 L17AI9@  34T *@    @  0$Q  (
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M/>@#T1&W(K#H1FLZPU,7>K:A9][1T'X%<UR%AXE\5/I\#6NCK- L857\MCO
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)J* "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>mcdcfooter.jpg
<TEXT>
begin 644 mcdcfooter.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 L17AI9@  34T *@    @  0$Q  (
M   *    &@    !'<F5E;G-H;W0 _]L 0P '!04&!00'!@4&" <'" H1"PH)
M"0H5#Q ,$1@5&AD8%1@7&QXG(1L=)1T7&"(N(B4H*2LL*QH@+S,O*C(G*BLJ
M_]L 0P$'" @*"0H4"PL4*AP8'"HJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ
M*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ_\  $0@ 3 'R P$B  (1 0,1 ?_$
M !\   $% 0$! 0$!           ! @,$!08'" D*"__$ +40  (! P,"! ,%
M!00$   !?0$" P $$042(3%!!A-180<B<10R@9&A""-"L<$54M'P)#-B<H()
M"A87&!D:)28G*"DJ-#4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T
M=79W>'EZ@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%
MQL?(R<K2T]35UM?8V=KAXN/DY>;GZ.GJ\?+S]/7V]_CY^O_$ !\!  ,! 0$!
M 0$! 0$        ! @,$!08'" D*"__$ +41  (! @0$ P0'!00$  $"=P !
M @,1! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:
M)B<H*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H*#
MA(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3
MU-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_:  P# 0 "$0,1 #\ ^D:*** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HS45P2+
M:4J2"$.,>N*\8T*S\3WR^%Q<^)]=C76K>Z^VC('D>7\R!25^0GID\D548WZB
M;L>V9IDLR00O+*P2-%+,Q/"@=37B,6O:U+I^D#Q5K&O:=IXLI MWI\#&6XN%
ME9<2$*2/D"D# !S5WQ5J=^MXL.H:OX@MM.;1U:P>UM3NO)R#N$P"<-C'RD <
M]JKD=Q<QZ[9WMOJ%G%=V4R3V\R!XY8VRKJ>A!]*GS7A*ZCJECH.BV]]J&N:3
M:QZ# VG+IMN6\^ZVG<LF%/(^4;3@8)YJSJ]QXQN(=8O[C5=4T^\TW2+.Y6UM
M1B-K@Y\P$8.?=11[/7<.8]LS5:SU*TU!IULKB.<V\IAF$;9\MQU4^AYKQ3Q1
MKVNQSZRUSJVOV6K)/&+"RLH&^S/;G9\V0I&>6R<@@\5--=:EI]Y>B2YU33-&
MG\0W)O[O3XF,P_=IY>,*2%+9R0#TI^STW#F/9K/4;34!,;*XCG$$K0R&-L['
M7JI]"/2K.:\(TR^U*T\/Q&2^UJST:YUJ[:^U""V(NR,#RB0%)4,<Y('85LZK
MJETFF^'3_;OB1/#\QG^T:DEL1=LX(\I7 3(4_-SMYP,TG#4.8]>S17B'A&]\
M5:KJ(/\ :>L2FVL;RX@BN04%S*LS+$L@(],<<?E4&EZYJSW^FBWUOQ'=7,EC
M=/J4%Y"R1PW A)"J=HZ-T )Z"CV;[AS'NV:*\6TRY\8Z;:V[V>IZGJEWJ'AI
M[SRKQ=PCN%9 H48&#ACP>I%:/@_Q%<6FK7-R-3US5-#@T[SKZ74K5]\-SN'R
MQC:"<@ME0"!CK2<':]PYCUBC->37FL74GCB\37-:\0Z;(+N,:7:Z=;%H)H"%
MPS?(0223NR1BJ>I:SXA3Q7=HM_K2:VNJ+'9:9%;DV4EIN'S,=N#E=Q+$@@]J
M%!L.8]EHKQ94\3W-TMVOB+6;<W/B2?3S O,<=MD\@%>V.&Z#BNZ^'<NH_P!F
MZK9ZK=W5XUCJMQ;03W?^L>)2-I)P-W4\T2A97N"=SKZ***@H**** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *1F"J6;@
M 9-+10!3_M?3SIPO_M<7V1ONS;OE/.,?7/&*;+K6FPVL5S+?0+#,<1R&08;Z
M?U]*Y.R7[+I&A7-W$PM;74KEYP8R?+W&94<CTRPY[9!J'2Y(+'Q)<ZG?P.FF
M72SBT+0L0"74M\N,C?C(XYQ56%<[J2[@B2-Y)5596"HQ/#$] /K2/?6T:3M)
M<1JMN,S$L/W?&>?3CFN773;IOAC%;R1NEW;VRS1H1\RLAWJOUX K$&DZE))9
M7$MM(&\33(^J)U^S[6\Q ?H@\OWHL%STE2&4$=#4=Q=0VJ*]Q(L:LZQJ3W9B
M H_$D"N L[O6Y-3A$]R8;\WI66$23L%B#G*^5M\L+LZ/]#DG(IH234M%-M<S
M7UVT&J69-VEQ,JS9E7) )!0@=5'"GIBBP7/0GGBBECBDD57E)"*3RV!DX_"H
M(]4LI;K[,EPAF\QH]G?<H!(_ $&LG7[B&QUO0Y[I_+ACDF#2-D@9B(&37/7M
MQYVOVLUY<WD=D+^X F@##;&85P-R\JI/<8^HI)!<]"HKSNZOM5#+';7-P=#^
MUNJ7-Q+*CLOEJ0#(HW[-Y?#'K@#..MG24U+4-2L(KV_O#9_Z0ZB*66/>H*!
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MVQ)HE3;OW!LX\P,!\NT#';.*>OAV^;3[^SBTW9;-<6[P+<>493MFW.-RD[D
MY&[YN2*+(+G5:CK$&G?9P8I;B6Y8K#%  6? R<9('3WJ=;^W^SPS3.MN)@"B
MSG8V3VP>_M69XDLWN[.. :;)>1;B<V\JQS0,!\KH20,@^_Y]*RH-+U2WF2YU
MS3%UN>:QBA<H8SY4@!WC#D#:Q()([CI2MH!T"ZW9/J$MH\J*8U0[W<!6W9P
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MS\H.<]B <8)'6M22>*(H)940NVU0S ;CZ#U-<VJZC?\ BB-]1TF\CL;.3%H
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MI;A8SYJS-.#N/WV7:3^55=;L],N26U-&;;$8\!B/E<@?S K8IC11NP+HK$<
MD4 <Y);Z--9L56=8Q=&7=&[*5D5<9!!XX%*R:-?3K'()Y)6A2'<[MG:&#*2?
M7)Z^QKHA#$%VB-<>F*3R(MV?+7/KB@#GI;C1G@O5=9BERP>?KRPP!].@HN_[
M$=KHW,3EIW1G?G.Y<8VGMC';WKH3;PDD^6N3[4"VA&<1)R<GY?\ /K0!CVB:
M?+KIN4\][GY@OF.2J# )VCH,\5N4Q8(E;<L:AO4"GT %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__
!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>mcdcmini.jpg
<TEXT>
begin 644 mcdcmini.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 L17AI9@  34T *@    @  0$Q  (
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M"I'0BE+ #)( ^M "T4@8$9!!'KF@,"< @GZT +12%E'5@/QI<CUH **3<"<
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D%% "BTMQTA3_ +YIPMX1TB0?\!HHH >J*OW5 ^@I:** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>mcdcsig.jpg
<TEXT>
begin 644 mcdcsig.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 L17AI9@  34T *@    @  0$Q  (
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LHD,QN/LJ'?,5V^8[,69L9.,DFMNBL_:SY'3OHVF_57M^;"RO<****R&?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>seal.jpg
<TEXT>
begin 644 seal.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 L17AI9@  34T *@    @  0$Q  (
M   *    &@    !'<F5E;G-H;W0 _]L 0P ! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M_]L 0P$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\  $0@ 9P$' P$B  (1 0,1 ?_$
M !\   $% 0$! 0$!           ! @,$!08'" D*"__$ +40  (! P,"! ,%
M!00$   !?0$" P $$042(3%!!A-180<B<10R@9&A""-"L<$54M'P)#-B<H()
M"A87&!D:)28G*"DJ-#4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T
M=79W>'EZ@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%
MQL?(R<K2T]35UM?8V=KAXN/DY>;GZ.GJ\?+S]/7V]_CY^O_$ !\!  ,! 0$!
M 0$! 0$        ! @,$!08'" D*"__$ +41  (! @0$ P0'!00$  $"=P !
M @,1! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:
M)B<H*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H*#
MA(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3
MU-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_:  P# 0 "$0,1 #\ _J*_9K^%
MOQ+_ &E=%^-?Q#\8?M??M7^%[[3?VOOVQ?AOH^@?#_QK\/M!\*Z)X-^%G[2?
MQ*^'_@G1=*TN^^%NLW$,&D>%?#VDZ=YL]_<W5TUNUU>7$]S-+*WT7_PQ9X@_
MZ/>_;C_\.;\,O_G,U@_\$X_^22_';_L_?_@H1_ZV/\9:_0&@#X<_X8L\0?\
M1[W[<?\ X<WX9?\ SF:/^&+/$'_1[W[<?_AS?AE_\YFON.FNP49)"\$[B0%
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M_P"%?_#C0?$'A>YLX]&^'WAF^L;W3M5O9KA9X+]5F1WAN8IXS&(BO0/VC_\
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M81^&Y?%,/BGQ?+--^T+\.M*U/5=9L_'NK:)J6LZWX2_,;QSX_P#C=\6OBO\
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M[4G@/_@H?XP_;$^$&I_ [P9\&OVP_@KIWP__ &^_V;#\1_'?V34OBEX>2_\
M#_A;X\_!GQ7:?!!+#7/'.F>"[JWT[5V\4^$_ B^)VBU&UU&>*YU5?$.G</\
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M*_$'5?V<O$OQ+^/'P.UN;2?C[\5O''[37@/P5%XV^&6CZE\"?%OA>QTOX:?
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MX(EL[:W2_4^CQZ)X,T;X)>(?B3HVLV5Y_P $W/%=EX)D^.\'A.X^(_@+P?\
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M?PMI'A;["@\;>&-;^&?PZ\6^%OBK9_$/Q/I/P-TKP9JVO:?XD^(_P_OOA/\
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M_K=E/;7$W&>'?^"IGP'\3_M+^)OV9K#X6?M407WA"Z\=IKWQSUG]GCQEX?\
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MYG-WIS]JZD54JJ%**H23YG-<O[H_&3_@I/\  [X0_$3]F+X;1^$_BM\5KO\
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M1T3PW9Z;JMQING:#::6^M:QI%UKGB>Y@U']H/C-^U3J_[9W_  3K^'M[X_\
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MNKOQ)K&MW>B^+O#6@?U??LW:3)X=_9W^ V@S>>9="^"_PMTF1KF9KBXDEL/
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M -4_X6_SS_/%%'[1_P#RD!_X)L?]>O[9G_JG_"U% S1_X)Q_\DE^.W_9^_\
MP4(_];'^,M?H   ,  #T P/RK\__ /@G'_R27X[?]G[_ /!0C_UL?XRU^@-
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MC]N#Q9\!/@!\-OAO\)_&/P+M?ACJ_P "/^"M/Q/\ >)/$NC:WXY9?CQ^S?\
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M>7V\:=2UZ<4OYX/'O@'_ (*?:9??'_PC\#+S]K34/" _9<_8@T7X8>)?CO\
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M"4<+0@O:4\(J/LO;>_)RH>SC&=22Y7*4Z4)T9O2].O7Y>6=1S7\[OQ,\&?\
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MCX=FN?!>K?#?7-1\/WEMI'BJTL[RQN]4NY4N;>5BZAA&GJ__  U3_P %2O\
MI$YX2_\ %A7PG_\ G0T44 '_  U3_P %2O\ I$YX2_\ %A7PG_\ G0T?\-4_
M\%2O^D3GA+_Q85\)_P#YT-%% !_PU3_P5*_Z1.>$O_%A7PG_ /G0T?\ #5/_
M  5*_P"D3GA+_P 6%?"?_P"=#110 ?\ #5/_  5*_P"D3GA+_P 6%?"?_P"=
M#1_PU3_P5*_Z1.>$O_%A7PG_ /G0T44 '_#5/_!4K_I$YX2_\6%?"?\ ^=#1
M_P -4_\ !4K_ *1.>$O_ !85\)__ )T-%% !_P -4_\ !4K_ *1.>$O_ !85
M\)__ )T-'_#5/_!4K_I$YX2_\6%?"?\ ^=#110 ?\-4_\%2O^D3GA+_Q85\)
M_P#YT-'_  U3_P %2O\ I$YX2_\ %A7PG_\ G0T44 '_  U3_P %2O\ I$YX
M2_\ %A7PG_\ G0T?\-4_\%2O^D3GA+_Q85\)_P#YT-%% !_PU3_P5*_Z1.>$
MO_%A7PG_ /G0T?\ #5/_  5*_P"D3GA+_P 6%?"?_P"=#110 ?\ #5/_  5*
M_P"D3GA+_P 6%?"?_P"=#2?\-4?\%2C@G_@DWX1)'0_\/"OA-Q]/^+0\444
M+_PU1_P5*_Z1.>$O_%A7PG_^=#1_PU3_ ,%2O^D3GA+_ ,6%?"?_ .=#110
M?\-4_P#!4K_I$YX2_P#%A7PG_P#G0T?\-4_\%2O^D3GA+_Q85\)__G0T44 '
M_#5/_!4K_I$YX2_\6%?"?_YT-'_#5/\ P5*_Z1.>$O\ Q85\)_\ YT-%% !_
MPU3_ ,%2O^D3GA+_ ,6%?"?_ .=#1_PU3_P5*_Z1.>$O_%A7PG_^=#110 ?\
M-4_\%2O^D3GA+_Q85\)__G0T?\-4_P#!4K_I$YX2_P#%A7PG_P#G0T44 '_#
M5/\ P5*_Z1.>$O\ Q85\)_\ YT-'_#5/_!4K_I$YX2_\6%?"?_YT-%% '-^#
M(/VZ?C[^V-^R[\4?CM^Q?X<_9J^'?P!TKX^7&H^);/\ :F\"_&R[UV_^*'@7
H2O"VDZ1;>&O#G@GPOJ%FT5YIZW,FI&ZN+:* 2QRV^^2.1"BB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">S-3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">COMSTOCK INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">NV<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">65-0955118<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">117 American Flat Road<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Virginia City<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NV<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">89440<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">775<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">847-5272<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001120970<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Nov. 21, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0001120970<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">Comstock Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">S-3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">S-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTableNa', window );">Offering Table N/A</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OffsetTableNa', window );">Offset Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CombinedProspectusTableNa', window );">Combined Prospectus Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_CombinedProspectusTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_CombinedProspectusTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OffsetTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OffsetTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Offerings<br></strong></div></th>
<th class="th">
<div>Nov. 21, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=1', window );">Offering: 1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457oFlg', window );">Rule 457(o)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Common stock, $0.000666 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxOfferingPricPerScty', window );">Proposed Maximum Offering Price per Unit</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=2', window );">Offering: 2</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457oFlg', window );">Rule 457(o)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Preferred stock, $0.000666 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=3', window );">Offering: 3</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457oFlg', window );">Rule 457(o)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Debt<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Debt securities<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=4', window );">Offering: 4</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457oFlg', window );">Rule 457(o)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Other<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Rights<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=5', window );">Offering: 5</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457oFlg', window );">Rule 457(o)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Other<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Units<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=6', window );">Offering: 6</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457oFlg', window );">Rule 457(o)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Other<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Warrants<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=7', window );">Offering: 7</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457oFlg', window );">Rule 457(o)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Other<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Unallocated (Universal) Shelf<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=8', window );">Offering: 8</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457oFlg', window );">Rule 457(o)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Unallocated (Universal) Shelf<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 200,000,000.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 27,620.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">(1) We are registering under this registration statement such indeterminate number of shares of common stock and preferred stock, such indeterminate principal amount of debt securities, such indeterminate number of warrants to purchase common stock, preferred stock and/or debt securities, such indeterminate number of units and such indeterminate number of rights, as may be sold by the registrant from time to time, which together shall have an aggregate initial offering price not to exceed $200,000,000. If we issue any debt securities at an original issue discount, then the offering price of such debt securities shall be in such greater principal amount at maturity as shall result in an aggregate offering price not to exceed $200,000,000, less the aggregate dollar amount of all securities previously issued hereunder. We may sell any securities we are registering under this registration statement separately or as units with the other securities we are registering under this registration statement. We will determine, from time to time, the proposed maximum offering price per unit in connection with our issuance of the securities we are registering under this registration statement. The securities we are registering under this registration statement also include such indeterminate number of shares of common stock and preferred stock and amount of debt securities as we may issue upon conversion of or exchange for preferred stock or debt securities that provide for conversion or exchange, upon exercise of warrants or rights or pursuant to the antidilution provisions of any of such securities. In addition, pursuant to Rule 416 under the Securities Act of 1933, as amended (the "Securities Act"), the shares we are registering under this registration statement include such indeterminate number of shares of common stock and preferred stock as may be issuable with respect to the shares we are registering as a result of stock splits, stock dividends or similar transactions. (2) We will determine the proposed maximum aggregate offering price per class of security from time to time in connection with our issuance of the securities we are registering under this registration statement and we are not specifying such price as to each class of security pursuant to General Instruction II.D. of Form S-3 under the Securities Act. (3) Registration fee calculated pursuant to Rule 457(o) under the Securities Act, based on aggregated indeterminate number of securities to be sold by the registrant.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total amount of registration fee (amount due after offsets).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum aggregate offering price for the offering that is being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxOfferingPricPerScty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum offering price per share/unit being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxOfferingPricPerScty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal4lItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTitl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The title of the class of securities being registered (for each class being registered).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTitl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Type of securities: "Asset-backed Securities", "ADRs/ADSs", "Debt", "Debt Convertible into Equity", "Equity", "Face Amount Certificates", "Limited Partnership Interests", "Mortgage Backed Securities", "Non-Convertible Debt", "Unallocated (Universal) Shelf", "Exchange Traded Vehicle Securities", "Other"</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_PrevslyPdFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_PrevslyPdFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_Rule457oFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 457<br> -Subsection o<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_Rule457oFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=4">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=4</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=5">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=5</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=6">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=6</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=7">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=7</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=8">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=8</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Nov. 21, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOfferingAmt', window );">Total Offering</a></td>
<td class="nump">$ 200,000,000.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlPrevslyPdAmt', window );">Previously Paid Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlFeeAmt', window );">Total Fee Amount</a></td>
<td class="nump">27,620.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOffsetAmt', window );">Total Offset Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NetFeeAmt', window );">Net Fee</a></td>
<td class="nump">$ 27,620.00<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NetFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NetFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOfferingAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOfferingAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOffsetAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOffsetAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlPrevslyPdAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlPrevslyPdAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>10</ContextCount>
  <ElementCount>37</ElementCount>
  <EntityCount>2</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="lode20251007_s3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://comstock.inc/20250630/role/statement-document-and-entity-information</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="ex_869180.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="ex_869180.htm">
      <IsDefault>true</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995211 - Document - Offerings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesOfferingTable</Role>
      <ShortName>Offerings</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="ex_869180.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>lode-20250630.xsd</File>
    <File>lode-20250630_def.xml</File>
    <File>lode-20250630_lab.xml</File>
    <File>lode-20250630_pre.xml</File>
    <File doctype="S-3" isOnlyDei="true" isUsgaap="true" original="lode20251007_s3.htm">lode20251007_s3.htm</File>
    <File doctype="EX-FILING FEES" original="ex_869180.htm">ex_869180.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>logo02.jpg</File>
    <File>logomd.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="18">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="66">http://xbrl.sec.gov/ffd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>32
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "lode20251007_s3.htm": {
   "nsprefix": "lode",
   "nsuri": "http://comstock.inc/20250630",
   "dts": {
    "schema": {
     "local": [
      "lode-20250630.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/currency/2025/currency-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd",
      "https://xbrl.sec.gov/exch/2025/exch-2025.xsd",
      "https://xbrl.sec.gov/naics/2025/naics-2025.xsd",
      "https://xbrl.sec.gov/sic/2025/sic-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "lode-20250630_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "lode-20250630_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "lode-20250630_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "lode20251007_s3.htm"
     ]
    }
   },
   "keyStandard": 15,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 26,
   "unitCount": 1,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 15
   },
   "report": {
    "R1": {
     "role": "http://comstock.inc/20250630/role/statement-document-and-entity-information",
     "longName": "000 - Document - Document And Entity Information",
     "shortName": "Document And Entity Information",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "d_2025-01-01_2025-06-30",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "b",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lode20251007_s3.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "d_2025-01-01_2025-06-30",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "b",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lode20251007_s3.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://comstock.inc/20250630/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://comstock.inc/20250630/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "dei_CityAreaCode",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://comstock.inc/20250630/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://comstock.inc/20250630/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://comstock.inc/20250630/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://comstock.inc/20250630/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentInformationTable",
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://comstock.inc/20250630/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://comstock.inc/20250630/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "dei_DocumentType",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://comstock.inc/20250630/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "dei_EntityAddressAddressLine1",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://comstock.inc/20250630/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "dei_EntityAddressCityOrTown",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://comstock.inc/20250630/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "dei_EntityAddressPostalZipCode",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://comstock.inc/20250630/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "dei_EntityAddressStateOrProvince",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://comstock.inc/20250630/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://comstock.inc/20250630/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityDomain",
     "presentation": [
      "http://comstock.inc/20250630/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://comstock.inc/20250630/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://comstock.inc/20250630/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://comstock.inc/20250630/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://comstock.inc/20250630/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://comstock.inc/20250630/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "dei_EntityRegistrantName",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://comstock.inc/20250630/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://comstock.inc/20250630/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://comstock.inc/20250630/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://comstock.inc/20250630/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://comstock.inc/20250630/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "dei_LocalPhoneNumber",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    }
   }
  },
  "ex_869180.htm": {
   "dts": {
    "inline": {
     "local": [
      "ex_869180.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 9,
    "http://xbrl.sec.gov/ffd/2025": 7,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 9,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 107,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2025": 66,
    "http://xbrl.sec.gov/dei/2025": 3
   },
   "report": {
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": null,
     "uniqueAnchor": null
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
     "longName": "995211 - Document - Offerings",
     "shortName": "Offerings",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "3",
     "firstAnchor": {
      "contextRef": "offrl_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ex_869180.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "offrl_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ex_869180.htm",
      "first": true,
      "unique": true
     }
    },
    "R4": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "4",
     "firstAnchor": {
      "contextRef": "rc",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ex_869180.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "rc",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ex_869180.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r9"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r9"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee previously paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r9"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r9"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r9"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r9"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r9"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r9"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r6",
      "r9"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r9"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r9"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>33
<FILENAME>0001437749-25-035999-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001437749-25-035999-xbrl.zip
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M:'X*K^(IU27_/>0__AUV">YZRI@EX6R<Y\UU@1C/9P+@3)/_SF8SK%CX._F
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M], &WFC3^GEY=_^-,6AND^G2'3T\6V<L[K>[A*HA["/]H1@KB1YBB_HBT(#
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M</[$1 2R&2)"4'VX*-ZV60+GQSO2815>]*Y=%5%@; .\I_5B4;123T,DG=)
M94N;':IYV)D6G/X[WU5<7._-Q_O6F^]'&G<D4Q5FI^JP3<,&Q(>=+>8@W.*T
MZ.!D5U3&5&;O3LF227;](OQYF$"E.@<_G134#HU!Y/O,XQ_K--T'#_?!P\\A
M>&C#4$_1_)_!3W=+ ;KW'CB,I^;[:#@QZ/AD6/:=UG*=ER(%U,)\;@]<30,/
MZI";T;+6U<"];3IN-^D&M%L2R3-BP]D;M%QRA_<O_K6!*!NB?5-N52%LHD>G
MSL4=IJ68'.\FP)F\QB(9=E^SSL+2K5FY':)9%?""=VK<].F_VD82V'MQ(TG<
M'J$'D3N(8.0.28VM*JJ=U%"Y@S>'/DC'KZ1QC(ZUJH#0+9FD.L.X*,QB/(5_
M=)S H2['V/^A;5<+1OM<KK(&YB//!=84M)52191(=\$ D,$12MJ'$DSJ:<+E
MC)U8@],A+R7$ZV.@'CVBB@QS]U</SA\DSX6WXJ>L>MVLEMWTEE@WDH.+HBMS
MN,3^VG,.\3>'W!S"C6%:@U%L&[_8Z<5'KGM#&3@B5#IP/5>3MIAAX O-F(-I
ML'[F+143E__ &3_0X89)<61OZ&[Y(9CTV8R.-LR(L>MP,-]T&<"RS]]@\6I;
MXIF*AB>5W% 9'M6,4><4!A"8]Z+U'A5"&@0(<9-7^0TX-"FSV)%+D8+\S)@E
MSS;*;?+YBD3504U70<LPKQ3L.6,Q%+".RH;SRYJR!.+5.Z0=_F9X?UI53UOS
MJD%/77ZMIF06FQ-_:^,MU2S2@XE+O)I).V3JOZ*^EV NM6.#H9>XX,5A@GQJ
ML#7HF6J:^6S!.X7U3NO&265^L5LN<JRV1$/KNFBZE94_K"V46EE*T-H1R>(6
M,,I_K&@J\:W(0)_6U8S_HM\8<KBJ:[C4,LF:!H-TS C'9Q\7Z)),@U*L34@/
M5,QE6-5' $4DO;!MJ(G(IF4HF'JG>"=O9,(@[6" 9$T]!976,NN=_=;-L8L=
M!FL:F5_LC.5A.TV))\NZH"97&"//9[9%<K3%RE:<_HA5HL;>.P:JC+SX?5.:
M_#:/'SS\$YPY6T*]&Y#E[XA,^"]]5XR-.+Q#'06X4*>*<XB/X&D%W,V(QS'"
M\0,9@$')2V70H7"&]HH[PA8'B4%3#KT!ZDV_-GD?8]S'&/<QQD!U&C=B5[2F
M?=\-%>9+:?KG]. .4LBQJ:L*3\?*3EV1J>WMX,HR,'7$[6SX4'!-5+]Y^ =C
MDG<UFJ[7-0'8E_4-!]=@!1HVRY]F2TQH@:.-I:MT2R2R.W!N-A*@&">[GDZ9
MVL'VFT3G 6Y-I:KD*%&TXK*XQN?EX :XY9=!9)=-GILZ5ZJ8Y5!@*\ 4]0,N
MZ:*;4'?;!/R4JIVCQZ'?Z!"? !_DMBND"4@@#Z)CMH<%SB[)76D8:I,[W_2=
M+@EVKF4B%DH?,^U,+9X6<MZ#C\;C*F\9B&O^2CF@#E=+%!.?T<\D"M&6BEO8
MDDRYCFP"'/;$^$3&*MA2]K-U9(-D(+DB;G+BR6=%,#3(+[F6\@/C@)+ H)CU
MOI^[Z(QN[DJ3[O1BV(<=OB:WG)80PP[!?54O]HSW\I <K%UZVIK]Q=\*%\4F
MEB2:M2O';?#:;X/$_79+W%4_M+H;@N"_LQ_?Q#CEBKHYF/K/9C BS&D";JRB
M& ?QJ*<G3)M\5N#):9(/W&&<DPYQ^CM?]>D?R,G,,;H&E1,%[W69Z0&W8B%]
M:_(9CE"4CDG3 KW55>*D8<U1#?IP2P0;H<"N>/%H"H[-Q<G1KHAX[^W[66"8
MC8$,<.1R 13^.54(/\7G'D47:A@A48V*/:N3=3WTE:58S%1+%=U.Y6O0OJ9W
M.U$Q>DV$" V/PS,Y@:'W<4DA>0HWG)?2JQ[K8'!U^#Y9Q1H"WVEKMD^^(R%M
M>=EQ. 2B(&8FIAB_4'3TO&B(0* !1RQ;7O5%/($3IB@I/6),$I\N5,@UJ34!
M:><P&J!-V6C+^Q#OJ"H*QZ"/=D>;M/G:&:)CA3N $0A89@O+&PJ:*^0U[)6T
M"$'.'-T\RB<32ICX=> JYXCC>RH'(!T8#ZS*G3E^HCH/QCC2*\!G[=F'</<A
MW'T(US\V"*/R#%/-NU+0I]\XHAZY::*A<XUB<[(@V.40#19HQQWNNIQ,J0A-
MS'(%_L=4F,B*:[2KT%'9BE8V-,$_.W*_%\[5VB$)BT_ O2,8C[YZ\/#Q5DB'
MWDH[(@_ZE3<J#0,-<;2 4V.:Z1@!&4>B@L2->X8UI@4[>T_K<K68%-EA2A@_
M&$&#P0Q3CHB?+>NVS=O68MS8!<JP3ZVM=271:Y-_@ W5S@J2OL]1[M1Y*J91
M*(E'9Q<G3W\]3DY./E,I7/^*/ZQ^?/[B[+?SY,5S+!-\=79R<7)\_L,?5S]^
MIJ_L/<'H1E"-CX:2(# #%YJHQ3D'. N?HV#?.QM[T?.MR/_SG"N&;1(Q 5>I
M& \9GDU]G^ ?W15SWYM YXMFEION.-K-M>C!UD<5]HMBZ!SDAAI+<';!(F*X
M;YMSCZ4TJ:6 &JUI'!]"( ,M1M,D'S)!JVU/C9 @;"#0V?J=O@N-V$@WCC)'
M;@%X6K6B'O4N\PG3_YKAG7BYQ0QSYS,F1B@HO#0S=[K,L?D-? __K9O6-!]&
MBMJ9@4J9,(694QP-@FF]":%L,[\:8D&17KE"%@FT,1Q[P6BP@.+9KM6'S ^H
M?$SWED*"0-#N[ 9_;/_&>"%W(S/10FHLI<(6O*SK+K(>O95#VV/)8KV4R]^O
M(Y6QE_C>,VG202'$%9)<X&?_7-4=/ZR]A1\M@ANKOBQR+[P 8Z-UPS-1D;3#
M/U=M=IES)\&LM5TH7"[ T%_ .U#O>!.:]]N2P0WA!&\YG^_1M<(]BL9<S),3
M7+^%"FHX;6WLIE;\(E^0(Q5-#@TMF/6&(U8PM2Y8C&)J^,P'XF=I&)*VL;?4
MVY7&ZI+(4QI;0U7%?!L))+IQ$>C#MKJ)OC<]C[#T$XR,\!Z;?/[4MNK@_FKD
MX'Z.VQ"F4*:;S);5CP*:D;_:Y"D>$J2&R14_<B7F\(B=.^1?5*7HN/ZFR=PI
MGS7NY$FF:@:'3W^?BL=RZDS]Z<^\Z:?=6%0<F28F =2SO%GZ!  3W*P5%F7P
M.4K;T]HETBFN,6%VR>!BD[JY@0-+U2*=M83KHOM+B:7)JPHX2\HE\'Y5/@=O
M.];Y=1\RWH>,]R'C>Y[GQYF&W#NN=[+2=#X9XPV^XO#:]D4+\H/;!9W#7)$!
M&V =UC*:0K0MHN.^6U?4B[?2Y<82::K<4@]%:LS]$R3#)'U9UC?MYXA\7A-A
MN3A[=7YQ?"SS=YX\/3Z[.'E^\O3HXA@C+D>O+GXY/KW OT]>G'Z&K[\NS DG
M9=&RS]\S-DR!)'M:BC.P8YO D?9AP)'M#'0<X2A#!QD$#K[Z=/CRWO$S.DKL
M\\GWER\>?I'@D;+,9ACGM7^WRVQJ_K[[@O*Q1N>H-AK03W[BV0ST"1QR__;O
M__9O/W0-_ /_.S./O$:E,,U*<]),Z@X\;7ML?OW='^ABN.:]^ IJVO 9?^QF
M=H!PZL,457_YXJLO$CBG^=^/OMAPX(_?[[C_>QR<_2'_]^^I!PMOG4,5F=2[
M3^17#_^@UHEO!?\E0=+RI)?K+K+EW_D.HODX,K [7+[I>WV8=WF_TOK3[?=1
M:=A\HD69?<E?@;VZ?(.5!N"R34HPU/<+\=;J[BY"CU&0NH''SI)S.GC!37ZW
M,P^^#1UBVV73J,C4X_<;F6)J9>]#0P-&02O]Q),8[$[W58G=15&6Q4H38R#$
ME.%_,==@[;M0S"DZCL!OB*6@5FOS4'L_8N]'[/V(;?8C'N[]B&WR(S8T,"+&
MV%N8=F]G\#_^J-[&)S<3Y!/<<QK^&PR@TZ/?(L=7<O0S_($FSM^W8I;>4EY@
M%\5-P/W4;-%6VL_$KH<P=F@A/K$0QO#,?^@0QC[!OT_P?XH)_KM Y;<:*P]V
M:O+L^*>+K</*CT0Z'X^#YX\6R*Z1O*J$(>I)<M*V*XHZ$)*B,4AZ?5V"0(/L
M\A*IM#K-VYCQW?S*9X)X"!37;Q#C=X2)X;.8!EC&YHWA(@H;)G;>68A4E_+@
MX'(=8WW'T'>B%3:@4QQ3)@1C0[7/GV/0\]X81JZL1/3>NG#@ >.Z>9EF18L.
MU*IHKR)7Z1@S][GJEYK#31CDS[]+XX05#$F:S8A3V4&2[)K![W@DYG$(2Y[D
M^ &+W^&'C!!^=!18MU87C"ZQ:6=&>SQ9+86*Y"WN^%;ZYD!$ B&G&EH[=A\:
ML_#XP5A241BV\ 'N93XKBWS%/V&^NT$1UG012I5_G1+7%?WO=VGR-?T;;HT<
M+-]LH]P-@]U,TXE %FX*UNAR$F2M;HH2=' DF'#.%99<B"!LB[9D94YJWV#J
MU.4,29;Z2JQ1JDS%"')IM%F91RH%]$"W<*UFHSIBQI6OIE:':[:*>H9,S TJ
M3T<$/;BUO5/>D1V96Z>&YK QJ\??<+XHC5)-2Z?8&*7T^"&#6A_M 1Z28B?C
M@F]P;@D +R<87LAPV$8&Y0"NKNX(@>UOB%5@MH7RD8_*1R.STW !=+>)/*AR
M!T/MK59P9"G\AT66PC6U$1YQ(0ZW/S4+#DI]FK4DSX,V0V<Z29BDO.D@G4VG
MC="0@SQBF7:^]O33/79\B52EY$6OTBRYR4E@"U@AKOT0!0FV#II6Q+)WF"K<
MMA%4LJ;4W 5SP>\P/MUK)9^?>V+N_%*8-)[Y.L/6]PTNA],)JAM":QDZS -M
MK:)I]V$:3VN">+NE*],9)CZZMW]O"OTXP87!L!;@HE.T*NRXA&/$,02 \LR\
MXD+;]<9>W<#6W#YM,A_4)D6_.6DM'6P\11$YE70U(%D2\U53D<.A>.MRWJ3(
M/R9VQ&R&17]NLZLN,EM]XE^.K8'JT:4Y>7C>GX,;75Q6R5/#Q%.8)5BK[$&H
MJWHA?8?8K.8K%?].>,:GD0->[:KH81][M-$)QGJ4=Z3B3JP#SIO*5@G+<+9P
MV:_6;3WGJ6E.I'>W'F)T*<M)('#4I&F:,PB.PC1OJ'_<8E5FJL:?=;4]+M-D
MLNJD6Q;SI#-_ =\@F61(94>EE%9<D;28_TVC<Z+._:NJN/6"-J.T7V;4G#VV
M.B;GKG(ES\R8L&#ZV\CA\2$E:Y_;V.<V/L7<QAI-5:S35'=32L-1K"8/=[10
MR.G.#=JZ(&)]OW(YE>"SU3%WT"K!F1A3,K;1))N),BY6/>R*:Z><?69^H+.J
M'8T!-MXK.&I" 3#YH7=OVY .F43L+1#B;/X0E8>>NJ@U0X1E8S#DJDWR[B87
MZ'+?9%@_'Z-38$>ST9W-G!8SZV79&R%5*KSK%A[Y_QB/[2AF'-/00SQ-Q[7H
M.U\9PJ#,1MO""7L].F'$#D2"B?]HG<)!#2!AA(39=I C/L]F3G]P6Q?#@OV"
M.&J"BE\,7C3Y)@J.0P\;:+BXI\W/&63T-<$QN'M.E0IS9@M"5CLG+1(Z3U7<
ME3K+7(,+9?N51F9-G@YV6S$53VR6P^K-6IDZFTU0G/VF3"*:18B0!VWI?B['
MQ;,I9*(;GMK.Z/?UAX4)B/BQC_JN1\E:X[_)N1MM*GW1.?@*_T8B('O\ULO(
MX4OB[\D%28S0=<*5?-46+OMB=-E=TPR*C?I1J7[#:5Z!%'-5L&];H0(#_3"\
M=CJM17H"C%0\\;$5<XJ^3M,5_[(CR.#\J"_K5>N1137]M0TM*:<QWJ,@>Q:#
M[P\6+F+YEL)NU:X3=S/=,S/?Q= >T+/-G$%V@;=0MJMUMOY:\T[G#CFXWT9"
M5]:TI$6\0]S*W);VE#+NT>I=K!;!C>$F__M1"AZCZ\;:Y9?86VNQ*KMB6>9&
MVK=P+>L- XN^A2-A)^M.T;?20K87%-P03: 1*,J7HKT[R\'M=H9,-@7?.V\\
M,]ATX+6:*9;8_^[!PZ^V<!&7HX>-=$2B/H;!&3.T&,YX$*B.?*N:*ZD<F#HS
MFKSDX@MJ25]1S_?;-&BQ;EOGP")F;1[<',9YZ)O-Q!@X,\H<358R7LF48#I2
M_'">3;&+$YXA:IA])L@M7/]_WA6[,113<5B.%\:K1)0BT6-3WC($=O@Q:)/=
MY""QBJT.X0?W@=5]8'4?6!W=V\W:O8W[D"%V-^A238MFNEH@=&&:^US(9'6A
MUZ#P$R;KT6'BMOK29\\WV57?FR>G)'N#/1;RMC7M>"]=FP90S\WE-OKR[>!:
MN"/0'5T."S&'8RX.3%9:..)8]$X_=_B9"OWP[.58= L';0L'HB/2!<V\K:O2
MO>/3+[80 7^KAJC[?(IR,)*?R!UPP,)A _E9OJS;@IIFXI)<\G4V%$=Q6A(:
MNBZD:83/>T]*!UU>)X7*]S7AQ]8.;I.'F!/;##0^04;8L1_U=3$C[EEW"W">
M;62R$V+I LWZ.7ADV*";9U8!2&7"$?J!CV$(",P\=T/S$L'T)FIR*>%##E[.
MU_(_73_0 VDG<N+&ZEY7VHH<VK"KPZ9M-%O.@8%ER2K1CDB;63<PNBW<?ZL[
MX(/\S2:XOB).DIRY60NGG@7?/^D.6.+#P'YWA43&7MF)AGD?VJ/3A"D&'PI;
MN?(WPIR!7T:& ]M8:Y_XKTP8) J<3@E%%6#7&Q<ZJ8P&H?D*",^U'T;'A$.'
M..1=[U17+GS6>WN%P_0NB\/U_,H<J^0PM+>%6^!Z+2!;>'4=O+*_N.:P[ZF9
M 7 6L_#VHC0V'ZC+H6A?47/.@=OJ$W +%^AF=($TE>^0G;"%D_+F#HI[R&;B
M[&%7L&;@;*#9[:0N#*5\ZVDQ[,4"E]T:S2.]4X,>7>*X' [;.=J\Z>&P15.V
MM3?*8(#C(28/*QR--;&19W.H^O9;*#*W]["UPUH.U1\M'A?L3)\IOE+_9@NG
M]%_W+;RB'<7)J54E?VSA_&3#]:U!69F@&8RKS,>A 3UD$]RQD?JP0$2W< 8G
MPS6E]PDN8(>KO&K=GFWR8C%924.N/D"FX'9DI9@9G\3,[X/!^V#P9Q@,G@Y7
MZ=XK3*@I%3350L1;;JGT^5%*__F*]CW^Z^M/=(-_J$K<X5+<6$CX$M.25+>"
M;55@TDF3T*R96+N%TM53 722 ^?ZL.376):VA7.9#Y>M>L+-3H8OW\<T*3A1
MS_)YMBJ[OECB/=:2(_AWE<Y6\]!?-&>;*8+&]H]MT7GE:*$W B-@%$.(%O6Q
M%,E,RE1-N&4(QG"WW("WHX^0YPMN_=>3DW6[=ZO]W_EP9>-:@9O6('$9U0O%
MI_8.,XM+N7VS>SE<LQ@6]*V%" L]#?^:(V!<9KIA[U;8LB='7'R&V8Q%/2OF
M""Z!HV^6JF.0*WG+G'K$6E]!#=*C, G9X-6(#S\Z/_;;D@\>E7U"GEM*?*WI
M<SQC^I;2DOYDHOP<YHYTE_L6EX3$X:9H<X:QU]C==29=#ZG.YEWR1CU8/WV?
M_A*-4Y&-M0-]IN&/?<ZQ$R$&FK3&^*#X'1L@TJ=@@#7G46]/#%4LI&MV? _+
M"<O+W0O4-<5Z2*<Y)0<QG;I]MJ87J3@AI5&IG_V>5BLUUI3CV/3@38/V%"E8
M5T*S@Y/VC%),.]<9]L(77"LZMANKSET+9=$DAU_-0VB_-/^37JT<5VX+>*'<
M-6XU;1V?7F4%)I3-/7ZJLX9JE9X5#2PKHSOI=T4^3V0)KW,I6VK2Y"7L2E+.
M5&QY@1PH</LF[(^"]Y9H_ VG3NU(J+4$*%^;0JKJI*S!*&J2*S!\A1",>WF;
MT@'39\5=5(R2?*7^C^6LSS%Z?P4'<]O:#K9;*'/#<;HCU;4&YXN)]VAN:_F4
M6@-SLG6S%MI^2VX\A.6WPV5F8<-A5:.B_2+*^02:HZLO.9K-3>V#$]S 1X).
MF>$+])K"$])FSAX8QL*'SB7L6QZ/=E!!B3<6,#7(1V=S(S  >S5X YR7=BY8
M@NFP(==>R[Y^OTCZBBMH<6#S5<-0OZGI$J1FO_?HX'5H 'Q\WP: 7=\_C=+X
MV02V1]WB)9E#7%L1O=N^ _0^O+L/[]Z3@_'$4QPF/^XA.OK:FFS?*7I9Y@(%
M_$4;'3UG2HOAK^.LP)5 B3@,T@MJ]10=V"(YJ#.VJ@]4JM=HXT>/P#DY=%;3
M?(5>(WA\'?R C2=XXBV.F/5E94R8: LUMN^3%TOP QBY]+3&;"BZG]@1;8EU
M>P(HA+F _4&0&#J$[)"^1<\%F1QXGL1T42B#);[63-71I\Y'G;/WB5>X>:,*
MUPD2*6"VK"R$.&<+;9;A 'C_%)2Z7Q-8E9!H43&-T-#!&!RZ2DZU/V,JC>V!
M%%RF+8->' ?9]>9SDM2K?LN^^J:20'V:S%8&PE(L%JO*'U(/ A@\R/ B49R#
MXAA"RR'XW):B6FB9PQ:=H+M+NY<<4M_$VD)!&H[^'V=.Z_3ZU3O[A/VDT.YT
M828W]7;O;AS&& U6;.%B#$?&3^L.)\=28_;#K=Y$DO\[[V]75J1E.6!5JT.,
MB2?$HHS2:E(H'9UM=(14Z\U9/5TQAZ/U#_@NCE*ZIQ4\E;) W@_O]Q060OHY
M']^ZQFV)HR^W6X*&H_\G?A"$]W/>HII# LC!/6D/YK@']NX+.90H!8-E-]CZ
M1_XI-WB0C5>-T.L=%(?6D)*2"31O'$VM^&X@SW"UD;ZU%.XO%)?M<,R5)T_7
M:IAVM)&I.2B*0TV:8!#LM+')B+.8=ISLU*_HF(<5,7>J>S&)5UOD,0^+0&A\
M>H!N"XOS; E&ZU@!28_0P7UMS0+D"VI6KL;JH+AV#\RP"*7,+Y%<UD^0R*)Q
M$UY<D)PLC\^\,<47/TI1S<4O)^>F[<O?$OCW4?+SKR]^.OK5??C["?SH-,$F
M,;\='YV>G/Z,W0WQSY/39\>G%Z_.CI-?CL^.3T[)O4W.CI\?GYT=/P,_,3DZ
M?88W/3O^^>0<OH,/Y4ZF22*WGGGYXOSDXNCL;\F+,QC Z8O?3DZ/(U^GR>^_
MG#S])?GMZ&_)3\?)!?C4%W#+G_Y&OWOZXK>71Z?P(_Q#6@O3 .!#[KZ(WYP=
M8VO&\^3%[Z<P5OSZEQ>_/H-_TM/T9#S'P?SZ:_+RU1D,X/C\,]?Z7_SXZO37
MX_-S?DO=:AG^?'EV? X3Q)-Y=$J]*U^<G?Q_\,'9L7QY=''R5UJ4__97Y>^X
MT&H!<!%/+LYERG$6>?G/N \FSO/9T>DY"$F:'/_?I[\<G?Y\C->\//K;;W!%
M:M?,'^/YJ^,ULD3C&A2>O].X3I/S5R!!+U 2^$*0!;KK__OJ^/R^$W!@ABSO
M0/L!WA5N_-O1LV.<H T&![]2@\/6H2"%[V!XARF-S<WZRU^/G_&<\Z->G?,.
MAFMQN?YZ].LK]^WO)_#M3W^3 =)+'I^=\\O]?O;B].?GKT!9G)P^/:9W4LO#
M6XQOG*Z;@#3Y!5X57NWD%*\^OQ"=LH]#[N.0^SBDDEBSC<_MB14>V.>_X+$%
M!^2O)[^=7/!![*X"%?@[''G':?+3JPO8D!?XR<NC,U"\<I"J\QAW_-AY#$H!
M%=+P3\S9$)SQIZ* U]TY=NG?6$N::VF(\,E3.-O@^Q%C@BZ+_?*!5!%_W@=\
MQ*V[6.MN4-0U-.(QN=A/63)\BYIQ2 <&\\<$T7?_  .=W7>BM158;$/M)L)L
MW&WR%'Y=S^!-4HSUV @/>1TZ"/>9&UUW8XFGR)GR; Q][%CHBY*WO17L>W04
M'4F]/+^$X#1)+<7G.XKT=/3B-U<(;R@ZU(?7Z+6W?=\-4X>@F\&)0O\(B1&F
MM_KQ+MYZ; J+CZ:.+4.:12'R<DJQ4PSMKZ0/37ZYXGS&%@K", GW;_EBPL#D
ME%F:$:<*.[<B,H@>/X5A2)#+#">"#N-7M0&O1Q-'80 U5MA\E9>FGU?1&(B,
MN.>^.RX?]C>[/#P6.7 <9NI>PF71@9[IPQA2'1C@/UYFM[:5O.IXP[RZC9.X
MN;P$D7B04 N$KBY)\&Z$?#L:XJ =A]0\JP8&2GLDZ]H:02\/UH5>X=K\LJ;6
M"M@D#3\6T"2OU;*A>H&[O*8$5]Q;2@5O^)*DT"^+:Q?#, M] Z_58>[+)NHH
M% ]*^<VM:PZ125]J5A32_\4MBB\!!0R]:$BW:XKR@%,%M8_(++\85AE;FL I
M2LT"?[ML$$DQ=4AL=1\F,G+LZ'DS+1Q)G<@\,Q_89<U@4%4.;UH0M,01+$3$
MO@?7$$;5*.D"RBL5C=#DF;22RV28.<Q5%77J^FV8R:"K#'6*;=N(H"U%"M-=
M@>5]>:4F$,[I[#7?6I GW++3#!EV/ 8ZNY(CZ_3CJ#:HP^S8%BK?8>+VTSKI
M9Z_TQ#$?! I0-SA_!O9&^X?996N)FQ)U!^L.[.&+(#G"&^$1"&=H:QMKV5%D
M:FLRPM=/8 20;L%6SVWHO/73WZ)Q9BOX<0@14[4R:-55'J34ZIS)[7H49%8Y
M<9_)5[5+L%B%1GA>JLI7[RA8@MO(2F [H7+5(E@RQW>JIJJ[&25\W,<D__Y<
M7I%*RN7UQ_J7$@:,EI=T5;!YKG(C Y%:@^W;+YJ$9P2+?&'9>)SRV#G$\<M<
MYUH1T&+/M#BQ4 1JKW&>LD=9RFEG^)#!S7-:J:)+"G-9F(]##['#I%"):$8X
MR997A/&]7>9B)*3) F;2?.5#)# 55<]64^&>IW/(:0 -^4\#E64K=ZJZ,7_$
MI\KU"G;PQEL:NVE^&G%]B-X)+5SN'+5$.A-8Z@X=VC9OA((-1M=* 2B-KNA6
M#">R9WA"$B(?LLW(\.G&8&UMD[. D,TVIR*3R*DPI:V,"BX:!0GN@V@]>^3(
M-'[L+:NUG>^60;791/+DRI+9V0*NZ(W2D]XXCRFU/C32/B0_P"M[)1]C*CLX
MQ&QQ+L$-%$",NWN$F3[S0T;YI$YL[#=L-Z=F\?LB2L;OF+@6U$*3974?VMZ'
MMO>A[7N66" L)7:6]>%(YF#0&H4PA--LU0Z=,U&LA46G&K#_JK+H/\(L9+Z[
M>&2+/#8U ]0S#8M6_!VCQ7<])J^-WHVT9$OD!3,5]H@^V708D>9*C8GV!952
M!)9\R5V)YI9HT()&S N::62N6V-6L[?J3>0K?XAXHRD"@\O2-1F0<E=SN*T7
M#E\BW@HJ!.]K.1/)E^.H;%F\CD?=!]?%GC2F(_9\R(1J#5:/'D*6DS]E,,X2
MR=0L_^6X0*E-PR^+:UB6)BC8ADZP':GU@J*N<-9N)(1;Z!\,5P>\,LZMZ^LU
M]ZVL$2Y5"?BK28U L$Q]5I0R-TKO.X:L_%J,&O/WMZ$DA2-049-9W;11%!?L
MD=(@N$&EKKQFD+T]XXQD&7#*3<ZLA1?;98$:&QPE/5YB(UY@=^(58.F]Q"7Q
M\G;;)[QJL;\9\?;]R+J.2N^<SW\1&A>O\WQ)Z3:J 0Z.2S8G%AEXVQFU:4:"
M[6[@V.SU$MR@>V"CON4 FYR=:WH-)NQ_&SG?J)FAC1Z,T'::,8?CB#-QDH.E
M$H('N LEQV5E3C%_&[92EW6T&M![4=?)9J.WCX#=#]SEZ/2K%30<[::>FCU,
ME]^\G\DTR76*J%[DG)4%EX1:JU( @;I["UI>'%-OKG(]56T_Q6Z#PZGXJ.8R
M8_5T8@A82Y<',:%\3245560EJ&I74_FB-\GYJG]W#E&8%!2'*1I_ZNC#:;9D
MIH>Y3(I(&TT]O+EW!VE7EX6#'JR]I?P*YDFU"3FMO[32!JYD)Z7%0Y(H>1Q*
M^MSBQ4;,FBW4A,..V47?J,9( *\2)@54^$VV0G;9Y$SHP]7F<*67SM0+0=4E
M&:7$;_O%8;T%=K<6JW9AN(/ZE3#!MB"]QO1[%E=.N=1!*;)41Z9TVV93Y@Y,
M3TGHV:S!O(\!X S<.RB]F&=%2:ZH43LP#VY>''.S<VX"]V7:6?R&%U+SDEMJ
M>3SJ4.O7Q* H6";Z:'!>9&1'H )+NG$G[&FX[614]D52?[E1CQOUS#.TCYKM
MHV;[J-G]7$^]*\7S@PU?%]132BD,T'S$3A-OJJVW*Q[5<!17H@ALO'RTM#9-
M5AR>( ^-^%#P9WS<"YU-T9JA<8L[_.WV':3:K1[+JUH5"'-I4'2[YV3)+'ST
MET[^\Y^KNGL2/(D_C*@([XF)/#*B.&0BDC\]6@<0' R+#KLV<Q]/$<3).Q]$
M-A(;37O!47.\QY BZ_+1D3)#A7HUHT><B+;,*YCR\< IS@5%1L?ASR,Y:H8X
MJX!KS[P9G%N/\I)A0*C?+C.L0?1FMO:S]P('4OGK<&',!U@BC: U>76.F:>J
M";CZ :C>-+D2XD6$.W9=W53YK8/ R.N+(P:KMS,[;-T6"T&<SBNUOD.L8/[;
MU*PEMWO$PXY3OYOU9=LX<)M&4(@;)?$'JK+1(A?!->*-8NAH&3(9=!_V&:1W
MR)D8J?DU$+.QG\2K?8VAL/;>T6OE8W,QC1(^F<)BP?<C[^,WJK/M3OI7[LKF
M&8X!".I#1'U7YF.=+CF2Y.E2[T.CN0?#JP>J85AOKVO"%,>Y.\G+^N:PWPER
M;L'<'_SP3"-IYD -<5!<I5B"HV]GQ&B='/T.MA16&X0<^=2MJ>[%V%U4_0XV
MW5H<8;!VANQ#H.:+[+6#Y!LJ=A]!*]1CN[*JPSZYKRQQ8_09-' =HS;!@^ >
MH@LLWIM40<JE#RT'SWN5#Y03Z#^3TEAB"T06;F \^^C</CJW3=&Y3\1VB#L$
M'NVZQ._1WE^[VZ,5HU936\M773/_/CDX.N2$]JWCB0[LY1'/@M(BAH72,A%?
M4:01SX95A0H'3PWJD&=8]*8U^C$KBA"N?5A@KB-GV5W'VP?6.=IL5(0@/93@
M9K23YA\[N#I,3"]QRNIP+_$![T+8 UV(,\ \2PKSSP^3&6QZ.S*<1:QL@9L=
M_'3H72%G>:L/ZC;D>HX518XR=GH\F]%Z2-=9HO9R_A_]9'_GH<F3>*C;@W%5
M=%;VT/6WPT?X*/;J6S <TC7S/L,,IR'+T]9?A.=;PR:=U;>942@V/)W_2_8
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M<1NF$O\AN\P=!B2RFV0#P%G=%J))3;@ZDRV!S0 KXW+Q'[WJN7W =!\PW:J
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MX,A#>+&D9;MI_6V&-CB@U'(/2'\<^VR/)#ZD/)[E^#>.'L5$4;3K"1E,$U.
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MCP8[KQ_HBD;Q5%P9&N4PBJI88/@J?H=#%Q&QR&R?DX:=#XJ>$;S"%4PB \S
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MDKQRG>LJK".8K&BWTWDWP-TGY!@D L(#T=)GOKP<&"BN6>,SN*?I($JOQ3I
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M0UU!-8V5^GYI,03/QQPR@N;,MY0E4QBE2%KE(^X2ZW$#KOS"N0;^C((IN9V
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MNW8\]?J(7CMBSPX\UA# 90NJV[TN[$DB.47]+N,-2.(3$ N5_YB!;P:QUDE
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M!\/1.:3NZT+@+OY#<E-%TH*IG?54EL'R<RP#%K&40\G(Z8HVN%BIH?;T(M4
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MEC%GU'Z^\X1<<<MV#ESMU,OZH*WJ?+8G7\HOJJ<=O+% -[9<VLPY(FP;2H5
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MJPNZ@NTBPPSNB!%OKQ.=/08EW0,YAZ"]]_)61@==0S,\1"OA5:>$<;/.HN5
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MQ8#]??/%]0\)W)X\5(O5\V>3D+R][8?B\OWG=R\2'VP1PF\Y#358&.#!=/#
MB* _!+#WC*+XYMRM3E9^[Z<5GNO?WA[\'H"[<8-\9,P^RF'T>B,[H&P'E.V
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M^&P&0.CS9P- J+-9P-&:,0UV&JLDL<%Y@^YF]">#D'[*5TE;1>IF*P]?!%"
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MA(8UW)?8:%O.7;2KFT83%/XOFK(T;(VW^:U)PS9\)$/;ZL:?T+$^+?"/26F
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MFA?0Z*E?]^.#03WC UKXEAD!Q2V?VW"R0K;6E\B>':%8;E6U_.W7SUZ$FC1
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MJHX,E$5A65[/]EF$&0GQ-'VYH!NM!9N=,688<& -4_;"+6)R"OIW&P[!\E8
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MN*IM^5J2@;U%..C;3PKAJ=7T8R:1@A)]H$X!;*1<S8<9'-[8%-VVN@1@DU'
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MM-9PUL4%LC+@.0&DN6;O9WK+$*T6[U'U8+Z!<CB[S5=7T +2]Q+#>,Y+E]
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M1%[=NLZ\VZ)-W_]8XN9XPW20%%TH%"3]*;R92VY!3]"1\QG26L9%)[*#0YC
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MM^R61[H7[/=TL@>0$*<O+VI31]>&_P=02P,$%     @  8)U6[9U]0$L P
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M,KNYO&>C"'M]?N)!6;CV.DUWFN9OP6=02P,$%     @  8)U6T#>HL*#!0
M;QL   T   !E>%\X-S4V,#(N:'1M[5E;<]HX%'YN?L59.MNFLP8<TZ09<)AU
M TTOX3) =B9/.\*6L5I;<B4YA/WU>V3C!$C2=K==DF;V2=;UW(^^([N13N*V
M&U$2M'>>N)KIF+;IY9^'K_8/;*>&LVZ]&-QY@O._5*MP0CF51-, I@N81!D/
MJ.R(A,)02$UBJ,*>76_8=<=V]N&@:;]L-FP8]J!:;;L)U03\B$A%]5$ETV'U
ML+(<Y22A1Y50R(3H:D U]343O *^X)IR7*UI3--(<'K$1:6]X]8+IMVI"!:@
M]"+.MW-=5>POVD0F4MV"?" D"8L737CV.1.Z-6$)5="G<QB)A/!BL 4I"0+&
M9TVP&0>[ML=X"_Q,*B&;0#(M6H9F6A)*B)PQCHO32\@):7JIJR1F,QR4;!:5
MM/\5,Z@3LW9-JG+?\XTMSRW(1RQ05++P!ED\:]KN7D9LRC0XC5K#K4_;;MVL
MPB9M[VQ1JF=\JM+6DFK +DJZJV1\-#:51@4LF0&)T?+&T%36/J:S"BCIKPV@
M#'C0MTL1T_!'"G&_1%</V-C9NJ:6$\N[%T0RPG63FRB+6RLL?LR49N&BM13#
M[*BT![X64RK!<2PPT?PE\C?<\EL86*/V=1$?"XWO,]4R0-9H8HB/C*DT=&MP
MC)E4"F[!,*IU:D6X;Y.9,>5,2/"4$C[#BP)$"*]I)"ET1#RE1,(SDJ0M.!9)
M2O@"=L_&W@L+WG&_=M^6^6FMC[I46OB?<BW"&]R&.:;Z 77,%>Z 4ZIQV]=\
MX>&+?VN>FD04<ABB< GBDHA*BMC$7\JN!>RR%Z!QE:0ASG$?.=#" L*#?)CQ
M G<@X  \AEW@(:$4B97/(A2)./,1VDB:(L8!/-1 H@ FW>.W_7?'WBF,NL/!
M: +CLU[/&YU#QSN?#/IP/.B/!Z?O.MZDVX'A:/"^>SR!T_-\YJP_.;>@W_W#
MZW@68 A D(,J&H8&^EQ0Z(L+FIC\V[#S_.NT<H9WV0UA4!(%)$UCY'(:4\N(
MK#>48O"50DG]. NPBR '8Q2[0J),)9R[.M+,XPD,PYCS#$4?%:*CGO*3WS!E
M%')NHIER YR@0_TENWLYNR\!M7GMB89U8Q%47:;->H*0"T_$Y* CII#TC"DM
M"R,HC1PEJ&<+YA'S(YBC@"&+"R[7G7W.=)3S=,:9$6-L]BH84T1O3#/\-*2[
MEP@[^8R:S0E3BID$:29,!D+5\,"04^8@2;6X]TST'X3)\H98OQY0"? ="=N"
MW'0J1<LR=+W<01 N1T(:&QNS3*["9^E#XRQ!OA:Y]B-BMI,B#-==K728PBQB
M/7;A5F&,2W\SXVLA<^_V_@EI:*,XF J)2>:H8F.I1N-X649=]55*_++_O47:
M9J4S9X&.S"'VKZ8ZPP(5*UB)'Z8-2G++58WE(IS;5L"YK#W JHEQ=.IQD86-
M4X\I*1*96V?+Z_A.KGZLR;8I_%UXU()>;^QMGY];DMSVF?A',/@1.L6M%:5A
MH*Z#.^+V%<8M7* KF2ND+*@3%@0Q+>/9/ !<OQ8H#*^5MX*K;OE2L$(.6Y,N
M=K UN>RQ7?@/X]:YU\3ZJ,1^6X/W(N+P%@'3EDGW<FAO(8Q&6)U7)SF.QJ*2
M;IF3]11Z(D66/HRW@_\?X!XBC9\1I ["D/E(^+<]V&W8C1=PX-A@VX[]E6L2
M17]ZZ#@'+7"S-N.?,R87OP=%I-1\D;CUK TK2^;S>6UC>N-F7&/5%T91_*CB
M7&EI]9&[]&!8D^7.<(7"3/#2V=^'L<"2$5YG_J>8+E";)+#@*<Z4B[Q,"DDL
M3#HQMH& 0]O>:YA7DR]<Y>8'@Q\3I8XJI]YX4AUZ)]WJZU'7^V!^Y:S,#D_>
M3$8;8U%8E6)^<]"X"PQ/^F>]:T?+8<6M#7)1-_^G4*_YC[:_ 5!+ P04
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M"U/IOADA*Y  +/M113$$N@UO9QG8FA3IAB>L_3O$&PDW:UA3<J8M1P.'Q@7
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M-F.*96ML5J(P9+2 R=MD@D5&1[Y-T%9Q2'CA;N+ ,%%+],&]VK19;@7CJ9[
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M!&FI*N(TMVH3:YS5N;VKVKTV/K>C:]:+#C.7,D9!*V7TNKV&-\T:!G+%34B
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M*!W)RUU%^#-AC;(A0O^TPC<L.@K4F$!-2Y0]X(1]#6%3W1@=<:KKNT?6V;[
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M6:_UHIRXEO&P_G B$!!A<V@25M<.<H#3>5ZT"T/Q8PF]#\\P/P8 CP' SS
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MO3O.M<(;$Y0E6W"]WK"@)K<VQ6A+_=>,CL<;!+\0GAC/=A'\*'?\$9PP3Y
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M4L+/J7CY)7)TM0*>Z7TE'M6<K]3&2(N VY"P2?I[OAR2PNYT0<^5OCG6:5,
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M:6I!=H0<<&,'GS]8I^ZIA:3H!/-Q1.=2R@R):<-#73X!DV'NX0PLYVL[%E=
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M:$?V[) ?7,;#[5!R,S'J2 VGTQ4#K662@NUGP)\H:OKOO?5=(WTVO<ED9%9
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MBAS_ON YRCH1!8D\-1Y]4!,S?29QE$'B]UB^1>Z>X&/Y8Z0EP&W!(A_$]$V
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MIV1R[W[0DH\?>ZL BI!I2[/JO0(JU&RR^Q3Q%$T2F&7;$5H9#Y^,QDWFU(<
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MO%"$R" +/>%A"TP362X4&3)X)4%24Y,<LL^T+2Q;/D6OA?C#7Y(8]=R+H;\
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M?A>O?MK;VUX#>3/,<BF6,_$N$N_# EHK/)W@(;DSC69,R*\3YJ1>Y,#3+Q
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M0K\.,4IIBQ(#[T>CH TTBIJ7#'3+?D>Q'J#8MV++"6B  0@K)D1QOPH4M%2
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M6QNG;B,[R@-E#8S#YU&H1C@,U8 M BV2UTL[05.2=W^626N@3.\V\Q JU-7
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MY\L5W ^)CPH"-N*;W;%*0OB_XD/L#Y]Y$4A'='&VLK'Y<OO9SL"/<_5NK?*
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M;L=#7&H;SWGO.;>L;T)[:#H[6\IL%FQ/F97.S#ZM3U/]%?!"!P*PW OF4N_
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MU]@D)91[691_DYP\*B=SZAGUA/Z8S"&YIODW[X,?%&F6FV^Z^(W>P1W$^TQ
MWWGO?)VJ@L63_)VDF(X/3G[[_</NWNG1\<FSG6U.Y""+VDYGWL:B=+56,/J-
MN/X&C&PN'_R.YCZW6SUPMP)Q*-[>DJ'^A%@&I"#%%1[G>,%Z*1\IV,Z870K.
M&ONG/B6KS!039*,(K4OEA^J/T@_([_0#N)+^/2,$J]XN6>;@K>7P6GSB"*8
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MQ_L?]H^/]]]_EP#,H%T?H S49^!)*H'W^S^?_GZRO_?E^.#T8/_2P[TF!C.
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M+5;P+3^#HM/(B^<Q\BB4XQ4.?B!%V=1Y02DHR\2[ ]DJ0745I*$=(_VY"4"
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M"?C=O]4.C_?[)WO'!Y]/#XX.\1#A*SVZ\JD<)$UQ,7"T1FE&;4GWN%//"2E
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MAI M18'\$S3EN<VD8,_;*,^Q0H7SR0EU5B=/?3#PHZS=JC?J=COP@V0F"4[
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M=N"V-H3E-_\NP3?'V)A&D<P:UW[6V@.WY.)4 1ADC&E3H4*Q RNZ)FZI_DB
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M&5>&UY>).!BX]"X\+8*5+1C%PM5QN5M![+HM'>F3JIF/N$9&BH*QE1W%[I"
MSX_EG^;2.K*,*A\X_E<QTMQ>S-KK)8S:D+N_?R?8[-%M?$)PBI:E0M.G N.<
M@>@9JCB)&$OXT6*_K\HM^,"%93'P^>ON\?'NX6709WW54Q&J"C;88&)-H9@V
MN"XUJ4!?K:6S#*182##3>\E@?VM/Q9%-% VO"0#\/0.P&3+S%+',_*( ZU."
M4)E%V1+F#WY00?_"B$>1&*;L:^?E&":6^%,=E!^C(@4RR2<+;E#S;+=B@?9J
MI=J4-+L4Z,V"'1U*6.RW9B>-IS94!1;.+@^S=(.FE4%J#*<&(,_'D;HPR;GX
MQP>N5*Y6U#U *8%S6EV,HGY4F$Q1A<TSQ\(P78"I,[85=#R5>PFC5"H*'8-O
MVESL(X875PF+SVCZ,X4<4U;":" &F(U;!S:;H>30*'99<XL6=0T2?^8RQ\X5
M%DN]UOE,$+ZY[ZT1,J&\,D:<0^&&6D&SL_#<<9.EV;O4H=FR*?DBW5*Z 7]M
M1E%3#G8>A,3%$)NP'OFC!)G01."<:$"7-5/%M+HD] /3:V#.XVL8W89)KK$'
M7SZK,_K%M'J>+;XHL\5 XL9MGYO5N,[QD&E[KE"!YD)^RP\9('4-VM=D()OK
M7;VNW:S&-6R>5AD7$@'Y43(KN4:\'IWF>J+53]4#]BKDOQ6Y:!!P!JG+B>DH
MSQ:PWN9PEH8KF$.08XY5PGT+RJP;:&UN]$Y00,PE-R4?R<+MZNZ%]IS:5;KU
M54+D@!.$9'X'RWI.AD-5K3NU],6H:5'1&)0@I+8[&O:E7$$W86*>DNH\A7D$
MN69]E_6D4N?N7-F*S'T0&4'4-J&I9_P'ZZ+,T#(T8*WQ(>T:W_H:"Y^EA+.L
MC^+D%1N[W#?MUWJ<:V&F R-@QCL1B9&COF!'QAPJD4"X.]I%NOS1]0.'GT\*
MI<4+WV=A<^.9A&JL$Q94CYGFY';C#_W</IW%HR$75\EV7R*E5O=9:HA6[NZA
MW-&B@GL0&!;<L<J&&&=&P%X:1Z'/D*[<9^)Z:1P6Y=3^3E*46--=!R3,":^X
MQV&[W'>QW)4@OL7*2#<8 LI()+)=I[M$:CIQ8((O$:(RE_23'^+O>%M%-=W,
M2A@N<LX")\.&T?*Y (MVR>^ZMB]?IBS/ID7<\CZ!V[95>G=6I><G";'?S?I^
M<](,QBP:IR%EBMJ%NW5=2^W$2\IV&B-(YP(QTX^=&>"?7Q+J&TPLG?F\$@?L
M*  [D<Y7Q()1M#_3FU<SB[1:]EX80+5@WI(G8UNZ<J>E*[I1BBU2T5ET2^H%
M.\XM5F&6:J2(!LM(/JHX*?E]*S^YL^3GSPRKJ.JK*#,35>DF7+5"D(&/B,H<
M C3+X5=K0KPH%%8)";0YTE99W%KDUAC;!.$_4[:U F+Y'=;[CH31D(+>X5*I
M<-^;9D;+!GZ)+D\AKQYV=T[/5.([[EU3"ZBV-^0]E:ZE0K4STA9&6*.3A'E%
MI(P,DKA@J"V._BA-8 Z,USR-2TUU>AYQH]%RH@5*R]=92JBH:KWT?3OX'FC=
M9:^MNVSK+A^)54B8OWW'^_DJ&NZI  "IRE2';>;5F;K:OF;0:A K>RK3Y3LK
M-5:4ZKM=%8ZXZOU:-;DK$:?F:&)SS:EX7(CAQ2_F%)R:M[YR$9&W.]"MEI<M
M;\5*.ELJ6_5#I /061J%CP^0NZ"*=?EE[F-/IA@LCJP6D*I@R3,%5DN.HE^+
M6FD>>3/_U;(;*RX.1W1'=V/2-\/>FQ$U'V&@@LB:C98*;7PT'JLP8CR,?^9'
M,0G2H"0KR?^.PF9#.FT%U70<1&X9D&"DHJY![RL@^V3IIW%]@D.5;7KW5%M.
M5;1-WYD=ZN)&2]4X0T]"P.M%U17QJ5=8-RW8]9585\5SJ1KKY?L'<G4;C4PO
M^54B)505/5#GNA[Y_V?O39O;1K)TX<\SOP+1;\V]=@2DTFJ[VG7K#94M5VO:
MMCR2W'7[4P=()BFT08"-12KVK[]GS04 %]N2M9@3TV6;)(!$YLF39WG.<[RR
M:+MS[9Y6_O@%$AY62-?(5]\:993#FO==:XD'J,$;U059*)*KPX&AXEE1?$&[
MQ<LE^JXB7-2HQ=10\5R45'RBU[6.64+G/O(ZCN^Q@9MK\:E-!OQ6GVN*7 ?#
MV9/4NYT6<(]4%(\YRL7MKRE:+ 7Z,&F>/?-=>QYKM-71XKA AA=4"WYUDYQ6
M=YQ6&3!8\1'F"S!JWM="B)O #&NJW O><*S%WG1J(:J0CYC@O#CJFQ;*-N1@
M(36,EL?6MT@S)U*%38<D2,=M2,=)D]7<O7C=J7.G0E#IBK?K?VA=2$"B-MI4
M9V@,7D7N%6QVBZ*[IO0&1^FHXS&/<HK+1<<[%EX>A1-NAPC3&=.2%(T:+GGE
M]6A5A'G'8@F-3V>_V-?4"/2 >/W ="KI93(S24@245RP4KF#3&$;7X.9JVP7
M+[\:T_T>R>F[G%3BX_N358P2])/O1>/]'G1C%/8'C_HAYL9I3!]9U5P\N9S9
MH=/:3:D>;H6MHM4*KDO\ )8'Z:G/(H#@EUZ[&OH+.2'X*3=&",&WV[!!?#=L
M$+C@?GO!%00/;<%K43KP\4$2:N4$3QQK8L>?1_I #UF/\6%9[ST>ZRVR.[1F
M<<4DM"@>>KK:>^]^NZP-GZFD/I>RH<O8\)DSM9RT@:?H&VJ7!YK:W-^D-C>I
MS4=R]'[/=";L5%-!.>G1JEB4C*"OT83(JJ+U-5>I:X$Z.\0NU(T7XH';")S*
M]UOIILYK]\"!J,9=)(*MR?8C[9/TV7RNMPX$/GC8)+HV-E)-O\+C22. ]KT#
M4[[[+G01QDS HKXTV8B#&K;_E5>J'0>I4\P+>/\4JR7Q,F.8P_RN+-N;)--A
MNV/#I+/!\7U]P=4RG@^Q_%$]=4#+:).6KJ!#NKN["*'V,J%8GJ@EM$;3<MA,
MD:UW2!Y2JV>\U (MUS6;HI%O+2FM:DR1AHE-I_7ZP4%PHZA,.["QJ2.Y!TNI
MD4"-)L2*)\!GUK7-_\E&Y%(NZ6T2:(FB7%-)W#? [9VR4WLKT2(J!_,3)E*0
M0RYPT-Y)K%I)"'=>OC:N*U0[HDL_V7VYX*<?;+AWG5^_QBCPN5UF_3&J^OX+
M-(VIO_0BOY@^L28YG4 < 'ZUC$L_C'#/O2158,;:&\>4I,+IO(+SX_'9G>36
MG6A $-[\G&S%[\C#<^38-J9/V""&WE0*6://\F9JRJ+AWO4@+[6:UK3/, U
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M,(KEW#NVAIE)R+=T\,H1*+P%E'JLZ0E4B;>1#>QN/U]RZPV$?26$_7 #8=]
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MIU.N7TBGFA5@5]">:([<FHT<NMBOT1.X0.AHYEUG<:EL;P3FFX/,C"6%[*G
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M9R3<R+HQ<1V.*;PH[(C39 +F;S.R\5G+Q8KMHK$#2?"N5FZ*?-D*?A>G]<?
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MAF4MV&^"X4DZ\WIO16%Q@(!G#P-^?2^TOJ!\WJZZ$T$A7-L-"LKOE#[Y>]&
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MC>X\@*#N3W=7?*+FB/0U=9+IVAMO(8N#[2:D?-G:.$AH/RW[M2I#P:$;:;:
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M[/SF,W![2]<[*Q%L7!5HP=:7!=@&'';V(':VG]VKHW>N7^5E0B1$6,C'3\8
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M,&G?K"LA[=CWGE&88\$N08AGB747Q/(O6&LO+F M^)-\N(TROA<=,Z 3/L
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M])/_B=FK">K(OZ8(>EE]-5>R4*[,4B2YRPW5T\"_$<J.T]+-[2%6G)#2MB+
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M$]>&(5 4G?+S^&UL!;D0I'Q8 1)#!2Q^K=Q8>!78HE7E4HR\P2FSZ!@Y&.\
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MUK(GEA,GG(F@CBX"<"'PPA[#*$E6QX4X2H'2FG1' "2BSU'R5.<A%QA98+Y
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M^'%61Q'Z,)OY!+Z#CE@%\Z_]XR<B@'FS^E>@HQXZ=L_2\O.V$%PPVF!?.(Z
MPX?CH@VLC4T!<U-S2YBI.<Q\BX&9&<S2'+;9#%(%E*XK?+8'@@!P7?'+O I:
MUY6^VK  /C=E!:59;,I_QZ^P_"_\"GI_QP_%XLM\ZQ6_SJU:.SO?-YC!?Q?#
M(4!=[DN@O3.@! X#&G(*"#DL']$%_ ZHJZJJ+E!57[! ?8G:0K4ERS35U367
MK=326J:EM7*)NKS-GOY]4UBDIK9(8]%B#8W%WVEH:'PW\Z'QW><A2_YW)@ ?
M $M4@97 826%[P'%)0I*2Q3 ;LA55?") @)".5]!WF9=5H*<FS=?645UP4(U
MA7\*H9@I?1$N!A3F*2@ISE.<KZ*L.E])W0(2+E&:MV:IV?QM^X.TOH\Y8J[\
MW=D;)=O7KEMVX&&PQ>;8WYKM57XXY_KQ[2@*;[G\9NG1]3LRW$(<'N42K%:T
MN+]#?RK[_7$KL6=LI^'Y6\?N7GC2]EYXFU'3_D'D$1IW/#.OO);3*[;>Y1D6
M?^)B?D4=MV]\":"H"*&=)\>DHCS?4@YAC=G2>1""F.^UYIL?.?O=#(*'!YH_
M6JP+?AO[VSE[UV4H_.;1'Y1G *BLMWS4 H'(71'BX&Y%0+_["N%_CL#P+PA@
M)Z"N)+>Y!$  (K/2\I^/FQW==AW0E&1>1XF,<\Z/!5BY6]^+[1S$/,_Y$W7J
MC:S<?(3*"S"#%WAC"@:VM$GI-J=M_5&,9-Z'))*RA52_@)AB3P6!E(#S9A@V
MOR9JP#]LV6"9EF%;L44G:;"^6WQUB)@$ @]'1(@W++?S8@]?=_=LHR0,K;IJ
MV$!A%']F%%]<IA"WWL%;@;V[37Q/,SW/KW(C+'D75[_HT!8[-+,:\7-A\?3!
M*[WNH?Y4S)4^DDX +VYGTX1V! @XXPKTZ0@/4QGM+5=$X;?JM.)AZ-/6YJ5O
M_1E>O?L'[A=T3?=T,''Y?+<I$O*CXP:A^NE[?AZ)EZP]'<ALU%$=&;[A 'VC
M=B>\V9]*6HPLY"K6KV:VJ02/=2:&(24?1%.PX3N/DS5='C_94ODD\ZCX5$<F
MU[ND4:)1S0MNY(. NVFX9.J$R%>C(:9:WQ-E$5N<-1YI?#V$V1IY=6K3E/4(
M"/P. K_EMNXA.:U J)G$=\3^5-\A9!DR1D=?^F6Z)&NL(U&^+[0FZ;L/A30=
M_]3>!P+>]RG"= HID#_NW<]8K:-Y('^IV*-OL61(0GYNTT7>T1!!E@3ZOB[!
MQ6][(.GA#$K&CYV-[\0:YK_NK6I?N+Z60]XA!H'#4[8;.@2) =>:FGV>G!?Q
M>IP*T.](!["!SD_+=(?K[UA-)ZDMB-!\U^EGE^9;R?.&TRNTZ9Z%;T\<MSX4
MY^!J:HV5?O_I-?.D*%Z?'^9:QN\[8%.Y:I70ZY6URN9W6>PQ8ZDM*S2*SF'D
MW)JR'LND.]1*4D3P5P>O#6>D5XGN9D6\OTO>\(/=@I)4ZLL^Y>(%QNL4]&S/
MQ%2G*?NFQ,1&L!K?NZ,"=I#WUT3KHA;Q?,FU2R1EV2A*/VOI\1#$\K*[/I\Z
MD56-X^3.<E<04'&(D^BE7I3\ 0*^]Z\3_#3.XKSZE^EEMU4[P;G.#-:3)<B!
M &XYUZN[2[O/# 0&$%<<D<E]#)I)C,)UQQA38/1"H'X!89JR**'#C8=*SMA8
M0O]^JT^=S:&^ PUL00Y'XTBS^4E*7L@O[NVP8\N6-HKMTI@MW<(<U]4_H1 ]
MQM/2%-\B<HK&R62E0%%R24LU0P,S:GX)?5UE\_,N?RNVC!4X(*AHA;9!X@'L
MC>S+3:,Y+1\O96"BAQZ4-IA='E]XY6-L<%V+9M[XE.^P_\[ _0\>69Y^=CF&
MY5K.]JGE5M9C.Z6[K,E5@W[+XUP\D9+)%@M8:Y;@8[51>9_WCJI;;>:IG+;N
M"[8\H3@Q' 3<8+CI?CY6,LY9J<NJO9]^TO:2 Z&J7>TJ8H^X<U,'""SB?T@D
M-TOGY8,O^F654B^!)S$2 >U2CU=-G1-*K7%VQ:M( 2.A[[RZ0>!V:;XDG4[R
M2$[_/OM'6BAQ=?KH,5'IC>9=>W15E$&@6:3>L.GUT!46@VP^;EXOE/[4$4:9
M[K[8CBR\%['NO%1)=#R'YF\]:$/VX-,M&55UE![;UJ)GN>67+YV)?-G4*B$@
MA*?)$OT7W9[]G/7)*S@\>EQ/$!%^;80BU3B1$MLIF'_1KU>J+1"[C3P7C]";
MP\9 (+^TL"# _-R>Y,/]5TVL=01<CCJWIYJZZ7*)3FHD4)=(-*\H9?-MF.Y8
M2@OL KO'/I?H,_IZ6OW77=RXW:FI,=AP]7@IRW-2\&BI(_)%8$!B<AP>9OAR
MM#M#C*6EGL7[P%/W+L>5@$#]^";!&+M6_V=^1TZ!K4!_3_VA9)TLL3OZYXSR
M_$A4SB"N9*I " )PYD;I#YC'YQR1=%?1"KHH.4-T=&U!\RX7ON[!I]C:FB(K
M#E]M4&I]RZ]6FM_6P9YL<FV[_QY^ P32$ ']IR6TL\W9I\83B;U$'2-<7J]'
MKUVZCMIE+I:6QGX1ARR0+3SVOF!=?F=U1=MK9O-8(ME/<JN7EWWLI,=R#\M;
MIB%<UU7VD7%]G*9> ;V-WDZ9O)R#'-A7G2%C2Z,+6&ND/Q+TLO&77]_(0!\1
M+]\\C/])/S>9&R59UBY!]@[^692S/Z'%<<,X@LIV2[P&]]PC8+MK/VZ#&1D]
M"=6MZ\+:^O"S&D?P.GR/ADC4..O:;9S8KR&"WG8[YZ+,#'ZWY76ZIQ/"L[_D
M06@8O,-69[C+A>?"2^;E>A;PR=9\+O+./?2Z\U/9R?30(%)2?V9/*[';5B6/
MJ?>L036>+4KOH^;T45\W-8* ZK% %^BFZ9;,@#W/.(E%ME^CQK\/1A4S!RM(
M*CQG(T,4 B$,?$/>-I!,.7W/8=UY$  [P"&-=7_E7190WK5ENZ/SO!_DW^^+
M@7^T&9G2T*QL]VQF.'N6CULOEVG\-0)Q^/.H>8ODY$Q&E2"G5WVE]>2SCLGI
M!5_&*7P>M7"6D%.&G_$L!+[F'_*10GE_*6 IUS2:R?O^)AV7]U=#N=F_;4K]
ML_@^SZ@XZX?B5W2?I:I?XP'95OSY\S$KT_N'KK8\;W+\BN-SLYC)4>7HW0$L
M0  BH",2@%)#"+'9;%[YS_8WGGRLQ7]0^-H6_\7'$B,CY4Y!4()Q1&P('AE\
M$/67_ "*8/8%NANT_)$X;-B7:?:B0PE_I[<3<%&SM!S&@;#P6;D<FC(^,@*%
MQGM$[L7/S/^-G?ER&3"S1@"@(B<<=_QM;I6P6!PQ^AN6,BXV(BP"B\82HR!*
MW<%U9A!2SH/H14%$ FX7&HN.#2*@0^3H#T6C9Y47?E:>X<Q('*/"#/X/^*]$
MC(UT<_!R^S;XWW*<\6'H;SC*09$$MZ"P;W@:*#0T#IU <,3O=G/>&XS#1<X(
M5+^POU%>$(Z+3=P6&1'V)5*:GYW?_84]$]T0=&@0,9(PHQZ'CB7\&W6/+^QO
MU=6"P^QQD;C8OP5WR><!VW=]%<S <,%A9\X+"+AH))& 1_\]< LCH4#^"U<]
M&$>  OHO?#5HB</_J2[?54OD7879^\)W<FIFX13EM/H,J?IN-C"'H6,EU(7.
MZP!Y_;9RKEX#YNJUN7IMKEZ;J]?FZK6Y>FVN7OO_M%Z39SMKY-_F[I_S(2B+
M [9!900."(;*"0-@'Q .]0G0@9?WHB$-K?^%A@%@#1@#IL#7NNMSY:(BSZ8@
M&^#;I;O#"81HF(D)%F\<-),C&:-P428)0=$F9L:F)L!61$)T$ J#)A@$HZ$<
MW<YPA,DV-(@(L3/TM'0V=8ZV1X='[$Z,1;LFNKBA$C$HFQ!#!'SA5H1\*B-H
M&J/0B$@".A9O@,:C[+ZW/_#]C#@!!DFBT(0@@X2H2"P>EF!G*!\ @_HS;!-#
M [D* 6-GZ.6\SX  )<N8"(*!N?$68W,C"XM-!J&Q05'H>%PLQL#,V-(0FC(V
M)!1V8,?.V0DARLYPUK'X^'CC> MC7&R8B9F-C8V)J;F)N;D1I&&$/X0E!"48
M8?%K#6?'17A]'?9-/"*\Y.& #"TTD)O: ;D3&Q%-B,!A#8*@$H1@9T@D1H3
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M<U?A+-0O1,J'X2)U6F?&0A*3JUX$KNP$.Z3L ,*%X_\"4$L! A0#%     @
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M2P$"% ,4    "  !@G5;I"9N,7T7  "WCP  #0              @ %_#@$
M97A?.#<Y-3$Q+FAT;5!+ 0(4 Q0    (  &"=5MPTEN]Z(\  #!S P -
M          "  2<F 0!E>%\X.#@V,S0N:'1M4$L! A0#%     @  8)U6UQP
M,(95!   .A4  !$              ( !.K8! &QO9&4M,C R-3 V,S N>'-D
M4$L! A0#%     @  8)U6YZ?/"_B!    2X  !4              ( !OKH!
M &QO9&4M,C R-3 V,S!?9&5F+GAM;%!+ 0(4 Q0    (  &"=5M#?<2_F@@
M $IC   5              "  =._ 0!L;V1E+3(P,C4P-C,P7VQA8BYX;6Q0
M2P$"% ,4    "  !@G5;*W?V1Y8$  #1+@  %0              @ &@R $
M;&]D92TR,#(U,#8S,%]P<F4N>&UL4$L! A0#%     @  8)U6PRK%E-/ @$
M/W\' !,              ( !:<T! &QO9&4R,#(U,3 P-U]S,RYH=&U02P$"
M% ,4    "  !@G5;\]-W4V4=  #N.P  "@              @ 'ISP( ;&]G
M;S R+FIP9U!+ 0(4 Q0    (  &"=5NKFGHPA@P  !T-   *
H  "  7;M @!L;V=O;60N:G!G4$L%!@     -  T &P,  "3Z @    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>lode20251007_s3_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:thunderdome="http://www.RDGFilings.com"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="lode-20250630.xsd" xlink:type="simple"/>
    <context id="d_2025-01-01_2025-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001120970</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <unit id="NonApplicable">
        <measure>thunderdome:item</measure>
    </unit>
    <dei:AmendmentFlag contextRef="d_2025-01-01_2025-06-30" id="ixv-3467">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="d_2025-01-01_2025-06-30" id="ixv-3468">0001120970</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="d_2025-01-01_2025-06-30" id="c3">S-3</dei:DocumentType>
    <dei:EntityRegistrantName contextRef="d_2025-01-01_2025-06-30" id="c4">COMSTOCK INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="d_2025-01-01_2025-06-30" id="c5">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="d_2025-01-01_2025-06-30" id="c6">65-0955118</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="d_2025-01-01_2025-06-30" id="c7">117 American Flat Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="d_2025-01-01_2025-06-30" id="c8">Virginia City</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="d_2025-01-01_2025-06-30" id="c9">NV</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="d_2025-01-01_2025-06-30" id="c10">89440</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="d_2025-01-01_2025-06-30" id="c11">775</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="d_2025-01-01_2025-06-30" id="c12">847-5272</dei:LocalPhoneNumber>
    <dei:EntityFilerCategory contextRef="d_2025-01-01_2025-06-30" id="c13">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="d_2025-01-01_2025-06-30" id="c14">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="d_2025-01-01_2025-06-30" id="c15">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>ex_869180_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
      xlink:type="simple"/>
    <context id="rc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001120970</identifier>
        </entity>
        <period>
            <startDate>2025-11-21</startDate>
            <endDate>2025-11-21</endDate>
        </period>
    </context>
    <context id="offrl_1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001120970</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-21</startDate>
            <endDate>2025-11-21</endDate>
        </period>
    </context>
    <context id="offrl_2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001120970</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>2</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-21</startDate>
            <endDate>2025-11-21</endDate>
        </period>
    </context>
    <context id="offrl_3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001120970</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>3</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-21</startDate>
            <endDate>2025-11-21</endDate>
        </period>
    </context>
    <context id="offrl_4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001120970</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>4</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-21</startDate>
            <endDate>2025-11-21</endDate>
        </period>
    </context>
    <context id="offrl_5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001120970</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>5</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-21</startDate>
            <endDate>2025-11-21</endDate>
        </period>
    </context>
    <context id="offrl_6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001120970</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>6</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-21</startDate>
            <endDate>2025-11-21</endDate>
        </period>
    </context>
    <context id="offrl_7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001120970</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>7</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-21</startDate>
            <endDate>2025-11-21</endDate>
        </period>
    </context>
    <context id="offrl_8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001120970</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>8</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-21</startDate>
            <endDate>2025-11-21</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <ffd:FormTp contextRef="rc" id="ixv-449">S-3</ffd:FormTp>
    <ffd:SubmissnTp contextRef="rc" id="ixv-450">S-3</ffd:SubmissnTp>
    <ffd:FeeExhibitTp contextRef="rc" id="ixv-451">EX-FILING FEES</ffd:FeeExhibitTp>
    <dei:EntityCentralIndexKey contextRef="rc" id="ixv-452">0001120970</dei:EntityCentralIndexKey>
    <dei:EntityRegistrantName contextRef="rc" id="ixv-453">Comstock Inc.</dei:EntityRegistrantName>
    <ffd:OfferingTableNa contextRef="rc" id="hiddenrcOfferingTableNa" xsi:nil="true"/>
    <ffd:OffsetTableNa contextRef="rc" id="hiddenrcOffsetTableNa">N/A</ffd:OffsetTableNa>
    <ffd:CombinedProspectusTableNa contextRef="rc" id="hiddenrcCombinedProspectusTableNa">N/A</ffd:CombinedProspectusTableNa>
    <ffd:FeeRate
      contextRef="offrl_7"
      decimals="INF"
      id="ixv-457"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FormTp contextRef="rc" id="ixv-545">S-3</ffd:FormTp>
    <dei:EntityRegistrantName contextRef="rc" id="ixv-546">Comstock Inc.</dei:EntityRegistrantName>
    <ffd:PrevslyPdFlg contextRef="offrl_1" id="ixv-547">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="offrl_1" id="ixv-548">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="offrl_1" id="ixv-549">Common stock, $0.000666 per share</ffd:OfferingSctyTitl>
    <ffd:Rule457oFlg contextRef="offrl_1" id="ixv-550">true</ffd:Rule457oFlg>
    <ffd:MaxOfferingPricPerScty
      contextRef="offrl_1"
      decimals="INF"
      id="ixv-551"
      unitRef="USD">0.00</ffd:MaxOfferingPricPerScty>
    <ffd:MaxAggtOfferingPric
      contextRef="offrl_1"
      decimals="INF"
      id="ixv-552"
      unitRef="USD">0.00</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="offrl_1"
      decimals="INF"
      id="ixv-553"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="offrl_1"
      decimals="INF"
      id="ixv-554"
      unitRef="USD">0.00</ffd:FeeAmt>
    <ffd:PrevslyPdFlg contextRef="offrl_2" id="ixv-555">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="offrl_2" id="ixv-556">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="offrl_2" id="ixv-557">Preferred stock, $0.000666 per share</ffd:OfferingSctyTitl>
    <ffd:Rule457oFlg contextRef="offrl_2" id="ixv-558">true</ffd:Rule457oFlg>
    <ffd:MaxAggtOfferingPric
      contextRef="offrl_2"
      decimals="INF"
      id="ixv-559"
      unitRef="USD">0.00</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="offrl_2"
      decimals="INF"
      id="ixv-560"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="offrl_2"
      decimals="INF"
      id="ixv-561"
      unitRef="USD">0.00</ffd:FeeAmt>
    <ffd:PrevslyPdFlg contextRef="offrl_3" id="ixv-562">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="offrl_3" id="ixv-563">Debt</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="offrl_3" id="ixv-564">Debt securities</ffd:OfferingSctyTitl>
    <ffd:Rule457oFlg contextRef="offrl_3" id="ixv-565">true</ffd:Rule457oFlg>
    <ffd:MaxAggtOfferingPric
      contextRef="offrl_3"
      decimals="INF"
      id="ixv-566"
      unitRef="USD">0.00</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="offrl_3"
      decimals="INF"
      id="ixv-567"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="offrl_3"
      decimals="INF"
      id="ixv-568"
      unitRef="USD">0.00</ffd:FeeAmt>
    <ffd:PrevslyPdFlg contextRef="offrl_4" id="ixv-569">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="offrl_4" id="ixv-570">Other</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="offrl_4" id="ixv-571">Rights</ffd:OfferingSctyTitl>
    <ffd:Rule457oFlg contextRef="offrl_4" id="ixv-572">true</ffd:Rule457oFlg>
    <ffd:MaxAggtOfferingPric
      contextRef="offrl_4"
      decimals="INF"
      id="ixv-573"
      unitRef="USD">0.00</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="offrl_4"
      decimals="INF"
      id="ixv-574"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="offrl_4"
      decimals="INF"
      id="ixv-575"
      unitRef="USD">0.00</ffd:FeeAmt>
    <ffd:PrevslyPdFlg contextRef="offrl_5" id="ixv-576">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="offrl_5" id="ixv-577">Other</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="offrl_5" id="ixv-578">Units</ffd:OfferingSctyTitl>
    <ffd:Rule457oFlg contextRef="offrl_5" id="ixv-579">true</ffd:Rule457oFlg>
    <ffd:MaxAggtOfferingPric
      contextRef="offrl_5"
      decimals="INF"
      id="ixv-580"
      unitRef="USD">0.00</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="offrl_5"
      decimals="INF"
      id="ixv-581"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="offrl_5"
      decimals="INF"
      id="ixv-582"
      unitRef="USD">0.00</ffd:FeeAmt>
    <ffd:PrevslyPdFlg contextRef="offrl_6" id="ixv-583">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="offrl_6" id="ixv-584">Other</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="offrl_6" id="ixv-585">Warrants</ffd:OfferingSctyTitl>
    <ffd:Rule457oFlg contextRef="offrl_6" id="ixv-586">true</ffd:Rule457oFlg>
    <ffd:MaxAggtOfferingPric
      contextRef="offrl_6"
      decimals="INF"
      id="ixv-587"
      unitRef="USD">0.00</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="offrl_6"
      decimals="INF"
      id="ixv-588"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="offrl_6"
      decimals="INF"
      id="ixv-589"
      unitRef="USD">0.00</ffd:FeeAmt>
    <ffd:OfferingSctyTp contextRef="offrl_7" id="ixv-590">Other</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="offrl_7" id="ixv-591">Unallocated (Universal) Shelf</ffd:OfferingSctyTitl>
    <ffd:Rule457oFlg contextRef="offrl_7" id="ixv-592">true</ffd:Rule457oFlg>
    <ffd:PrevslyPdFlg contextRef="offrl_8" id="ixv-593">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="offrl_8" id="ixv-594">Unallocated (Universal) Shelf</ffd:OfferingSctyTp>
    <ffd:Rule457oFlg contextRef="offrl_8" id="ixv-595">true</ffd:Rule457oFlg>
    <ffd:MaxAggtOfferingPric
      contextRef="offrl_8"
      decimals="INF"
      id="ixv-596"
      unitRef="USD">200000000.00</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="offrl_8"
      decimals="INF"
      id="ixv-597"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="offrl_8"
      decimals="INF"
      id="ixv-598"
      unitRef="USD">27620.00</ffd:FeeAmt>
    <ffd:TtlOfferingAmt contextRef="rc" decimals="INF" id="ixv-599" unitRef="USD">200000000.00</ffd:TtlOfferingAmt>
    <ffd:TtlFeeAmt contextRef="rc" decimals="INF" id="ixv-600" unitRef="USD">27620.00</ffd:TtlFeeAmt>
    <ffd:TtlPrevslyPdAmt contextRef="rc" decimals="INF" id="ixv-601" unitRef="USD">0.00</ffd:TtlPrevslyPdAmt>
    <ffd:TtlOffsetAmt contextRef="rc" decimals="INF" id="ixv-602" unitRef="USD">0.00</ffd:TtlOffsetAmt>
    <ffd:NetFeeAmt contextRef="rc" decimals="INF" id="ixv-603" unitRef="USD">27620.00</ffd:NetFeeAmt>
    <ffd:OfferingNote contextRef="offrl_8" id="ixv-604">(1) We are registering under this registration statement such indeterminate number of shares of common stock and preferred stock, such indeterminate principal amount of debt securities, such indeterminate number of warrants to purchase common stock, preferred stock and/or debt securities, such indeterminate number of units and such indeterminate number of rights, as may be sold by the registrant from time to time, which together shall have an aggregate initial offering price not to exceed $200,000,000. If we issue any debt securities at an original issue discount, then the offering price of such debt securities shall be in such greater principal amount at maturity as shall result in an aggregate offering price not to exceed $200,000,000, less the aggregate dollar amount of all securities previously issued hereunder. We may sell any securities we are registering under this registration statement separately or as units with the other securities we are registering under this registration statement. We will determine, from time to time, the proposed maximum offering price per unit in connection with our issuance of the securities we are registering under this registration statement. The securities we are registering under this registration statement also include such indeterminate number of shares of common stock and preferred stock and amount of debt securities as we may issue upon conversion of or exchange for preferred stock or debt securities that provide for conversion or exchange, upon exercise of warrants or rights or pursuant to the antidilution provisions of any of such securities. In addition, pursuant to Rule 416 under the Securities Act of 1933, as amended (the "Securities Act"), the shares we are registering under this registration statement include such indeterminate number of shares of common stock and preferred stock as may be issuable with respect to the shares we are registering as a result of stock splits, stock dividends or similar transactions. (2) We will determine the proposed maximum aggregate offering price per class of security from time to time in connection with our issuance of the securities we are registering under this registration statement and we are not specifying such price as to each class of security pursuant to General Instruction II.D. of Form S-3 under the Securities Act. (3) Registration fee calculated pursuant to Rule 457(o) under the Securities Act, based on aggregated indeterminate number of securities to be sold by the registrant.</ffd:OfferingNote>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
